cl_id,name,EC_No,CAS_No,cl_classification,sourse,num_of_notifiers,ghs_and_notifiers
100731,"Tris(pentane-2,4-dionato-O,O')gallium",238-377-0,14405-43-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,40,H315:40;H302:40;H335:39;H319:40;H351:38;H332:40;H312:39
100732,"L-Tyrosine, O-(1,1-dimethylethyl)-",606-132-0,18822-59-8,Not Classified,Notified C&L,2,Not classified:2
100733,Tetrabutylammonium hydrogen sulphate,251-068-5,32503-27-8,Acute Tox. 4;Skin Corr. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,294,H412:102;H318:101;H314:105;H302:248;H319:188;H315:180;H335:137;Not classified:3;H332:1;H312:1
100735,"Banana, Musa balbisiana, ext.",306-509-7,97281-11-3,Flam. Liq. 2,Notified C&L,1,H225:1
100758,Sodium 4-vinylbenzenesulphonate,220-266-3,2695-37-6,Skin Irrit. 2;Eye Irrit. 2A,REACH registration C&L,489,H319:449;H315:487;H318:38;H302:38;H335:43;Not classified:2
100761,"reaction mass of: 1-(1,1-dimethylpropyl)-4-ethoxy-cis-cyclohexane;1-(1,1-dimethylpropyl)-4-ethoxy-trans-cyclohexane",426-530-6,,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H315:0;H400:0;H410:0
100762,"dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-3-(4-methoxybenzoyl)acetamido)-4-chlorobenzoate",403-990-6,70950-45-7,Aquatic Chronic 4,Harmonised C&L,0,H413:0
100763,4-chloro-N-cyclopentylbenzylamine,266-097-9,66063-15-8,Acute Tox. 4;Acute Tox. 1;Skin Irrit. 2;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H315:1;H302:1;H331:1;H400:1;H311:1;H410:1
100765,"4H-1-Benzopyran-4-one, 6-β-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-",609-600-2,38953-85-4,Not Classified,Notified C&L,4,Not classified:3;H319:1;H315:1;H335:1
100768,Sodium amide,231-971-0,7782-92-5,Water-react. 1;Skin Corr. 1A;Aquatic Acute 1,REACH registration C&L,192,H260:18;H314:192;H400:170;H318:53;H261:119;Not classified:2
100769,Hexyl D-glucoside,259-217-6,54549-24-5,Eye Dam. 1,REACH registration C&L,106,H318:106
100772,"benzene-1,4-diamine dihydrochloride;p-phenylenediamine dihydrochloride",210-834-9,624-18-0,Acute Tox. 3;Acute Tox. 3;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H301:0;H319:0;H331:0;H400:0;H317:0;H311:0;H410:0
100774,"Musks, ext.",290-070-0,90064-09-8,Flam. Liq. 2,Notified C&L,88,H225:88
100777,"Benzenesulfonic acid, 2-methyl-5-nitro-, alkaline condition products, reduced",215-392-0,1325-35-5,Not Classified,Notified C&L,60,Not classified:60
100779,Dicyclohexyl disulphide,219-851-6,2550-40-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,128,H319:127;H315:127;H335:127;Not classified:1
100781,"Reaction mass of (1RS,6SR,11SR)-2,2,9,11-tetramethylspiro[5.5]undec-8-en-1-yl and (1RS,6RS,11RS)-2,2,9,11-tetramethylspiro[5.5]undec-8-en-1-ylacetate",457-350-6,744266-61-3,Skin Sens. 1B,Notified C&L,38,H317:38
100783,"Gases (petroleum), dry sour, gas-concn.-unit-off;Refinery gas;[The complex combination of dry gases from a gas concentration unit. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]",270-774-4,68477-92-9,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;Not classified:0;H340:0
100788,N-(2-ethylphenyl)-3-hydroxynaphthalene-2-carboxamide,272-795-4,68911-98-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
100789,Ergosine,209-226-6,561-94-4,Acute Tox. 3,Notified C&L,39,H301:38;H302:1;H361:1;H362:1;H332:1;H312:1
100793,"2,3,4-trimethylthiophene",217-268-1,1795-04-6,Flam. Liq. 3,Notified C&L,1,H226:1
100796,2-(ethylammonio)-N-methylpyridinium dimethanesulphonate,259-377-7,54856-23-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
100800,4-hydroxyphenylarsonic acid,202-641-3,98-14-6,Acute Tox. 3;Acute Tox. 3;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H301:1;H350:1;H331:1;H400:1;H410:1
100803,(3S)-1-azabicyclo[2.2.2]octan-3-amine dihydrochloride,601-641-4,119904-90-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:42
100804,"1-bromo-3,4,5-trifluorobenzene",418-480-9,138526-69-9,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1;Carc. 2;Aquatic Chronic 2,Harmonised C&L,0,H318:0;H315:0;H226:0;H351:0;H411:0
100808,2-chloroacetamidine monohydrochloride,233-675-7,10300-69-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:39;H315:39;H335:39;H314:5;H317:5;H302:1;H332:1;H312:1;H318:1
100815,"thiofanox (ISO);3,3-dimethyl-1-(methylthio)butanone-O-(N-methylcarbamoyl)oxime",254-346-4,39196-18-4,Acute Tox. 2;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H300:0;H400:0;H310:0;H410:0
100816,Bornyl isovalerate,261-849-2,59672-05-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
100817,"2,4,6-tribromoresorcinol",219-442-2,2437-49-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
100818,Triisopropylamine,222-317-5,3424-21-3,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H302:39;H335:39;H225:38;H319:39;H332:1;H312:1
100820,(Z)-tetradec-9-enyl acetate,240-780-1,16725-53-4,Aquatic Chronic 4,Notified C&L,79,H413:40;Not classified:34;H411:5;H315:6;H319:1;H335:1
100822,"Propanoic acid, 2-(acetyloxy)-, ethyl ester",608-421-7,2985-28-6,,Notified C&L,1,Not classified:1
100824,"Alcohols, C9-11",266-367-6,66455-17-2,Not Classified,Notified C&L,753,Not classified:698;H411:33;H304:20;H400:20;H410:21;H318:1;H302:1;H315:1
100825,N-acetylglutamic acid,214-708-4,1188-37-0,Not Classified,REACH registration C&L,14,Not classified:14
100827,2-(4-methylthiazol-5-yl)ethanol,205-272-6,137-00-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,421,H319:96;H315:96;H335:95;Not classified:324;H302:1
100828,safrole,616-892-5,8006-80-2,Acute Tox. 4;Skin Irrit. 2,Notified C&L,103,H315:38;H302:67;Not classified:36;H350:29
100830,Dimethylphosphoramidic dichloride,211-641-2,677-43-0,Skin Corr. 1B,Notified C&L,45,H314:45;H318:1;H335:1
100833,Dirhodium trisulphate,234-014-5,10489-46-0,Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,57,H318:13;H290:13;H314:17;H400:2;H410:2;H341:3;H319:40;H315:40;H335:40;H271:1;H302:1;H332:1;H312:1
100836,"Alcohols, C14-18",267-009-1,67762-30-5,Not Classified,Notified C&L,755,Not classified:755
100846,2-methoxyphenethyl alcohol,231-029-9,7417-18-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H315:1;H335:1;Not classified:1
100850,"α, α,α,4-tetrachlorotoluene;p-chlorobenzotrichloride",226-009-1,5216-25-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;STOT SE 3;Carc. 1B;STOT RE 1;Repr. 2,Harmonised C&L,0,H372:0;H315:0;H302:0;H335:0;H361:0;H350:0;H312:0
100852,"1-Oxa-6-azacyclopentadecan-15-one, 13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-.beta.-D-xylo-hexopyranosyl]oxy]-, (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-",617-500-5,83905-01-5,Skin Sens. 1;Resp. Sens. 1,Notified C&L,122,H334:119;H317:120;H372:35;H400:35;H410:35;H373:2;H413:1;H319:1;H315:1;H335:1;H302:1
100854,Pentyl chloroformate,211-336-4,638-41-5,Flam. Liq. 3;Skin Corr. 1B;Acute Tox. 3,REACH registration C&L,81,H331:2;H314:80;H226:81;H290:39;H302:40;H330:39;H318:1;H312:1;H332:1;H310:1;H300:1
100855,"Chromate(1-), bis[4-[[1-(3-chlorophenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl]azo]-3-hydroxy-N-methylbenzenesulfonamido(2-)]-, compds. with N-cyclohexylcyclohexanamine and 2-ethyl-1-hexanamine",275-167-8,71076-98-7,Not Classified,Notified C&L,2037,Not classified:2037
100857,Cyclizine,201-445-5,82-92-8,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H301:38;H315:38;H319:38;H335:38;H361:1
100859,3-methyloxazolidin-2-one,243-361-1,19836-78-3,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,177,H400:89;H410:89;H318:83;Not classified:5
100862,(2-Butyl-5-nitro-1-benzofuran-3-yl)(4-hydroxyphenyl)methanone,464-300-7,,Aquatic Chronic 1,Notified C&L,2,H410:2;H400:1
100868,Bis(2-ethylhexyl) azelate,203-091-7,103-24-2,Not Classified,REACH registration C&L,76,Not classified:76
100870,2-chloro-p-phenylenediamine,210-441-2,615-66-7,Acute Tox. 4;Skin Sens. 1,REACH registration C&L,36,H302:36;H317:2;H319:33;H315:33;H335:31;H332:1;H312:1
100871,7-chloro-3-methyl-quinoline-8-carboxylic acid,618-627-9,90717-03-6,Aquatic Chronic 3,Notified C&L,160,H412:156;Not classified:4
100872,"Dodecylbenzenesulphonic acid, compound with 2,2',2''-nitrilotriethanol (1:1)",248-406-9,27323-41-7,Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,754,H412:157;H318:335;H314:156;H319:308;H315:513;H301:84;H302:141;Not classified:66;H335:30;H312:1;H334:1;H317:1
100875,1-bromo-4-(methylamino)anthraquinone,204-920-5,128-93-8,,Notified C&L,35,Not classified:33;H413:2;H319:1;H315:1;H335:1
100876,Triethyl phosphite,204-552-5,122-52-1,Flam. Liq. 3,REACH registration C&L,265,H226:255;H412:154;H317:187;H302:178;H315:56;H335:53;H319:61;H332:57;H312:12;Not classified:2;H413:2;H361:1;H371:1
100880,S-(acetamidomethyl)-L-cysteine monohydrochloride,249-230-5,28798-28-9,Not Classified,Notified C&L,1,Not classified:1
100884,"Amines, bis(hydrogenated rape oilalkyl)methyl, N-oxides",440-250-1,,Aquatic Chronic 4,Notified C&L,3,H413:3
100886,Zirconium(IV) ethoxide,605-975-1,18267-08-8,Flam. Sol. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H228:43;H335:44
100889,6-Methoxy-2-naphthoic Acid,607-425-6,2471-70-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:45;H315:45;H335:44;H302:1
100890,Hydratropic acid,207-752-0,492-37-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:49;H315:49;H335:43
100892,p-ethylphenetole,216-438-2,1585-06-4,Not Classified,Notified C&L,88,Not classified:88
100893,"Residual oils (petroleum), solvent-dewaxed;Baseoil - unspecified;[A complex combination of hydrocarbons obtained by removal of long, branched chain hydrocarbons from a residual oil by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly greater than C",265-166-0,64742-62-7,Carc. 1B,Harmonised C&L,0,H350:0
100899,"Fatty acids, C16-18 and C18-unsatd., distn. residues",274-561-7,70321-71-0,Not Classified,Notified C&L,1,Not classified:1
100901,"(1E)-1,3-dichloroprop-1-ene",431-460-4,10061-02-6,Flam. Liq. 3;Acute Tox. 3;Asp. Tox. 1;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,2,H315:2;H226:2;H335:2;H301:2;H304:2;H319:2;H332:2;H311:2;H317:2;H410:2
100902,Nitrazepam,205-665-2,146-22-5,Acute Tox. 4,Notified C&L,46,H302:46;H341:1;H362:1;H336:1;H361:1
100904,Young Living Blue Tansy Essential Oil,640-019-7,8016-87-3,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,26,H412:25;H302:25;H319:1;H226:1
100905,"2,4,5-trimethylthiazole",237-107-9,13623-11-5,Acute Tox. 4,Notified C&L,1450,H302:1415;H318:49;H315:58;H226:69;H335:57;H319:9
100908,"Naphthenic acids, molybdate complexes",276-612-9,72379-29-4,,Notified C&L,1,Not classified:1
100912,"Propanenitrile, 3-[[4-[2-(4-nitrophenyl)diazenyl]phenyl](2-phenylethyl)amino]-",607-377-6,244291-57-4,Not Classified,Notified C&L,3,Not classified:3
100919,"2-Propenoic acid, 2-ethylhexyl ester, polymer with ethenylbenzene",607-573-1,25153-46-2,Not Classified,Notified C&L,6,Not classified:6
100920,"1-bromo-4-(1,1,2,2-tetrafluoroethoxy)benzene",272-431-4,68834-05-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39;H302:1;H332:1;H312:1
100921,2-oxoheptanedioic acid,241-191-2,17126-90-8,Acute Tox. 4,Notified C&L,39,H302:38;H319:1;H315:1;H335:1
100924,"1H-Imidazole-1-ethanamine, 4,5-dihydro-, 2-(C7-17 and C7-17-unsatd. alkyl) derivs.",291-471-3,90411-92-0,Skin Corr. 1A;Eye Dam. 1;STOT SE 2;STOT SE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,24,H318:21;H314:21;H371:21;H400:21;H410:21;Not classified:3
100925,"Formic acid, compd. with hydrazinecarboximidamide (1:1)",600-530-8,104188-36-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
100931,Reactive BROWN DER 8589,434-540-7,,Not Classified,Notified C&L,1,Not classified:1
100934,2-Cyanobenzeneboronic acid,604-090-8,138642-62-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H315:48;H335:47;H302:7;H332:1;H312:1
100935,"4-(ethoxycarbonyl)-3,5-dimethoxybenzoic acid",279-663-5,81028-93-5,Eye Irrit. 2,Notified C&L,38,H319:38
100936,"Alpha,4-dichloro-2-nitrotoluene",213-345-9,938-71-6,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H314:38;H335:38
100944,"Fatty acids, C16-18, barium salts",292-883-6,91002-07-2,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,16,H332:11;H302:16
100953,2-methylpiperidine-1-propanol,202-372-1,94-88-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
100958,Disodium C-[2-[2-[2-(dodecyloxy)ethoxy]ethoxy]ethyl] sulphonatosuccinate,255-623-2,42016-08-0,Not Classified,Notified C&L,1,Not classified:1
100960,"L-Ornithine, N5-[[[(2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl]amino]iminomethyl]-",606-419-0,200115-86-2,Not Classified,Notified C&L,1,Not classified:1
100971,"Cola (genus), ext.",272-824-0,68916-19-8,Flam. Liq. 2,Notified C&L,1377,H225:1290;Not classified:87
100972,N-methylatropinium bromide,220-700-1,2870-71-5,Acute Tox. 4,Notified C&L,38,H302:38
100978,"N-{2-[(4,6-dimethoxy-1,3,5-triazin-2-yl)carbonyl]-6-fluorophenyl}-1,1-difluoro-N-methylmethanesulfonamide",620-056-5,874195-61-6,STOT RE 2;Aquatic Chronic 1,Notified C&L,1,H373:1;H410:1
100980,malononitrile,203-703-2,109-77-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H301:0;H331:0;H400:0;H311:0;H410:0
100986,Ethyl hydrogen sulphate,208-758-6,540-82-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,42,H318:38;H315:38;Not classified:4
100989,"reaction mass of: 1,7-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane;2,3-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane",427-040-5,,Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H314:0;H400:0;H410:0
100990,"4,4'-dichloro-α-phenylbenzylic alcohol",202-029-6,90-97-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
100996,4-bromo-3-chloroaniline,244-370-3,21402-26-6,Acute Tox. 4,Notified C&L,46,H302:46;H373:6;H332:8;H311:4;H312:4;H315:1;H319:1
100997,Ethylbenzenesulphonic acid,260-690-6,57352-34-8,Not Classified,REACH registration C&L,2,Not classified:2
100999,trans-4-(trans-4-(4-Methylphenyl)-cyclohexyl)-cyclohexancarbaldehyde,605-043-4,156140-04-4,Not Classified,REACH registration C&L,2,Not classified:2
101001,Cyclododecene,216-117-7,1501-82-2,Asp. Tox. 1,REACH registration C&L,27,H304:2;H315:25
101007,"2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11-icosafluoroundecanoic acid",217-184-5,1765-48-6,,Notified C&L,5,H314:5;H302:5
101012,"dithianon (ISO);5,10-dihydro-5,10-dioxonaphtho(2,3-b)(1,4)dithiazine-2,3-dicarbonitrile",222-098-6,3347-22-6,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H302:0;H410:0
101013,"Nitramide, N-nitro-, ammonium salt (1:1)",604-184-9,140456-78-6,Expl. 1.1;Flam. Sol. 2;Acute Tox. 4;STOT SE 2,Notified C&L,1,H371:1;H201:1;H228:1;H302:1
101015,"4,4,5,5-tetrachloro-1,3-dioxolan-2-one",404-060-2,22432-68-4,Acute Tox. 4;Skin Corr. 1B;Acute Tox. 2,Harmonised C&L,0,H330:0;H314:0;H302:0
101017,"(2α,4aα,8β)-hexahydro-1,1,5,5-tetramethyl-2H-2,4a-methanonaphthalen-8(5H)-one",249-648-8,29461-13-0,Not Classified,Notified C&L,234,Not classified:234
101022,"7a-ethyldihydro-1H,3H,5H-oxazolo[3,4-c]oxazole",231-810-4,7747-35-5,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,740,H318:142;H315:732;H412:570;H332:699;H317:696;H319:590;H312:147;H411:45;H335:74;H334:36;H400:25;H410:25;Not classified:5
101023,Chlorodiphenylphosphine,214-093-2,1079-66-9,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,332,H318:303;H290:262;H302:275;H412:262;H314:331;Not classified:3;H312:1;H332:1;H330:1;H411:2;H335:1
101026,2-methylimidazole,211-765-7,693-98-1,Repr. 1B,Harmonised C&L,0,H360:0
101027,"α-cyano-4-fluoro-3-phenoxybenzyl 3-[2-chloro-2-(4-chlorophenyl)vinyl]-2,2-dimethylcyclopropanecarboxylate",274-110-4,69770-45-2,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 3,Notified C&L,100,H315:41;H301:65;H319:76;H331:38;H317:41;H311:41;H370:35;H372:35;H360:35;H310:35;H300:35;H410:59;H330:27;H335:24;H400:24
101030,Barium cyanide,208-822-3,542-62-1,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H330:38;H310:38;H300:38;H400:38;H410:38
101031,Cadmium dipotassium tetracyanide,238-371-8,14402-75-6,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,15,H330:14;H310:14;H350:14;H300:14;H400:14;H410:14;H301:1;H331:1;H311:1
101038,"2,3,5,6-tetrahydro-2-methylphthalic anhydride",255-853-3,42498-58-8,Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0,H318:0;H334:0;H317:0
101039,"9,12-octadecadienoic acid (Z,Z)-, dimer, polymer with (chloromethyl)oxirane, 4,4''-(1-methylethylidene)bis[ph enol] and 2-propenoic acid, nonanoate",614-904-3,69029-35-2,Skin Sens. 1,Notified C&L,99,H317:99;H315:1;H335:1;H319:1;H400:1;H410:1
101040,(Z)-3-(9-octadecenylamino)propiononitrile,247-628-3,26351-32-6,Skin Corr. 1B;Aquatic Chronic 1,REACH registration C&L,38,H314:38;H410:38;H400:2
101041,"Oxytocin, monoacetate (salt)",228-347-5,6233-83-6,Acute Tox. 4;Repr. 1A;Aquatic Chronic 4,Notified C&L,52,H413:35;H360:52;H302:35;H301:17;H331:17;H317:17;H334:17
101043,Sodium 4-(3-hydroxy-5-methyl-4-phenylazopyrazol-2-yl)benzenesulphonate,228-808-0,6359-82-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:40;H315:38;H302:38;H335:38;Not classified:2
101050,"Astragalus membranaceus, ext.",303-391-9,94166-93-5,Not Classified,Notified C&L,1,Not classified:1
101062,2-butyl-3-(4-hydroxybenzoyl)-5-nitro-benzofuran,604-244-4,141645-16-1,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,38,H400:2;H410:36;Not classified:1;H371:1
101065,Diisodecyl phenyl phosphate,257-153-3,51363-64-5,Not Classified,Notified C&L,19,Not classified:18;H315:1;H330:1;H335:1;H319:1;H317:1
101066,"Octadecanoic acid, ester with 2,2'-[oxybis(methylene)]bis[2-(hydroxymethyl)-1,3-propanediol]",266-404-6,66555-11-1,Not Classified,Notified C&L,25,Not classified:25
101067,"Wool wax, bisulfited, sodium salt",296-082-2,92202-47-6,Skin Irrit. 2,Notified C&L,29,H315:28;Not classified:1
101068,2-Methyl-1-propanol potassium salt,604-594-8,14764-60-4,Self-heat. 1;Skin Corr. 1B,Notified C&L,38,H251:38;H314:38
101075,2-mercaptoethanesulphonic acid,222-167-0,3375-50-6,Skin Corr. 1B,Notified C&L,38,H314:38
101077,Diethoxyphosphorylmethyl 4-methylphenylsulfonate,437-680-7,,Aquatic Chronic 2,REACH registration C&L,1,H411:1
101078,Ammonium hydrogencarbonate,213-911-5,1066-33-7,Acute Tox. 4,REACH registration C&L,482,H302:474;H412:40;Not classified:8;H319:4;H400:3;H411:2;H315:1;H335:1;H332:1
101080,"2-amino-5-ethyl-1,3,4-thiadiazole",237-921-4,14068-53-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,199,H319:199;H315:199;H335:199
101084,"Mucuna pruriens, ext.",290-071-6,90064-10-1,Repr. 2,Notified C&L,2,H361:1;H319:1;H315:1;H302:1;H335:1
101087,"Sophora japonica, ext.",290-329-8,90131-19-4,Acute Tox. 3,Notified C&L,1,H301:1
101088,Bis(pentafluorophenyl)methanol,217-185-0,1766-76-3,,Notified C&L,6,H319:6;H315:6;H335:6
101089,Iron(3+) ethanolate,225-760-2,5058-42-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:43;H228:5
101090,"Boron, (benzenemethanamine)trifluoro-, (T-4)-, reaction products with Bu glycidyl ether",270-821-9,68478-46-6,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,24,H412:2;H318:1;H314:2;H302:2;Not classified:22
101094,4-methoxybutan-2-one-dimethylacetal,229-555-9,6607-66-5,Flam. Liq. 3,Notified C&L,38,H226:38
101096,Mebeverine hydrochloride,220-400-0,2753-45-9,Acute Tox. 4,Notified C&L,87,H302:87;H318:42;H410:42
101098,Tolbutamide,200-594-3,64-77-7,,Notified C&L,7,H317:4;H302:2;H370:1;H361:1
101100,Lithium D-gluconate,262-443-8,60816-70-8,Acute Tox. 4,Notified C&L,3,H302:3
101102,Anthracene,204-371-1,120-12-7,Not Classified,REACH registration C&L,464,Not classified:7;H319:451;H400:11;H317:9;H410:16;H315:11;H335:9;H351:1
101104,"Siloxanes and Silicones, polyoxyalkylene-",617-987-4,87244-72-2,Not Classified,Notified C&L,68,Not classified:68
101106,3-Methyl-4-(4-trifluoromethylsulfanyl-phenoxy)-phenylamine oxalate,929-675-8,,Acute Tox. 4,REACH registration C&L,2,H302:2
101110,"2,2-dimethylpropane-1,3-diyl cyclohex-4-ene-1,2-dicarboxylate",255-180-5,41026-17-9,Skin Sens. 1;Eye Irrit. 2A,REACH registration C&L,6,H319:6;H317:6
101111,"2,3,6-trichlorobenzaldehyde",225-104-5,4659-47-6,Skin Corr. 1B,Notified C&L,40,H314:39;H319:1;H315:1
101113,4-benzylpiperidine,250-535-0,31252-42-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:40
101123,Phenylphosphonic acid,216-388-1,1571-33-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,96,H318:30;H315:23;H302:88;H314:72;H335:1;Not classified:1
101124,2-bromo-2-nitropropane,226-668-5,5447-97-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H315:42;H302:38;H335:42;H319:42;H332:38;H312:38
101126,"1,2,4,5-tetrachloro-3-methoxybenzene",230-061-0,6936-40-9,Acute Tox. 4;Skin Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,42,H413:38;H315:38;H302:38;H335:38;Not classified:4
101128,Amidinourea phosphate,241-659-6,17675-60-4,Acute Tox. 4,REACH registration C&L,6,H302:4;Not classified:2;H312:2;H332:2
101139,"Isophthalic acid, dianhydride with diethyl bis(hydrogen carbonate)",245-027-0,22483-52-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2
101142,N-methylpyridine-4-methylamine,230-198-6,6971-44-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H315:1;H335:2;H314:1;H302:1
101143,"3-Pyridinecarbonitrile, 1-ethyl-1,2-dihydro-6-hydroxy-5-[2-(4-methoxy-2-nitrophenyl)diazenyl]-4-methyl-2-oxo-",610-477-2,49744-42-5,Not Classified,Notified C&L,16,Not classified:16
101144,p-nitrophenyl β-D-mannopyranoside,252-633-9,35599-02-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
101148,"Sodium 1,2-diisobutoxycarbonylethanesulphonate",204-839-5,127-39-9,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,125,H318:17;H315:110;H319:108;H335:38
101150,"Acetic acid, 2-(7-chloro-5-phenyl-3H-1,4-benzodiazepin-2-yl)hydrazide",620-268-8,28910-89-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H315:1;H335:1;Not classified:1
101156,4-guanidinobutyric acid,207-331-1,463-00-3,Not Classified,Notified C&L,2,Not classified:2
101159,3'-methylacetanilide,208-678-1,537-92-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H302:39;H335:38
101160,4-Propionylcyclohexylbenzol,608-991-7,344348-40-9,Not Classified,Notified C&L,1,Not classified:1
101165,tert-butyl {(1S)-1-[(2R)-oxiran-2-yl]-2-phenylethyl}carbamate,431-870-3,,Acute Tox. 4;Skin Sens. 1B;Muta. 2;Aquatic Chronic 2,REACH registration C&L,2,H411:1;H341:1;H302:1;H317:1;Not classified:1
101169,Bis(2-ethylhexyl) carbonate,238-925-9,14858-73-2,Skin Irrit. 2,REACH registration C&L,66,H315:65;Not classified:1
101176,benomyl (ISO);methyl 1-(butylcarbamoyl)benzimidazol-2-ylcarbamate,241-775-7,17804-35-2,Skin Irrit. 2;Skin Sens. 1;STOT SE 3;Muta. 1B;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H315:0;H360:0;H340:0;H335:0;H400:0;H317:0;H410:0
101177,"1-Propene, hydroformylation products, distn. residues",306-506-0,97281-08-8,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Repr. 2,Notified C&L,83,H318:83;H315:83;H226:83;H361:83;H317:83
101180,5-(tert-butyl)hexahydro-2H-azepin-2-one,251-188-8,32741-89-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H302:38;H335:38
101183,Bis(2-(2-butoxyethoxy)ethoxy)methane,205-598-9,143-29-3,Not Classified,REACH registration C&L,198,Not classified:143;H412:55
101192,"2-(chloromethyl)-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine hydrochloride (1:1)",603-200-1,127337-60-4,Skin Sens. 1;Eye Dam. 1,REACH registration C&L,103,H318:98;H317:97;H319:5;H315:5;H335:4;H350:1;H302:1
101193,4-fluorobenzylamine,205-430-4,140-75-0,Skin Corr. 1B,REACH registration C&L,57,H314:57;H318:1;H312:1;H332:1;H302:1
101195,Allyldichloromethylsilane,217-498-2,1873-92-3,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,42,H225:42;H314:42
101200,2-(trimethylammonium)ethoxycarboxybenzene-4-sulfonate,411-010-3,,Skin Sens. 1,Harmonised C&L,0,H317:0
101201,"Biphenyl-2-ol, ethoxylated, esters with acrylic acid",500-247-9,72009-86-0,Skin Sens. 1A;Repr. 2;Aquatic Chronic 2,REACH registration C&L,4,H411:2;H361:2;H317:4;H319:2;H315:2
101203,Dipentyl succinate,211-452-5,645-69-2,Aquatic Acute 1,Notified C&L,38,H400:38
101207,"3,7-dimethylocta-2,6-diene-1-thiol",253-845-4,38237-00-2,Flam. Liq. 3;Acute Tox. 4,Notified C&L,113,H302:64;H226:113
101210,3-chloro-4-nitrotoluene,254-199-6,38939-88-7,Acute Tox. 4,Notified C&L,72,H302:39;Not classified:33
101213,2-[1-(but-2-enyl)pent-3-enyl]pyridine,218-156-5,2057-42-3,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,38,H315:38;H335:38;H301:38;H319:38;H413:38
101214,"2,6-di-tert-butyl-4-(4,6-bis(octylthio)-1,3,5-triazin-2-ylamino)phenol",213-590-1,991-84-4,Not Classified,REACH registration C&L,1656,Not classified:161;H413:1464;H317:32
101215,Linoleic acid,200-470-9,60-33-3,Not Classified,Notified C&L,2349,Not classified:2058;H319:226;H315:248;H335:184;H413:20;H318:3;H314:1
101218,N-(4-chloro-3-cyano-7-ethoxyquinolin-6-yl)acetamide,619-565-5,848133-76-6,Not Classified,REACH registration C&L,3,Not classified:1;H302:2;H315:1;H319:1;H332:1;H312:1
101220,5-nitrothiazol-2-ylamine,204-490-9,121-66-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,62,H319:55;H315:55;H302:55;H335:53;H351:9;H312:5;H332:5;H350:1;H361:2;H340:1;H341:1
101226,"Carbonic acid, cobalt salt",231-419-9,7542-09-8,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1,Notified C&L,2,H319:1;H334:2;H302:1;H317:2;H360:1;H350:1;H400:1;H410:1;H341:1
101228,"Residual oils (petroleum), hydrocracked acid-treated solvent-dewaxed;Baseoil - unspecified;[A complex combination of hydrocarbons produced by solvent removal of paraffins from the residue of the distillation of acid-treated, hydrocracked heavy paraffins and boiling approximately above 380 °C (716 °F).]",295-499-7,92061-86-4,Carc. 1B,Harmonised C&L,0,H350:0
101234,"but-2-yne-1,4-diol;2-butyne-1,4-diol",203-788-6,110-65-6,Acute Tox. 3;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 3;STOT RE 2,Harmonised C&L,0,H373:0;H301:0;H314:0;H331:0;H317:0;H312:0
101235,Nicorandil,265-514-1,65141-46-0,Acute Tox. 4;Eye Dam. 1,Notified C&L,65,H318:39;H302:64;Not classified:2;H361:1
101236,"2,4,6-tri-tert-butylphenol",211-989-5,732-26-3,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,647,H319:546;H400:610;H410:572;H315:89;H302:190;H413:16;Not classified:11;H411:9;H373:4;H335:5;H372:5;H317:5
101237,1H-imidazole-4-carbaldehyde,221-227-3,3034-50-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:47;H315:47;H335:46;H302:4;H332:2;H312:2
101240,Bis(2-ethylhexyl) adipate,203-090-1,103-23-1,Not Classified,REACH registration C&L,1051,Not classified:1016;H400:30;H410:12;H319:10;H315:9;H411:3;H302:1;H332:1;H312:1;H351:1;H361:1;H413:1
101241,"Resin acids and Rosin acids, hydrogenated, Me esters",232-476-2,8050-15-5,Aquatic Chronic 3,REACH registration C&L,1896,H412:1504;Not classified:356;H317:59;H413:32
101249,"(6S,8S,9S,10R,11S,13S,14S,17R)-17-acetyl-11,17-dihydroxy-6,10,13-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one",615-123-0,7055-53-0,STOT RE 2;Aquatic Chronic 4,REACH registration C&L,2,H373:2;H413:2
101252,4-chloro-3-nitrobenzanilide,255-463-3,41614-16-8,Eye Irrit. 2,Notified C&L,38,H319:38
101253,N-ethyl-N-nitrosourea,212-072-2,759-73-9,Acute Tox. 3;Acute Tox. 4;Acute Tox. 4;Carc. 1B;Repr. 1B,Notified C&L,40,H360:40;H301:40;H350:40;H332:40;H312:40
101254,"1,2,4,5-tetramethyl-1H-imidazole",217-100-7,1739-83-9,Eye Dam. 1,REACH registration C&L,3,H318:2;H319:1;H315:1
101257,"4,4'-sulphinyldiresorcinol",248-129-3,26948-96-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
101258,"1-Butanol, 2-amino-3-methyl-, (2R)-",922-908-4,4276-09-9,,Notified C&L,5,H319:4;H315:4;H318:1;H314:1;H302:1
101259,"2,6-dichloropyridine",219-282-3,2402-78-0,Acute Tox. 3,Notified C&L,57,H301:55;H315:8;H335:6;H319:8;H311:5;H350:1;Not classified:2;H341:1;H331:1
101261,Tridec-1-ene,219-443-8,2437-56-1,Eye Irrit. 2,Notified C&L,47,H319:39;H304:5;Not classified:3
101264,"3,3'-dithiobis[2-methylfuran]",249-095-2,28588-75-2,Acute Tox. 4,Notified C&L,1499,H302:1286;H319:160;H315:153;H301:60;H318:42
101266,"[3-[[3-[(5-chloro-2-hydroxyphenyl)azo]-2,6-dihydroxyphenyl]azo]-2-hydroxy-5-nitrobenzenesulphonato(3-)]iron",277-503-9,73507-31-0,Not Classified,Notified C&L,4,Not classified:4
101267,Silver fluoride,231-895-8,7775-41-9,Skin Corr. 1B,Notified C&L,47,H314:47;H302:5;H400:5;H332:5;H312:5;H318:2
101268,"1,1,1-Trifluoro-4-iodobutane",610-281-7,461-17-6,,Notified C&L,7,H319:7;H315:7;H335:6
101271,1-(4-butoxyphenyl)ethan-1-one,227-248-4,5736-89-0,,Notified C&L,5,H319:5;H315:5
101275,Hexadecanoic wheat protein,604-651-7,148812-63-9,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H318:1
101276,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-nitro-, disodium salt, reaction products with 4-[(4-aminophenyl)azo]benzenesulfonic acid, sodium salts",215-397-8,1325-54-8,Not Classified,REACH registration C&L,2097,Not classified:2074;H317:19;H319:4;H335:4
101277,"1H-pyrazolo[3,4-d]pyrimidin-4-amine",219-174-6,2380-63-4,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,REACH registration C&L,46,H315:41;H335:41;H301:46;H319:41;H261:1;H331:1;H311:1
101278,5-bromo-2-hydroxybenzonitrile,254-958-1,40530-18-5,Acute Tox. 4;Eye Irrit. 2,Notified C&L,42,H319:40;H302:41;H312:2;H332:2;H301:1;H331:1;H311:1;H315:2;H335:2
101280,"Phosphoric acid, esters with low cholesterol lanolin alcs.",291-925-0,90506-61-9,Not Classified,Notified C&L,1,Not classified:1
101282,"Physalis alkekengi, ext.",290-157-3,90082-67-0,Flam. Liq. 3;Skin Sens. 1,Notified C&L,2,H317:2;H226:2
101283,pyridin-3-yl N-methyl-N-(6-{methyl[(pyridin-3-yloxy)carbonyl]amino}hexyl)carbamate,619-158-2,95701-58-9,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H302:1;H317:1
101284,Molybdic acid,231-970-5,7782-91-4,Not Classified,REACH registration C&L,111,Not classified:20;H319:92;H373:67;H335:91;H315:15;H332:8;H302:8;H372:1
101285,tert-butyl 2-ethylperoxybutyrate,219-850-0,2550-33-6,Not Classified,Notified C&L,60,Not classified:55;H242:5;H315:5
101287,"Lavender, Lavandula angustifolia angustifolia, ext., acetylated",305-093-4,94334-13-1,Acute Tox. 4;Acute Tox. 2,Notified C&L,77,H330:77;H302:77
101290,4-Acetoxystyrene,607-905-5,2628-16-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,67,H319:67;H315:67;H302:67;H317:67;H334:5;H335:2
101292,Trichloro(phenyl)silane,202-640-8,98-13-5,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,132,H312:104;H318:37;H314:131;H330:45;H335:27;Not classified:1;H332:1;H290:1
101294,Bromacil,206-245-1,314-40-9,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,177,H400:174;H302:174;H410:136;H315:71;H335:71;H319:71;Not classified:3
101295,Strontium titanium trioxide,235-044-1,12060-59-2,Not Classified,REACH registration C&L,124,Not classified:123;H319:1
101299,"2,3',4'-Trichloroacetophenone",610-094-0,42981-08-8,,Notified C&L,6,H314:6;H318:1
101304,"Hexasodium 6,18-dihydrodinaphtho[2,3-i:2',3'-i']benzo[1,2-a:4,5-a']dicarbazole-5,7,12,17,19,24-hexyl hexasulphate",233-440-9,10169-29-6,Not Classified,Notified C&L,1,Not classified:1
101305,"2,2'-[[4-[(2,4-dinitrophenyl)azo]phenyl]imino]bisethanol",262-071-6,60129-67-1,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H302:38;H335:38;H319:38;H317:38
101308,Heptyl formate,203-949-0,112-23-2,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1,Notified C&L,151,H318:126;H315:151;H226:151;H319:25
101311,Tetrabutylammonium hydrogen sulphide,281-792-7,84030-21-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38,H319:38;H315:38
101313,"Kinase (enzyme-activating), uro-",232-917-9,9039-53-6,,Notified C&L,39,Not classified:39
101321,diisopropylamine,203-558-5,108-18-9,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Harmonised C&L,0,H225:0;H314:0;H332:0;H302:0
101322,o-toluidinium chloride,211-252-8,636-21-5,Acute Tox. 4;Acute Tox. 4;Carc. 1B,Notified C&L,43,H312:39;H350:39;H332:39;H330:3;H311:3;H351:1
101323,"2,3-Difluor-1-propoxy-4-[4-(4-propylcyclohexyl)-cyclohexyl]-benzol",927-601-9,,Not Classified,Notified C&L,1,Not classified:1
101326,"4H-1,2,4-triazol-4-ylamine",209-533-5,584-13-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,92,H319:55;H315:55;H335:54;H302:34;H351:6;H361:2;H373:1
101329,2-methylfuran-3-thiol,249-094-7,28588-74-1,Flam. Liq. 3;Acute Tox. 3;Eye Dam. 1;Acute Tox. 1,Notified C&L,1706,H301:1706;H318:1663;H330:1664;H226:1706;H315:2;H335:2;H319:3
101333,"2,2-dimethyl-5-(1-methylpropenyl)tetrahydrofuran",231-028-3,7416-35-5,Flam. Liq. 3,Notified C&L,1441,H226:1441
101336,butyltricyclohexylstannane,230-358-5,7067-44-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H400:0;H332:0;H410:0;H312:0
101340,"(3,4-dihydro-2H-1-benzothiopyran-4-yl)ammonium chloride",239-980-1,15857-70-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
101341,2-(2-Pyridyl)malondialdehyde,674-212-2,212755-83-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2
101347,1-(phenylsulphonyl)aziridine,233-676-2,10302-15-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H315:38;H302:38;H335:38
101348,"2-butyl-4,4,6-trimethyl-1,3-dioxane",259-210-8,54546-26-8,Aquatic Chronic 3,REACH registration C&L,1585,H412:1348;Not classified:236;H319:1
101352,"4,4'-dihydrazinostilbene-2,2'-disulphonic acid",247-453-2,26092-49-9,,Notified C&L,34,Not classified:34
101353,"5-diethoxymethyl-1,3-benzodioxole",254-956-0,40527-42-2,Acute Tox. 4,REACH registration C&L,91,H302:1;Not classified:90
101354,"3-chloro-α,α,α-trifluorotoluene",202-642-9,98-15-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,66,H319:46;H315:46;H226:50;H335:45;Not classified:16;H412:4
101355,Tin di(acetate),211-335-9,638-39-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,44,H312:44;H332:44;H302:44
101357,Diboron calcium tetraoxide,237-224-5,13701-64-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,222,H319:192;H315:116;H335:115;Not classified:30
101358,"2,2,o,p'-tetrachlorovinylidenebisbenzene",222-318-0,3424-82-6,Acute Tox. 4;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H351:38;H400:38;H302:41;H410:38
101361,Oxfenicine,251-061-7,32462-30-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H302:39;H335:39
101364,"(S)-propane-1,2-diamine bis((2S,3S)-2,3-dihydroxysuccinate) dihydrate",924-425-4,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H319:2;H315:2;H335:2
101365,"Solvent naphtha (coal);Light Oil Extract Residues, high boiling;[The distillate from either high temperature coal tar, coke oven light oil, or coal tar oil alkaline extract residue having an approximate distillation range of 130°C to 210°C (266°F to 410°F). Composed primarily of indene and other polycyclic ring systems containing a single aromatic ring. May contain phenolic compounds and aromatic nitrogen bases.]",266-013-0,65996-79-4,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
101366,(E)-1-chlorobut-2-ene,225-516-5,4894-61-5,Flam. Liq. 2;Skin Corr. 1B;STOT SE 3,Notified C&L,71,H225:38;H314:71;H335:38;H302:33;H412:33;H332:33;H317:33
101367,Butyltrichlorosilane,231-381-3,7521-80-4,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B,Notified C&L,45,H314:45;H302:38;H226:45;H318:2;H335:1;H290:1
101368,malachite green oxalate,219-441-7,2437-29-8,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H318:0;H302:0;H361:0;H400:0;H410:0
101370,"4,4'-[(isopropylidene)bis(p-phenyleneoxy)]bis[N-methylphthalimide]",259-143-4,54395-52-7,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3,Notified C&L,38,H302:38;H335:38;H319:38;H332:38;H334:38
101372,2-heptylcyclopentanone,205-273-1,137-03-1,Skin Irrit. 2,REACH registration C&L,1692,H315:1426;H411:1651;H318:38;H335:38
101374,"Triisooctyl 2,2',2''-[(butylstannylidyne)tris(thio)]triacetate",247-295-4,25852-70-4,,Notified C&L,1,H373:1;H315:1;H302:1;H319:1;H411:1
101375,Cyclohexylmethyl chloroformate,228-052-1,6099-86-1,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H335:1;H314:1;H332:1;H312:1
101381,Atropic acid,207-753-6,492-38-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,8,H319:7;H315:7;H335:6;H302:2;H332:1
101387,5-nitrofuran-2-acrylaldehyde,217-499-8,1874-22-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Muta. 2;Repr. 2,REACH registration C&L,2,H315:2;H335:2;H361:2;H319:2;H341:2
101388,Reaction product of Hexamethylenediisocyanate - isocyanurat with Mercaptopropyltrimethoxysilane,917-966-2,,Not Classified,Notified C&L,46,Not classified:46
101392,"Gases (petroleum), depropanizer overheads;Petroleum gas;[A complex combination of hydrocarbons produced by distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]",270-773-9,68477-91-8,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;Not classified:0;H340:0
101395,Zirconium disilicide,234-911-1,12039-90-6,Not Classified,REACH registration C&L,5,Not classified:5
101410,"1-tert-butoxy-N,N,N',N'-tetramethylmethylenediamine",227-383-9,5815-08-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,62,H319:62;H315:62;H226:62;H335:62
101411,"dipicrylamine, ammonium salt",220-639-0,2844-92-0,Expl. 1.1;Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H373:0;H330:0;H201:0;H310:0;H300:0;H411:0
101418,"2,3-dihydroxybenzonitrile",268-005-2,67984-81-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
101421,"2-bromo-1-(3,5-dihydroxyphenyl)ethanone",613-114-6,62932-92-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
101423,2-chlorothiazole,221-228-9,3034-52-4,Flam. Liq. 3;Acute Tox. 4;Eye Dam. 1,Notified C&L,46,H318:40;H302:41;H226:42;H319:6;H315:6;H335:5
101424,2-[[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]methyl]oxirane,440-920-3,,Acute Tox. 4;Repr. 2,REACH registration C&L,2,H361:2;H302:2
101426,Clofedano,212-340-9,791-35-5,Acute Tox. 3,REACH registration C&L,1,H301:1
101427,2-bromo-4'-chloro-2'-(o-fluorobenzoyl)acetanilide,216-437-7,1584-62-9,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,5,H400:4;H410:4;H319:1;H315:1;H335:1
101429,"1,1-diethoxytrimethylamine",214-707-9,1188-33-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H226:40;H335:44;H225:5
101431,"Distillates (petroleum), solvent-dewaxed heavy naphthenic;Baseoil - unspecified;[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-167-6,64742-63-8,Carc. 1B,Harmonised C&L,0,H350:0
101432,Basic red 46,602-156-0,12221-69-1,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,6,H412:3;H318:6;H411:3;H302:3
101435,Ethylenesulphonyl fluoride,211-640-7,677-25-8,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3;STOT SE 3;Muta. 2,Notified C&L,39,H226:39;H335:39;H301:39;H314:39;H331:39;H311:39;H341:39
101436,Cananga Odorata Flower Oil,616-893-0,8006-81-3,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,220,H412:191;H304:192;H315:216;H317:194;H361:14;H319:26;H301:1;H411:2;H302:1;H413:1
101437,Furan-2-acetic acid,220-380-3,2745-26-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H318:39;H315:39;H302:39;H335:39
101440,Methyl 2-(4-isopropylphenyl)propionate,262-853-7,61566-34-5,Repr. 2,Notified C&L,39,H361:38;H302:1
101444,"Tar bases, coal, quinoline derivs. fraction;Distillate Bases",274-560-1,70321-67-4,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
101447,tert-butyl nitrite,208-757-0,540-80-7,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H225:0;H332:0;H302:0
101449,trichlorosilane,233-042-5,10025-78-2,Flam. Liq. 1;Pyr. Liq. 1;Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4,Harmonised C&L,0,H302:0;H314:0;H332:0;H224:0;H250:0
101457,Bis(p-fluorophenyl)sulphone,206-847-4,383-29-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H315:3;H335:3;H302:2;H332:2;H312:2
101464,Chlorohydroquinone,210-442-8,615-67-8,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H315:41;H335:40;H319:41;H317:39;H311:43;H302:9;H332:1;H312:1
101465,"3'(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide",604-794-5,151319-34-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,52,H319:40;H315:40;H335:40;H362:11;H361:11;H302:3;H332:3;H312:2;H373:1
101468,Cyclododecylamine,216-118-2,1502-03-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
101471,(S)-2-amino-4-methyl-N-(4-nitrophenyl)valeramide,224-047-3,4178-93-2,Skin Sens. 1;Eye Irrit. 2,Notified C&L,39,H319:39;H317:39
101472,"1-(3,4-dihydro-2-naphthyl)pyrrolidine",244-371-9,21403-95-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
101475,6-amino-2-(ethylthio)-1H-pyrimidin-4-one,253-579-9,37660-22-3,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H315:38;H335:38
101476,"Disodium [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']ferrate(2-)",238-785-9,14729-89-6,Not Classified,Notified C&L,2,Not classified:2
101477,Phenylmercury stearate,203-217-0,104-59-6,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H373:38;H330:38;H310:38;H300:38;H400:38;H410:38
101480,"Molybdenum, [bis(2-ethylhexyl)carbamodithioato-.kappa.S,.kappa.S'](ditridecylcarbamodithioato-.kappa.S,.kappa.S')dioxodi-.mu.-thioxodi-, branched",607-718-9,253873-83-5,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H411:1;H315:1
101482,"2-(2,4,6-trichlorophenoxy)propionic acid",212-297-6,778-83-6,Acute Tox. 4,Notified C&L,38,H302:38
101483,Mersalyl acid,207-637-5,486-67-9,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H373:38;H330:38;H310:38;H300:38;H400:38;H410:38
101484,N-methyl-1-(methylthio)-2-nitrovinylamine,263-266-9,61832-41-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,197,H319:196;H315:196;H335:195;H302:1
101485,"Butan-2-one O,O'-(methoxymethylsilanediyl)dioxime",280-973-8,83817-72-5,Flam. Liq. 2;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,23,H225:23;H315:22;H319:23;H317:23;H373:1;H336:1
101488,3-methyl-5-phenyl-1H-pyrazole,222-099-1,3347-62-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H302:39;H335:40
101489,"Antimony, compound with chromium (1:1)",234-998-6,12053-12-2,,Notified C&L,4,H411:4;H332:4;H302:4
101493,"propazine (ISO);2-chloro-4,6-bis(isopropylamino)-1,3,5-triazine",205-359-9,139-40-2,Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H351:0;H400:0;H410:0
101500,1'-hydroxy-2'-acetonaphthone,211-918-8,711-79-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
101508,"N,N-diethyl-p-(phenylazo)aniline",219-616-8,2481-94-9,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,182,H315:78;H302:134;H412:2;H319:163;H317:2;H335:55;H351:43;H332:41;H312:41;Not classified:9;H341:6;H413:2
101510,2-(4-amino-2-nitroanilino)ethanol,220-701-7,2871-01-4,Skin Sens. 1A;Aquatic Chronic 2,REACH registration C&L,77,H411:22;H317:62;H319:52;H315:50;H335:42;H332:3;H312:3;H302:2;H412:1
101511,"Bis(p-aminophenyl)-4-methylenecyclohexa-2,5-dienylideneammonium acetate",227-918-6,6035-94-5,Not Classified,REACH registration C&L,42,Not classified:2;H351:40
101513,Dimethylpolysiloxane,613-154-4,63148-60-7,,Notified C&L,40,Not classified:35;H319:5;H315:5
101517,"2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9-hexadecafluorononanoyl chloride",207-033-1,423-95-0,Skin Corr. 1B,Notified C&L,1,H314:1
101521,N-(o-toluoyl)glycine,255-622-7,42013-20-7,Not Classified,Notified C&L,4,Not classified:3;H319:1;H315:1;H335:1
101522,"1,5-dimethyl-1-vinylhex-4-enyl isovalerate",214-259-4,1118-27-0,Not Classified,Notified C&L,274,Not classified:235;H319:39;H315:39;H335:39
101524,Cyclooctatetraene,211-080-3,629-20-9,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H315:41;H335:40;H225:41;H304:41;H319:41
101530,"9-Octadecen-1-ol, (Z)-, phosphate",253-455-4,37310-83-1,Eye Dam. 1,REACH registration C&L,474,H318:464;H315:459;H319:10;H335:3
101531,Trimethylenediamine,203-702-7,109-76-2,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 2;Skin Corr. 1B;Skin Sens. 1B;Eye Dam. 1;Resp. Sens. 1B,REACH registration C&L,221,H318:174;H302:221;H226:220;H314:220;H310:220;H317:173;H334:173;H311:1
101533,"4,4'-dimethoxybenzophenone",202-028-0,90-96-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:45
101537,Sulfadimidine sodium,217-840-0,1981-58-4,Acute Tox. 4,Notified C&L,51,H302:50;H334:4;Not classified:1
101539,Disoprofol,218-206-6,2078-54-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1492,H319:1455;H315:1455;H302:1492;H335:1425;H400:32;H314:35;H410:32;H312:6;H336:1;H411:2;H360:1
101544,"(2α,4aα,8α)-hexahydro-1,1,5,5-tetramethyl-2H-2,4a-methanonaphthalen-8(5H)-one",249-649-3,29461-14-1,Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,4,H411:4;H315:4;H361:2
101545,4-methylthiazole,211-764-1,693-95-8,Acute Tox. 4,Notified C&L,1500,H302:1495;H319:168;H315:210;H226:203;H318:42;H335:82;H332:24;H312:24
101548,"[1S-(1α,3aβ,4α,8aβ)]-2-(decahydro-4,8,8-trimethyl-1,4-methanoazulen-9-ylidene)ethyl acetate",248-510-4,27530-63-8,Not Classified,Notified C&L,10,Not classified:10
101551,"Sodium 2,5-dichlorosulphanilate",255-302-7,41295-98-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H302:1;H335:1;H319:1;H332:1;H312:1
101555,"Disodium 2-[[4,5-dihydro-3-methyl-5-oxo-1-(4-sulphonatophenyl)-1H-pyrazol-4-yl]azo]benzoate",228-809-6,6359-83-7,Not Classified,REACH registration C&L,15,Not classified:4;H412:11
101556,6-dimethylaminopurine,213-344-3,938-55-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
101558,N-(5-((diphenylphosphoryl)methyl)-4-(4-fluorophenyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide,608-289-0,289042-10-0,Skin Sens. 1,Notified C&L,4,H317:4
101561,"Pimenta racemosa, ext.",285-385-5,85085-61-6,Asp. Tox. 1;Skin Sens. 1;Eye Irrit. 2;Muta. 2;Carc. 2;Aquatic Chronic 2,Notified C&L,1430,H304:1429;H319:1430;H351:1426;H317:1430;H411:1427;H341:1426;H302:139;H226:66;H315:3;H412:2
101569,"Dodecylbenzenesulphonic acid, compound with 1-aminopropan-2-ol (1:1)",255-854-9,42504-46-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,39,H318:39;H315:26;H412:13;H302:13
101570,"Coffee, bean, roasted, ext.",272-823-5,68916-18-7,Not Classified,REACH registration C&L,102,Not classified:101;H226:1
101571,"Fatty acids, butter",287-506-7,85536-25-0,Not Classified,Notified C&L,90,Not classified:88;H318:2;H315:1;H314:1
101574,"chrysoidine dihydrochloride;4-(phenylazo)benzene-1,3-diamine dihydrochloride",281-549-5,83968-67-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H318:0;H315:0;H302:0;H400:0;H410:0;H341:0
101579,JASMONITRILE,428-160-0,,Acute Tox. 4;Skin Irrit. 2,Notified C&L,24,H315:24;H302:24;H317:24
101581,"1,2-Naphtoquinonediazide-5-sulfonylchloride (or sulfonic acid) esters with 4,6-bis(1-(4-hydroxyphenyl)-1-methylethyl)-1,3-dihydroxybenzene",433-990-1,,Flam. Sol. 1,REACH registration C&L,2,H228:2
101584,3-AZIDO-3-DEOXY-5-O-TRITYLTHYMIDINE,608-402-3,29706-84-1,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H312:1;H400:1;H410:1
101586,"N-[2-[(2-bromo-4,6-dinitrophenyl)azo]-5-(diethylamino)-4-methoxyphenyl]acetamide",260-255-0,56548-64-2,Skin Sens. 1,Notified C&L,88,H317:63;Not classified:25
101587,"2-ethylhexanoic acid, compound with 2,4,6-tris[(dimethylamino)methyl]phenol",257-154-9,51365-70-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,59,H319:59;H315:59
101592,"Trioctadecyl 2-hydroxypropane-1,2,3-tricarboxylate",231-896-3,7775-50-0,Not Classified,Notified C&L,479,Not classified:479
101594,methyl 3-cyanobenzoate,620-003-6,13531-48-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,3,H312:2;H332:2;H302:2;Not classified:1;H315:1;H335:1;H319:1
101596,"Reaction mass of 1,2-Diacetoxy-3-butene and 1,2-Dihydroxy-3-butene, monoacetate",445-630-0,,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,84,H302:84;H412:84;H319:84;H402:1;H317:84
101597,"N-[2-[(2-chloro-4,6-dinitrophenyl)azo]-5-(diethylamino)phenyl]acetamide",266-405-1,66557-45-7,Skin Sens. 1,REACH registration C&L,38,H317:36;Not classified:2
101605,Scandium trihydroxide,241-658-0,17674-34-9,Not Classified,Notified C&L,2,Not classified:2
101606,"[1,1'-bicyclohexyl]-1-ol",220-799-1,2903-12-0,Acute Tox. 4,Notified C&L,38,H302:38
101610,"methyl (3aR,4R,7aR)-2-methyl-4-(1S,2R,3-triacetoxypropyl)-3a,7a-dihydro-4H-pyrano[3,4-d]oxazole-6-carboxylate",415-670-3,78850-37-0,Eye Dam. 1,Harmonised C&L,0,H318:0
101612,"Alcohols, C7-9-branched, C8-rich",295-250-2,91994-92-2,Aquatic Chronic 2,Notified C&L,35,H411:34;Not classified:1
101613,Copper fluoride hydroxide,237-614-5,13867-72-6,,Notified C&L,4,H319:4;H315:4;H302:4;H335:4
101620,1-tert-Butoxycarbonylpyrrolidine,617-940-8,86953-79-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39
101623,"2-ethyl-2-(hydroxymethyl)-1,3-propanediyl dioleate",246-625-4,25111-05-1,Not Classified,REACH registration C&L,18,Not classified:18
101627,2-(phosphonooxy)ethyl acrylate,250-927-1,32120-16-4,Skin Corr. 1B;Eye Dam. 1,Notified C&L,199,H318:128;H314:115;H319:71;H302:32;H315:13;H317:13
101632,"Dipeptidase, proline",232-791-5,9025-32-5,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,43,H319:38;H315:38;H334:43;H335:38
101636,4-ethoxy-3-methoxyphenylacetic acid,204-372-7,120-13-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
101640,2-[[4-[ethyl(2-hydroxyethyl)amino]phenyl]azo]-6-methoxy-3-methylbenzothiazolium hydrogen sulphate,277-752-3,74186-16-6,Eye Irrit. 2,Notified C&L,2,H319:2
101641,p-nitrophenyl iodoacetate,250-536-6,31252-85-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
101642,"Diammonium 4,4'-bis[(3,4-dihydroxyphenyl)azo]stilbene-2,2'-disulphonate",216-389-7,1571-36-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
101647,N-benzylpyridin-2-amine,230-060-5,6935-27-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,44,H318:39;H315:44;H302:43;H335:43;H319:5
101653,Dilanthanum dioxide sulphide,234-750-7,12031-43-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H302:1;H335:1;H319:1;H332:1;H312:1
101654,"1H-Benzimidazole-4,6-disulfonic acid, 2,2'-(1,4-phenylene)bis-, disodium salt",429-750-0,180898-37-7,Not Classified,REACH registration C&L,2,Not classified:2
101655,"2-ethyl-2-(hydroxymethyl)propane-1,3-diyl adipate",302-544-7,94110-05-1,Not Classified,Notified C&L,1,Not classified:1
101657,"1,1-bis(methylthio)-2-nitroethylene",237-108-4,13623-94-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,48,H319:48;H315:48;H335:47
101658,"Cucumber, ext.",289-738-4,89998-01-6,Not Classified,Notified C&L,130,Not classified:130
101661,"Endo-bicyclo[2.2.2]oct-5-ene-2,3-dicarboxylic anhydride",246-171-7,24327-08-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
101663,Alpha-D-cellobiose octaacetate,226-304-5,5346-90-7,Not Classified,Notified C&L,1,Not classified:1
101664,"1,2-dihydro-3,4,5,6-tetraphenylphthalic anhydride",230-197-0,6971-41-1,Aquatic Acute 1,Notified C&L,38,H400:38
101668,"2-Propenenitrile, reaction products with 1,3-benzenedimethanamine",292-054-9,90530-16-8,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,59,H318:56;H302:59;H412:59;H314:59;H332:58;H317:59;H312:1;H331:1
101673,Bis(3-nitrophenyl) disulphide,208-677-6,537-91-7,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H410:38
101682,Flunitrazepam,216-597-8,1622-62-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,160,H319:128;H302:160;H373:24;H412:2;H336:1;H361:1;H362:1
101683,Ethyl oxirane-2-carboxylate,225-105-0,4660-80-4,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,39,H319:39;H315:39;H317:39;H226:38
101684,3-hydroxynonyl acetate,262-444-3,60826-15-5,Not Classified,Notified C&L,88,Not classified:88
101688,"Benzeneacetic acid, 3,5-dimethoxy-",923-817-2,4670-10-4,,Notified C&L,4,H319:4;H315:4;H335:4
101689,(Z)-octadec-9-enol,205-597-3,143-28-2,Not Classified,REACH registration C&L,556,Not classified:511;H319:38;H315:44;H336:3
101692,N-(cyclohexylthio)phthalimide,241-774-1,17796-82-6,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,86,H400:59;H317:83;H410:81;Not classified:3;H411:1;H319:3;H315:1;H373:1
101697,N-benzylformamide,228-739-6,6343-54-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Resp. Sens. 1;STOT SE 3,Notified C&L,39,H318:38;H315:39;H302:38;H335:38;H334:38;H319:1
101699,N-hydroxy-1H-adenine,227-125-5,5667-20-9,Repr. 2,Notified C&L,39,H361:38;H319:1;H315:1;H335:1
101701,"[3R-(3α,3aβ,7β,8aα)]-2,3,4,7,8,8a-hexahydro-3,8,8-trimethyl-1H-3a,7-methanoazulene-6-methyl acetate",215-789-9,1405-92-1,Not Classified,Notified C&L,239,Not classified:238;H411:1
101706,Fentanyl,207-113-6,437-38-7,Acute Tox. 2,Notified C&L,76,H300:75;H330:36;H310:33;H361:12;H362:10;H317:12;H413:9;H334:12;H370:1;H336:3;Not classified:1;H301:1;H412:2
101707,"Tetrasodium 4-amino-5-hydroxy-6-[(1-sulphonato-2-naphthyl)azo]-3-[[4-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]azo]naphthalene-2,7-disulphonate",282-059-4,84083-11-4,Not Classified,Notified C&L,3,Not classified:3
101709,"Hydrocarbons, C>4",271-960-8,68647-60-9,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Repr. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,14,H373:14;H315:14;H336:14;H225:14;H304:14;H361:14;H411:14
101711,Ethyl 3-aminobutyrate,226-153-5,5303-65-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H226:38;H335:38
101713,p-[[p-benzyloxyphenyl]sulphonyl]phenol,263-920-3,63134-33-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H315:1;H302:1;H319:1;H332:1;H312:1
101715,"1-Propanone, 3-(dimethylamino)-1-(3-methoxyphenyl)-2-methyl-, hydrochloride (1:1)",609-494-8,37951-53-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,3,H315:2;H302:2;H319:2;H317:2;H411:2;Not classified:1
101717,"2-Ethylhexan-1-ol, propoxylated",500-248-4,72136-61-9,Aquatic Chronic 3,Notified C&L,1,H412:1
101719,Tantalum,231-135-5,7440-25-7,Flam. Sol. 1;Self-heat. 2,REACH registration C&L,367,H252:198;H228:276;Not classified:91;H319:43;H315:43;H335:43
101720,"2,4,5-T (ISO);2,4,5-trichlorophenoxy acetic acid",202-273-3,93-76-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H315:0;H302:0;H335:0;H319:0;H400:0;H410:0
101722,6-Maleimidohexanoic Acid,611-311-1,55750-53-3,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,52,H318:38;H315:52;H335:51;H319:14
101725,"N,N-bis(4-aminophenyl)benzene-1,4-diamine",227-791-7,5981-09-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:1
101726,pentyl nitrite,207-332-7,463-04-7,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H225:0;H332:0;H302:0
101728,Ethylhydrazinediylium oxalate,229-618-0,6629-60-3,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Carc. 1B;Aquatic Chronic 2,Notified C&L,3,H302:3;H350:2;H317:2;H312:3;H411:2
101732,Pentane-1-thiol,203-789-1,110-66-7,Acute Tox. 4;Acute Tox. 4,Notified C&L,1470,H332:1456;H302:1467;H225:184;H331:10;H315:5;H335:5;H319:5;H312:2
101735,"Disodium 1-amino-4-[[3-[(2-bromo-1-oxoallyl)amino]-2,4,6-trimethyl-5-sulphonatophenyl]amino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate",265-515-7,65147-24-2,Skin Sens. 1,Notified C&L,11,H317:11
101736,"Cocoa, powd., alkalized",305-748-4,95009-22-6,Not Classified,REACH registration C&L,9,Not classified:9
101739,"Rosin, decarboxylated",232-477-8,8050-18-8,Not Classified,Notified C&L,1,Not classified:1
101748,"Potassium (1R,3S)-3-formyl-2,2-dimethylcyclopropanecarboxylate",921-472-2,,Acute Tox. 4,REACH registration C&L,1,H302:1
101750,"Titanium, acetylacetone Bu alc. iso-Pr alc. complexes",306-507-6,97281-09-9,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,47,H318:47;H315:47;H317:47
101754,"Naphtha (petroleum), steam-cracked, hydrotreated, C",292-637-8,90641-13-7,Asp. Tox. 1,Harmonised C&L,0,H304:0
101755,Diethyl 2-methyloxosuccinate,212-071-7,759-65-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
101757,2-chloroanilinium chloride,205-274-7,137-04-2,,Notified C&L,5,H373:4;H301:4;H331:4;H400:5;H311:4;H410:5;H330:1;H310:1;H300:1
101762,4-methoxybenzamide,222-319-6,3424-93-9,,Notified C&L,5,H319:5;H315:5;H335:4
101765,3-formylphenyl acetate,251-890-4,34231-78-2,,Notified C&L,7,H319:7;H315:7;H335:1
101766,3-Methoxythiophene,479-350-5,17573-92-1,Flam. Liq. 3,Notified C&L,2,H226:2
101768,"[R(R*,R*)]-2,3-bis(acetoxy)succinic acid",257-303-8,51591-38-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
101769,"2,3-dichloropyridine",219-281-8,2402-77-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,49,H319:49;H315:49;H335:48;H302:6;H311:4
101771,"4-(2,5,6,6-tetramethylcyclohex-2-enyl)but-3-en-2-one",201-219-6,79-69-6,Aquatic Chronic 2,REACH registration C&L,1683,H411:37;Not classified:1347;H412:299;H317:1
101772,Ethyl N-methylaminoacetate hydrochloride,258-037-5,52605-49-9,Not Classified,REACH registration C&L,3,Not classified:2;H319:1;H315:1;H335:1
101773,"Aluminum 1,8,15,22-tetrakis(phenylthio)-29H,31H-phthalocyanine chloride",605-466-4,167093-23-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:45
101774,3-ethylthiophene,217-267-6,1795-01-3,Flam. Liq. 3,Notified C&L,2,H226:1;H225:1
101775,(R)-(+)-1-Phenylethanol,604-814-2,1517-69-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,44,H318:43;H315:44;H302:43;H335:4;H301:1;H319:1;H331:1;H311:1
101776,"4,4,4-Trifluoro-1-butanol",610-282-2,461-18-7,Flam. Liq. 3;Acute Tox. 4;Eye Irrit. 2,Notified C&L,47,H319:45;H302:39;H226:47;H315:7;H335:6;H332:1;H312:1
101777,"Fir, Abies sibirica, ext.",294-351-9,91697-89-1,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1498,H315:1319;H226:1498;H304:1498;H319:1498;H317:1498;H411:25;H400:1437;H410:1472
101782,"1,2,3,5-tetrafluoro-4-nitrobenzene",206-246-7,314-41-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
101783,"2-nitro-2-phenyl-1,3-propanediol",410-360-4,5428-02-4,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;STOT RE 1;Aquatic Chronic 2,Harmonised C&L,0,H372:0;H302:0;H317:0;H312:0;H411:0
101789,4-(2-hydroxyethyl)guaiacol,219-175-1,2380-78-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
101790,"2,3-dihydro-1,4-dithiino[2,3-c]furan-5,7-dione",234-015-0,10489-75-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
101795,4-nitrophenylacetic acid,203-168-5,104-03-0,Eye Dam. 1;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,85,H318:6;H400:5;H341:6;H410:5;H319:79;H315:80;H335:79;H412:1
101803,"Zircon, silicon zirconium grey",305-909-9,95193-95-6,Not Classified,Notified C&L,1,Not classified:1
101805,"4,4'-dichlorobenzophenone",228-509-5,6284-79-3,,Notified C&L,5,H319:5;H315:5;H335:5
101806,"Mulberry, Morus nigra, ext.",290-072-1,90064-11-2,Not Classified,Notified C&L,41,Not classified:41
101807,Dierbium trioxide,235-045-7,12061-16-4,Not Classified,REACH registration C&L,84,Not classified:69;H319:15;H315:9;H335:9;H332:1
101810,"Rape oil, reaction products with N-(2-aminoethyl)piperazine",295-498-1,92061-85-3,Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,1,H314:1;H302:1;H317:1;H410:1
101811,"N,N-bis(2-hydroxypropyl)benzamide",436-010-0,,Not Classified,Notified C&L,1,Not classified:1
101819,"Cyclohexane, oxidized, non-volatile residue",270-147-5,68411-76-7,Eye Dam. 1,REACH registration C&L,1,H318:1
101820,"Proteinase, Bothrops atrox serine",232-918-4,9039-61-6,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,38,H319:38;H315:38;H334:38;H335:38
101823,"(3'-carboxymethyl-5-(2-(3-ethyl-3H-benzothiazol-2-ylidene)-1-methyl-ethylidene)-4,4'-dioxo-2'-thioxo-(2,5')bithiazolidinyliden-3-yl)-acetic acid",422-240-9,166596-68-5,Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H318:0;H317:0
101824,Tetracycline hydrochloride,200-593-8,64-75-5,Acute Tox. 4;Skin Irrit. 2;Repr. 2;Lact.;Aquatic Chronic 4,REACH registration C&L,157,H315:110;H302:3;H361:23;H362:41;H413:2;H319:111;H335:108;H373:35;H360:35;H400:35;H410:35;H312:1;H332:2;H317:1;H301:1
101825,ethyldimethylamine,209-940-8,598-56-1,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Harmonised C&L,0,H225:0;H314:0;H332:0;H302:0
101827,13-cis-retinal,207-456-1,472-86-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4,Notified C&L,38,H312:38;H315:38;H332:38;H302:38
101829,"Betaines, C12-18-alkyldimethyl",288-457-4,85736-48-7,Not Classified,Notified C&L,1,Not classified:1
101832,Sodium 2-[(1-oxododecyl)amino]ethanesulphonate,274-695-6,70609-66-4,Not Classified,REACH registration C&L,2,Not classified:2
101833,"Soaps, stocks, vegetable-oil, acidulated, spent acids",272-793-3,68911-90-0,Not Classified,Notified C&L,1,Not classified:1
101836,Rubidium carbonate,209-530-9,584-09-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,71,H319:71;H315:41;H335:41;H311:1
101837,"3,3'-methylenebis[5-methyloxazolidine]",266-235-8,66204-44-2,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1A;Eye Dam. 1;Acute Tox. 4;Muta. 2;Carc. 1B;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,650,H373:20;H318:96;H302:649;H412:7;H314:620;H350:20;H332:475;H317:49;H311:20;H341:20;H312:144;H413:37;H315:30;H335:29;H411:33;Not classified:1
101839,Terbium,231-137-6,7440-27-9,Not Classified,REACH registration C&L,61,Not classified:13;H315:4;H251:4;H319:4;H413:4;H228:48;H260:4
101841,Flumetasone,218-370-9,2135-17-3,Repr. 1B,REACH registration C&L,50,H360:9;H351:40;H373:2;H341:1;H302:2;H315:1;H335:1;H361:1;H319:1;H332:1;H312:1;H372:1
101843,"Diethyl 4-oxopentane-1,2-dicarboxylate",413-860-0,,Not Classified,Notified C&L,1,Not classified:1
101844,"α,α,α-trifluoro-m-toluidine",202-643-4,98-16-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,67,H411:21;H318:9;H315:17;H302:64;H312:51;H373:47;H330:55;H319:14;H335:7;H301:3;H331:3;H311:2;H351:1
101847,cadmium nitrate;cadmium dinitrate,233-710-6,10325-94-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Muta. 1B;Carc. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H372:0;H302:0;H340:0;H350:0;H400:0;H332:0;H410:0;H312:0
101848,DL-2-hydroxy-4-methylvaleric acid,233-677-8,10303-64-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
101851,Ammonium dihydrogen citrate,224-694-1,4450-94-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,42,H319:37;H315:37;H400:14;H302:14;Not classified:5
101853,"Dimethyl [1,1'-biphenyl]-4,4'-dicarboxylate",212-341-4,792-74-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
101855,"Urea, polymer with 1,2-ethanediamine and formaldehyde",609-102-5,35238-68-7,Not Classified,Notified C&L,1,Not classified:1
101856,"m-(3,5-dichlorophenoxy)benzaldehyde",279-661-4,81028-92-4,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H318:38;H302:38;H400:38;H317:38;H410:38;H319:1;H315:1;H335:1
101857,"(6R,7R,14S)-7-acetyl-7,8-dihydro-3,6-O-dimethyl-6,14-ethanomorphine",927-274-2,,Not Classified,Notified C&L,1,Not classified:1
101862,"Bis[3-[[4-(diethylamino)phenyl]azo]-1,2-dimethyl-1H-indazolium] tetrachlorozincate",277-506-5,73507-57-0,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H319:2;H400:2;H302:2;H410:2
101863,"Light oil (coal), coke-oven;Crude benzole;[The volatile organic liquid extracted from the gas evolved in the high temperature (greater than 700°C (1292°F)) destructive distillation of coal. Composed primarily of benzene, toluene, and xylenes. May contain other minor hydrocarbon constituents.]",266-012-5,65996-78-3,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
101864,2-bromothiazole,221-229-4,3034-53-5,,Notified C&L,8,H319:7;H315:7;H335:7;Not classified:1
101871,Potassium isooctadecanoate,266-369-7,66469-15-6,Not Classified,Notified C&L,2,Not classified:2
101875,(4-aminobutyl)guanidinium sulphate,219-617-3,2482-00-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:2;H315:2;H335:2;Not classified:1
101876,2-hydroxybenzoic acid 2-butyloctyl ester,431-090-3,190085-41-7,Aquatic Chronic 4,Harmonised C&L,0,H413:0
101877,"Benzenesulfonic acid, C14-44-branched and linear alkyl derivs., calcium salts, overbased",294-233-7,91696-74-1,Not Classified,REACH registration C&L,36,Not classified:34;H319:2
101878,[No public or meaningful name is available],451-260-0,10152-77-9,Flam. Liq. 2;Acute Tox. 4,Notified C&L,25,H225:25;H302:25
101880,(2-cyanophenyl)acetic acid,242-510-8,18698-99-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
101884,(3-chloro-4-methoxyphenyl)methanaminium chloride,609-972-6,41965-95-1,Eye Dam. 1,REACH registration C&L,48,H318:47;H301:45;H315:3;H331:1;H311:1;H335:2
101885,"2,3-butanedione monoxime",200-348-5,57-71-6,Not Classified,Notified C&L,2,Not classified:1;H315:1;H302:1;H335:1;H319:1;H332:1;H312:1
101886,"triadimenol (ISO);(1RS,2RS;1RS,2SR)-1-(4-chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol;α-tert-butyl-β-(4-chlorophenoxy)-1H-1,2,4-triazole-1-ethanol",259-537-6,55219-65-3,Acute Tox. 4;Repr. 1B;Lact.;Aquatic Chronic 2,Harmonised C&L,0,H362:0;H411:0;H360:0;H302:0
101889,"Paraformaldehyde, oligomeric reaction products with 4-tert-butylphenol, 4-nonylphenol, m-phenylenebis(methylamine) and trimethylhexane-1,6-diamine",500-618-5,161278-27-9,Not Classified,Notified C&L,143,Not classified:135;H302:7;H412:4;H314:8;H332:8;H317:8;H411:3;H318:3;H335:1;H361:1;H400:1;H410:1
101895,"Reaction mass of (2E)-1-chloro-6,6-dimethyl-2-Hepten-4-yne and (2Z)-1-chloro-6,6-dimethyl-2-Hepten-4-yne",700-081-9,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,3,H319:3;H315:3;H335:1
101898,"7-Chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid",617-846-7,86393-33-1,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,41,H412:39;H302:41;H319:1;H315:1;H335:1
101899,Melanins,232-473-6,8049-97-6,Not Classified,Notified C&L,40,Not classified:40
101903,But-3-enenitrile,203-701-1,109-75-1,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 4;Eye Dam. 1;Acute Tox. 2;Repr. 1B;STOT RE 2;STOT RE 2,REACH registration C&L,106,H373:60;H318:60;H360:60;H330:5;H226:51;H301:106;H312:105;H311:1;H331:95;H315:40;H319:46;H335:5;H361:4;H332:1
101904,"D-Glucose, ether with glycerol",309-496-6,100402-60-6,Not Classified,REACH registration C&L,85,Not classified:85
101905,tolylfluanid (ISO);dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;[containing < 0.1% (w/w) of particles with an aerodynamic diameter of below 50 μm];dichloro-N- [(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;[containing = 0.1 % (w/w) of particles with an aerodynamic diameter of below 50 µm],211-986-9,731-27-1,,,0,H315:0;H335:0;H319:0;H400:0;H317:0
101910,"Phenol, [[[3-(dimethylamino)propyl]amino]methyl]-, isobutylenated",276-581-1,72318-87-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:3;H315:3
101911,"4,4,8-trimethyltricyclo[6.3.1.02,5]dodecan-1-ol",207-458-2,472-97-9,Flam. Liq. 3,Notified C&L,1374,H226:1286;Not classified:88
101915,"ethyl 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylate",927-913-5,160844-75-7,Not Classified,REACH registration C&L,4,Not classified:3;H319:1;H315:1
101921,Methyl cinnamate,203-093-8,103-26-4,Skin Sens. 1B,REACH registration C&L,1730,H317:1431;Not classified:299;H302:24
101924,7-amino-4-methyl-2-quinolone,243-363-2,19840-99-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
101925,"Alcohols, soya, reaction products with 2-(dimethylamino)ethanol and maleic anhydride",286-038-0,85186-55-6,Not Classified,Notified C&L,22,Not classified:22
101928,"Naphtha (coal), distn. residues;Light Oil Redistillate, high boiling;[The residue remaining from the distillation of recovered naphtha. Composed primarily of naphthalene and condensation products of indene and styrene.]",292-636-2,90641-12-6,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
101929,"5-methyl-6-(3-methyl-2-butenyl)cyclohex-4-ene-1,2-dicarboxylic anhydride",240-782-2,16726-03-7,Acute Tox. 4,Notified C&L,9,H302:9;H411:1
101931,Manganese di(acetate),211-334-3,638-38-0,Not Classified,REACH registration C&L,685,Not classified:57;H319:627;H315:628;H335:58;H351:39;H332:41;H312:41;H361:1;H317:2;H334:1;H302:1
101933,Chlordiazepoxide hydrochloride,207-117-8,438-41-5,Acute Tox. 4;Repr. 2,Notified C&L,45,H361:43;H302:45;H341:5;H412:1;H360:1;H336:1;H362:1
101934,Titanium oxide phosphate,235-797-6,12738-90-8,Not Classified,Notified C&L,25,Not classified:25
101935,"Monopotassium 6-chloro-3,4-dihydro-3-(trichloromethyl)-2H-1,2,4-benzothiadiazine-7-sulphonamidate 1,1-dioxide",226-157-7,5306-80-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
101936,"Alkanes, C2-3;Petroleum gas",270-652-0,68475-58-1,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;Not classified:0;H340:0
101942,"6-chloro-N-ethyl-4-methyl-4-phenyl-4H-3,1-benzoxazin-2-amine monohydrochloride",260-380-0,56776-32-0,Acute Tox. 4;Eye Dam. 1,Notified C&L,158,H318:157;H302:158
101944,Disodium 1-[2-[(2-hydroxyethyl)(1-oxooctadecyl)amino]ethyl] 2-sulphonatosuccinate,303-766-7,94213-61-3,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,2,H319:2;H412:1;H315:2
101945,m-fluorocinnamic acid,207-281-0,458-46-8,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,2,H315:2;H335:1;H301:1;H319:2;H331:1;H311:1
101946,"bis(dimethyl-(2-hydroxyethyl)ammonium) 1,2-ethanediyl-bis(2-hexadecenylsuccinate)",421-660-1,,Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H318:0;H317:0
101947,"3',6'-dihydroxy-5(or 6)-isothiocyanatospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one",248-207-7,27072-45-3,Resp. Sens. 1,Notified C&L,3,H334:3
101948,1-iodobutane,208-824-4,542-69-8,Flam. Liq. 3;Acute Tox. 3,Notified C&L,50,H331:42;H226:50;H319:5;H315:4;H332:4;Not classified:1;H302:2;H312:1;H335:2
101950,"Fatty acids, C14-18 and C16-18-unsatd., distn. residues",274-563-8,70321-73-2,Not Classified,Notified C&L,13,Not classified:9;H319:4;H315:4
101951,"1,3-bis[(4-aminophenyl)(2-hydroxyethyl)amino]propan-2-ol tetrahydrochloride",416-320-2,,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H318:2;H315:2;H400:2;H317:2;H410:2
101953,"Propane-1,3-diyl bis(4-aminobenzoate)",260-847-9,57609-64-0,Not Classified,REACH registration C&L,102,Not classified:45;H319:57;H315:19
101956,5-chloro-N-cyclohexylpentanamide,605-156-9,15865-18-6,Not Classified,REACH registration C&L,2,Not classified:2
101957,C.I. Reactive Red 239,606-052-6,185323-68-6,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H334:1;H317:1
101966,"Fatty acids, C18, unsatd., dimers, reaction products with N,N-dimethyl-1,3-propanediamine and 1,3-propanediamine",605-296-0,162627-17-0,Skin Sens. 1A,REACH registration C&L,484,H317:484;H226:441
101968,"Gases (petroleum), gas concn. reabsorber distn.;Refinery gas;[A complex combination of hydrocarbons produced by distillation of products from combined gas streams in a gas concentration reabsorber. It consists predominantly of hydrogen, carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide and hydrocarbons having carbon numbers in the range of C1 through C3.]",270-776-5,68477-93-0,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;Not classified:0;H340:0
101970,"Benzaldehyde, 2-methoxy-5-(1-methylethyl)-",617-773-0,85902-68-7,,Notified C&L,4,H319:4;H315:4
101972,"(3β, 5α, 6β)-3-(acetyloxy)-5-bromo-6-hydroxy-androstan-17-one",419-790-7,4229-69-0,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H317:0
101974,"Citrus tangerina, aceite",616-990-8,8016-85-1,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,190,H315:190;H226:165;H304:127;H400:91;H317:127;H410:127
101976,3-(isononyloxy)propylamine,249-554-7,29317-52-0,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 2,Notified C&L,1,H411:1;H314:1;H302:1
101978,"Benzoic acid, 2-[4-(diethylamino)-2-hydroxybenzoyl]-, hexyl ester",608-453-1,302776-68-7,Aquatic Chronic 4,Notified C&L,21,H413:21
101981,"1H-Indole, 1-[1-(2-pyridinylmethyl)-4-piperidinyl]-",611-837-1,594827-31-3,Acute Tox. 3;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H301:1;H411:1;H319:1
101984,Borax,601-071-6,11130-12-4,Repr. 1B,Notified C&L,30,H360:25;Not classified:5
101985,"N-[3-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)phenyl]acetamide",237-924-0,14070-48-5,Flam. Sol. 2,Notified C&L,3,H228:2;Not classified:1
101988,(S)-Ethyl piperidine-3-carboxylate,609-464-4,37675-18-6,Eye Dam. 1,Notified C&L,43,H318:41;H319:2;H315:4;H335:3
101989,Piperidine-1-propanol,203-216-5,104-58-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:39;H315:40;H335:40;H312:6;H314:6;H332:6;H302:6;H412:1;H318:1
101994,Chromium selenide,234-999-1,12053-13-3,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H373:42;H301:42;H331:42;H400:42;H410:42
101995,"Alkenes, C10-18 α-",287-627-5,85566-17-2,Not Classified,Notified C&L,13,Not classified:13
101996,"Kerosine (petroleum), hydrotreated;Kerosine - unspecified;[A complex combination of hydrocarbons obtained from the distillation of petroleum and subsequent hydrotreatment. It consists predominantly of alkanes, cycloalkanes and alkylbenzenes having carbon numbers predominantly in the range of C",309-944-0,101631-19-0,Asp. Tox. 1,Harmonised C&L,0,H304:0
101999,"Malic acid, sodium salt",221-460-0,3105-51-9,Not Classified,Notified C&L,76,Not classified:62;H319:14;H315:14;H335:14
102002,Potassium Peroxymonosulfate [>45%(T) as KHSO5],609-357-2,37222-66-5,,Notified C&L,6,H315:4;H302:5;H335:5;H319:4;H317:4;H272:5;H334:4;H318:1;H290:1;H314:2
102005,"Amides, C8-18 and C18-unsatd., ethoxylated",614-635-1,68603-39-4,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,8,H411:7;H315:7;H317:7;Not classified:1
102006,Cotinine,207-634-9,486-56-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:44;H315:44;H302:45;H335:44;Not classified:4
102009,"Tannins, salts with 2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propen-1-yl]-1,3,3-trimethyl-3H-indolium",614-855-8,68957-25-5,Acute Tox. 3;Skin Corr. 1;Aquatic Acute 1,Notified C&L,3,H301:3;H314:3;H400:3
102010,4-Sulfophthalic acid trisodium salt,608-849-4,3325-08-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
102015,"2,6-dichlorocinnamic acid",226-301-9,5345-89-1,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,44,H315:44;H335:43;H301:38;H319:44;H400:38
102016,"Fatty acids, C14-18 and C16-18-unsatd., Me esters",267-007-0,67762-26-9,Not Classified,REACH registration C&L,324,Not classified:324
102019,(2S)-2-methylbutanoic acid,605-661-4,1730-91-2,Skin Corr. 1B,Notified C&L,40,H314:40;H312:1;H318:1;H302:1
102023,"Disodium 5-(5-(fluoro-2-substitued-alkylamino)-heteromonocyclylamino)-2- sulphonatophenylazo)-1-alkyl-1,2-dihydro-6-hydroxy-4-alkyl-2-oxo-3- pyridinealkanesulphonate",402-740-3,,Resp. Sens. 1,REACH registration C&L,3,H334:1;Not classified:2
102024,2-ethoxy-5-prop-1-enylphenol,202-370-0,94-86-0,Not Classified,Notified C&L,365,Not classified:325;H319:40;H315:40;H335:39
102026,"1,1,1,2,3,3,3-heptafluoro-2-iodopropane",211-643-3,677-69-0,Acute Tox. 3;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,55,H372:4;H331:4;H400:4;H410:4;H319:45;H315:45;H332:39;H335:44;Not classified:6
102028,5-chloro-2-[2-[3-[(5-chloro-3-ethyl-3H-benzothiazol-2-ylidene)ethylidene]-2-(diphenylamino)cyclopent-1-en-1-yl]vinyl]-3-ethylbenzothiazolium perchlorate,258-689-0,53655-17-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H315:39;H302:38;H335:39;H319:39;H332:38;H312:38;H317:1
102037,"2-(3-BENZO(1,3)DIOXOL-5-YL-2-METHYL-PROPYLIDENEAMINO)-BENZOIC ACID METHYL ESTER",601-113-3,111753-60-7,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,155,H319:92;H411:92;H400:38;H410:38;H413:25;H225:1;H317:1
102038,"Dodecanoic acid, ester with 1,2-ethanediol",253-458-0,37318-14-2,Not Classified,Notified C&L,6,Not classified:6
102043,Heptan-2-yl [(5-chloroquinolin-8-yl)oxy]acetate,619-447-3,99607-70-2,Skin Sens. 1;Acute Tox. 4;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,318,H373:168;H400:225;H332:168;H317:269;H410:280;H319:36;H302:1
102044,"4,4'-bis(dimethylamino)benzophenone;Michler's ketone",202-027-5,90-94-8,Eye Dam. 1;Muta. 2;Carc. 1B,Harmonised C&L,0,H350:0;H318:0;H341:0
102050,"Oxacyclopentadec-10-en-2-one, 13-methyl-",438-810-5,329925-33-9,Not Classified,REACH registration C&L,1325,Not classified:2;H410:1323;H400:389
102056,"10,10-dimethylanthracen-9(10H)-one",226-666-4,5447-86-9,Acute Tox. 4,REACH registration C&L,2,H302:2
102058,Cyclodecanone,216-119-8,1502-06-3,Eye Irrit. 2,Notified C&L,39,H319:39
102062,Triethyl orthoformate,204-550-4,122-51-0,Flam. Liq. 3,Notified C&L,506,H226:444;H319:213;H315:105;H335:59;Not classified:7
102063,"N,N-bis(trimethylsilyl)formamide",239-530-4,15500-60-4,Flam. Liq. 3,Notified C&L,38,H226:38
102066,Methyl (triphenylphosphoranylidene)acetate,220-018-4,2605-67-6,Not Classified,REACH registration C&L,3,Not classified:2;H301:1;H315:1;H319:1;H335:1
102069,"Octanoic acid, compound with octylamine (1:1)",241-477-7,17463-34-2,Acute Tox. 4;Skin Corr. 1A,REACH registration C&L,40,H314:7;H302:7;Not classified:33
102070,Methyl L-tyrosinate,214-095-3,1080-06-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2
102071,Lithium iodoacetate,265-905-7,65749-30-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H315:40;H302:40;H335:40;H319:40;H332:40;H312:40
102072,"Benzenamine, 4-[(4-aminophenyl)(4-imino-2,5-cyclohexadien-1-ylidene)methyl]-, N-Me derivatives, molybdatephosphates",268-006-8,67989-22-4,Self-heat. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,117,H319:8;H252:1;H400:27;H317:1;H411:1;Not classified:88;H318:19;H410:24;H315:2;H335:2;H413:2;H412:1
102073,"Aluminium, compound with zirconium (3:1)",234-462-1,12004-83-0,,Notified C&L,4,H319:4;H315:4;H335:4
102078,Disodium pentacyanonitrosylferrate,238-373-9,14402-89-2,Acute Tox. 3,Notified C&L,49,H301:49;H331:3;H311:3
102080,(Z)-1-benzo[b]thien-2-ylethanone oxime hydrochloride,410-780-8,,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H373:0;H318:0;H302:0;H317:0;H411:0
102088,"1H-Indene-1,3(2H)-dione, 2-(3-hydroxy-2-quinolinyl)-",616-202-2,75216-45-4,Skin Sens. 1B,Notified C&L,2,H317:2
102095,"1,3,2-dioxathiane 2-oxide",224-044-7,4176-55-0,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,39,H318:39;H315:39;H317:39;H335:38
102102,"[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-tetrahydrofuran-2-yl-methanone hydrochloride",613-138-7,63074-08-8,Not Classified,Notified C&L,3,Not classified:1;H361:1;H302:1;H319:1
102105,9H-carbazol-4-ol,258-034-9,52602-39-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,46,H319:46;H315:46;H335:45
102106,"1,3-dimethyluracil",212-856-4,874-14-6,Not Classified,REACH registration C&L,3,Not classified:2;H319:1;H315:1;H335:1
102107,"2-Propenenitrile, reaction products with 3-amino-1,5,5-trimethylcyclohexanemethanamine",292-053-3,90530-15-7,Skin Corr. 1B;Skin Sens. 1A;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,478,H411:8;H318:128;H314:377;H317:478;H332:288;H302:413;H319:101;H412:109;H312:24
102110,"Alcohols, C11-14-secondary, β-[(hydroxyethyl)amino]",284-279-6,84836-93-1,Not Classified,Notified C&L,20,Not classified:20
102112,"dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]methyl} imidazole-4,5-dicarboxylate",443-910-7,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
102113,Dipotassium aquapentachlororuthenate,238-374-4,14404-33-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
102115,"6,9,10-trimethylundeca-3,5,9-trien-2-one",211-450-4,645-68-1,Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,2,H411:2;H315:2;H317:2
102116,"3-(2H-Benzotriazolyl)-5-(1,1-di-methylethyl)-4-hydroxy-benzenepropanoic acid octyl esters",603-204-3,127519-17-9,Aquatic Chronic 2,Notified C&L,156,H411:156
102119,Calcium zirconium trioxide,234-586-6,12013-47-7,Not Classified,Notified C&L,3,Not classified:3
102125,"Distillates (petroleum), catalytic reformed hydrotreated light, C",285-509-8,85116-58-1,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
102126,4-ethylmorpholine 4-oxide,220-402-1,2754-11-2,Ox. Liq. 2,Notified C&L,1,H272:1
102128,"3,3-diphenylpropyl methyl ammonium chloride",608-414-9,29768-15-8,Eye Irrit. 2;STOT SE 3,REACH registration C&L,1,H319:1;H335:1
102136,Veratraldehyde,204-373-2,120-14-9,Acute Tox. 4;Skin Sens. 1B,REACH registration C&L,1749,H302:1749;H317:66;H319:102;H315:105;H335:8;H301:1;H314:1;H331:1;H411:1
102138,Tetradecan-3-one,211-081-9,629-23-2,Eye Irrit. 2,Notified C&L,38,H319:38
102141,Desoxycortone,200-596-4,64-85-7,Carc. 2;STOT RE 2,Notified C&L,38,H373:38;H351:38
102142,1-bromo-2-nitrobenzene,209-409-0,577-19-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H319:45;H315:45;H302:43;H335:44;H373:8;H332:5;H312:5;H301:6;H330:3;H311:6;H331:3;H411:1;H412:1
102143,"Polyphenyls, quater- and higher, partially hydrogenated",273-316-1,68956-74-1,,Notified C&L,65,Not classified:65
102144,Disodium hydroxy(sulfonato)acetate,608-408-6,29736-24-1,Not Classified,REACH registration C&L,513,Not classified:72;H319:441
102149,3-[3-(2-dodecyloxy-5-methylphenylcarbamoyl)-4-hydroxy-1-naphthylthio]propionic acid,421-490-6,167684-63-1,Aquatic Chronic 4,Harmonised C&L,0,H413:0
102152,2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropionic acid,255-626-9,42017-89-0,Acute Tox. 4;Aquatic Chronic 1,REACH registration C&L,95,H302:94;H410:1;H413:51;H400:39;H319:2;H315:2;H335:2;H373:1;H361:1;H351:1;H261:1;H411:1
102153,"Pyrrolidine, 1-[[(4-nitrophenyl)methyl]sulfonyl]-",608-939-3,340041-91-0,Not Classified,Notified C&L,1,Not classified:1
102154,4-methyl hydrogen L-aspartate hydrochloride,240-880-5,16856-13-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
102163,6-Bromohexan-1-ol,610-072-0,4286-55-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H315:47;H335:45
102165,"3,4-Difluor-4-(4-trans-propylcyclohexyl)-[1,1-biphenyl]",617-701-8,85312-59-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:1;H315:1;H413:1;Not classified:1
102170,[2-[[4-[(2-chloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]trimethylammonium acetate,286-185-0,85187-95-7,Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,8,H318:8;H400:6;H317:6;H410:6;H412:2
102171,"2,3-dichloro-6-(trichloromethyl) pyridine",610-670-1,51492-01-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,55,H319:55;H315:55;H302:55
102178,"N,N-dimethyl-9-[3-(4-methylpiperazin-1-yl)propylidene]-9H-thioxanthene-2-sulphonamide",227-001-0,5591-45-7,,Notified C&L,1,H351:1;H302:1
102179,"2,2,3,3,4,4,4-heptafluorobutyl acrylate",207-036-8,424-64-6,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H302:38;H226:44;H335:44;H319:44;H332:38;H312:38;H315:6;H411:4
102186,"Reaction mass of 4,8-diamino-2-[4-(2-ethoxyethoxy)phenyl]-1,5-dihydroxy-9,10-anthraquinone and 4,8-diamino-2-(4-ethoxyphenyl)-1,5-dihydroxy-9,10-anthraquinone",600-569-0,104491-84-1,Skin Sens. 1,REACH registration C&L,1,H317:1
102187,Dec-9-en-1-ol,235-878-6,13019-22-2,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1749,H319:1730;H315:1749;H335:39
102192,N-4-hydroxyphenylstearamide,203-165-9,103-99-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
102194,"Di-μ-chlorodichlorobis[(1,2-η)-cyclohexene]diplatinum, stereoisomer",262-073-7,60134-75-0,Flam. Liq. 3;Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1,Notified C&L,12,H334:11;H317:11;H302:8;H226:7;H315:5;H335:4;H319:5;H332:1;H312:1;H413:1
102200,"1-(2-fluoro[1,1'-biphenyl]-4-yl)ethan-1-one",255-935-9,42771-79-9,,Notified C&L,1,H302:1
102202,"Galactosidase, α-",232-792-0,9025-35-8,Resp. Sens. 1,Notified C&L,13,H334:13
102204,5-ethyl-4-hydroxy-2-methylfuran-3(2H)-one,248-513-0,27538-09-6,,Notified C&L,1259,H319:1259;H315:1259;H302:1259
102205,"Oils, Macadamia tetraphylla",603-277-1,128497-20-1,Not Classified,Notified C&L,2,Not classified:2
102207,Trisodium 5-[[5-methyl-4-[(4-nitro-2-sulphonatophenyl)azo]-2-(3-sulphonatopropoxy)phenyl]azo]salicylate,277-753-9,74186-17-7,Not Classified,Notified C&L,1313,Not classified:1313
102208,"Bentonite, calcined",292-716-7,90989-60-9,Not Classified,Notified C&L,34,Not classified:34
102218,Hexadecylamine,205-596-8,143-27-1,Skin Corr. 1;Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,98,H373:21;H318:36;H304:3;H314:97;H400:93;H410:53;H302:52;H315:1
102219,"2-Propenoic acid, 2-methyl-, 3-(trimethoxysilyl)propyl ester, reaction products with vitreous silica",310-178-4,122334-95-6,Not Classified,Notified C&L,1,Not classified:1
102223,tert-butylpyrazine,251-186-7,32741-11-0,Flam. Liq. 3;Acute Tox. 4,Notified C&L,93,H302:88;H226:88;H319:5;H315:5;H335:4
102224,Potassium toluenesulphonate,250-228-1,30526-22-8,,Notified C&L,1,Not classified:1
102226,Iron phosphide,235-798-1,12751-22-3,Flam. Sol. 1;Self-heat. 1,Notified C&L,92,H251:83;H228:85;Not classified:5;H370:2;H360:2;H372:2
102227,"BISPHENOL A, EPICHLOROHYDRIN, DIETHYLENETRIAMINE",614-663-4,68610-56-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,27,H319:20;H315:20;Not classified:7
102229,Trichloro(dodecyl)silane,224-769-9,4484-72-4,Skin Corr. 1B,Notified C&L,43,H314:43;H318:1;H290:1
102232,Bromotrimethylgermane,213-913-6,1066-37-1,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,38,H314:38;H226:38
102233,"9,10,12,13-tetrabromooctadecanoic acid",217-266-0,1794-89-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
102234,(5α).-androstane,207-116-2,438-22-2,Not Classified,Notified C&L,3,Not classified:3
102235,"O,O,O-tris(2(or 4)-C",406-940-1,126019-82-7,Aquatic Chronic 2,Harmonised C&L,0,H411:0
102237,"Fennel, Foeniculum vulgare dulce, ext.",282-892-3,84455-29-8,Acute Tox. 4;Asp. Tox. 1;Skin Sens. 1;Muta. 2;Carc. 2,Notified C&L,386,H302:342;H304:384;H351:384;H317:386;H341:384;H411:111;H315:40;H226:40;H319:37;H371:36;H410:36;H316:1;H227:1;H401:1;H332:1
102238,"1,1,1,3,5,5,5-heptamethyltrisiloxane",217-496-1,1873-88-7,Flam. Liq. 3,REACH registration C&L,145,H226:43;H225:102;H315:102;H319:102;H335:101
102243,2-chloropropyl(diethyl)amine hydrochloride,212-788-5,869-25-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:1
102244,Lymecycline,213-592-2,992-21-2,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1,Notified C&L,2,H334:1;H332:1;H302:1;H317:1;H315:1;H335:1;H361:1;H319:1;H362:1
102252,tert-butyl piperazine-1-carboxylate,611-489-0,57260-71-6,Not Classified,REACH registration C&L,68,Not classified:10;H319:51;H315:51;H335:50;H314:7;H318:1;H302:1;H411:1
102255,"thioquinox (ISO);2-thio-1,3-dithiolo(4,5,b)quinoxaline",202-272-8,93-75-4,Acute Tox. 4,Harmonised C&L,0,H302:0
102259,"1- Cyclopropyl- 6- fluoro- 1,4- dihydro- 4- oxo- 7- (1- piperazinyl)- 3-quinolinecarboxylic acid hydrochloride monohydrate",617-845-1,86393-32-0,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,172,H319:133;H412:115;Not classified:27;H334:14;H317:15;H315:14;H335:13;H410:3;H302:3;H336:1;H373:1;H400:2;H413:1;H362:1;H411:1;H361:1;H332:1;H312:1
102261,Olibanum,232-474-1,8050-07-5,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1522,H315:1471;H226:1480;H304:1480;H400:1469;H317:1511;H410:1462;H411:48;H412:2;H316:1;H401:1;H302:1
102263,"Calcium diethyl bis[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]phosphonate]",265-512-0,65140-91-2,STOT SE 3,REACH registration C&L,163,H335:93;Not classified:69;H334:1
102266,"phosmet (ISO); S-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl] O,O-di-methyl phosphorodithioate; O,O-dimethyl-S-phthalimido-methyl phosphorodithioate",211-987-4,732-11-6,Acute Tox. 3;Acute Tox. 4;STOT SE 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H370:0;H301:0;H361:0;H400:0;H332:0;H410:0
102268,Potassium ruthenium tetraoxide,233-835-6,10378-50-4,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H272:42;H335:42
102274,"2',(2')'-dibenzylideneoxalohydrazide",229-617-5,6629-10-3,Acute Tox. 4;Acute Tox. 4,Notified C&L,90,H312:55;H302:55;H319:21;H315:21;H317:21;Not classified:14
102278,"3,5,5-trimethylhexanoic acid",221-975-0,3302-10-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,793,H318:257;H315:288;H302:780;H319:528;H412:20;Not classified:8;H335:6
102280,MEXANYL GZ,416-630-8,,Not Classified,REACH registration C&L,4,Not classified:3;H413:1
102281,"2-bromo-1,1,3-trimethoxypropane",212-074-3,759-97-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
102282,"Alcohols, C7-9-iso-, C8-rich, ethoxylated",616-606-9,78330-19-5,Eye Irrit. 2,Notified C&L,78,H319:56;H315:43;H318:2;H302:1;H412:1;H400:1;H411:1
102284,Dodecamethylenediamine,220-489-6,2783-17-7,Acute Tox. 4;Skin Corr. 1;Eye Dam. 1;Acute Tox. 3;Aquatic Acute 1,REACH registration C&L,55,H318:7;H302:51;H314:45;H331:3;H400:2;Not classified:4;H317:44;H319:5;H315:6;H335:5;H411:1
102294,Mixture of isomers,405-820-6,30025-38-8,Not Classified,REACH registration C&L,4,Not classified:4
102295,"Fatty acids, palm-oil, potassium salts",266-119-7,66072-07-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H319:4;H315:4
102298,"4-(2,2,3-trimethyl-6-methylenecyclohexyl)-3-buten-2-one",201-218-0,79-68-5,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,10,H400:10;H317:10;H410:10
102300,"Protein hydrolyzates, silk, Et esters",605-555-8,169590-80-1,Not Classified,Notified C&L,1,Not classified:1
102301,"N-(tert-butoxycarbonyl)-1-(2,4-dinitrophenyl)-L-histidine",246-569-0,25024-53-7,Eye Irrit. 2,Notified C&L,1,H319:1
102309,"reaction product of toluenediisocyanate ( reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate) and aniline (molarratio 1:2)",430-960-1,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
102312,DL-pin-2(3)-ene,219-445-9,2437-95-8,Skin Irrit. 2,Notified C&L,31,H315:31
102313,2-chloropyridine 1-oxide,219-284-4,2402-95-1,,Notified C&L,4,H315:4;H302:4;H335:4;H319:4;H332:4;H312:4
102317,"(S)-4'-(2-methylbutyl)[1,1'-biphenyl]-4-carbonitrile",264-464-8,63799-11-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:1;H315:1;H302:1;H413:1;Not classified:1
102320,Scandium oxide,235-042-0,12060-08-1,Not Classified,Notified C&L,31,Not classified:29;H413:1;H319:1;H315:1;H335:1
102321,3-Fluoro-4-methoxybenzonitrile,608-835-8,331-62-4,,Notified C&L,6,H315:6;H302:4;H319:6;H332:4;H312:4;H301:2;H335:1;H331:1;H311:1
102323,Aluminum magnesium zinc carbonate hydroxide,605-549-5,169314-88-9,Aquatic Chronic 3,Notified C&L,117,H412:101;Not classified:16
102324,1-fluorooctane,207-333-2,463-11-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H226:38;H335:39
102327,3-hydroxy-4-methoxycinnamic acid,208-676-0,537-73-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
102329,"Leptactina senegambica, ext.",305-095-5,94334-14-2,Acute Tox. 4;Acute Tox. 2,Notified C&L,81,H330:52;H302:52;H331:18;Not classified:11;H317:1
102332,"Toluene, dibenzyl derivative",249-706-2,29589-57-9,Aquatic Chronic 4,Notified C&L,38,H413:38
102343,4-(trifluoromethyl)phenylacetonitrile,219-052-2,2338-75-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H315:44;H302:43;H335:43;H319:44;H332:43;H312:43;H301:2;H331:2;H311:2
102345,"9-chloro-6α-fluoro-11β,21-dihydroxy-16α-methylpregna-1,4-diene-3,20-dione 21-hexanoate",225-513-9,4891-71-8,Repr. 1A;STOT RE 1,Notified C&L,24,H372:24;H360:24
102348,"(±)-7-[(3-chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid S,S-dioxide",276-851-9,72797-41-2,Repr. 2;Lact.;STOT RE 2,REACH registration C&L,2,H362:2;H361:2;H373:2
102351,"3,3-dimethylbutyryl chloride",230-356-4,7065-46-5,Flam. Liq. 2;Skin Corr. 1C,REACH registration C&L,46,H225:46;H314:7;H318:40;H315:39;H290:1
102352,2-methoxyphenylacetone,226-008-6,5211-62-1,Not Classified,REACH registration C&L,3,Not classified:2;H319:1;H315:1;H335:1
102358,Dipotassium trithiocarbonate,209-531-4,584-10-1,Not Classified,Notified C&L,20,Not classified:20
102366,Methyl 3-phenylpropionate,203-092-2,103-25-3,Not Classified,Notified C&L,234,Not classified:234
102369,"2,5-dibromopyridine",210-839-6,624-28-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H315:47;H335:46;H302:1;H332:1;H312:1
102372,thallium,231-138-1,7440-28-0,Acute Tox. 2;Acute Tox. 2;STOT RE 2;Aquatic Chronic 4,Harmonised C&L,0,H373:0;H300:0;H330:0;H413:0
102373,3-thietan-1-ol,233-678-3,10304-16-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H302:1;H335:1;H319:1;H332:1;H312:1
102374,2-chloro-p-toluidine,210-440-7,615-65-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,44,H318:38;H315:43;H302:42;H412:38;H332:42;H312:42;H373:4;H319:5;H370:1;H372:1;H301:2;H331:2;H311:2
102376,"Alkanes, C1-2;Petroleum gas",270-651-5,68475-57-0,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;Not classified:0;H340:0
102377,"Ruthenium, di-.mu.-chlorodichlorobis[(1,2,3,4,5,6-.eta.)-1-methyl-4-(1-methylethyl)benzene]di-",922-316-6,52462-29-0,,Notified C&L,33,Not classified:33
102378,3-methyl-(1H)-pyrazin-2-one,243-362-7,19838-07-4,,Notified C&L,5,H319:5;H315:5;H335:4
102383,Pentyl toluene-4-sulphonate,224-693-6,4450-76-4,Acute Tox. 4;Skin Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,38,H413:38;H315:38;H302:38;H335:38
102386,"1,8-diamino-4,5-dihydroxyanthraquinone",204-921-0,128-94-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:38;H315:38;H335:38;H317:3;Not classified:1
102387,"Alkyl iodides, C8-14, γ-ω-perfluoro",289-100-5,85995-91-1,Not Classified,Notified C&L,37,Not classified:37
102393,"1-(2,2,3,3,4,4,4-heptafluoro-1-oxobutyl)-1H-imidazole",251-063-8,32477-35-3,,Notified C&L,7,H319:7;H315:7;H335:5
102394,Sodium [N-[2-[bis(carboxymethyl)amino]ethyl]-N-(2-hydroxyethyl)glycinato(3-)]manganate(1-),260-381-6,56779-88-5,Not Classified,Notified C&L,1,Not classified:1
102403,4-hydroxyquinoline-2-carboxylic acid,207-751-5,492-27-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
102405,"Ammonium [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']ferrate(1-)",244-302-2,21265-50-9,Not Classified,Notified C&L,149,Not classified:93;H319:56
102408,Sodium 4-hydroxynaphthalene-1-sulphonate,228-050-0,6099-57-6,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,40,H319:4;H315:4;Not classified:36;H335:2
102412,"N,N-Diisopropylmethylamine",600-434-6,10342-97-9,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,38,H225:38;H314:38
102418,"4,5-dihydro-2-undecyl-1H-imidazole-1-ethanol",205-271-0,136-99-2,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,464,H318:3;H302:3;H314:4;H400:3;H410:3;Not classified:441;H319:19
102420,"dichloro-1,3,5-triazinetrione;dichloroisocyanuric acid",220-487-5,2782-57-2,Ox. Sol. 2;Acute Tox. 4;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H335:0;H319:0;H400:0;H272:0;H410:0
102421,3-(trifluoromethyl)-o-toluidine,259-145-5,54396-44-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,60,H319:48;H315:48;H335:41;H318:11;H314:11;H302:19;H330:11;H332:7;H312:7;H301:2;H311:2
102423,n-butyronitrile,203-700-6,109-74-0,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Harmonised C&L,0,H225:0;H301:0;H311:0;H331:0
102425,"Benzenamine, 3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)-",601-780-0,121451-05-6,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1,Notified C&L,1,Not classified:1;H302:1;H317:1;H410:1
102431,Barium 3-hydroxy-4-[(4-methyl-2-sulphonatophenyl)azo]-2-naphthoate,241-806-4,17852-98-1,Not Classified,REACH registration C&L,47,Not classified:29;H302:18
102432,3-(N-benzyl-N-methylamino)propan-1-ol,227-381-8,5814-42-6,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H315:1;H335:1
102436,"Magnesium, Bu octyl complexes",304-790-0,94279-45-5,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1B,REACH registration C&L,18,H250:18;H314:18;H260:18
102437,Bis(3-aminopropiononitrile) fumarate,218-208-7,2079-89-2,Repr. 1B,Notified C&L,43,H360:39;H361:4;H319:1;H315:1;H302:1
102438,"Light oil (coal), semi-coking process;Fresh oil;[The volatile organic liquid condensed from the gas evolved in the low-temperature (less than 700°C (1292°F)) destructive distillation of coal. Composed primarily of C",292-635-7,90641-11-5,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
102440,Biuret,203-559-0,108-19-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,292,H319:261;H315:261;H335:260;Not classified:31
102443,"2,4-bis[(4-dodecylphenyl)azo]resorcinol",265-390-9,65087-00-5,Not Classified,REACH registration C&L,201,Not classified:201
102444,"Ethanone, 2-chloro-1-(3-hydroxyphenyl)-",613-113-0,62932-90-5,Acute Tox. 3;Aquatic Chronic 3,Notified C&L,83,H301:83;H412:83
102450,Diisotridecyl hydrogen phosphate,248-208-2,27073-01-4,Not Classified,Notified C&L,6,Not classified:2;H314:3;H318:2;H302:1;H315:1
102451,"Lithium 2-[4-[(hexahydro-2,4,6-trioxopyrimidin-5-yl)azo]phenyl]-6-methylbenzothiazole-7-sulphonate",252-518-3,35342-16-6,,Notified C&L,84,Not classified:84
102452,"1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione",207-280-5,458-37-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,220,H319:208;H315:207;H335:206;Not classified:12
102453,"Stearic acid, monoester with triglycerol",248-403-2,27321-72-8,Not Classified,Notified C&L,28,Not classified:28
102454,2-chloro-5-nitrobenzoic acid,219-739-7,2516-96-3,Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,55,H319:16;H317:9;H318:38;H315:45;H302:40;H335:45;H400:38;H412:1
102455,4-hydroxyindole,219-177-2,2380-94-1,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,50,H318:2;H315:49;H302:3;H335:48;H317:2;H411:2;H319:47
102456,Diboron cobalt(2+) tetraoxide,253-842-8,38233-75-9,Not Classified,Notified C&L,1,Not classified:1
102457,"Fatty acids, C8-18 and C18-unsatd., distn. residues",274-562-2,70321-72-1,Not Classified,Notified C&L,17,Not classified:9;H319:8;H315:1
102459,"3,8-dinitro-6-phenylphenanthridine",280-064-6,82921-86-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
102461,Epoxiconazole,603-768-0,133855-98-8,Carc. 2;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,196,H351:196;H400:156;H360:194;H411:196;H361:2
102464,2-ethoxy-3-methylpyrazine,251-184-6,32737-14-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,129,H319:129;H315:129;H335:128
102468,Difluoro(fluorosulphonyl)acetyl fluoride,211-642-8,677-67-8,Skin Corr. 1B;Eye Dam. 1,Notified C&L,39,H318:38;H314:39;H301:1;H330:1;H311:1
102471,p-bromoethylbenzene,216-439-8,1585-07-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,13,H319:10;H315:10;H335:9;Not classified:3
102472,"Dipotassium 1,3,4-thiadiazole-2,5-dithiolate",225-043-4,4628-94-8,Acute Tox. 4,Notified C&L,1,H302:1
102474,4-tert-butylphenol formaldehyde resin,607-533-3,25085-50-1,Not Classified,Notified C&L,301,Not classified:130;H317:120;H400:51;H410:51
102476,"Betaines, C12-14-alkyldimethyl",266-368-1,66455-29-6,Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,246,H412:100;H318:116;H314:99;H319:115;H315:147;H335:69;H400:37
102480,GLYCERYL POLY(OXYPROPYLENE) TRIAMINE,613-700-1,64852-22-8,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,377,H412:198;H318:368;H315:317;H319:109;H312:52;H314:53;H302:52;H301:33;H411:34;Not classified:5;H335:2
102482,"1-(4-methoxy-2,2,6,6-tetramethyl-3-cyclohexen-1-yl)ethan-1-one",240-621-6,16556-48-2,Acute Tox. 4;Skin Sens. 1,Notified C&L,1374,H302:1374;H317:1374
102486,"Ethyl 2,3,6,6-tetramethylcyclohex-2-ene-1-carboxylate",278-776-7,77851-07-1,Not Classified,Notified C&L,113,Not classified:113
102488,"Magnesium, l-aspartate potassium complexes",308-013-6,97808-90-7,Not Classified,Notified C&L,1,Not classified:1
102492,"Europium (III) chloride, anhydrous",233-040-4,10025-76-0,Eye Dam. 1;Aquatic Chronic 2,Notified C&L,7,H411:4;H318:4;Not classified:1;H319:2;H315:2;H335:1
102494,Cydonia oil,616-989-2,8016-84-0,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Resp. Sens. 1;Aquatic Acute 1,Notified C&L,113,H315:112;H226:74;H304:88;H400:39;H334:39;H317:49;H411:49
102495,Santalol,234-262-4,11031-45-1,Skin Sens. 1B,Notified C&L,1401,H317:1323;Not classified:78
102499,2-Fluor-1-trifluormethoxy-4-[4-(trans-4-propylcyclohexyl)-1-cyclohexen-1-yl]-benzene,929-211-4,,Not Classified,Notified C&L,1,Not classified:1
102502,Butyl toluene-4-sulphonate,212-295-5,778-28-9,Skin Sens. 1B;Muta. 2,REACH registration C&L,59,H341:2;H317:2;H302:38;H319:19;H315:19;H335:18
102507,"2,5-diethyl-3,4-diphenylcyclopenta-2,4-dien-1-one",257-523-4,51932-77-5,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H410:38
102511,Divanadium tris(sulphate),237-226-6,13701-70-7,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1;Repr. 2;Aquatic Chronic 3,REACH registration C&L,44,H318:4;H290:4;H412:2;H314:4;H361:4;H372:2;H411:2;H302:38;Not classified:2
102512,"3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,14-pentacosafluorotetradecane-1-sulphonyl chloride",272-148-6,68758-57-6,,Notified C&L,47,Not classified:47
102516,"2,5-difluorobenzyl alcohol",278-325-4,75853-20-2,Eye Dam. 1,Notified C&L,45,H318:38;H319:7;H315:7;H335:5
102517,Sodium hydrogen maleate,221-461-6,3105-55-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:41;H315:41;H335:40;H302:3;H317:2
102518,"Naphtha (petroleum), heavy straight run, arom.-contg.;Low boiling point naphtha;[A complex combination of hydrocarbons obtained from a distillation process of crude petroleum. It consists predominantly of hydrocarbons having carbon numbers in the range of C",309-945-6,101631-20-3,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
102520,"3,3,3-trifluoro-DL-alanine",241-478-2,17463-43-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:44
102521,2-oxo-4-phenylbutyric acid,211-916-7,710-11-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
102528,"Santolina chamaecyparissus, ext.",284-647-6,84961-58-0,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1,Notified C&L,277,H304:277;H317:277;H226:277;H412:92
102532,7-hydroxy-3-(4-hydroxyphenyl)-4-benzopyrone,207-635-4,486-66-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,53,H319:49;H315:49;H335:5;Not classified:3;H312:1;H332:1;H302:1
102533,"Carbonic acid, ethyl methyl ester",433-480-9,623-53-0,Flam. Liq. 2,Notified C&L,108,H225:93;Not classified:15
102534,"Aluminium, compound with titanium (3:1)",234-461-6,12004-78-3,,Notified C&L,4,H319:4;H315:4;H228:4;H335:4
102540,"Alcohols, C16-18",267-008-6,67762-27-0,Not Classified,REACH registration C&L,2109,Not classified:693;H319:1336;H315:1336;H413:80;H412:1
102541,Isononyl heptanoate,275-878-3,71720-31-5,Not Classified,Notified C&L,1,Not classified:1
102542,"2-(4-methoxyphenyl)-5-(1-naphthyl)-1,3,4-oxadiazole",254-112-1,38736-16-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,38,H315:38;H302:38;H335:38;H319:38;H413:38
102546,"Quaternary ammonium compounds, C12-18-alkyl[(ethylphenyl)methyl]dimethyl, chlorides",273-318-2,68956-79-6,Flam. Liq. 3,Notified C&L,67,H226:28;H400:34;H314:34;H302:37;H312:19;Not classified:5
102549,"Lecithins, hydrogenated",295-786-7,92128-87-5,Not Classified,REACH registration C&L,196,Not classified:196
102551,Naphthalene-2-sulphonic acid,204-375-3,120-18-3,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,286,H318:237;H314:284;H302:140;H351:28;H411:28;H290:6;Not classified:1
102552,"2,2-dimethoxyethylamine",245-026-5,22483-09-6,Flam. Liq. 3;Skin Corr. 1B,REACH registration C&L,94,H314:93;H226:93;H318:6;Not classified:1
102554,1-dimethylamino-2-methylbutan-2-ol,277-827-0,74347-10-7,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B,Notified C&L,1,H314:1;H302:1;H226:1
102561,2-[(4-methylphenyl)methylene]heptan-1-al,283-718-9,84697-09-6,Not Classified,Notified C&L,248,Not classified:225;H411:23;H400:23;H317:23;H410:23
102563,2-methylpropyl 2-(dimethylamino)benzoate,270-898-9,68480-21-7,Not Classified,Notified C&L,88,Not classified:88
102566,"2,4-dicyano-3-methylglutaramide",226-665-9,5447-66-5,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,38,H301:38;H331:38;H311:38
102568,Ethenzamide,213-346-4,938-73-8,Not Classified,Notified C&L,24,Not classified:24
102570,"1,2,4-Benzenetricarboxylic acid, decyl octyl ester",268-007-3,67989-23-5,Not Classified,Notified C&L,161,Not classified:161
102574,3-methoxy-3-methylbutan-1-ol,260-252-4,56539-66-3,Eye Irrit. 2,REACH registration C&L,1918,H319:1901;H304:15;H336:15;Not classified:2;H302:2;H318:1
102576,"Disodium [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']magnesate(2-)",238-372-3,14402-88-1,Not Classified,REACH registration C&L,112,Not classified:108;H318:4
102577,"1,2,3,4,5,6,7,8-octahydroanthracene",214-094-8,1079-71-6,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 2,Notified C&L,38,H411:38;H318:38;H315:38;H335:38
102580,"1,2,3,6-tetrahydropyridine",211-766-2,694-05-3,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H225:39;H315:40;H319:40;H335:40
102588,"6-Methyleneandrost-4-ene-3,17-dione",606-312-9,19457-55-7,Repr. 2,Notified C&L,5,H361:5;H315:2;H302:2;H335:2;H319:2
102589,"chlordane (ISO);1,2,4,5,6,7,8,8-octachloro-3a,4,7,7a-tetrahydro-4,7-methanoindan",200-349-0,57-74-9,Acute Tox. 4;Acute Tox. 4;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H351:0;H400:0;H410:0;H312:0
102590,2-hexyldecyl 12-[(1-oxooctadecyl)oxy]octadecanoate,309-389-4,100258-45-5,Not Classified,Notified C&L,1,Not classified:1
102592,Slack wax (petroleum);[A complex combination of hydrocarbons obtained from a petroleum fraction by solvent crystallization (solvent dewaxing) or as a distillation fraction from a very waxy crude. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C,265-165-5,64742-61-6,Carc. 1B,Harmonised C&L,0,H350:0
102594,"Benzenemethanethiol, .alpha.-methyl-",613-066-6,6263-65-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT RE 2,Notified C&L,1417,H373:1412;H315:1416;H302:1328;H335:1416;H319:1416;H400:38;H332:42;H410:38;H312:42;Not classified:1
102599,Vinylpyrazine,224-045-2,4177-16-6,Acute Tox. 4,Notified C&L,132,H302:126;H318:38;H315:42;H226:44;H335:42;H319:4;H301:1;H311:1;H331:1
102602,Trimethylsilyl isocyanate,214-256-8,1118-02-1,Flam. Liq. 2;Eye Irrit. 2;Acute Tox. 3;Resp. Sens. 1;STOT SE 3,Notified C&L,45,H335:45;H225:45;H319:44;H331:41;H334:45;H315:6;H330:4;H301:1
102607,"2-[(3,3,5-trimethylcyclohexyl)acetyl]cyclopentan-1-one",283-434-5,84642-57-9,Not Classified,Notified C&L,88,Not classified:88
102614,Ethyl dichlorofluoroacetate,206-849-5,383-61-9,,Notified C&L,1,H314:1
102615,Calcium tin trioxide,234-585-0,12013-46-6,Carc. 1A;Aquatic Chronic 3,REACH registration C&L,6,H350:1;H412:1;H319:5;H315:5;H335:5
102617,1-[(dimethylamino)ethyl]-4-methylpiperazine,249-705-7,29589-40-0,Skin Corr. 1B;Skin Sens. 1B;Eye Dam. 1;Resp. Sens. 1,Notified C&L,83,H318:83;H314:83;H334:83;H317:83
102619,Pentyltriphenylphosphonium bromide,244-374-5,21406-61-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44
102620,3-hydroxybenzophenone,235-879-1,13020-57-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
102621,Pentachloroacetone,217-188-7,1768-31-6,Acute Tox. 3;Acute Tox. 1,Notified C&L,2,H301:2;H330:2
102622,Chloroxuron,217-843-7,1982-47-4,Acute Tox. 4;Aquatic Acute 1,Notified C&L,41,H400:38;H332:38;Not classified:3
102623,3-Amino-2-chloro-4-methylpyridine,603-756-5,133627-45-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,45,H318:38;H315:44;H302:44;H335:43;H319:6;H332:5;H312:5;H301:1
102627,4-(2-Propyn-1-yl)morpholine,611-607-0,5799-76-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H226:1;H335:1
102630,Diethyl hexafluoroglutarate,207-035-2,424-40-8,,Notified C&L,8,H319:5;H315:5;H332:6;H335:5;H314:2;H312:1;H302:1;H330:1
102631,"Poly[imino(1-oxo-1,12-dodecanediyl)]",607-456-5,24937-16-4,Not Classified,Notified C&L,68,Not classified:68
102635,"3-[(4-amino-5-methoxy-o-tolyl)azo]naphthalene-1,5-disulphonic acid",263-264-8,61827-75-6,Not Classified,Notified C&L,2037,Not classified:2037
102636,"Resin acids and Rosin acids, tall-oil, esters with triethylene glycol",284-010-2,84776-84-1,Not Classified,Notified C&L,3,Not classified:3
102637,"Methyl 1,2,3,4-tetrahydro-6-quinolyl ether",204-374-8,120-15-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
102638,Sodium laurate,211-082-4,629-25-4,Skin Irrit. 2;Eye Dam. 1,Notified C&L,222,H318:122;H315:137;Not classified:53;H335:52;H319:47;H411:2
102639,"2-(4,6-Diphenyl-1,3,5-triazin-2-yl)-5-((hexyl)oxy)-phenol",604-583-8,147315-50-2,Aquatic Chronic 4,Notified C&L,106,H413:106
102640,Dicyclopropyl ketone,214-331-5,1121-37-5,Flam. Liq. 3,Notified C&L,101,H226:101;H318:6;H315:6;H302:6;H335:4;Not classified:2;H412:1
102645,Ethyl [(4-methylphenyl)sulphonyl]carbamate,226-952-9,5577-13-9,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,5,H319:3;H412:2;H302:2;H315:1;H335:1
102647,2-chloro-6-methylnicotinic acid,250-229-7,30529-70-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
102652,"Naphthalenesulfonic acids, polymers with formaldehyde, sodium salts",617-836-2,86352-09-2,Not Classified,Notified C&L,6,Not classified:6
102653,"Polyphosphoric acids, potassium salts",273-317-7,68956-75-2,Not Classified,Notified C&L,1,Not classified:1
102654,3-allylrhodanine,215-941-4,1457-47-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
102658,"6-cyclohexyl-1-hydroxy-4-methylpyridin-2(1H)-one, compound with 2-aminoethanol (1:1)",255-464-9,41621-49-2,Ox. Sol. 1;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,108,H318:8;H271:4;H314:4;H400:60;H317:9;H410:7;H319:47;H315:48;H335:46;H302:3;H332:4;H334:5;Not classified:1;H373:1;H361:1;H312:1;H228:1
102661,"Docosanoic acid, monoester with glycerol",250-097-0,30233-64-8,Not Classified,REACH registration C&L,22,Not classified:22
102664,"Disodium 2,2'-methylenebisnaphthalenesulphonate",305-377-8,94481-50-2,Not Classified,Notified C&L,1,Not classified:1
102665,"D-gluconic acid, compound with 2-aminoethanol (1:1)",243-795-1,20405-61-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,28,H319:25;H315:25;Not classified:3
102670,4-(Phenylthio)-benzenamine,601-260-3,1135-14-4,Acute Tox. 4,Notified C&L,38,H302:38
102673,"Pomegranate, ext.",284-646-0,84961-57-9,Not Classified,Notified C&L,117,Not classified:116;H319:1
102675,Chlorodimethylsilane,213-912-0,1066-35-9,Flam. Liq. 1;Water-react. 3;Skin Corr. 1A;Acute Tox. 3,REACH registration C&L,2353,H331:2263;H261:2263;H314:2339;H224:2269;H225:80;H318:71;H315:10;H319:10;H335:10;Not classified:4;H290:1
102676,(S)-piperidine-2-carboxylic acid,221-462-1,3105-95-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:45
102678,"4-hydroxy-2,5-dimethylfuran-2(3H)-one",222-908-8,3658-77-3,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1A;Eye Dam. 1,REACH registration C&L,1820,H318:61;H314:62;H302:510;H317:1401;H319:1339;H400:24;Not classified:1;H320:1
102680,"potassium sodium 4-(4-chloro-6-(3,6-disulfonato-7-(5,8-disulfonato-naphthalen-2-ylazo)-8-hydroxy-naphthalen-1-ylamino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-(2-sulfatoethanesulfonyl)-phenylazo)-naphthalene-1,7-disulfonate",412-490-7,,Skin Sens. 1,Harmonised C&L,0,H317:0
102681,"1,4,7-trioxacyclotridecane-8,13-dione",229-554-3,6607-34-7,Eye Irrit. 2;STOT RE 2,Notified C&L,84,H319:84;H373:84
102686,"Fatty acids, C8-10, compds. with N,N-dimethyl-1,3-propanediamine",297-419-6,93571-91-6,Acute Tox. 4;Skin Corr. 1A;Aquatic Acute 1,Notified C&L,36,H400:36;H314:36;H302:36
102687,4-methoxyphenylacetic acid,203-166-4,104-01-8,Eye Irrit. 2,REACH registration C&L,1333,H319:3;H302:1331;H318:44;H315:45;H335:44
102689,"(2S)-2-[(5α,7α)-3,6-dimethoxy-17-methyl-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-7-yl]-3,3-dimethylbutan-2-ol",605-274-0,16196-70-6,Acute Tox. 2;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1,REACH registration C&L,92,H315:4;H319:92;H300:4;H332:92;H317:4;H334:4;H373:88;H302:88;H361:88
102690,DL-threonine dihydrogen phosphate,248-512-5,27530-80-9,Skin Irrit. 2,Notified C&L,38,H315:38
102696,"Quaternary ammonium compounds, N,N,N'-tris(hydroxyethyl)-N,N'-dimethyl-N'-tallow alkyltrimethylenedi-, dichlorides",295-496-0,92061-83-1,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Aquatic Chronic 1,Notified C&L,58,H318:58;H302:58;H314:58;H400:57;H410:58;H319:1
102697,6-butyltetrahydro-2H-pyran-2-one,221-974-5,3301-94-8,Not Classified,REACH registration C&L,353,Not classified:353
102699,Manganese carbonate,209-942-9,598-62-9,Not Classified,REACH registration C&L,206,Not classified:202;H370:3;H372:4;H411:1
102705,1-[3-(p-fluorobenzoyl)propyl]-4-methylpiperazinium chloride,216-599-9,1622-79-3,Acute Tox. 4,Notified C&L,50,H302:49;Not classified:1;H312:1;H332:1;H361:1
102707,Methyl 2-[[[3-(4-hydroxy-4-methylpentyl)-3-cyclohexen-1-yl]methylene]amino]benzoate,268-252-6,68039-34-9,Not Classified,Notified C&L,233,Not classified:233
102711,1-Ethyl-4-ethynylbenzene,609-817-2,40307-11-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39;H227:1
102713,Bacitracin zinc,215-787-8,1405-89-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,Notified C&L,3,H315:2;H335:2;H412:1;H319:2;H317:2;Not classified:1
102718,"Yam, Dioscorea villosa, ext.",290-441-7,90147-49-2,Not Classified,Notified C&L,7,Not classified:6;H226:1
102723,Allylidene di(acetate),212-789-0,869-29-4,Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 3;STOT SE 3,REACH registration C&L,39,H315:1;H335:1;H319:1;H300:39;H331:39;H314:38
102727,"Phosphoric acid, dodecyl ester",235-799-7,12751-23-4,Skin Corr. 1B,REACH registration C&L,77,H314:35;Not classified:35;H318:30;H319:5;H315:7;H302:1
102728,Octaboron trizinc pentadecaoxide,282-893-9,84455-32-3,Not Classified,Notified C&L,1,Not classified:1
102729,S-phenyl chlorothioformate,236-679-7,13464-19-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H302:38;H335:38
102730,"2,2',4,4'-tetrachlorobiphenyl",219-444-3,2437-79-8,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H373:38;H400:38;H410:38;Not classified:3
102731,"α-D-Glucopyranoside, β-D-fructofuranosyl, polymer with 2-(chloromethyl)oxirane",608-012-3,26873-85-8,Not Classified,Notified C&L,2,Not classified:2
102738,"Fatty acids, rape-oil, Me esters, mixed with rape oil, sulfurized",295-700-8,92128-09-1,,Notified C&L,1,Not classified:1
102739,methylhydrazine,200-471-4,60-34-4,Carc. 1B,Harmonised C&L,0,H350:0
102743,"(E)-3',4'-dimethoxycinnamic acid",238-801-4,14737-89-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,26,H319:26;H315:26;H302:25;H335:26
102745,1-bromo-4-cyclohexylbenzene,246-623-3,25109-28-8,Aquatic Chronic 4,Notified C&L,38,H413:38
102748,Linolenic acid,207-334-8,463-40-1,Not Classified,Notified C&L,2190,Not classified:1903;H317:233;H334:51;H315:23;H319:3;H335:2
102750,"fenoprop (ISO);2-(2,4,5-trichlorophenoxy)propionic acid",202-271-2,93-72-1,Acute Tox. 4;Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H315:0;H302:0;H410:0
102753,3-[(4-amino-2-methoxyphenyl)azo]-5-chloro-4-hydroxybenzensulfonic acid,920-888-1,,Not Classified,REACH registration C&L,2,Not classified:2
102757,N-(3-chloro-4-fluorophenyl)-6-nitro-7-(phenylsulfonyl)quinazolin-4-amine,620-069-6,945553-94-6,Not Classified,REACH registration C&L,3,Not classified:2;H319:1;H360:1
102759,(3-chloro-2-hydroxypropyl)dimethyl[3-[(2-methyl-1-oxoallyl)amino]propyl]ammonium chloride,274-831-4,70729-70-3,Not Classified,Notified C&L,1,Not classified:1
102760,4-Propoxybenzoic Acid,611-129-2,5438-19-7,,Notified C&L,7,H319:7;H315:7;H335:6
102761,3-(trifluoromethyl)phenylacetonitrile,219-053-8,2338-76-3,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H315:47;H302:46;H226:43;H335:46;H319:47;H332:46;H312:46;H301:1
102762,rosin; colophony,232-475-7,8050-09-7,Skin Sens. 1,Harmonised C&L,0,H317:0
102764,"Bentonite, acid-leached, calcined",292-715-1,90989-59-6,Not Classified,Notified C&L,34,Not classified:34
102770,"1H-Pyrazole-3-carboxylic acid, 4,4'-[1,2-ethenediylbis[(3-sulfo-4,1-phenylene)imino(6-chloro-1,3,5-triazine-4,2-diyl)imino(6-sulfo-3,1-phenylene)azo]]bis[4,5-dihydro-5-oxo-1-(4-sulfophenyl)-, hexasodium salt",277-436-5,73398-37-5,Not Classified,Notified C&L,13,Not classified:13
102771,EPTC (ISO);S-ethyl dipropylthiocarbamate,212-073-8,759-94-4,Acute Tox. 4,Harmonised C&L,0,H302:0
102774,Isopropyl thiourea,605-626-3,1719-76-2,,Notified C&L,6,H302:5;H301:1;H332:1;H311:1;H319:1;H315:1;H335:1
102775,1-(methylamino)propan-2-ol,240-712-0,16667-45-1,,Notified C&L,34,Not classified:33;H315:1;H302:1;H335:1;H319:1;H332:1
102776,Tetramethyl-2-thiourea,220-488-0,2782-91-4,Acute Tox. 4,Notified C&L,56,H302:56
102780,"Benzene, 2,4-diisocyanato-1-methyl-, homopolymer",607-844-4,26006-20-2,Skin Sens. 1;Eye Irrit. 2,Notified C&L,208,H319:168;H317:168;H318:38;H334:16;Not classified:2
102783,3-icosenylsuccinic anhydride,258-603-1,53520-67-5,,Notified C&L,34,Not classified:34
102785,9-decenoic acid,238-410-9,14436-32-9,Skin Irrit. 2,Notified C&L,1441,H315:1441;H319:42;H335:41
102786,"Mg-cordierite, aluminium magnesium silicate (4:2:5)",603-401-4,1302-88-1,Not Classified,REACH registration C&L,3,Not classified:3
102788,"2-Naphthalenesulfonic acid, 7-(benzoylamino)-4-hydroxy-3-[[4-[(4-sulfophenyl)azo]phenyl]azo]-, compds. with N,N'-bis(mixed Ph and tolyl and xylyl)guanidine monohydrochloride",277-504-4,73507-36-5,Acute Tox. 4,Notified C&L,1,H302:1
102789,"1,4-diaminoanthraquinone",204-922-6,128-95-0,Acute Tox. 3;Skin Sens. 1;STOT RE 2,Notified C&L,143,H301:91;H373:97;H317:98;Not classified:31;H302:12;H319:9;H315:8;H335:3;H341:1
102791,"1,1,5,5,5-hexamethyl-3-[(trimethylsilyl)oxy]trisiloxane",217-497-7,1873-89-8,Flam. Liq. 3,Notified C&L,43,H226:43
102792,"2,3,5,6-tetrachloropyridine",219-283-9,2402-79-1,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,99,H411:60;H302:61;H317:55;H301:38;H315:5;H335:4;H319:5
102793,Coke (coal),266-010-4,65996-77-2,,Notified C&L,39,Not classified:38;H228:1
102798,"3,3,5-trimethylcyclohexan-1-one",212-855-9,873-94-9,Eye Irrit. 2;STOT SE 3,REACH registration C&L,1395,H319:106;H335:108;H332:1289;H315:61;H302:3;H351:3;H312:3;H318:1
102800,"1H-Benzimidazole, 6-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-, sodium salt, hydrate (2:2:3)",605-368-1,164579-32-2,Acute Tox. 4,Notified C&L,111,H302:110;H412:8;H319:3;H413:3;H315:4;H312:5;H332:5;H335:1;Not classified:1
102801,Samarium (III) oxide,235-043-6,12060-58-1,Not Classified,Notified C&L,190,Not classified:107;H400:83;H410:83
102804,"Mullein, Verbascum thapsus, ext.",290-074-2,90064-13-4,Flam. Liq. 3,Notified C&L,1288,H226:1288
102808,Diallyldibutylstannane,239-368-4,15336-98-8,,Notified C&L,4,H301:4;H315:4;H319:4;H335:4
102809,"Ethanethiol, 2,2'-[1,2-ethanediylbis(oxy)]bis-, polymer with 2,2'-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bis[oxirane]",600-675-7,105710-07-4,Not Classified,Notified C&L,9,Not classified:9
102811,"Physic nut, ext.",290-158-9,90082-68-1,Not Classified,Notified C&L,2,Not classified:1;H319:1;H412:1;H315:1;H302:1
102814,"1,3,5-trifluoro-2-nitrobenzene",206-248-8,315-14-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H315:47;H302:45;H335:41;H319:47;H332:45;H312:45;H330:1;H301:1;H311:1
102816,"2-[[(4-methoxyphenyl)methylhydrazono]methyl]-1,3,3-trimethyl-3H-indolium chloride",254-198-0,38936-35-5,Acute Tox. 3;Eye Dam. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43,H318:42;H330:34;H301:42;H400:36;H410:36;H411:6;Not classified:1;H312:1
102818,Diphenylammonium chloride,208-675-5,537-67-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1
102826,"Dinaphtho[1,2,3-cd:1',2',3'-lm]perylene-9,18-dione, dodecyl derivs.",270-145-4,68411-75-6,Acute Tox. 4,Notified C&L,56,H312:55;H319:1
102828,1-[4-(phenylthio)phenyl]ethan-1-one,233-443-5,10169-55-8,Skin Sens. 1;Eye Dam. 1,Notified C&L,40,H318:39;H317:39;H319:1;H315:1
102831,1-Methoxy-4-(4-trans-propylcyclohexyl)-benzene,617-272-7,81936-32-5,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
102833,Mibolerone,223-046-5,3704-09-4,Repr. 1B,Notified C&L,38,H360:38
102834,"Glycerol, ethoxylated, esters with acrylic acid",500-322-6,144086-03-3,Acute Tox. 4;Skin Sens. 1A;Eye Dam. 1;Acute Tox. 3;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,194,H318:85;H302:86;H335:85;H412:85;H331:85;H317:86;H319:73;Not classified:36
102837,2-hexylcyclopent-2-enone,202-417-5,95-41-0,Not Classified,Notified C&L,1558,Not classified:1546;H315:12
102841,"2-(2,4,6-tribromophenoxy)ethyl acrylate",230-874-0,7347-19-5,Not Classified,Notified C&L,71,Not classified:71
102844,"2,4-diamino-5-phenylthiazole hydrobromide",227-874-8,6020-54-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H302:38;H335:38
102849,Zinc arsenate,236-683-9,13464-44-3,Acute Tox. 3;Acute Tox. 3;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H301:1;H350:1;H331:1;H400:1;H410:1
102857,Dipotassium pentachloronitrosylruthenate,238-919-6,14854-54-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:42
102859,"Poly(oxy-1,2-ethanediyl), α-(1-oxododecyl)-ω-[(1-oxododecyl)oxy]-",618-406-7,9005-02-1,Not Classified,Notified C&L,110,Not classified:90;H319:20
102860,"2,5-dimethylfuran-3-thiol",259-800-5,55764-23-3,Flam. Liq. 3;Acute Tox. 4,Notified C&L,1545,H302:1545;H226:1545
102864,Andalusite (Al2O(SiO4)),235-352-6,12183-80-1,Not Classified,Notified C&L,2,Not classified:2
102865,Citrulline,206-759-6,372-75-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,63,H319:55;H315:55;Not classified:8
102867,"disulfoton (ISO);O,O-diethyl 2-ethylthioethyl phosphorodithioate",206-054-3,298-04-4,Acute Tox. 2;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H300:0;H400:0;H310:0;H410:0
102872,7-hydroxy-8-methylazabicyclo[3.2.1]octan-3-one,227-677-7,5932-53-6,Not Classified,Notified C&L,2,Not classified:2
102873,2-imino-1-methylimidazolidin-4-one hydrochloride,242-898-9,19230-81-0,Not Classified,Notified C&L,1,Not classified:1
102874,Diantimony pentoxide,215-237-7,1314-60-9,Not Classified,REACH registration C&L,799,Not classified:162;H411:494;H302:494;H319:123;H315:123;H335:123;H413:17;H332:9
102876,"2,3-dibromosuccinic acid",208-396-9,526-78-3,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,44,H318:2;H314:43;H319:1;H315:1;H302:1;Not classified:1
102878,m-ethylbenzaldehyde,251-896-7,34246-54-3,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
102880,"4-butylbenzene-1,3-diol",606-191-2,18979-61-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,91,H319:91;H315:91;H400:89;H302:91;H335:1
102882,"N,N'-(2,5-dichloro-1,4-phenylene)bis[4-[[2-chloro-5-(trifluoromethyl)phenyl]azo]-3-hydroxynaphthalene-2-carboxamide]",257-776-0,52238-92-3,Not Classified,REACH registration C&L,147,Not classified:147
102883,"Anthoxanthum odoratum, ext.",289-562-8,89957-44-8,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1414,H411:1379;H302:1318;H412:11;H225:1;H317:1;Not classified:1
102890,"5-(4-methoxyphenyl)-3H-1,2-dithiole-3-thione",208-528-5,532-11-6,Aquatic Acute 1,Notified C&L,1,H400:1;H410:1
102891,"Phosphorous trichloride, reaction products with 1,1'-biphenyl and 2,4-bis(1,1-dimethylethyl)phenol",601-600-0,119345-01-6,Not Classified,Notified C&L,193,Not classified:193
102892,4-chlorobenzothiazol-2-ylamine,243-439-5,19952-47-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
102897,3-methyl-5-nitro-2-pyridone,244-647-9,21901-34-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,44,H318:38;H315:44;H302:38;H335:43;H319:6;H301:1;H331:1;H311:1
102898,Copper(2+) acrylate,243-503-2,20074-76-4,,Notified C&L,5,H319:5;H315:5;H335:5
102902,6-Methoxy-1-indanone,603-948-9,13623-25-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
102909,"[(2R,4R)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl 4-methylbenzenesulfonate",603-791-6,134071-44-6,Not Classified,Notified C&L,1,Not classified:1
102910,Tris(2-(2-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)ethoxy)ethyl)orthoborate,924-843-7,,Not Classified,REACH registration C&L,2,Not classified:2
102914,Naphthalene-2-thiol,202-082-5,91-60-1,Acute Tox. 4,Notified C&L,301,H302:301;H319:5;H315:5;H335:4
102915,"3,6-dichloro-2-(trichloromethyl) pyridine",605-944-2,1817-13-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,144,H319:144;H315:144;H302:144
102917,Triammonium trioxalatoferrate,238-090-0,14221-47-7,Acute Tox. 4;Acute Tox. 4,Notified C&L,2045,H312:2045;H302:2045;H315:1;H335:1;H319:1
102920,Pentyl octanoate,211-328-0,638-25-5,Not Classified,Notified C&L,139,Not classified:139
102921,p-chlorophenylacetic acid,217-521-6,1878-66-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,203,H319:164;H315:164;H335:162;H312:41;H332:41;H302:2
102924,Methyl N-carbamoylmaleamate,203-316-9,105-63-5,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
102925,"1,4:3,6-dianhydro-D-glucitol",211-492-3,652-67-5,Not Classified,REACH registration C&L,119,Not classified:119
102927,2-iodotoluene,210-422-9,615-37-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H319:50;H315:50;H335:49;H302:1;H332:1;H312:1
102929,"2-isobutyl-2-isopropyl-1,3-dimethoxypropane",430-800-9,129228-21-3,Skin Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H315:0
102933,Octyl 2-butenoate,245-279-1,22874-79-9,Not Classified,Notified C&L,89,Not classified:89
102935,N-hydroxybenzamide,207-797-6,495-18-1,,Notified C&L,94,H319:94;H315:94;H341:93;H335:93
102937,Digadolinium trioxide,235-060-9,12064-62-9,Not Classified,REACH registration C&L,260,Not classified:119;H400:83;H410:83;H319:59;H315:1;H335:1;H413:1
102939,"α6-[(tert-butylamino)methyl]-3-hydroxypyridine-2,6-dimethanol monoacetate",265-862-4,65652-44-0,Eye Irrit. 2,Notified C&L,1,H319:1
102941,Ethyl (E)-2-decenoate,230-918-9,7367-88-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1425,H319:1413;H315:1413;H335:1288;Not classified:11;H413:1
102944,1-(2-hydroxyphenyl)-3-phenylpropan-1-one,222-521-4,3516-95-8,Not Classified,REACH registration C&L,174,Not classified:8;H400:83;H410:83;H302:43;H319:40;H315:40;H335:39
102946,"Dichlorobis[1,1'-thiobis[ethane]]platinum",239-373-1,15337-84-5,,Notified C&L,5,H319:5;H315:5;H335:5;H302:1
102947,4-hydroxyphenyl β-D-glucopyranoside,207-850-3,497-76-7,Not Classified,Notified C&L,35,Not classified:33;H319:2;H315:2;H335:2
102949,methyl 2-benzylidene-3-oxobutyrate,420-940-9,15768-07-7,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H319:0;H411:0;H315:0
102954,Nicotinaldehyde (3-pyridylmethylene)hydrazone,236-431-8,13362-77-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
102955,m-nitrobenzenesulphonyl fluoride,206-492-5,349-78-0,Skin Corr. 1B,Notified C&L,40,H314:40
102956,"2-methoxy-1,3-dioxolane",243-229-3,19693-75-5,Flam. Liq. 3,Notified C&L,39,H226:39
102958,"Fatty acids, C12-20 and C12-20-unsatd., sulfated, sodium salts",292-862-1,91001-88-6,Not Classified,Notified C&L,1,Not classified:1
102961,"(1R,4R,5S)- 4-(1,1-Dichloro-2,2,2-trifluoroethyl)-6,6-dimethyl-3-oxabicyclo[3.1.0]hexan-2-one",606-114-2,187592-70-7,Acute Tox. 4,REACH registration C&L,1,H302:1
102963,"1,3-dichloro-1,1,3,3-tetramethyldisiloxane",219-278-1,2401-73-2,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,49,H225:45;H314:45;Not classified:4;H318:1;H290:1
102968,Pyridine-2-ethanesulphonic acid,272-989-9,68922-18-9,Skin Corr. 1B;Eye Dam. 1,Notified C&L,39,H318:38;H314:38;H319:1;H315:1
102971,"6'-(isobutylethylamino)-3'-methyl-2'-phenylamino-spiro[isobenzo-2-oxofuran-7,9'-[9H]-xanthene]",410-890-6,95235-29-3,Aquatic Chronic 4,Harmonised C&L,0,H413:0
102980,trans-p-methylcinnamic acid,217-479-9,1866-39-3,,Notified C&L,5,H319:5;H315:5;H335:4
102987,2-thiophen-2-ylpropanoic acid,611-216-5,54955-39-4,Acute Tox. 4,REACH registration C&L,3,H302:3;H318:1;H315:1;H335:1
102989,"Cellulose, carboxymethyl ether, calcium salt",618-566-8,9050-04-8,Not Classified,Notified C&L,3,Not classified:3
102995,3-pyridylmethanol,202-864-6,100-55-0,Eye Irrit. 2,REACH registration C&L,58,H319:57;H315:54;H335:51;H301:1;H311:1;H226:1;H331:1
103000,"Distillates (coal), solvent extn., hydrocracked middle;[Distillate obtained from the hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180°C to 300°C (356°F to 572°F. Composed primarily of two-ring aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes having carbon numbers predominantly in the range of C",302-692-2,94114-56-4,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
103004,"Benzeneacetaldehyde, α-propylidene-",609-046-1,3491-63-2,,Notified C&L,5,H319:5;H315:5;H335:5
103006,Lead dibromide,233-084-4,10031-22-8,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,44,H373:44;H360:44;H302:43;H400:44;H332:43;H410:44;H301:2;H312:1;H350:1;H331:1
103007,"Extract oils (coal), coal tar-residual pyrolysis oils, naphthalene oils;Redistillates;[A neutral oil obtained by debasing and dephenolating the oil obtained from the distillation of high temperature tar and pyrolysis residual oils which has a boiliing range of 225°C to 255°C (437°F to 491°F). Composed primarily of substituted dinuclear aromatic hydrocarbons.]",310-170-0,122070-79-5,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
103008,2-methylglutaronitrile,224-923-5,4553-62-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 2,REACH registration C&L,40,H301:39;H330:39;H311:39;H319:1;H315:1;H302:1
103009,3-Fluorobenzoic hydrazide,610-486-1,499-55-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:40
103011,"Fatty acids, C8-18 and C18-unsatd., ethoxylated propoxylated",619-247-6,96873-84-6,Not Classified,Notified C&L,1,Not classified:1
103012,4-aminopentyldiethylamine,205-435-1,140-80-7,Skin Corr. 1B,Notified C&L,42,H314:40;H315:2;H335:1;H301:1;H319:2;H311:1;H302:1;H332:1;H312:1
103014,Cyclohexyl cyclopent-2-ene-1-acetate,265-740-0,65405-69-8,Not Classified,Notified C&L,88,Not classified:88
103017,"2,2-dimethoxyethylmethylamine",204-520-0,122-07-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,48,H319:42;H315:10;H226:48;H335:9;H318:6
103020,S-isopropyl 3-methylthiobutyrate,251-936-3,34322-06-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,113,H319:88;H315:88;H226:113
103022,Doxorubicin,245-495-6,23214-92-8,Acute Tox. 4;Carc. 1B,Notified C&L,38,H350:38;H302:38
103026,Sodium acetylide,213-908-9,1066-26-8,Water-react. 2;Skin Corr. 1B,Notified C&L,42,H261:38;H314:42;H226:4;H260:4;H332:4;H312:4
103031,"Methyl 3,7-dimethyloct-6-enoate",218-874-9,2270-60-2,Not Classified,Notified C&L,88,Not classified:88
103032,4-bromo-2-nitrotoluene,262-536-3,60956-26-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44;H302:5;H312:5;H332:1
103033,"Sodium 1-amino-9,10-dihydro-9,10-dioxo-4-(2,4,6-trimethylanilino)anthracene-2-sulphonate",229-008-4,6397-02-0,Not Classified,REACH registration C&L,209,Not classified:167;H319:42;H315:42;H335:42
103035,"2,5-dimethylbenzenethiol",223-649-3,4001-61-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:42;H302:5;H331:4;H312:5;H332:1
103036,"Dl-Proline, 5-oxo-, compd. with N2-coco acyl-l-arginine Et ester",305-928-2,95370-65-3,Eye Irrit. 2A;Aquatic Acute 1,REACH registration C&L,2,H319:2;H400:1
103037,"Phosphoric acid, mono- and bis(branched and linear stearyl) esters",307-243-4,97553-81-6,Skin Corr. 1B;Eye Dam. 1,Notified C&L,6,H318:6;H314:6
103038,"1-(2,4,4-trimethyl-2-cyclohexen-1-yl)-2-buten-1-one",251-632-0,33673-71-1,Not Classified,Notified C&L,137,Not classified:137
103040,Virginiamycin,234-244-6,11006-76-1,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1,Notified C&L,2,H318:1;H302:1;H317:1;Not classified:1
103041,"1,3-dichloro-1,1,3,3-tetraphenyldisiloxane",231-815-1,7756-87-8,,Notified C&L,1,H314:1
103044,Trimagnesium dicitrate,222-093-9,3344-18-1,Not Classified,REACH registration C&L,68,Not classified:68
103045,2-[2-[2-(dodecyloxy)ethoxy]ethoxy]ethanol,221-280-2,3055-94-5,Eye Irrit. 2,Notified C&L,79,H319:40;H318:39;H400:38;H315:3
103048,"Alcohols, C16-18, distn. residues",271-645-5,68603-17-8,Not Classified,Notified C&L,531,Not classified:531
103049,Mullite,215-113-2,1302-93-8,Not Classified,REACH registration C&L,299,Not classified:265;H319:21;H315:21;H335:13
103051,(±)-1-methyl-4-(1-methylvinyl)cyclohexene,231-732-0,7705-14-8,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H315:0;H226:0;H400:0;H317:0;H410:0
103057,"4,5-dihydrooxazole",208-000-4,504-77-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H302:1;H335:1;H319:1;H332:1;H312:1
103058,"4-ethoxy-2,6-di(nonyl)-1,3-dioxane",920-431-6,,Eye Irrit. 2;Repr. 2,REACH registration C&L,1,H319:1;H361:1
103059,Formanilide,203-136-0,103-70-8,,Notified C&L,8,H302:5;Not classified:3
103064,"2,6-diisopropyl-m-cresol",249-016-1,28434-93-7,,Notified C&L,33,Not classified:33
103067,"Lactic acid, compound with 3-[2-(dimethylamino)ethyl] 1-(2-ethylhexyl) toluene-2,4-dicarbamate (1:1)",269-358-5,68227-46-3,Acute Tox. 4;Repr. 1B;Aquatic Chronic 1,REACH registration C&L,131,H400:131;H360:131;H302:131;H410:131
103068,Bromo[4-(dimethylamino)phenyl]magnesium,615-983-7,7353-91-5,Skin Corr. 1B,Notified C&L,42,H314:42;H318:2;H225:1;H302:1
103069,Yttrium trifluoride,237-257-5,13709-49-4,Not Classified,REACH registration C&L,220,Not classified:4;H319:215;H315:216;H335:215;H302:44;H332:44;H312:44;H413:1;H372:1
103070,"Marjoram, sweet, ext.",282-004-4,84082-58-6,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,1603,H315:281;H336:3;H226:1577;H304:1602;H319:20;H317:1602;H411:1416;H302:1313;H314:1322;H318:282;H412:2;H400:1;H410:1
103072,"Oils, capelin",297-105-9,93334-31-7,Not Classified,Notified C&L,1,Not classified:1
103074,"Penta-1,4-dien-3-ol",213-080-9,922-65-6,Flam. Liq. 3;Acute Tox. 4,Notified C&L,41,H302:41;H226:41;H315:1;H335:1;H319:1;H332:1;H312:1;H412:1;H351:1;H401:1;H317:1
103075,2'-(4-chloro-3-cyano-5-formyl-2-thienyl)azo-5'-diethylaminoacetanilide,405-200-5,104366-25-8,Skin Sens. 1,Harmonised C&L,0,H317:0
103076,3-[[2-(acetyloxy)ethyl][4-[(4-nitrophenyl)azo]phenyl]amino]propiononitrile,269-950-3,68391-42-4,Aquatic Chronic 3,REACH registration C&L,34,H412:20;Not classified:14
103077,Fludroxycortide,216-196-8,1524-88-5,Eye Irrit. 2,Notified C&L,41,H319:40;H315:2;H302:2;H335:2;H332:2;H312:2;H341:1;H372:1;H361:1
103081,2-(4-nitrophenyl)propiononitrile,256-731-2,50712-63-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,3,H319:3;H315:3;H335:3
103083,vernolate (ISO);S-propyl dipropylthiocarbamate,217-681-7,1929-77-7,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H302:0
103086,"Betaines, (C12-18-amidoalkyl)dimethyl",264-378-0,63641-59-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,35,H319:33;H411:33;H315:33;H226:33;Not classified:1;H412:1;H318:1
103087,Cyanomethyl benzenesulphonate,234-093-6,10531-13-2,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,Notified C&L,38,H318:38;H302:38;H314:38;H332:38;H312:38
103088,"Naphtha (petroleum), light, C",295-442-6,92045-60-8,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
103090,Diphenylthioxostannane,243-739-6,20332-10-9,,Notified C&L,5,H301:5;H315:5;H319:5;H335:4;H331:1;H400:1;H311:1;H410:1
103093,"2-(4-chlorophenyl)-2,4-dihydro-5-methyl-3H-pyrazol-3-one",235-884-9,13024-90-3,Not Classified,Notified C&L,1,Not classified:1
103098,N-ethylaniline,203-135-5,103-69-5,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2,Harmonised C&L,0,H301:0;H331:0;H373:0;H311:0
103099,Isobutyrophenone,210-275-0,611-70-1,Not Classified,REACH registration C&L,129,Not classified:86;H319:43;H315:43;H335:42
103100,"Soaps, stocks, capelin-oil, acidulated",297-499-2,93572-68-0,Not Classified,Notified C&L,1,Not classified:1
103102,"Lithium Manganese (III,IV) oxide",601-724-5,12057-17-9,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 4,Notified C&L,3,H413:3;H332:3;H302:3
103108,2-methyl-1-(p-tolyl)piperazine,252-811-6,35947-11-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
103111,3-Methylfuran,618-895-7,930-27-8,Acute Tox. 4;Acute Tox. 3,Notified C&L,44,H331:40;H302:38;Not classified:3;H301:2;H311:1;H226:1;H225:2;H332:1
103112,"Amylase, β-",232-566-1,9000-91-3,Resp. Sens. 1,REACH registration C&L,49,H334:49
103113,"Phosphoric acid, mono- and bis(C12-16-branched and linear alkyl) esters",306-983-5,97468-30-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
103114,Bis(piperidinothiocarbonyl) hexasulphide,213-537-2,971-15-3,Not Classified,REACH registration C&L,146,Not classified:59;H413:81;H317:6;H319:1;H315:1;H335:1
103125,"1,1,1,3,3,3-hexafluoropropane-2,2-diamine",217-087-8,1737-80-0,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H225:38;H315:38;H319:38;H335:38
103126,"Ethanol, 2,2'-iminobis-, N-coco alkyl derivs.",263-163-9,61791-31-9,Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1;Acute Tox. 2;Aquatic Acute 1,Notified C&L,993,H318:741;H302:865;H330:456;H314:906;H400:800;H317:456;H410:298;Not classified:39;H319:26;H315:46;H335:1
103128,"2,4-dichloro-5-(trifluoromethyl)pyrimidine",609-648-4,3932-97-6,Acute Tox. 2;Eye Irrit. 2,Notified C&L,60,H319:54;H300:52;H314:4;H315:5;H302:3;H335:3;H332:3;H312:3;H301:2;H317:1;H334:1
103132,"2-Pyrimidinamine, N-phenyl-",611-509-8,57356-49-7,Not Classified,Notified C&L,1,Not classified:1
103133,(R)-3-(1-methyl-2-pyrrolidinylmethyl)-5-[2-phenylsulphonyl)vinyl]-1H-indole,605-904-4,180637-89-2,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;STOT RE 2,REACH registration C&L,2,H373:2;H318:2;H302:2;H317:2
103138,N-Acetyl-D-mannosamine monohydrate,616-491-5,7772-94-3,Not Classified,Notified C&L,9,Not classified:8;H319:1;H315:1;H302:1;H335:1
103140,Butyl anthranilate,231-816-7,7756-96-9,Skin Irrit. 2;Skin Sens. 1B,REACH registration C&L,168,H315:45;H317:3;Not classified:123;H319:42;H302:39;H335:41
103143,Triphenylgermanium chloride,216-617-5,1626-24-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H315:39;H302:38;H335:38;H319:39;H332:38;H312:38
103144,Cinnamyl bromide,224-511-5,4392-24-9,Skin Corr. 1B,Notified C&L,45,H314:45;H318:2;H290:1
103147,"tribenuron-methyl (ISO);methyl 2-[N-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-N-methylcarbamoylsulfamoyl]benzoate",401-190-1,101200-48-0,Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H373:0;H400:0;H317:0;H410:0
103148,"Dibutyl hydrogen phosphate, vanadium salt",252-745-8,35837-53-7,Acute Tox. 4,Notified C&L,1,H302:1
103151,"Extract oils (coal), tar base, collidine fraction;Distillate Bases;[The extract produced by the acidic extraction of bases from crude coal tar aromatic oils, neutralization, and distillation of the bases. Composed primarily of collidines, aniline, toluidines, lutidines, xylidines.]",273-077-3,68937-63-3,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
103152,"Methyl (8,9,10-trinorborn-5-en-2-yl) ketone",225-767-0,5063-03-6,Acute Tox. 4,Notified C&L,40,H302:40
103157,"N,N-bis(2-hydroxyethyl)hexadecan-1-amide",231-427-2,7545-24-6,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H411:1;H318:1;H315:1
103158,"Lactic acid, compound with N-[2-[(2-hydroxyethyl)amino]ethyl]octadecanamide (1:1)",268-167-4,68016-02-4,Not Classified,Notified C&L,32,Not classified:31;H360:1
103159,"Caesalpinia crista, ext.",295-979-6,92201-49-5,Not Classified,Notified C&L,1,Not classified:1
103162,1-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium,418-440-0,136997-71-2,Skin Sens. 1,Harmonised C&L,0,H317:0
103164,5-Bromo-2-thiophenesulfonamide,611-018-9,53595-65-6,Skin Corr. 1B,Notified C&L,2,H314:1;H319:1;H315:1
103166,Diyttrium oxide silicate,234-730-8,12027-88-2,Not Classified,Notified C&L,1,Not classified:1
103168,(Z)-dodec-8-enol,255-019-9,40642-40-8,Skin Irrit. 2;Aquatic Acute 1,Notified C&L,7,H315:7;H400:7
103171,Sucrose pentapalmitate,249-406-1,29063-58-9,Not Classified,Notified C&L,1,Not classified:1
103172,"1-Allyl-trans-(2S,5R)-dimethylpiperazine",605-028-2,155836-78-5,Acute Tox. 4,Notified C&L,38,H312:38
103173,"Hydrogen [29H,31H-phthalocyaninesulphonato(2-)-N29,N30,N31,N32]cuprate(1-), compound with (Z)-octadec-9-enylamine (1:1)",288-107-0,85650-96-0,Eye Irrit. 2A,REACH registration C&L,84,H319:84
103177,2-[(2-hydroxyethyl)amino]ethyl dihydrogen orthoborate,269-587-0,68298-96-4,Not Classified,Notified C&L,6,Not classified:6
103179,"3,3,5-trimethylcyclohexyl acetate",267-430-0,67859-96-5,Not Classified,Notified C&L,115,Not classified:104;H411:11
103184,"Reaction mass of 2,2,5,8,12,15,15-heptamethyl-7,10-dioxa-4,13-diazahexadeca-3,13-diene-1,16-diyl didodecanoate and 2,2,5,8,12,15,18,18-octamethyl-7,10,13-trioxa-4,16-diazanonadeca-3,16-diene-1,19-diyl didodecanoate and 2,2,5,8,11,14,18,21,21-nonamethyl-7,10,13,16-tetraoxa-4,19-diazadocosa-3,19-diene-1,22-diyl didodecanoate",479-940-2,613246-75-6,Eye Dam. 1;Aquatic Chronic 4,REACH registration C&L,3,H413:3;H318:3
103185,bromoacetic acid,201-175-8,79-08-3,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1A;Skin Sens. 1;Acute Tox. 3;Aquatic Acute 1,Harmonised C&L,0,H301:0;H314:0;H331:0;H400:0;H317:0;H311:0
103186,"N,N''-(methyl-m-phenylene)bis[N',N'-dimethylurea]",247-842-7,26604-41-1,Not Classified,Notified C&L,91,Not classified:91
103188,3-bromoheptane,217-825-9,1974-05-6,,Notified C&L,5,H226:5
103191,"3(or5)-[[4-[benzylmethylamino]phenyl]azo]-1,2(or1,4)-dimethyl-1H-1,2,4-triazolium chloride",298-380-8,93804-07-0,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,2,H412:2;H318:2
103192,"Tamarindus, ext.",284-651-8,84961-62-6,Flam. Liq. 2,Notified C&L,1399,H225:1286;Not classified:113
103194,"Benzenesulfonic acid, mono- and dialkyl derivs., magnesium salts",615-420-5,71786-47-5,Not Classified,Notified C&L,85,Not classified:77;H413:8
103196,"Acorus calamus, ext., hydrogenated",287-327-4,85480-47-3,Not Classified,Notified C&L,88,Not classified:88
103201,Diiminosuccinonitrile,248-963-8,28321-79-1,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 3;STOT SE 3,Notified C&L,1,H315:1;H335:1;H301:1;H319:1;H331:1;H311:1
103202,Corsair Resin 5,,,Not Classified,Notified C&L,1,Not classified:1
103204,Spironolactone,200-133-6,52-01-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,174,H312:54;H351:115;H332:54;H302:61;H360:92;H373:44;H341:1;H412:2;H361:4;H372:4;H336:1;H362:5;Not classified:1;H400:1;H410:2
103205,N-[2-(imidazolidin-1-yl)ethyl]ethylenediamine,272-152-8,68758-73-6,Not Classified,Notified C&L,17,Not classified:16;H318:1;H314:1
103210,"Sodium 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulphonate",220-189-5,2657-00-3,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,53,H319:9;H412:6;H317:6;H242:47;H315:3
103213,p-tolyl isothiocyanate,210-745-5,622-59-3,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,46,H315:42;H335:42;H319:42;H317:39;H334:39;H312:6;H314:4;H332:6;H302:6;H301:1;H331:1
103214,"1,1',1'',1'''-[[(2-hydroxypropyl)imino]bis(ethylenenitrilo)]tetrapropan-2-ol",241-184-4,17121-34-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
103216,"pindone (ISO);2-pivaloylindan-1,3-dione",201-462-8,83-26-1,Acute Tox. 3;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H301:0;H372:0;H400:0;H410:0
103217,"Protein hydrolyzates, silk",306-235-8,96690-41-4,Not Classified,REACH registration C&L,161,Not classified:161
103218,2-Naphthyl N-methyl carbamate,609-875-9,4089-04-7,Acute Tox. 3,Notified C&L,38,H301:38
103220,"1,1'-methylenebis(3-methylpiperidine)",272-988-3,68922-17-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
103223,5-decenoic acid,286-861-5,85392-03-6,Not Classified,Notified C&L,5,Not classified:4;H319:1;H315:1
103229,Dimagnesium trisilicon octaoxide,239-076-7,14987-04-3,,Notified C&L,86,H413:83;Not classified:3
103230,"trans-4,4'-vinylenedipyridine",236-432-3,13362-78-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39
103231,"4,4'-dithiobis(5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile)",603-434-4,130755-46-3,STOT RE 2;Aquatic Chronic 1,REACH registration C&L,35,H373:35;H410:35;H400:33
103234,2-Chloro-5-chloromethylthiazole,600-684-6,105827-91-6,Acute Tox. 4;Acute Tox. 2;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,195,H302:194;H314:194;H310:156;H317:194;H411:194;H311:38;H319:1;H315:1;H335:1
103235,Ethoxy(pentafluoro)cyclotriphosphazene,608-823-2,33027-66-6,Skin Corr. 1C;Eye Dam. 1,Notified C&L,2,H318:1;H314:1;Not classified:1
103240,2-chlorobenzenesulphonyl chloride,220-807-3,2905-23-9,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,47,H314:47;H226:42;H318:1;H290:1;H319:1;H335:1
103241,"disodium 3,3'-[iminobis[sulfonyl-4,1-phenylene-(5-hydroxy-3-methylpyrazole-1,4-diyl)azo-4,1-phenylenesulfonylimino-(4-amino-6-hydroxypyrimidine-2,5-diyl)azo-4,1-phenylenesulfonylimino(4-amino-6-hydroxypyrimidine-2,5-diyl)azo]bis(benzenesulfonate)]",423-110-4,,Eye Dam. 1,Harmonised C&L,0,H318:0
103243,Benzyl 3-Bromopropyl Ether,611-122-4,54314-84-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:41;H335:40;H302:1;H332:1;H312:1
103244,"Fatty acids, C6-12",267-013-3,67762-36-1,Not Classified,Notified C&L,197,Not classified:60;H319:52;H315:52;H314:85;H318:50
103248,"Stearic acid, compound with 2,2'-iminodiethanol (3:1)",253-945-8,38455-64-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
103250,Germanium selenide,235-061-4,12065-10-0,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H373:38;H315:38;H301:38;H319:38;H331:38;H400:38;H311:38;H410:38
103254,4-methylveratrole,207-796-0,494-99-5,Not Classified,Notified C&L,127,Not classified:88;H319:39;H315:39;H335:38
103261,2'-deoxyguanosine 5'-(disodium phosphate),251-517-5,33430-61-4,Not Classified,Notified C&L,2,Not classified:2
103263,3-chloro-p-anisaldehyde,225-532-2,4903-09-7,,Notified C&L,6,H319:6;H315:6;H335:6
103268,Methyl 3-oxohexanoate,250-185-9,30414-54-1,Not Classified,REACH registration C&L,4,Not classified:2;H319:2;H315:2;H335:2;H227:1
103271,"1,2,3,4-tetrahydro-6-methylquinoline",202-083-0,91-61-2,Acute Tox. 4;Acute Tox. 4,Notified C&L,1677,H312:1637;H302:1675;H319:40;H315:40;H335:40;H332:5;H400:1
103274,"Octadecanoic acid, reaction products with 2-[(2-aminoethyl)amino]ethanol and urea, acetates (salts)",272-229-6,68784-21-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H319:3;H315:3;Not classified:1
103275,1-isopropyl-3-methylpyrazol-5-yl dimethylcarbamate;Isolan,204-318-2,119-38-0,Acute Tox. 2;Acute Tox. 1,Harmonised C&L,0,H300:0;H310:0
103278,"5,6,7,8-tetrahydro-2-naphthylamine",218-714-8,2217-43-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H315:1;H302:1;H335:1
103280,Ceftriaxone,277-405-6,73384-59-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,5,H315:5;H335:5;H319:5;H317:5;H334:5
103282,"Distillates (coal tar), upper, fluorene-free;Wash Oil Redistillate;[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists of aromatic polycyclic hydrocarbons, primarily diphenyl, dibenzofuran and acenaphthene.]",284-899-7,84989-10-6,Carc. 1B,Harmonised C&L,0,H350:0
103283,"Balsams, gurjun",232-444-8,8030-55-5,Asp. Tox. 1;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1500,H304:1500;H400:2;H317:3;H410:2
103285,Inorganic residual from kraft or soda pulping separated from green liquor in the chemical recovery cycle.,923-511-9,,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,32,H318:32;H315:32
103292,N-benzyl-4-methoxy-α-methylphenethylamine,256-155-1,43229-65-8,Acute Tox. 3;Aquatic Chronic 2,REACH registration C&L,8,H301:7;H411:3;H302:2;H314:4;H318:1;H315:1
103293,"Tar acids, coal, crude;Crude Phenols;[The reaction product obtained by neutralizing coal tar oil alkaline extract with an acidic solution, such as aqueous sulfuric acid, or gaseous carbon dioxide, to obtain the free acids. Composed primarily of tar acids such as phenol, cresols, and xylenols.]",266-019-3,65996-85-2,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
103295,"Quaternary ammonium compounds, C14-18-alkyltrimethyl, chlorides",268-077-5,68002-63-1,Not Classified,Notified C&L,9,Not classified:6;H400:3;H314:3;H302:3
103296,"Ethanol, 2,2'-[[(methyl-1H-benzotriazol-1-yl)methyl]imino]bis",618-165-8,88477-37-6,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,140,H412:140;H318:140;H302:140;H317:140
103297,"2,3-dibromo-3-phenylpropionic acid",228-516-3,6286-30-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39
103298,"Disodium 3,3'-[[6-[bis(2-hydroxyethyl)amino]-1,3,5-triazine-2,4-diyl]bis[imino(3-methoxy-4,1-phenylene)azo]]bis[benzenesulphonate]",257-775-5,52238-69-4,Not Classified,REACH registration C&L,79,Not classified:79
103299,"Poly(oxy-1,2-ethanediyl), a-(1-oxooctadecen-1-yl)-[?]-[[](1-oxooctadecen-1-yl)oxy]-",610-881-9,52668-97-0,Skin Irrit. 2,Notified C&L,444,H315:441;Not classified:3
103300,"1,3-Propanediol, 2-ethyl-2-(hydroxymethyl)-, polymer with 1,3-diisocyanatomethylbenzene and 2,2'-oxybis[ethanol], Me Et ketone oxime-blocked",603-168-9,126850-20-2,Not Classified,Notified C&L,1,Not classified:1
103304,"2,6-diisopropylaniline",246-305-4,24544-04-5,Aquatic Chronic 3,REACH registration C&L,118,H412:114;H319:7;Not classified:2;H315:2;H335:2
103307,Sodium 5-[(4-nitrophenyl)azo]salicylate,217-002-4,1718-34-9,,Notified C&L,6,H302:5;Not classified:1
103308,"Tetrahydrogen [μ-[[3,3'-[(3,3'-dihydroxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonato]](8-)]]dicuprate(4-), compound with 2,2'-iminodiethanol (1:4)",275-625-7,71566-21-7,Carc. 2;Aquatic Chronic 2,Notified C&L,1,H351:1;H411:1
103315,Timonacic,207-146-6,444-27-9,Acute Tox. 4;Eye Irrit. 2,Notified C&L,42,H319:40;H302:42;H315:1;H335:1
103317,"N,N'-(methylenedi-p-phenylene)bis(aziridine-1-carboxamide)",231-034-6,7417-99-4,Acute Tox. 4;Skin Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,39,H372:6;H302:9;H400:7;H317:7;H410:7;H341:7;H319:30;H315:30;H335:7;H312:2;H332:1;Not classified:1
103321,"4-methoxy-7H-furo[3,2-g][1]benzopyran-7-one",207-604-5,484-20-8,Resp. Sens. 1;Muta. 1B;Carc. 1B,Notified C&L,69,H350:43;H334:39;H340:39;H317:29;H314:1;H318:1;H361:1
103323,"1,2,4-Benzenetricarboxylic acid, ester with 1,2-ethanediol",275-346-0,71342-70-6,Not Classified,Notified C&L,1,Not classified:1
103324,3-iodobenzoyl chloride,216-979-4,1711-10-0,Skin Corr. 1B,Notified C&L,43,H314:43;H318:1;H290:1
103330,"Benzenesulfonic acid, C14-44-branched alkyl derivs., calcium salts, overbased",294-229-5,91696-70-7,,Notified C&L,1,Not classified:1
103332,Tricarbonyl([?]-cyclopentadienyl)manganese,235-142-4,12079-65-1,Acute Tox. 2,Notified C&L,48,H300:48;H330:10
103333,3-aminooxazolidin-2-one,201-299-2,80-65-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
103335,Disodium 5-[(4-nitro-2-sulphonatophenyl)azo]salicylate,229-301-7,6470-97-9,Not Classified,Notified C&L,33,Not classified:33
103336,Diminazene,208-644-6,536-71-0,Skin Irrit. 2;STOT SE 1;STOT RE 1,Notified C&L,35,H370:35;H315:35;H372:35
103338,Trinickel dicitrate,227-873-2,6018-92-4,Met. Corr. 1;Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;Muta. 2;Carc. 1A;Repr. 1B;STOT RE 1;Aquatic Chronic 1,REACH registration C&L,16,H372:11;H290:6;H315:5;H360:11;H302:6;H340:5;H341:11;H350:11;H351:5;H400:11;H320:5;H317:11;H410:11;H334:11;Not classified:5;H319:1
103339,(3-bromophenyl)acetic acid,217-522-1,1878-67-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,6,H319:4;H315:4;H314:1;H335:1;Not classified:1
103340,Vanadium dichloride,234-176-7,10580-52-6,Acute Tox. 4;Skin Corr. 1A,Notified C&L,39,H314:39;H302:39
103343,"N-methyl-2,4-dinitro-N-phenyl-6-(trifluoromethyl)aniline",264-102-9,63333-32-4,Acute Tox. 2;Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3,Notified C&L,38,H315:38;H330:38;H335:38;H310:38;H319:38;H300:38
103345,Tetrapentylammonium chloride,225-606-4,4965-17-7,Skin Corr. 1B;Skin Sens. 1,Notified C&L,41,H314:40;H317:38;H315:1;H301:1;H319:1;H331:1;H311:1
103350,"1,2-O-isopropylidene-α-D-glucofuranose",242-420-9,18549-40-1,Not Classified,REACH registration C&L,6,Not classified:6
103352,Sodium bis[2-[[2-hydroxy-5-[(phenylamino)sulphonyl]phenyl]azo]-3-oxo-N-phenylbutyramidato(2-)]cobaltate(1-),275-624-1,71562-83-9,Aquatic Chronic 2,Notified C&L,41,H411:41
103353,"6,6-dimethyl-5,7-dioxaspiro[2.5]octane-4,8-dione",227-044-5,5617-70-9,Not Classified,Notified C&L,2,Not classified:1;H319:1;H315:1;H335:1
103354,Sodium taurinate,230-875-6,7347-25-3,Eye Irrit. 2,Notified C&L,1,H319:1
103355,"Fatty acids, C9-13-neo-, copper salts",292-985-0,91031-79-7,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,2,H411:2;H400:2;H302:2
103356,"Pepper (Piper), P. longum, ext.",290-150-5,90082-60-3,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,88,H315:78;H226:78;H304:78;H400:42;H317:78;H410:78;Not classified:10
103357,1-(aminomethyl)cyclohexan-1-ol,223-648-8,4000-72-0,Acute Tox. 4;Eye Dam. 1,Notified C&L,39,H318:39;H302:39;H315:1;H335:1
103362,"O,O-diethyl hydrogen phosphorodithioate",206-055-9,298-06-6,Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,REACH registration C&L,41,H314:41;H332:2;H302:2;H301:38;H330:39;H311:39
103364,Trimethyl(octadecyloxy)silane,242-554-8,18748-98-6,Not Classified,REACH registration C&L,64,Not classified:64
103367,2-hydroxy-1-naphthylammonium chloride,214-830-8,1198-27-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,44,H315:44;H302:39;H335:43;H319:44;H351:40;H332:39;H312:39;H341:4
103370,Sodium bromide,231-599-9,7647-15-6,Not Classified,REACH registration C&L,782,Not classified:233;H360:441;H319:87;H400:23;H410:18;H372:4;H315:2;H335:2;H332:2;H228:2;H302:2
103375,4-hydroxybutyl stearate,239-372-6,15337-64-1,Not Classified,Notified C&L,2,Not classified:2
103378,2-[(2-cyanoethyl)[p-[(p-nitrophenyl)azo]phenyl]amino]ethyl carbanilate,240-090-0,15958-27-7,Not Classified,Notified C&L,9,Not classified:9
103379,4-[[2-chloro-5-(trifluoromethyl)phenyl]azo]-3-hydroxy-2-naphthoic acid,257-777-6,52238-94-5,Not Classified,REACH registration C&L,73,Not classified:35;H315:38;H302:38;H335:38;H319:38;H413:38
103381,(,227-678-2,5932-68-3,Skin Sens. 1A,Harmonised C&L,0,H317:0
103384,"1,2-Cyclohexanedicarboxylic acid, 1,2-diisononyl ester",431-890-2,166412-78-8,Not Classified,REACH registration C&L,134,Not classified:134
103387,"Annatto tree, ext.",289-561-2,89957-43-7,Not Classified,Notified C&L,95,Not classified:71;H319:24;H315:24
103391,phosphorus pentoxide,215-236-1,1314-56-3,Skin Corr. 1A,Harmonised C&L,0,H314:0
103393,4-pentylphenyl 4-octyloxybenzoate,256-682-7,50649-56-4,Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,38,H319:38;H413:38
103395,Custom Yellow #2,,,Not Classified,Notified C&L,1,Not classified:1
103397,Di-2-naphthylamine,208-529-0,532-18-3,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H400:38;H302:38;H317:38;H410:38;H319:1;H315:1
103398,"2-[(2-methyl-1-oxoallyl)oxy]-1-[[(2-methyl-1oxoallyl)oxy]methyl]ethyl 2,9-diaza-16-methyl-12-[[(2-methyl-1-oxoallyl)oxy]methyl]-11,14-dioxa-10,15-dioxoheptadec-16-enoate",279-630-5,80937-22-0,Skin Corr. 1B;Skin Sens. 1,Notified C&L,1,H314:1;H317:1
103399,Bis(dodecylthio)dimethylstannane,257-111-4,51287-84-4,Acute Tox. 4;Skin Sens. 1A;Aquatic Chronic 3,REACH registration C&L,568,H412:459;H302:18;H317:18;H372:86;H413:86;H332:56;H361:86;Not classified:23
103402,"Baccharis dracunculifolia, ext.",305-297-3,94406-01-6,Not Classified,Notified C&L,113,Not classified:113
103407,"Reaction mass of 2-Propenoic acid, 2-((1S)-1-((1R)-3,3- and 2-Propenoic acid, 2-((1R)-1-((1R)-3,3-",459-080-4,,Skin Sens. 1B,Notified C&L,24,H317:24
103411,2-chlorohexane,211-329-6,638-28-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1;H226:1
103412,"3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane",444-420-6,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
103413,Pentafluorophenylhydrazine,212-586-7,828-73-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:44;H315:44;H335:43;H312:4;H332:4;H302:1
103414,"Phenol, 4,4'-(1-methylethylidene)bis-, sulfonated",283-306-9,84604-28-4,Skin Irrit. 2;Eye Dam. 1,Notified C&L,36,H318:36;H315:36
103418,"1-methyl-1,2-ethanediyl dioleate",203-315-3,105-62-4,Not Classified,REACH registration C&L,234,Not classified:234
103420,N-furfuryl-N-methylamine,225-278-2,4753-75-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H226:39;H335:39
103422,"Cinchona lancifolia, ext.",289-708-0,89997-71-7,Flam. Liq. 3,Notified C&L,1374,H226:1374
103424,2-bromoaniline,210-421-3,615-36-1,Acute Tox. 4;Acute Tox. 3;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,49,H373:47;H411:3;H302:48;H311:46;H315:6;H319:6;H332:6;H335:1;H312:2;H301:1;H331:1;H400:1;Not classified:1;H410:1
103425,"[4-[[4-(dimethylamino)phenyl]imino]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride",224-773-0,4486-05-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
103427,Brefeldin A,606-528-3,20350-15-6,Acute Tox. 3,Notified C&L,43,H301:41;H302:2;H312:1;H332:1
103428,Diamminebis(nitrito-N)palladium,238-918-0,14852-83-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:40;H335:39;H317:1;H302:2;H332:1;H312:1;H200:1
103431,Nicotinonitrile,202-863-0,100-54-9,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,209,H318:4;H302:209;H319:205;H315:205;H335:201;H312:4;H412:1
103437,"1,3-dimethyl 2-[2-(2-amino-6-chloro-9H-purin-9-yl)ethyl]propanedioate",473-300-6,,Skin Sens. 1;Eye Irrit. 2A,Notified C&L,1,H319:1;H317:1
103444,"[2aS-(2aα,4aα,5α,7bα)]-5-(β-D-glucopyranosyloxy)-2a,4a,5,7b-tetrahydro-1-oxo-1H-2,6-dioxacyclopent[cd]inden-4-ylmethyl acetate",238-137-5,14259-45-1,Acute Tox. 4,Notified C&L,38,H302:38
103447,"Cellulose, 2-hydroxyethyl 2-[2-hydroxy-3-(trimethylammonio)propoxy]ethyl 2-hydroxy-3-(trimethylammonio)propyl ether, chloride",611-015-2,53568-66-4,Aquatic Chronic 2,Notified C&L,89,H411:52;H412:37
103448,Titanium tetrakis(dimethylammonium),221-904-3,3275-24-9,Flam. Liq. 2;Water-react. 1;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,74,H318:5;H302:27;H225:74;H260:67;H314:74;H332:5;H331:22;H261:4
103449,4-fluorobenzenesulphonyl chloride,206-493-0,349-88-2,Skin Corr. 1,REACH registration C&L,98,H314:98;H302:34;H318:1;H290:1;H335:1
103450,2-[2-(diethylamino)ethoxy]ethanol,205-436-7,140-82-9,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,54,H312:50;H318:14;H314:41;H319:2;H315:2;H335:1
103451,α-bromo-m-fluorotoluene,207-263-2,456-41-7,Skin Corr. 1B;STOT SE 3,Notified C&L,50,H314:50;H335:40;H318:3;H290:2;H319:2;H302:2;H332:1;H312:1;H227:1
103453,Sodium 2-formylbenzenesulphonate,213-758-4,1008-72-6,Not Classified,REACH registration C&L,52,Not classified:48;H319:4;H315:4;H335:2
103454,Purin-6(1H)-one,200-697-3,68-94-0,Not Classified,REACH registration C&L,11,Not classified:9;H319:2;H315:2;H335:2
103457,Methylergometrine maleate,260-734-4,57432-61-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Repr. 2,Notified C&L,44,H301:44;H331:40;H361:40;H311:40;H362:4;H360:4
103460,Chromium triacetate,213-909-4,1066-30-4,Skin Sens. 1B,REACH registration C&L,2243,H317:17;Not classified:2184;H319:40;H315:40;H412:1;H332:1;H302:1
103461,"2,6-dimethylbenzoyl chloride",244-646-3,21900-37-8,Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H318:1;H290:1;H314:1
103464,"Trisodium 5-[[4-chloro-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[(2-sulphonatophenyl)azo]naphthalene-2,7-disulphonate",245-494-0,23211-47-4,Not Classified,Notified C&L,1,Not classified:1
103465,"Gelsemium sempervirens, ext.",283-489-5,84650-08-8,,Notified C&L,1,H225:1;H332:1;H302:1
103469,15-hydroxypentadecanoic acid,225-026-1,4617-33-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
103470,"Butane, 1,1'-[Methylenebis(oxy)]bis[3-methyl",607-069-1,22418-64-0,Flam. Liq. 3,Notified C&L,25,H226:25
103472,"Propanoic acid, 3,3'-thiobis-, di-C16-22-alkyl esters",292-035-5,90529-98-9,Not Classified,REACH registration C&L,10,Not classified:10
103480,"3,7-dimethyloct-7-enyl isobutyrate",205-318-5,138-23-8,Not Classified,Notified C&L,88,Not classified:88
103481,m-chlorocinnamic acid,217-478-3,1866-38-2,,Notified C&L,5,H319:5;H315:5;H335:4
103484,"1,1,2,2-Tetrafluoro-N,N-dimethylamine",604-996-3,1550-50-1,Acute Tox. 2;Acute Tox. 1;Skin Corr. 1A;Acute Tox. 1,Notified C&L,36,H300:35;H314:36;H310:35;H330:33;H225:3
103487,bis{4-[2-(prop-1-en-1-yl)phenoxy]phenyl}methanone,481-100-5,,Skin Sens. 1;Aquatic Chronic 4,Notified C&L,1,H413:1;H317:1
103488,"Fatty acids, tall-oil, reaction products with boric acid (H3BO3) and diethanolamine",294-785-9,91770-03-5,Skin Sens. 1B,REACH registration C&L,458,H317:447;Not classified:7;H319:2;H315:4;H411:1;H413:1
103490,"Petroleum;Crude oil;[A complex combination of hydrocarbons, It consists predominantly of aliphatic, alicyclic and aromatic hydrocarbons. It may also contain small amounts of nitrogen, oxygen and sulfur compounds. This category encompasses light, medium, and heavy petroleums, as well as the oils extended from tar sands. Hydrocarbonaceous materials requiring major chemical changes for their recovery or conversion to petroleum refinery feedstocks such as crude shale oils; upgraded shale oils and liquid coal fuels are not included in this definition.]",232-298-5,8002-05-9,Carc. 1B,Harmonised C&L,0,H350:0
103493,C.I. Acid Brown 314,602-011-1,12219-81-7,Not Classified,Notified C&L,3,Not classified:3
103494,"(1,1,3,3-tetramethyl-1,3-disiloxanediyl)dimethyl diacetate",226-345-9,5360-04-3,Not Classified,Notified C&L,26,Not classified:26
103498,"Naphtha (petroleum), heavy hydrocracked;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C",265-079-8,64741-78-2,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
103505,"[3-(2,3-epoxypropoxy)propyl]diethoxymethylsilane",220-780-8,2897-60-1,Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,645,H412:10;H317:604;H315:482;H335:481;H319:482;H341:441;H411:5
103506,"N-[(2-nitrophenyl)thio]-L-valine, compound with dicyclohexylamine (1:1)",231-654-7,7675-57-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 1,Notified C&L,38,H315:38;H302:38;H335:38;H319:38;H410:38
103507,"Oils, petitgrain, terpene-free",614-781-6,68915-85-5,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,113,H411:103;H315:103;H317:103;H318:25;Not classified:10
103511,"Fatty acids, C12-18 and C16-18-unsatd., sulfurized",292-863-7,91001-89-7,Not Classified,Notified C&L,6,Not classified:6
103514,Hydroxocobalamin hydrochloride,261-200-3,58288-50-9,Not Classified,Notified C&L,1,Not classified:1
103520,Ammonium wolframate,234-732-9,12028-06-7,Not Classified,Notified C&L,2,Not classified:2
103522,"Disodium 4,4'-[[2,4-dihydroxy-5-(hydroxymethyl)-1,3-phenylene]bis(azo)]bisnaphthalene-1-sulphonate",224-924-0,4553-89-3,Not Classified,REACH registration C&L,14,Not classified:14
103526,"4-Thiazolidinecarboxylic acid, 2-oxo-, (R)-",606-375-2,19771-63-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H315:38;H335:38;H318:1
103530,3-(phenoxymethyl)-2-benzofurancarboxylic acid,249-139-0,28664-92-8,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
103534,"Benzeneacetic acid, α,2-dihydroxy-, sodium salt (1:1)",617-474-5,83554-63-6,Not Classified,Notified C&L,31,Not classified:31
103535,1-nitroso-2-naphthol,205-043-0,131-91-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:44;H315:44;H302:44;H335:43;H400:5;H373:1
103537,"Poly(oxy-1,2-ethanediyl), .alpha.-(carboxymethyl)-.omega.-(octyloxy)- (4-11 EO)",611-013-1,53563-70-5,Eye Dam. 1,Notified C&L,524,H318:524;H315:83;Not classified:33
103538,Acid green 73,602-024-2,12219-93-1,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,5,H319:4;H412:4;Not classified:1
103540,"1-amino-4-bromo-9,10-dioxoanthracene-2-sulphonic acid",204-159-9,116-81-4,Skin Sens. 1,Notified C&L,88,H317:83;H319:4;H315:4;H335:4;Not classified:1
103541,Methyl propyl sulphide,223-403-5,3877-15-4,Acute Tox. 4,Notified C&L,1417,H302:1364;H226:88;H225:43;H315:48;H319:48;H335:48
103542,"Oxybispropylenebis[(1,5,9,13,17,21-hexamethyl-7,15,23,23-tetraphenoxy-3,6,8,11,14,16,19,22-octaoxa-7,15,23-triphosphatricos-1-yl)(phenyl)phosphine]",279-499-4,80584-86-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Muta. 2,Notified C&L,18,H319:16;H315:16;H341:16;H317:16;Not classified:2
103546,"Phthalic anhydride, oligomeric reaction products with 3-aminopropyltriethoxysilane",500-321-0,131618-03-6,Not Classified,Notified C&L,1,Not classified:1
103547,"2,2-bis[[(1-oxooctyl)oxy]methyl]butyl 2-[[[6-[2,2-bis[[(1-oxodecyl)oxy]methyl]butoxy]-1,6-dioxohexyl]oxy]methyl]-2-[[(1-oxooctyl)oxy]methyl]butyladipate",304-706-2,94278-18-9,Not Classified,Notified C&L,2,Not classified:2
103549,Heptadecanoic acid,208-027-1,506-12-7,Not Classified,Notified C&L,139,Not classified:67;H319:72;H315:72;H335:58
103554,"Phosphoric acid, mono- and bis(branched and linear octyl) esters",307-242-9,97553-80-5,Skin Corr. 1B,Notified C&L,2,H314:2
103556,3-Methoxy-4-methyl-benzoesÃ¤uremethylester,609-142-3,3556-83-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H315:39;H335:39;H312:1;H332:1;H302:1
103560,4-ethyl-m-xylene,212-860-6,874-41-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H315:38;H302:38;H335:38;H226:1
103562,4-acetamido-5-methoxy-2-methylbenzenesulphonyl chloride,268-233-2,68039-14-5,Skin Corr. 1A,Notified C&L,31,H314:31
103568,"Fumaric acid, iron(2+) salt",231-731-5,7705-12-6,Not Classified,Notified C&L,36,Not classified:36
103573,Digadolinium dioxide sulphide,235-598-4,12339-07-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H319:2;H315:2;H335:2;Not classified:2;H302:1;H332:1;H312:1
103574,rosin ester,938-117-2,,Not Classified,Notified C&L,2,Not classified:1;H319:1;H315:1;H335:1
103575,4-(4-bromophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidinyl decanoate,278-065-1,75067-66-2,Acute Tox. 4;Acute Tox. 4;STOT SE 3,Notified C&L,8,H336:7;H332:7;H302:8;H312:1;H361:1
103576,"4-Picoline, 2-(benzylamino)-",235-882-8,13021-71-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
103580,DL-2-hydroxy-2-phenylacetic acid,210-277-1,611-72-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,110,H318:59;H315:95;H302:55;H335:94;H319:49;Not classified:4
103583,"Gasoline, coal solvent extn., hydrocracked naphtha;[Motor fuel produced by the reforming of the refined naphtha fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of aromatic and naphthenic hydrocarbons, their alkyl derivatives and alkyl hydrocarbons having carbon numbers in the range of C",302-691-7,94114-55-3,Carc. 1B,Harmonised C&L,0,H350:0
103585,"3,6,9,12,15-pentaoxaheptacosan-1-ol",221-281-8,3055-95-6,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,40,H318:39;H315:39;H335:39;H302:1
103587,"6-chloro-1,3-dihydroindol-2-one",421-330-5,56341-37-8,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1,Notified C&L,1,H400:1;H302:1;H317:1
103591,4-acetoxycinnamic acid,239-512-6,15486-19-8,,Notified C&L,5,H319:5;H315:5;H335:4
103592,"1,1-dichloro-1-fluoroethane",404-080-1,1717-00-6,Aquatic Chronic 3;Ozone 1,Harmonised C&L,0,H412:0;H420:0
103594,"Mallow, Malva sylvestris, ext.",282-003-9,84082-57-5,Flam. Liq. 3,Notified C&L,5,H226:4;Not classified:1
103595,"3,7-bis(diethylamino)phenoxazin-5-ium perchlorate",246-465-5,24796-94-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:38;H315:38;H335:38;H301:2;H318:2;H400:2;H410:2;H228:1
103597,4-(5-Ethyl-tetrahydropyran-2-yl)-phenol,921-114-5,,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,2,H318:2;H315:2;H335:2;H317:2;H411:2
103599,"Amides, from 2-(2-aminoethoxy)ethanol manuf. low-boiling by-products and low-boiling tall-oil fatty acids",274-327-4,70131-54-3,Eye Dam. 1,Notified C&L,16,H318:8;Not classified:8
103601,"Cyclohexane-1,4-diol",209-126-2,556-48-9,Acute Tox. 4;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H302:39;H335:40;H315:1
103603,Diethyl p-aminobenzylphosphonate,243-504-8,20074-79-7,,Notified C&L,5,H319:5;H315:5;H335:5
103605,"4-nonylphenol, reaction products with formaldehyde and dodecane-1-thiol",404-160-6,164907-73-7,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H413:0;H317:0
103607,nitrapyrin (ISO);2-chloro-6-trichloromethylpyridine,217-682-2,1929-82-4,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H302:0
103610,"1,2,4-Butanetriol, (2S)-",610-080-4,42890-76-6,Not Classified,Notified C&L,4,Not classified:4
103611,Terbacil,227-595-1,5902-51-2,Acute Tox. 4,Notified C&L,55,H302:54;H400:14;H410:14;Not classified:1
103613,N-(2-pyridylmethyl)pyridine-2-methylamine,216-266-8,1539-42-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:41;H335:40
103615,"Lycopodium clavatum, ext.",282-002-3,84082-56-4,Not Classified,Notified C&L,1,Not classified:1
103616,(R)-α-(trifluoromethyl)benzyl alcohol,234-094-1,10531-50-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:38;H227:1
103618,"2,2'-[[3-chloro-4-[[4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]phenyl]imino]bisethyl bis(hydrogen sulphate), potassium sodium salt",287-719-5,85567-07-3,Skin Sens. 1;Eye Dam. 1,REACH registration C&L,18,H318:3;H317:3;H252:1;Not classified:15
103621,"Naphtha (petroleum), light catalytic cracked sweetened;Low boiling point cat-cracked naphtha;[A complex combination of hydrocarbons obtained by subjecting naphtha from a catalytic cracking process to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons boiling in a range of approximately 35°C to 210°C (95°F to 410°F).]",295-441-0,92045-59-5,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
103635,Scandium trifluoride,237-255-4,13709-47-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,45,H301:39;H331:39;H311:39;H315:5;H302:4;H335:5;H319:5;H332:4;H312:4;Not classified:1
103638,L-2-hydroxy-2-phenylacetic acid,210-276-6,611-71-2,Eye Dam. 1,REACH registration C&L,167,H318:144;Not classified:11;H314:9;H319:3;H315:5;H335:2
103640,Diethyl [(ethylthio)methyl]phosphonate,258-971-3,54091-78-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
103644,Tetraoctadecylammonium bromide,264-211-1,63462-99-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:42
103647,o-isopropylphenyl isocyanate,260-105-4,56309-56-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H315:44;H302:39;H335:43;H319:44;H332:40;H312:39;H330:5;H301:5;H334:5
103649,"Tridecanamine, N-tridecyl-, branched and linear",309-798-8,101012-97-9,Skin Corr. 1A;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,584,H412:584;H318:559;H314:584
103650,reaction product of aminoacids and palmitoyl chloride.,925-014-2,,Skin Corr. 1C,Notified C&L,1,H314:1
103653,"Tetrasodium 4,4'-bis[[p-[(p-sulphonatophenyl)azo]phenyl]-N,N,O-azoxy]stilbene-2,2'-disulphonate",251-142-7,32651-66-4,Eye Irrit. 2;STOT SE 3,Notified C&L,25,H320:21;H335:21;Not classified:4
103659,"Iron, compound with niobium (2:1)",234-676-5,12023-22-2,Not Classified,Notified C&L,1,Not classified:1
103662,"3-ethyl 5-methyl 4-(2-chlorophenyl)-1,4-dihydro-2-[2-(1,3-dihydro-1,3-dioxo-(2H)isoindol-2-yl)-ethoxymethyl]-6-methyl-3,5-pyridinedicarboxylate",413-410-3,88150-62-3,Aquatic Chronic 4,Harmonised C&L,0,H413:0
103663,"Hexanedioic acid, polymer with 2,2-bis(hydroxymethyl)-1,3-propanediol, (9Z)-9-octadecenoate",614-289-1,68130-33-6,Not Classified,Notified C&L,3,Not classified:3
103666,"(6R-(6α,7β(z)))-7-((2-Amino-4-thiazolyl)-(methoxyimino)acetyl)amino)-3-(((5-carboxymethyl)-4-methyl-2-thiazolyl)thio)methyl)-oxo-5-thia-1-azabizyclo(4.2.0)oct-2-en-2-carboxansäure-dinatriumsalz",617-833-6,86329-79-5,Skin Sens. 1;Resp. Sens. 1,Notified C&L,3,H334:3;H317:3
103668,"Dimethyl 2,2'-[(4-methylbenzene-1,2-diyl)bis(oxy)]diacetate",700-270-6,52589-39-6,Not Classified,REACH registration C&L,5,Not classified:5
103671,N-9H-fluoren-4-ylacetamide,248-964-3,28322-02-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Muta. 2,Notified C&L,42,H319:38;H315:38;H341:42;H335:38
103674,"2-Naphthalenesulfonic acid, 7-amino-4-hydroxy-3-[2-[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-8-[2-[2-sulfo-4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-, sodium salt (1:4)",612-023-9,607724-37-8,Not Classified,REACH registration C&L,8,Not classified:7;H318:1;H317:1
103675,"1,1,2,2-tetrachloro-[1,2-2H2]ethane",251-634-1,33685-54-0,Acute Tox. 1;Acute Tox. 2;Aquatic Chronic 2,Notified C&L,48,H411:48;H330:48;H310:48;Not classified:1
103676,"Fatty acids, palm-oil, sodium salts",263-162-3,61790-79-2,Not Classified,Notified C&L,93,Not classified:93
103678,"N,N'-(10,15,16,17-tetrahydro-5,10,15,17-tetraoxo-5H-dinaphtho[2,3-a:2',3'-i]carbazole-4,9-diyl)bis(benzamide)",205-044-6,131-92-0,Skin Sens. 1B,REACH registration C&L,22,H317:2;Not classified:20
103679,"3,5-dichloro-2,4,6-trifluoropyridine",217-088-3,1737-93-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,101,H319:96;H315:100;H335:99;H330:44;H318:4;H301:5;H310:6;H400:4;H410:4;H314:1;H311:1;H331:1;H300:1
103680,"Carbonic acid, magnesium salt",231-817-2,7757-69-9,Not Classified,Notified C&L,68,Not classified:68
103683,4-cyclohexyl-α-methylnaphthalene-1-acetic acid,275-196-6,71109-09-6,Acute Tox. 4,Notified C&L,38,H302:38
103687,2-chloro-5-nitrobenzophenone,251-811-3,34052-37-4,Eye Irrit. 2,Notified C&L,40,H319:40;H315:1
103689,"Chromate(1-), bis[3-(hydroxy-κO)-4-[2-[2-(hydroxy-κO)-3,5-dinitrophenyl]diazenyl-κN1]-N-phenyl-2-naphthalenecarboxamidato(2-)]-, sodium (1:1)",600-899-5,109125-50-0,,Notified C&L,1,Not classified:1
103692,"(2,6-dichlorophenyl)hydrazine monohydrochloride",256-730-7,50709-36-9,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H315:40;H335:39;H301:39;H319:44;H332:44;H312:44;H302:6;H331:1;H311:1
103694,2-methyloctane,221-748-6,3221-61-2,Flam. Liq. 3,Notified C&L,43,H226:43;H315:4;H336:4;H335:4;H304:5;H319:4;H400:4;H410:4
103696,"1,7-bis(4-hydroxy-3-methoxyphenyl)heptane-3,5-dione",609-201-3,36062-04-1,Not Classified,Notified C&L,2,Not classified:2
103705,3-Hydroxy-2-(3-carboxy-2-hydroxy-5-nitro-phenylazo)-but-2-enoic-acid-N-(2-ethylhexyl)-amide,600-747-8,,Not Classified,Notified C&L,2037,Not classified:2037
103708,Diytterbium oxide silicate,234-731-3,12027-89-3,Not Classified,Notified C&L,1,Not classified:1
103711,"Benzeneacetic acid, 4-(chloromethyl)-α-methyl-, methyl ester",617-111-0,80530-54-7,,Notified C&L,3,H315:3;H302:3;H335:3;H319:3;H332:3;H312:3
103713,2-chloracetamide,201-174-2,79-07-2,Acute Tox. 3;Skin Sens. 1;Repr. 2,Harmonised C&L,0,H301:0;H361:0;H317:0
103721,"amylase, α-",232-565-6,9000-90-2,Resp. Sens. 1,Harmonised C&L,0,H334:0
103723,2-bromoheptane,217-824-3,1974-04-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H226:38;H335:38
103731,"1,1,1,2,2,3,4,5,5,5-decafluoro-3-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-4-(trifluoromethyl)pentane",256-522-6,50285-18-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
103732,Prednisolone 21-acetate,200-134-1,52-21-1,Acute Tox. 2,Notified C&L,90,H300:38;H373:35;H360:32;H319:11;H361:15;H302:8;H315:2;H335:2;H332:5;H312:4;Not classified:1
103735,Trichloromethanesulphenyl chloride,209-840-4,594-42-3,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 1,Notified C&L,74,H301:74;H314:73;H330:73;H311:40;H335:33;H312:34;H370:1;H372:1;H315:1;H319:1;H331:1
103736,"N,N,N-trimethylanilinium chloride",205-319-0,138-24-9,Acute Tox. 3;Acute Tox. 3,Harmonised C&L,0,H301:0;H311:0
103737,2H-Tetrazole-5-hexadecanoic acid,618-002-0,873874-15-8,,Notified C&L,1,Not classified:1
103739,"2,5-dimethyl-1-phenyl-1H-pyrrole",201-461-2,83-24-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
103742,4-Methoxythiobenzamide,607-252-6,2362-64-3,Skin Sens. 1,Notified C&L,44,H317:38;H332:6;H302:6
103748,Nialamide,200-079-3,51-12-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,38,H315:38;H302:38;H335:38;H319:38;H351:38;H332:38;H312:38
103752,(7R)-7-(4-carboxybutanamido)cephalosporanate amidohydrolase (enzyme substance),611-406-8,56645-46-6,Resp. Sens. 1,REACH registration C&L,2,H334:2
103756,"1H-Azepine-1-propanenitrile, hexahydro-2-oxo-",615-970-6,7336-15-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,83,H319:83;H315:83
103759,Tetrachloroauric acid,240-948-4,16903-35-8,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;STOT RE 2;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,150,H373:11;H318:105;H290:17;H302:106;H314:150;H411:11;H412:92;H317:127;H335:4
103760,"N-(carboxymethyl)-3-[(2Z)-docos-2-enoylamino]-N,N-dimethylpropan-1-aminium",447-060-8,,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H315:3;H400:3;H410:3
103765,"Fatty acids, C8-18 and C18-unsatd., zinc salts",267-012-8,67762-34-9,Not Classified,Notified C&L,3,Not classified:2;H400:1
103777,Bis(tridecan-1-yl) hydrogen phosphate,225-851-7,5116-95-0,Not Classified,Notified C&L,441,Not classified:441
103778,"Licorice, Glycyrrhiza glabra, ext., calcium salts",309-071-5,99811-79-7,Not Classified,Notified C&L,1,Not classified:1
103779,3-bromobenzoyl chloride,216-978-9,1711-09-7,Skin Corr. 1B,Notified C&L,48,H314:48;H335:2;H312:1;H332:1;H302:1;H318:2;H290:1
103780,"5'-Thymidylic acid, disodium salt",251-518-0,33430-62-5,Not Classified,Notified C&L,1,Not classified:1
103782,"4,5,6,7-tetrahydro-3,6-dimethylbenzofuran",207-795-5,494-90-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1629,H319:1622;H411:1628;H315:1628;H302:1628;Not classified:1;H412:1
103785,"reaction mass of: (2R,3R)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate;(2S,3S)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate",425-530-3,98769-75-6,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H318:0;H302:0
103787,2-benzylisoquinolinium chloride,252-666-9,35674-56-7,Not Classified,Notified C&L,21,Not classified:20;H412:1;H315:1;H335:1
103789,"2,3,5,6-tetrafluorophenylhydrazine",211-494-4,653-11-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H315:44;H302:44;H335:44;H319:44;H332:40;H312:39;H301:1;H331:1;H311:1
103792,"2,3,4,5-tetrachlorophenol",225-531-7,4901-51-3,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H318:41;H315:41;H335:41;H301:41;H400:38;H410:38;Not classified:1
103794,Methyl 2-chloroacrylate,201-298-7,80-63-7,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 1,Notified C&L,10,H330:8;H226:8;H301:10;H314:10;H311:10;H318:1
103796,"Sodium 3-amino-2,4,6-triiodobernzoate",614-015-0,67031-56-5,Not Classified,REACH registration C&L,2,Not classified:2
103797,Phthalazin-1(2H)-one,204-319-8,119-39-1,Acute Tox. 4,REACH registration C&L,42,H302:42;H319:1;H315:1
103798,Phenylacetylene,208-645-1,536-74-3,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,94,H319:89;H304:67;H315:84;H226:94;H335:39;H351:12;Not classified:2;H301:1;H311:1;H331:1
103800,4-methylphenetole,210-746-0,622-60-6,Acute Tox. 4,Notified C&L,38,H302:38
103803,4-4'-methylenebis(oxyethylenethio)diphenol,407-480-4,93589-69-6,Aquatic Chronic 2,Harmonised C&L,0,H411:0
103807,"Naphtha;Low boiling point naphtha;[Refined, partly refined, or unrefined petroleum products produced by the distillation of natural gas. It consists of hydrocarbons having carbon numbers predominantly in the range of C",232-443-2,8030-30-6,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
103808,BBP;benzyl butyl phthalate,201-622-7,85-68-7,Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H400:0;H360:0;H410:0
103809,"Distillates (coal tar), naphthalene oils, naphthalene-low;Naphthalene Oil Redistillate;[A complex combination of hydrocarbons obtained by crystallization of naphthalene oil. Composed primarily of naphthalene, alkyl naphthalenes and phenolic compounds.]",284-898-1,84989-09-3,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
103813,"Goldenrod, Solidago canadensis, ext.",306-234-2,96690-40-3,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,4,H304:3;H317:3;H226:3;H410:3;H315:1;Not classified:1
103815,o-Xylylendiamine,605-656-7,17300-02-6,Acute Tox. 4;Skin Corr. 1B,Notified C&L,127,H314:127;H302:127
103820,"2,2,2-trifluoro-1-(2-hydroxy-5-methylphenyl)ethan-1-one",275-078-4,70978-57-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
103822,"2,3-diethylpyrazine",239-800-1,15707-24-1,Acute Tox. 4,Notified C&L,1596,H302:1553;H318:38;H315:43;H335:42;H319:5
103823,"2,2,4,4-tetrafluoro-1,3-dithietane",217-001-9,1717-50-6,Flam. Liq. 3,Notified C&L,43,H226:43
103825,"3-(2,6-dichlorophenyl)-5-methylisoxazole-4-carboxylic acid",223-487-3,3919-76-4,,Notified C&L,5,H302:5
103828,Isopentyl undecenoate,235-514-6,12262-03-2,Not Classified,Notified C&L,88,Not classified:88
103834,"α,α,α-trifluoro-2-iodotoluene",207-147-1,444-29-1,Skin Corr. 1B,Notified C&L,45,H314:38;H319:7;H315:7;H335:6
103840,"Molybdenum, bis(ditridecylcarbamodithioato)di-μ-oxodioxo-di-, sulfurized",275-347-6,71342-89-7,Aquatic Chronic 2,Notified C&L,506,H411:442;Not classified:64
103841,Acridin-4-ol,242-013-6,18123-20-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
103843,"1-Naphthalenesulfonic acid, 4-diazo-3,4-dihydro-7-nitro-3-oxo-",611-029-9,5366-84-7,Not Classified,Notified C&L,1,Not classified:1
103844,"D-Glucopyranose, oligomeric, C10-16 (even numbered)-alkyl glycosides, Me ethers",600-301-2,1023311-89-8,Not Classified,Notified C&L,105,Not classified:83;H319:22;H315:22;H317:22
103847,"2,2-dimethyl-3-(2-methylpropenyl)cyclopropanemethanol",227-045-0,5617-92-5,Aquatic Chronic 2,Notified C&L,39,H411:38;Not classified:1
103848,"Perilla frutescens, ext.",290-151-0,90082-61-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1409,H319:1394;H411:1407;H315:1407;H317:1408;H304:121
103853,"alpha-1,alpha-1,alpha-3,alpha-3,5-pentamethyl-1,3-benzenediacetonitrile",427-220-3,120511-72-0,Aquatic Chronic 4,Notified C&L,4,H413:3;H319:1;H315:1
103856,"Dolomite (CaMg(CO3)2), calcined",281-192-5,83897-84-1,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,8,H318:8;H315:8;H335:8
103858,4-bromobutyl acetate,225-277-7,4753-59-7,Acute Tox. 4,Notified C&L,2,H302:1;Not classified:1
103866,(bicyclo[2.2.1]hept-5-en-2-yl)methyl acrylate,202-415-4,95-39-6,Not Classified,Notified C&L,2,Not classified:2
103867,Citronellyl hexanoate,234-175-1,10580-25-3,Not Classified,Notified C&L,88,Not classified:88
103877,m-toluoyl chloride,216-976-8,1711-06-4,Skin Corr. 1B;STOT SE 3,Notified C&L,47,H314:47;H335:38;H318:4;H290:2;Not classified:1
103880,5-methylsalicylaldehyde,210-357-6,613-84-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:41;H302:1
103886,"Benzamide, N,N'-[6,13-bis(acetylamino)-2,9-diethoxy-5a,6,12a,13-tetrahydro-3,10-triphenodioxazinediyl]bis-",611-599-9,57971-98-9,Not Classified,Notified C&L,1,Not classified:1
103887,"Quaternary ammonium compounds, C12-14-alkyl[(ethylphenyl)methyl]dimethyl, chlorides",287-090-7,85409-23-0,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,244,H318:45;H302:200;H314:208;H400:200;H410:46;H312:42;Not classified:36
103888,Cyacetacide,205-437-2,140-87-4,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H315:44;H335:43;H301:44;H319:44;H332:38;H312:38;H331:1;H311:1
103891,Ammonium methyl phosphonate,251-898-8,34255-87-3,Not Classified,Notified C&L,5,Not classified:5
103892,divanadium pentaoxide;vanadium pentoxide,215-239-8,1314-62-1,Acute Tox. 4;Acute Tox. 4;STOT SE 3;Muta. 2;STOT RE 1;Aquatic Chronic 2;Repr. 2,Harmonised C&L,0,H372:0;H302:0;H335:0;H361:0;H332:0;H411:0;H341:0
103893,2-acetoxymethylene-4-acetylphenylacetate,425-160-2,24085-06-1,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H373:0;H318:0;H302:0;H400:0;H317:0;H410:0
103894,"6,7-Epoxy-3,7-dimethyl-3-octen-1-yne",925-334-2,,Not Classified,Notified C&L,1,Not classified:1
103895,"1,2,3-trimethylbenzene",208-394-8,526-73-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1697,H319:1371;H315:1455;H226:1563;H335:555;Not classified:96;H304:102;H373:79;H411:9;H332:2;H371:1;H336:1;H372:1
103896,"reaction mass of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonato ethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate;2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate",450-010-8,,Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H318:0;H317:0
103897,Hexyl hydrogen phthalate,246-302-8,24539-57-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
103898,p-sec-octylphenol,248-330-6,27214-47-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
103899,Diphenyl-o-tolylphosphine,227-675-6,5931-53-3,,Notified C&L,4,H319:4;H315:4;H335:4
103902,2-bromonaphthalene,209-452-5,580-13-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,47,H319:43;H302:44;Not classified:3;H315:2;H335:2
103904,dodecyl β-D-glucopyranoside,261-614-4,59122-55-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
103906,"Ethyl 5-[3-chloro-4-[(2-cyano-4-nitrophenyl)azo]phenyl]-9-oxo-2,8,10-trioxa-5-azadodecanoate",277-408-2,73384-66-4,Not Classified,Notified C&L,1,Not classified:1
103907,"3,4-dimethylisoxazol-5-ylamine",243-437-4,19947-75-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39
103908,"1,1-diethoxy-2-methylpropane",217-107-5,1741-41-9,Flam. Liq. 3,Notified C&L,1413,H226:1375;H225:38
103909,"Fatty acids, C5-9, mixed esters with pentaerythritol and valeric acid",270-294-5,68424-33-9,Not Classified,Notified C&L,12,Not classified:12
103913,N-(5-chloro-pyridin-2-yl)-2-(4-cyano-benzoyl-amino)-5-methoxy-benzamide hydrochloride,921-397-5,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;STOT SE 2,REACH registration C&L,2,H312:2;H371:2;H332:2;H302:2
103914,Dipotassium nitrosodisulphonate,238-219-0,14293-70-0,Water-react. 1;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H260:39;H312:39;H332:39;H302:39
103915,"4-benzyl-1-[β,4-dihydroxy-α-methylphenethyl]piperidinium hydrogen tartrate",245-493-5,23210-58-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H315:39;H302:39;H335:39;H319:39;H332:39;H312:39
103917,"4-(3,4-dimethoxyphenyl)-4-oxocrotonic acid",279-631-0,80937-23-1,,Notified C&L,2,Not classified:1;H319:1;H315:1;H302:1;H335:1
103924,N-carbamoylmaleamic acid,203-314-8,105-61-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,42,H318:38;H315:42;H302:38;H335:42;H319:4
103926,"(±)-dihydro-3-hydroxy-4,4-dimethylfuran-2(3H)-one",201-210-7,79-50-5,Eye Irrit. 2,REACH registration C&L,58,H319:3;Not classified:55
103927,"1-Naphthaleneacetic acid, 4-cyclohexyl-",615-250-1,71109-06-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H301:1;H331:1;H311:1
103929,"Diphenylmethyl (6R,7R)-3-hydroxy-8-oxo-7-[(phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",611-177-4,54639-48-4,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,3,H334:3;H317:3
103930,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-leucine,252-662-7,35661-60-0,Not Classified,Notified C&L,8,Not classified:5;H312:2;H332:2;H302:2;H319:1;H315:1;H335:1
103931,"(8S,13S,14S,17S)-17-hydroxy-13-methyl-2,6,7,8,14,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-3-one",600-229-1,10161-33-8,Carc. 2;Repr. 2;STOT RE 1,REACH registration C&L,73,H351:2;H361:2;H372:2;H360:71
103933,2-naphthylamine,202-080-4,91-59-8,Acute Tox. 4;Carc. 1A;Aquatic Chronic 2,Harmonised C&L,0,H350:0;H302:0;H411:0
103939,"2,6-bis(1methylethyl)-N-[[6-(1-naphtalenyl)2-pyridinyl]methylene]-Benzanamine",610-735-4,518058-51-0,Aquatic Chronic 1,Notified C&L,1,H410:1
103941,4-methylpent-2-enal,226-348-5,5362-56-1,Not Classified,Notified C&L,90,Not classified:88;H226:2;H312:1;H317:1;H302:1
103943,"[(2E)-3-(5,5-dimethyl-1,3-dioxan-2-yl)-2-butenyl]triphenylphosphonium chloride",613-004-8,62285-89-6,Acute Tox. 3;Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,84,H301:84;H318:84;H317:84;H411:83
103945,Sodium chloride,231-598-3,7647-14-5,Not Classified,REACH registration C&L,1921,Not classified:1718;H319:203;H318:11;H315:10;H335:5;H373:5;H316:1;H320:1
103947,Reactive yellow 42,602-435-7,12226-63-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
103950,"1,2,3,4-tetrahydro-1-naphthylamine",218-712-7,2217-40-5,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,129,H318:84;H302:84;H412:84;H314:84;H402:1;H319:45;H315:45;H335:44
103954,Tantalum diboride,234-507-5,12007-35-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,209,H319:208;H315:208;H335:208;Not classified:1
103955,4-[(morpholinothio)thioxomethyl]morpholine,237-335-9,13752-51-7,Carc. 1B;Aquatic Chronic 2,REACH registration C&L,58,H350:57;H411:57;Not classified:1
103956,Indium arsenide,215-115-3,1303-11-3,Aquatic Acute 1,Notified C&L,56,H400:52;H301:4;H331:4;H373:4;H410:4
103958,"Triphosphoric acid, aluminum salt (1:?)",608-328-1,29196-72-3,Aquatic Chronic 4,Notified C&L,8,H413:8
103959,Lead(2+) tellurium tetraoxide,237-573-3,13845-35-7,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H373:1;H360:1;H302:1;H400:1;H332:1;H410:1
103963,3'-(trifluoromethyl)acetophenone,206-490-4,349-76-8,Aquatic Chronic 3,REACH registration C&L,81,H412:34;H319:47;H315:47;H335:46
103964,"Fatty acids, C14-18 and C16-22-unsatd., Me esters",285-208-1,85049-38-3,Not Classified,Notified C&L,1,Not classified:1
103968,"bioresmethrin (ISO);(5-benzyl-3-furyl)methyl (1R)-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate",249-014-0,28434-01-7,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
103971,Thiazolidine,208-002-5,504-78-9,Flam. Liq. 3,Notified C&L,46,H226:46;H319:4;H315:4;H335:4
103974,"1,1-dimethyl-2-selenourea",225-854-3,5117-16-8,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H373:39;H301:39;H331:39;H400:39;H410:39
103976,4-ethoxyphenol,210-748-1,622-62-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,156,H319:156;H315:156;H335:155
103978,dimercury dichloride;mercurous chloride;calomel,233-307-5,10112-91-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H315:0;H302:0;H335:0;H319:0;H400:0;H410:0
103984,4-pentylphenyl p-toluate,256-683-2,50649-59-7,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H400:38;H410:38;H413:1;Not classified:1
103985,"1,7,7-trimethylbicyclo(2,2,1)hept-2-yl thiocyanatoacetate;isobornyl thiocyanoacetate",204-081-5,115-31-1,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H302:0;H410:0
103987,N-glycylglycine,209-127-8,556-50-3,Eye Irrit. 2,Notified C&L,64,H319:44;Not classified:20;H335:1
103996,"Fatty acids, C16-18 and C18-hydroxy, oligomeric reaction products with adipic acid, decanoic acid, isooctadecanoic acid, octanoic acid, pentaerythritol and stearic acid",500-320-5,130353-58-1,Not Classified,REACH registration C&L,19,Not classified:19
103998,Glutamic acid hydrochloride,205-315-9,138-15-8,Skin Corr. 1A,Notified C&L,144,H314:74;Not classified:58;H318:13;H315:4;H335:4;H290:1
103999,"Fatty acids, C16-18-monounsatd., 2-(2-ethoxyethoxy)ethyl esters",292-982-4,91031-77-5,Not Classified,Notified C&L,8,Not classified:8
104000,"2,2'-[[3-chloro-4-[(2-chloro-4-nitrophenyl)azo]phenyl]imino]bisethanol",261-126-1,58104-46-4,Aquatic Chronic 3,Notified C&L,3,H412:3
104002,"2H-Pyran-2,4,6(3H,5H)-trione",600-640-6,10521-08-1,,Notified C&L,1,H319:1;H315:1;H335:1
104003,phenylmercury hydroxide,202-866-7,100-57-2,Acute Tox. 3;Skin Corr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H372:0;H301:0;H314:0;H400:0;H410:0
104004,IRGAPHOR ULTRAGREEN MX,436-040-4,,Not Classified,Notified C&L,83,Not classified:83
104005,Bis(2-ethylhexyl) hydrogen phosphate,206-056-4,298-07-7,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,982,H318:620;H314:827;H302:574;H312:841;H332:182;H315:114;Not classified:42;H412:37;H319:5;H290:2
104013,2-fluoropyridine,206-757-5,372-48-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H315:47;H226:47;H335:46;H302:1;H332:1;H312:1
104015,"1-ethyl-2-(8-heptadecyl)-4,5-dihydro-3-(2-hydroxyethyl)-1H-imidazolium ethyl sulphate",268-232-7,68039-12-3,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 3,Notified C&L,16,H319:14;H315:14;H401:8;H411:6;H314:1;Not classified:1
104016,"[1-[[(2-hydroxyphenyl)imino]methyl]-2-naphtholato(2-)-N,O,O']copper",239-763-1,15680-42-9,Acute Tox. 4,REACH registration C&L,91,H332:84;Not classified:7
104022,"3,6,9,12,15,18-hexaoxatriacontan-1-ol",221-282-3,3055-96-7,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1,Notified C&L,40,H318:39;H400:39;H302:39;H319:1;H315:1
104024,Ethyl phenylcyanoacetate,224-921-4,4553-07-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H315:40;H302:40;H335:39;H319:40;H332:39;H312:40
104025,"2,6-DIMETHYL-4-NITROANILINE",605-554-2,16947-63-0,Acute Tox. 4,Notified C&L,39,H302:39;H315:1;H335:1;H319:1;H332:1;H312:1
104027,N-[2-(dimethylamino)ethyl]acrylamide,213-124-7,925-76-8,Acute Tox. 4,Notified C&L,38,H302:38
104028,Fluoxymesterone,200-961-8,76-43-7,Repr. 2,Notified C&L,41,H361:40;H360:1
104030,"4-[(4-ethoxyphenyl)amino]-N,N-dimethyl-3-nitrobenzenesulphonamide",266-648-3,67338-59-4,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,8,H411:4;H317:5;Not classified:3
104031,"Naphtha (coal), solvent extn., hydrocracked;[Fraction of the distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30°C to 180°C (86°F to 356°F). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C",302-690-1,94114-54-2,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
104032,"(6R,7R)-7-amino-3-(5H-imidazo[1,2-b]pyridazin-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydroiodide",606-382-0,197897-11-3,Skin Sens. 1B;Resp. Sens. 1,Notified C&L,1,H334:1;H317:1
104034,Benzyl octanoate,233-620-7,10276-85-4,Not Classified,Notified C&L,90,Not classified:89;H226:1
104035,"Sodium 4-chloro-3-[4,5-dihydro-4-[(2-hydroxy-4-nitrophenyl)azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonate",302-440-1,94109-02-1,Not Classified,Notified C&L,9,Not classified:9
104036,C.I. Reactive Black 8,602-381-4,12225-26-2,Not Classified,Notified C&L,2,Not classified:2
104038,2-fluoro-5-nitropyridine,207-260-6,456-24-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
104045,"Acide4-(6(propenoyloxy)hexyloxy)benzoique,4-methoxyphenyl ester",444-080-9,82200-53-1,Skin Sens. 1;Aquatic Chronic 4,REACH registration C&L,3,H413:3;H317:3
104046,Zinc octadecyl phosphate,225-023-5,4615-31-0,,Notified C&L,3,Not classified:3
104049,"1,2,3,4,4a,7,8,8a-octahydro-2,4a,5,8a-tetramethyl-1-naphthyl formate",265-742-1,65405-72-3,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1611,H400:13;H410:13;H319:1338;Not classified:260
104051,"6H-dibenz[c,e][1,2]oxaphosphorin 6-oxide",252-813-7,35948-25-5,Skin Sens. 1B,REACH registration C&L,110,H317:27;Not classified:79;H319:4;H315:4;H335:2
104055,"1-iodopyrrolidine-2,5-dione",208-221-6,516-12-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,81,H319:73;H315:73;H302:69;H335:71;Not classified:7;H332:1;H312:1;H301:1
104056,"Quaternary ammonium compounds, benzyl-C12-16-alkyldimethyl, chlorides",270-325-2,68424-85-1,Acute Tox. 4;Skin Corr. 1B,Notified C&L,1659,H314:1621;H302:1094;H318:747;H301:531;H331:441;H400:1126;H311:535;H312:177;H410:99;H373:39;Not classified:31;H226:6;H319:5;H315:4;H290:5;H330:1;H332:1;H413:1;H411:1
104057,"Trisodium (2S-trans)-[18-carboxy-20-(carboxymethyl)-13-ethyl-2,3-dihydro-3,7,12,17-tetramethyl-8-vinyl-21H,23H-porphine-2-propionato(5-)-N21,N22,N23,N24]cuprate(3-)",234-242-5,11006-34-1,Not Classified,Notified C&L,126,Not classified:126
104060,"1,3-Propanediamine, N-[3-(C10-16-alkyloxy)propyl] derivs.",269-099-8,68187-46-2,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 1,Notified C&L,24,H314:24;H302:24;H410:24;H400:2
104061,"Phosphoric acid, octyl ester, branched and linear, compd. with diethanolamine",307-245-5,97553-82-7,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;STOT RE 2,Notified C&L,10,H313:10;H373:10;H318:10;H302:10;H314:10
104066,C,417-360-3,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2,Harmonised C&L,0,H312:0;H315:0;H302:0
104068,"p-[4,5-dihydro-4-[[2-methoxy-5-methyl-4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonic acid",262-538-4,60958-41-0,Not Classified,REACH registration C&L,11,Not classified:11
104071,EXOLIT OP 940,434-510-3,,Not Classified,Notified C&L,31,Not classified:31
104078,5-tert-butyl-3-methylpyrocatechol,218-668-9,2213-66-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:38;H315:41;H302:38;H335:41;H318:3
104083,Dipotassium tetrakis(cyano-C)palladate(2-),238-520-7,14516-46-2,,Notified C&L,5,H332:5;H302:5
104084,"2,4-dichlorobenzaldehyde",212-861-1,874-42-0,Skin Corr. 1B;Aquatic Chronic 2,Notified C&L,205,H411:164;H314:202;H319:3;H412:3;H315:3;H318:1
104085,3-(4-hydroxyphenyl)propionic acid,207-931-3,501-97-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
104092,"[(4,5-dihydro-5-thioxo-1,3,4-thiadiazol-2-yl)thio]acetic acid",258-728-1,53723-88-9,,Notified C&L,8,H319:8;H315:8;H335:7
104094,"1,3-diethoxypropane",413-140-6,3459-83-4,Flam. Liq. 3,Harmonised C&L,0,H226:0
104095,"1-amino-4-(ethylamino)-9,10-dihydro-9,10-dioxoanthracene-2-carbonitrile",263-606-6,62570-50-7,Not Classified,REACH registration C&L,91,Not classified:59;H341:32
104096,"[μ-[3-[[5-[[2,4-dihydroxy-5-[(2-hydroxy-3-nitro-5-sulphophenyl)azo]phenyl]methyl]-2,4-dihydroxyphenyl]azo]-2-hydroxy-5-nitrobenzenesulphonato(6-)]]diiron",286-920-5,85392-59-2,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,124,H319:124;H412:90;H315:33;H411:1
104098,Pentene,246-916-6,25377-72-4,Flam. Liq. 1;Aquatic Chronic 2,Notified C&L,6,H411:5;H224:6
104100,Phenyl isothiocyanate,203-138-1,103-72-0,Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Resp. Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,209,H315:4;H301:175;H314:169;H400:42;H317:168;H410:48;H334:162;H318:117;H341:116;H361:116;H331:7;H330:9;H311:10;H225:3;H335:2;Not classified:1
104102,Hexaammonium wolframate,234-733-4,12028-48-7,Acute Tox. 4,REACH registration C&L,109,H302:107;H319:84;H315:84;H412:7;H318:7;Not classified:2
104110,"1,2-dichloro-3-iodobenzene",219-276-0,2401-21-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
104113,Dicadmium tin tetraoxide,700-126-2,12185-56-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 1,Notified C&L,175,H302:174;H400:174;H332:174;H410:175;H312:174;H372:1;H330:1;H361:1;H350:1;H341:1
104115,"Matricaria recutita, ext.",282-006-5,84082-60-0,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1740,H315:1384;H304:1419;H319:6;H317:1384;H411:6;H412:1471;Not classified:234;H226:32;H402:2;H316:2;H302:1;H335:1
104116,"1-(2-hydroxyethoxy)-2,2,4-trimethylpentan-3-ol",273-409-7,68959-25-1,Eye Irrit. 2,Notified C&L,7,H319:7
104118,"Fatty acids, C18-unsatd., dimers, ethoxylated propoxylated",614-408-7,68308-89-4,Not Classified,Notified C&L,64,Not classified:64
104119,"Hexamethylene diisocyanate, oligomerisation product, blocked with 3,5-Dimethyl-1H-pyrrazole",605-318-9,163206-31-3,STOT RE 1,REACH registration C&L,137,H372:12;Not classified:116;H317:9
104120,"Docosanoic acid, compound with 2,2',2''-nitrilotriethanol (1:1)",246-462-9,24794-57-8,Not Classified,Notified C&L,6,Not classified:6
104121,3-[(4-chloro-2-nitrophenyl)amino]propan-1-ol,282-296-3,84145-68-6,Skin Sens. 1;Eye Irrit. 2,Notified C&L,38,H319:38;H317:38
104124,"Naphtha (petroleum), isomerization, C",295-440-5,92045-58-4,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
104126,({4-(3-Chloro-4-fluoro-phenylamino)-7-[(S)-(tetrahydro-furan-3-yl)oxy]-quinazolin-6-ylcarbamoyl}-methyl)-phosphonic acid diethyl ester,928-634-1,,,Notified C&L,1,Not classified:1
104131,cis-bicyclo[4.4.0]decane,207-770-9,493-01-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H315:38;H226:42;H335:38;H319:38;H332:42;H314:5;H318:1;H304:1;H331:1;H371:1;H400:1;H410:1;H411:1
104133,Citrus aurantium var. amara,614-782-1,68916-04-1,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,156,H315:146;H304:145;H400:107;H317:146;H410:143;H226:18;Not classified:10;H411:3;H318:1
104141,2-fluoro-3-nitroaniline,244-367-7,21397-11-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
104143,3-(Hydroxymethyl)-1-pentene,610-949-8,53045-70-8,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,2,H314:2;H302:2;H226:2
104145,Diiron titanium pentaoxide,234-679-1,12023-27-7,Not Classified,REACH registration C&L,4,Not classified:4
104147,Calcium chloride hexahydrate,616-496-2,7774-34-7,Eye Irrit. 2,Notified C&L,58,H319:58
104149,"Oxidase, l-amino acid",232-564-0,9000-89-9,Acute Tox. 2;Acute Tox. 2;Acute Tox. 1,Notified C&L,38,H300:38;H330:38;H310:38
104153,"Hexanedioic acid, polymer with 2,2-bis(hydroxymethyl)-1,3-propanediol, octadecanoate",614-290-7,68130-34-7,Not Classified,Notified C&L,1,Not classified:1
104154,Phentermine,204-522-1,122-09-8,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,42,H315:1;H301:39;H319:1;H332:1;H311:1;Not classified:3
104155,Silver iodide,232-038-0,7783-96-2,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,80,H400:40;H410:78;Not classified:2
104156,3-(2-aminoethyl)indol-5-ol--2-imino-1-methylimidazolidin-4-one sulphate (1:1),213-539-3,971-74-4,Repr. 2,Notified C&L,40,H361:40;H312:2;H332:2;H302:2
104157,(Z)-hex-3-enyl acetate,222-960-1,3681-71-8,Flam. Liq. 3,REACH registration C&L,1874,H226:1863;Not classified:11;H319:4;H315:4;H335:4;H302:1
104158,"4,4'-Sulfonylbis(2,6-dimethylphenol)",603-686-5,13288-70-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
104164,"[29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]iron",205-047-2,132-16-1,Not Classified,REACH registration C&L,56,Not classified:47;H319:5;H315:6;H335:5;H413:3;H312:1;H332:1
104170,Potassium nitrate,231-818-8,7757-79-1,Ox. Sol. 3,REACH registration C&L,2320,H272:2100;Not classified:124;H319:1324;H315:1323;H335:1320;H271:96;H412:38;H302:10;H373:5;H361:5;H371:5
104176,6-thioinosine,209-371-5,574-25-4,Acute Tox. 4,Notified C&L,38,H302:38
104177,"Aluminium, 6-hydroxy-5-[(4-sulfophenyl)azo]-2-naphthalenesulfonic acid complex",239-888-1,15790-07-5,Not Classified,REACH registration C&L,211,Not classified:201;H319:10
104178,"Fatty acids, C18-unsatd., dimers, oligomeric reaction products with fatty acids, C16-18 and C18-unsatd., branched and linear, tetraethylenepentamine and triethylenetetramine, reaction products with glycidyl tolyl ether",919-648-9,,Eye Dam. 1,Notified C&L,9,H318:9
104180,"3,6-bis(o-sulphophenylazo)-4,5-dihydroxynaphthalene-2,7-disulphonic acid",217-089-9,1738-02-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
104183,"3,3',5,5'-tetramethyl[1,1'-biphenyl]-4,4'-diamine dihydrochloride",264-769-6,64285-73-0,Not Classified,Notified C&L,2,Not classified:2
104185,4-acetamido-3-nitrobenzoic acid,216-265-2,1539-06-6,Skin Sens. 1,Notified C&L,42,H317:38;H319:4;H315:4;H335:4
104187,"1,6-Octadiene, 7-methyl-3-methylene-, acid-hydrated, geraniol fractions, distn. residues",274-325-3,70131-51-0,Not Classified,Notified C&L,88,Not classified:88
104190,N-(2-hydroxyethyl)-N-[2-(stearoylamino)ethyl]stearamide,231-734-1,7709-17-3,Eye Dam. 1,Notified C&L,50,H318:50
104196,"3-(1,1,2,2-tetrafluoroethoxy)aniline",212-610-6,831-75-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39;H302:1;H332:1;H312:1
104198,N-ethyl-N-[2-[1-(2-methylpropoxy)ethoxy]ethyl]-4-(phenylazo)aniline,252-021-1,34432-92-3,Acute Tox. 4;Skin Sens. 1B;Repr. 2;STOT RE 2;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,158,H373:15;H302:62;H361:8;H317:15;H410:9;Not classified:104;H413:42;H315:8;H331:8;H400:8;H332:8;H311:8;H411:2;H360:1
104199,Mebendazole,250-635-4,31431-39-7,Acute Tox. 4,Notified C&L,73,H302:72;H400:10;H361:3;H319:2;H315:2;H341:1;H371:1
104201,Praseodymium trifluoride,237-254-9,13709-46-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,218,H319:179;H315:179;H335:179;H301:38;H331:38;H311:38;H302:6;H332:6;H312:6;H413:2;Not classified:1
104205,"florasulam (ISO);2',6',8-trifluoro-5-methoxy-5-triazolo[1,5-c];pyrimidine-2-sulfonanilide",604-488-1,145701-23-1,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
104206,"2,2'-[(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[3-oxo-N-phenylbutyramide]",229-388-1,6505-28-8,Not Classified,REACH registration C&L,239,Not classified:224;H350:14;H412:1
104209,reaction mass of: dodecylphenyl dodecylhydroxybenzenecarboxylate;bis(dodecylphenyl)dodecyl hydroxybenzenedicarboxylate,426-140-6,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
104218,"2-Propenoic acid, 2-methyl-, polymer with ethenylbenzene",618-461-7,9010-92-8,Not Classified,Notified C&L,44,Not classified:44
104219,"Tanacetum vulgare, ext.",284-653-9,84961-64-8,Flam. Liq. 3;Acute Tox. 3,Notified C&L,288,H301:269;H226:276;H411:89;H412:13;H302:15;H304:3;H371:2;H317:3;H319:2;H315:2;H335:1
104221,"[3R-(3α,3aβ,6α,7β,8aα)]-octahydro-3,6,8,8-tetramethyl-1H-3a,7-methanoazulen-6-yl formate",254-693-1,39900-38-4,Not Classified,Notified C&L,113,Not classified:79;H319:34
104222,o-bromoethylbenzene,217-823-8,1973-22-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:45;H315:45;H335:44;H312:3;H332:3;H226:3
104223,"METHOXYPOLY(OXYETHYLENE/OXYPROPYLENE)‐2‐PROPYLAMINE (EO=6, PO=29)",617-489-7,83713-01-3,Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1,Notified C&L,545,H301:543;H318:543;H314:544;Not classified:1;H412:1
104226,"Coconut oil, sulfated, sodium salt",263-041-5,61789-20-6,Not Classified,Notified C&L,1,Not classified:1
104230,acrylamide;prop-2-enamide,201-173-7,79-06-1,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 4;Muta. 1B;Carc. 1B;STOT RE 1;Repr. 2,Harmonised C&L,0,H372:0;H315:0;H340:0;H301:0;H361:0;H319:0;H350:0;H332:0;H317:0;H312:0
104232,reaction mass of pentyl methylphosphinate and 2-methylbutyl methylphosphinate,402-090-0,87025-52-3,Skin Corr. 1B,Harmonised C&L,0,H314:0
104235,"N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]acrylamide",237-645-4,13880-05-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:42;H315:42;H335:42;Not classified:1
104239,"Siloxanes and Silicones, di-Me, hydroxy-terminated, ethoxylated",613-150-2,63148-55-0,Not Classified,Notified C&L,20,Not classified:20
104245,"3,3-bis(1-butyl-2-methyl-1H-indol-3-yl)phthalide",256-523-1,50292-91-6,Not Classified,Notified C&L,2,Not classified:2
104246,Aluminium tri-sec-butanolate,218-871-2,2269-22-9,Flam. Liq. 3;Eye Irrit. 2;STOT SE 3;STOT SE 3,REACH registration C&L,233,H319:16;H336:11;H226:233;H335:11;H312:177;H302:222;H311:45;H315:5;H318:1;H314:2
104256,Cyclohexyl phenyl ketone,211-923-5,712-50-5,Aquatic Chronic 2,REACH registration C&L,98,H411:98
104260,"1,1,2,2,3,3-hexafluoro-1-trifluoromethoxy-3-trifluorovinyloxypropane",442-390-9,,Flam. Liq. 2,REACH registration C&L,2,H225:2
104262,"6-chloro-2-(3-methoxypropyl)hexahydro-4H-thienol[3,2-e][1,2]thiazin-one 1,1 dioxide",918-431-6,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,2,H312:2;H332:2;H302:2
104263,"Fatty acids, C16-18 and C18-unsatd., Me esters",267-015-4,67762-38-3,Not Classified,REACH registration C&L,701,Not classified:701
104265,"N,N'-bis(2,2,6,6-tetramethyl-4-piperidyl)isophthalamide",419-710-0,42774-15-2,Acute Tox. 4;Eye Irrit. 2,Harmonised C&L,0,H319:0;H302:0
104267,p-(trifluoromethoxy)phenol,212-583-0,828-27-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,82,H315:46;H302:40;H335:45;H319:42;H332:40;H312:40;Not classified:33;H301:7;H318:5;H412:1;H314:3;H330:1;H311:1
104268,"Glycerol ethoxylated, propoxylated",618-655-1,9082-00-2,Not Classified,Notified C&L,192,Not classified:178;H302:13;H319:1;H315:1;H335:1
104269,"Decapotassium [[(phosphonatomethyl)imino]bis[ethane-2,1-diylnitrilobis(methylene)]]tetrakisphosphonate",300-052-7,93919-69-8,Skin Corr. 1A;Eye Dam. 1,Notified C&L,1,H318:1;H314:1
104271,Clobenzorex,236-434-4,13364-32-4,Acute Tox. 4,REACH registration C&L,3,H302:3
104276,MMCT,483-350-0,,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H315:1;H317:1
104278,Dilutetium(3+) trisulphate,239-074-6,14986-89-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H315:39;H335:38;Not classified:1;H312:1;H302:1
104279,Sodium sulphamidate,237-572-8,13845-18-6,Not Classified,REACH registration C&L,98,Not classified:98
104281,D-Proline Methyl Ester Hydrochloride,613-785-5,65365-28-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:40
104283,2-bromo-5-nitropyridine,224-777-2,4487-59-6,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H301:39;H315:44;H319:44;H335:42;H302:5;H312:4;H336:1
104284,Rhodium trihydroxide,244-508-2,21656-02-0,Aquatic Chronic 4,REACH registration C&L,17,H413:8;H315:9;H302:9;H335:9;H319:9;H332:9;H312:9
104291,N-acetyl-L-tyrosinamide,217-756-4,1948-71-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2
104295,3-ethoxyacrylonitrile,262-706-7,61310-53-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H315:39;H335:38;H302:2;H226:1
104297,Germanium diselenide,235-063-5,12065-11-1,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H373:38;H301:38;H331:38;H400:38;H410:38
104304,"5-chloro-1H-indole-2,3-dione",241-614-0,17630-76-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:41;H335:41
104308,4-(methylthio)butan-2-one,251-810-8,34047-39-7,Acute Tox. 4,Notified C&L,1400,H302:1286;H319:114;H315:114;H335:25
104309,"Benzene, 1,1'-oxybis-, tetrapropylene derivs., sulfonated, sodium salts",601-601-6,119345-04-9,Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,3097,H411:437;H318:454;Not classified:2191;H319:448;H315:467;H400:2;H410:2;H302:1
104310,"Cinchona calisaya, ext.",289-707-5,89997-70-6,Flam. Liq. 3,Notified C&L,897,H226:897
104315,"Quaternary ammonium compounds, C12-14-alkyltrimethyl, chlorides",287-091-2,85409-24-1,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B,Notified C&L,36,H312:33;H314:36;H400:36;H302:36
104316,Ethyltriphenylphosphonium acetate,252-743-7,35835-94-0,Acute Tox. 3;Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,103,H318:93;H315:98;H301:98;H312:2;H411:2;H335:96;H331:92;Not classified:5;H330:4;H319:5;H224:4;H412:1;H311:1
104319,2-[(2-cyanoethyl)[4-[(6-nitrobenzothiazol-2-yl)azo]phenyl]amino]ethyl ethyl carbonate,277-407-7,73384-65-3,Not Classified,Notified C&L,1,Not classified:1
104321,"4-Quinazolinamine, 6,7-dimethoxy-2-(1-piperazinyl)-",611-989-9,60547-97-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:38;H315:38;H302:40;H335:38;H373:1
104323,"2-(3,4-dimethoxyphenyl)-3-methylbutyronitrile",244-082-8,20850-49-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:1;H315:1;H302:2;H335:1;H301:1;H332:1
104329,1-(3-chloropropoxy)-4-fluorobenzene,217-000-3,1716-42-3,,Notified C&L,6,H319:6;H315:6;H335:5
104330,Sodium bis[2-[(2-hydroxy-5-nitrophenyl)azo]-3-oxo-N-phenylbutyramidato(2-)]cobaltate(1-),275-627-8,71566-26-2,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,130,H400:87;H410:85;Not classified:38;H411:4;H319:1;H315:1;H335:1
104339,"2H-1-Benzopyran-5-carboxylic acid, 2-cyclopropyl-7,8-dimethoxy-",617-579-6,845276-37-1,Not Classified,REACH registration C&L,1,Not classified:1
104340,acetochlor (ISO);2-chloro-N-(ethoxymethyl)-N-(2-ethyl-6-methylphenyl)acetamide,251-899-3,34256-82-1,Skin Irrit. 2;Skin Sens. 1;Acute Tox. 4;STOT SE 3;Carc. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H373:0;H315:0;H335:0;H361:0;H351:0;H400:0;H332:0;H317:0;H410:0
104346,(4-ethylphenyl)urea,252-207-2,34773-66-5,Acute Tox. 4,Notified C&L,38,H302:38
104348,"Phenol, 4-[[4-(dimethylamino)phenyl]azo]-, reaction products with sodium sulfide (Na2(Sx)), leuco derivatives",235-517-2,12262-25-8,Not Classified,REACH registration C&L,39,Not classified:39
104351,"Dipotassium [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']magnesate(2-)",239-803-8,15708-48-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:40;H315:40;H335:40;Not classified:2
104352,"Quaternary ammonium compounds, C16-18-alkyltrimethyl, chlorides",268-075-4,68002-62-0,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,12,H312:5;H314:12;H400:12;H302:12;H318:4
104355,"3,4-dimethoxyphenethyl alcohol",231-032-5,7417-21-2,Not Classified,REACH registration C&L,68,Not classified:34;H319:34;H315:1;H335:1
104356,"Distillates (petroleum), C",296-903-4,93165-19-6,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
104357,3-fluorobenzoyl chloride,216-977-3,1711-07-5,Skin Corr. 1B,Notified C&L,50,H314:50;H318:1;H290:1;H335:1;H227:1
104358,2-fluoro-m-xylene,207-144-5,443-88-9,Flam. Liq. 3,Notified C&L,44,H226:44;H319:1;H315:1;H335:1
104360,"2,4,5-triphenylimidazole",207-606-6,484-47-9,Acute Tox. 3,Notified C&L,1,H301:1
104361,Hexabromocyclododecane,247-148-4,25637-99-4,Repr. 2;Lact.,Harmonised C&L,0,H362:0;H361:0
104364,"1,2-Benzenedicarboxylic acid, ditallow alkyl esters",308-925-4,99035-59-3,Not Classified,Notified C&L,1,Not classified:1
104365,Trimethyl phosphite,204-471-5,121-45-9,Flam. Liq. 3,REACH registration C&L,129,H226:128;H312:56;H332:56;H302:125;H318:40;H315:68;H335:68;H361:27;H319:27;H360:1;H412:1;H373:1;H225:1;H317:1;H311:1;H413:1
104368,"2-Propenoic acid, butyl ester, reaction products with butadiene, sulfur and tri-Ph phosphite",300-339-7,93925-37-2,Not Classified,REACH registration C&L,571,Not classified:2;H412:569
104369,methyl methacrylate;methyl 2-methylprop-2-enoate;methyl 2-methylpropenoate,201-297-1,80-62-6,Flam. Liq. 2;Skin Irrit. 2;Skin Sens. 1;STOT SE 3,Harmonised C&L,0,H225:0;H315:0;H317:0;H335:0
104370,Ethyltrimethylammonium iodide,200-131-5,51-93-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
104371,"N-(2,6-dimethylphenyl)pyridine-2-carboxamide",700-273-2,39627-98-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,8,H319:6;H315:6;H302:7;H335:4;Not classified:1
104372,4-ethylpyridine,208-646-7,536-75-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,155,H319:120;H315:120;H226:155;H335:119;H340:25;H350:25;H302:4;H332:4;H312:4
104376,"4,4'-benzylidenedianiline",210-038-1,603-40-7,Aquatic Chronic 2,REACH registration C&L,2,H411:2
104377,Cyclohexylammonium acetate,230-871-4,7346-79-4,,Notified C&L,1,H312:1;H314:1;H228:1;H302:1
104383,Pempidine,201-211-2,79-55-0,Flam. Liq. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H226:43;H335:43;H301:43;H319:43
104384,3-(4-tert-butylphenyl)propionaldehyde,242-016-2,18127-01-0,Skin Irrit. 2;Skin Sens. 1B;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,1500,H373:1175;H412:1142;H315:1175;H317:1497;H361:1475;H301:308;H411:322;H302:14;Not classified:4
104388,4-bromo-2-chlorobenzoic acid,261-911-9,59748-90-2,Acute Tox. 3;Aquatic Acute 1,Notified C&L,45,H301:39;H400:39;H319:6;H315:5;H335:4;H312:1;H332:1;H302:1
104389,"4,7,13,16,21-pentaoxa-1,10-diazabicyclo[8.8.5]tricosane",250-592-1,31364-42-8,,Notified C&L,5,H319:5;H315:4;H335:4
104390,"2-chloro-5-(trifluoromethyl)benzenediazonium naphthalene-1,5-disulphonate (1:1)",286-351-2,85222-99-7,Not Classified,Notified C&L,9,Not classified:9
104393,"1,2,3-benzotriazin-4(1H)-one",201-971-5,90-16-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:39;H315:39;H302:44;H335:38;H332:5;H361:5
104397,"Cuprate(4-), [2-[[[[2-hydroxy-3-sulfo-5-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]phenylmethyl]azo]-5-sulfobenzoato(6-)]-, sodium",291-104-7,90341-72-3,Skin Sens. 1,Notified C&L,5,H317:5
104398,m-chlorophenylacetic acid,217-520-0,1878-65-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44
104399,Peanut oil,232-296-4,8002-03-7,Not Classified,Notified C&L,1565,Not classified:1564;H319:1;H226:1
104403,2-(2-heptadec-8-enyl-2-imidazolin-1-yl)ethanol,202-414-9,95-38-5,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,500,H373:222;H302:468;H314:465;H319:46;H400:439;H410:469;H318:355;H317:132;Not classified:31;H315:4;H372:1
104409,3-aminobenzene sulphonic acid;metanilic acid,204-473-6,121-47-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H312:0;H332:0;H302:0
104412,Diammonium hexachlororuthenate,242-552-7,18746-63-9,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,45,H301:39;H331:39;H311:39;H319:5;H315:5;H335:5;Not classified:1
104413,"7-methylocta-1,6-diene",404-210-7,42152-47-6,Flam. Liq. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H226:0;H410:0
104414,"7,7-dimethyl-3-oxa-6-azaoctan-1-ol",400-390-6,87787-67-5,Acute Tox. 4;Skin Corr. 1A,Harmonised C&L,0,H314:0;H302:0
104417,m-anisoyl chloride,216-975-2,1711-05-3,Skin Corr. 1B;STOT SE 3,Notified C&L,46,H314:46;H335:40;H318:1
104418,3-methyl-1-phenyl-1H-pyrazole,214-438-7,1128-54-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
104427,3-ethylpent-1-yn-3-ol,228-512-1,6285-06-9,Flam. Liq. 3,Notified C&L,44,H226:44;H319:1;H315:1;H335:1
104428,"2,3-xylenol",208-395-3,526-75-0,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Aquatic Chronic 2,Harmonised C&L,0,H301:0;H411:0;H314:0;H311:0
104429,"Fatty acids, C16-18 and C18-unsatd., 2-ethylhexyl esters",285-207-6,85049-37-2,Not Classified,REACH registration C&L,105,Not classified:105
104430,Cobalt acetate,227-676-1,5931-89-5,Not Classified,Notified C&L,104,Not classified:97;H400:7;H410:7
104431,"Methanone, 4-morpholinylphenyl-",604-539-8,1468-28-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1
104441,3-ethylpyridine,208-647-2,536-78-7,Acute Tox. 4,Notified C&L,1448,H302:1291;H226:162;H319:46;H315:46;H335:45;H340:25;H350:25;H332:4;H312:4
104443,Ditantalum pentaoxide,215-238-2,1314-61-0,Not Classified,REACH registration C&L,58,Not classified:56;H319:1;H315:1;H335:1;H413:1
104444,"Methyl N-ethyl-N-[4-[(5-nitro-2,1-benzisothiazol-3-yl)azo]phenyl]-β-alaninate",257-779-7,52239-04-0,Skin Sens. 1,REACH registration C&L,58,H317:5;Not classified:35;H319:18;H411:1
104445,"Leach residues, tellurium",273-814-9,69029-73-8,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 1A;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,2,H373:2;H302:1;H335:1;H319:2;H350:2;H332:2;H411:1;H360:1;H301:1;H400:1;H317:1;H410:1
104447,"α-(3,4-dimethylphenyl)-α-methyl-3,4-dimethyltoluene",217-108-0,1742-14-9,Not Classified,Notified C&L,4,Not classified:4
104449,2-Ethylhexenal Sumpf ENAL zur Rückstandskolonne,919-594-6,,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 1B,Notified C&L,1,H315:1;H226:1;H335:1;H304:1;H319:1;H350:1;H332:1;H317:1
104450,4-(butoxymethyl)-2-methoxyphenol,444-010-7,82654-98-6,Skin Sens. 1B,REACH registration C&L,56,H317:20;Not classified:36;H319:16;H315:2
104452,Sodium propionate,205-290-4,137-40-6,Not Classified,REACH registration C&L,353,Not classified:202;H319:86;H312:128;H315:63;H335:63;H302:5;H203:3
104454,"Amines, C11-14-branched alkyl, monohexyl and dihexyl phosphates",279-632-6,80939-62-4,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,777,H319:772;H411:772;H315:772;Not classified:5
104460,"Fatty acids, C5-10, mixed esters with pentaerythritol and valeric acid",270-295-0,68424-34-0,Not Classified,Notified C&L,7,Not classified:7
104465,reaction mass of isomers of: mono-(2-tetradecyl)naphthalenes;di-(2-tetradecyl)naphthalenes;tri-(2-tetradecyl)naphthalenes,410-190-0,132983-41-6,Eye Irrit. 2;Aquatic Chronic 4,Harmonised C&L,0,H319:0;H413:0
104467,"Magnesite (Mg(CO3)), calcined",281-193-0,83897-85-2,Not Classified,Notified C&L,32,Not classified:32
104469,ε-caprolactam,203-313-2,105-60-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Harmonised C&L,0,H315:0;H302:0;H335:0;H319:0;H332:0
104471,"Tricyclo(3.3.1.1'3,7)decane-1-carboxylic acid",212-584-6,828-51-3,Acute Tox. 4,REACH registration C&L,14,H302:4;H319:10;H315:10;H335:7
104472,"5-amino-N,N'-bis(2,3-dihydroxypropyl)isophthaldiamide",278-555-5,76820-35-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
104475,Ethyl 3-hydroxyoctanoate,230-919-4,7367-90-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
104476,"4-hydroxy-3,5-diiodobenzaldehyde",217-754-3,1948-40-9,,Notified C&L,5,H319:5;H315:5;H335:4
104481,"Hydrocarbons, C6-C7, n-alkanes, isoalkanes, cyclics, <5% n-hexane",921-024-6,,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,10,H315:9;H336:9;H225:8;H304:10;H411:9;H224:1;H413:1
104482,"5,6,7,8-tetrahydro-1-naphthylamine",218-713-2,2217-41-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:41;H335:40;H302:3;H332:1;H312:1
104484,methyl propionate,209-060-4,554-12-1,Flam. Liq. 2;Acute Tox. 4,Harmonised C&L,0,H225:0;H332:0
104485,Heptaminol,206-758-0,372-66-7,Skin Corr. 1B;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H314:1;H315:1;H335:1
104488,"1,7-bis(methoxydimethylsilyl)-1,7-dicarbadodecaborane(12)",241-615-6,17631-41-3,Flam. Sol. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1;H228:1
104489,ethyl acrylate,205-438-8,140-88-5,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 4;STOT SE 3,Harmonised C&L,0,H315:0;H302:0;H335:0;H225:0;H319:0;H332:0;H317:0;H312:0
104492,Bis(p-methoxyphenyl)iodonium bromide,242-899-4,19231-06-2,STOT RE 2,Notified C&L,1,H373:1
104493,"1,1,3,3-tetramethyldisiloxane",221-906-4,3277-26-7,Flam. Liq. 2,REACH registration C&L,212,H225:212;H315:3;H319:2
104494,4-nitrobenzenediazonium tetrafluoroborate,207-261-1,456-27-9,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,39,H312:38;H314:39;H332:38;H302:39;H318:1
104495,2-[bis(2-hydroxyethyl)amino]ethyl oleate,233-621-2,10277-04-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,179,H319:124;H315:127;Not classified:52;H318:3
104497,"esbiothrin;S-bioallethrin;(S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate;(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate",249-013-5,28434-00-6,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H332:0;H302:0;H410:0
104501,N-(prop-2-ynyloxy)phthalimide,225-024-0,4616-63-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H315:3;H335:2
104503,"Rubus idaeus, ext.",284-554-0,84929-76-0,Flam. Liq. 2,Notified C&L,1405,H225:1288;Not classified:72;H226:44;H319:1
104510,2-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether,200-076-7,51-03-6,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,255,H400:234;H410:238;H361:6;Not classified:5;H330:4;H411:6;H331:2;H310:2;H311:1
104511,Bis(4-hydroxyphenethyldimethylammonium) sulphate,210-749-7,622-64-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
104513,Protionamide,238-093-7,14222-60-7,Acute Tox. 4,Notified C&L,129,H302:129;H319:1;H315:1
104514,Quinolin-6-amine,209-453-0,580-15-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,45,H319:45;H315:45;H302:4;H335:5;H332:4;H312:4
104515,"2,3-epoxypropan-1-ol;glycidol;oxiranemethanol",209-128-3,556-52-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Muta. 2;Carc. 1B;Repr. 1B,Harmonised C&L,0,H315:0;H360:0;H302:0;H335:0;H319:0;H350:0;H331:0;H312:0;H341:0
104518,"3-dodecyldihydrofuran-2,5-dione",219-880-4,2561-85-5,Eye Dam. 1;Aquatic Chronic 4,Notified C&L,39,H413:38;H318:38;H319:1;H315:1
104520,"Oxirane, (chloromethyl)-, polymer with .alpha.-hydro-.omega.-hydroxypoly(oxy(methyl-1,2-ethanediyl))",618-635-2,9072-62-2,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,274,H319:268;H315:229;H317:230;H412:23;Not classified:6;H335:1
104523,"Penicillin, calcium salt",215-795-1,1406-07-1,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H334:1;H317:1
104526,"Hydrocarbons, C16-C20, n-alkanes, isoalkanes, cyclics, aromatics (2-30 %)",919-006-8,,Asp. Tox. 1;Aquatic Chronic 4,REACH registration C&L,61,H413:61;H304:61
104529,Butyl lactate,205-316-4,138-22-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1927,H319:1739;H315:1902;H318:180;H335:64;Not classified:5;H336:1
104531,"12,13-epoxytrichothec-9-ene-3α,4β,15-triol 4,15-diacetate",218-873-3,2270-40-8,Acute Tox. 2;Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 1,Notified C&L,129,H315:129;H330:129;H310:129;H319:129;H300:129
104532,3-methyl-1-phenethylbutylamine,229-007-9,6396-93-6,Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,34,H314:34;H302:34
104536,"Pregn-4-ene-3,11,20-trione",208-222-1,516-15-4,Acute Tox. 3,Notified C&L,39,H301:38;H360:1
104539,chloroacetyl chloride,201-171-6,79-04-9,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1A;Acute Tox. 3;STOT RE 1;Aquatic Acute 1,Harmonised C&L,0,H372:0;H301:0;H314:0;H331:0;H400:0;H311:0
104543,4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine,419-240-6,171054-89-0,Eye Dam. 1,Harmonised C&L,0,H318:0
104546,Sodium [2H4]tetrahydroborate(1-),239-764-7,15681-89-7,Water-react. 1;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B,Notified C&L,46,H260:41;H301:46;H314:46;H311:44;H331:4;H261:5;H318:1;H360:1
104548,gallium arsenide,215-114-8,1303-00-0,Carc. 1B;STOT RE 1;Repr. 1B,Harmonised C&L,0,H350:0;H360:0;H372:0
104554,"3,3'-dihydro-β,β-carotene-4,4'-dione",231-424-6,7542-45-2,Not Classified,Notified C&L,84,Not classified:84
104555,4-pentyloxyaniline,254-695-2,39905-50-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H315:39;H302:39;H335:39;H319:39;H332:39;H312:39
104556,"N-(2,6-dichlorophenyl)-5-ethoxy-7-fluoro-[1,2,4]triazolo[1,5-c]pyrimidine-2-sulfonamide",604-487-6,145701-21-9,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,17,H400:16;H410:16;H319:1;H315:1
104561,"brodifacoum (ISO);4-hydroxy-3-(3-(4'-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin",259-980-5,56073-10-0,Acute Tox. 1;Acute Tox. 1;Acute Tox. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1A,Harmonised C&L,0,H372:0;H360:0;H330:0;H310:0;H300:0;H400:0;H410:0
104562,Manganese diphosphate,258-729-7,53731-35-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,51,H315:51;H302:51;H319:51;H332:51;H312:51
104564,Phenyl isocyanate,203-137-6,103-71-9,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1A;Eye Dam. 1;Acute Tox. 1;Resp. Sens. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,275,H318:102;H302:239;H226:218;H330:239;H335:120;H314:234;H400:105;H317:249;H410:39;H334:265;H411:71;Not classified:31;H412:25;H315:10;H319:10;H301:4;H373:1;H351:1;H332:1
104568,Oxycodone,200-960-2,76-42-6,Acute Tox. 4;STOT SE 3;Lact.,REACH registration C&L,48,H362:8;H336:8;H302:48;H334:2;H332:2;H317:2;H318:1;H412:1
104569,3-(hydroxymethylphosphinoyl)propionic acid,239-144-6,15090-23-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,40,H319:39;H315:40;H302:40;H318:1
104572,Undec-8-enal,261-202-4,58296-81-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,17,H319:14;H412:14;H315:15;H317:14;Not classified:2;H411:1
104574,Nonan-3-one,213-125-2,925-78-0,Eye Irrit. 2,Notified C&L,1545,H319:1545
104575,Ciclobendazole,250-637-5,31431-43-3,Skin Sens. 1,Notified C&L,38,H317:38
104576,"1-Piperazinecarboxylic acid, 4-[(2,3,4-trimethoxyphenyl)methyl]-, ethyl ester",611-007-9,53531-01-4,,Notified C&L,2,H302:2
104582,CITRUS GRANDIS (GRAPEFRUIT) PEEL OIL,616-973-5,8016-20-4,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,208,H315:207;H226:207;H304:168;H400:131;H317:168;H410:168;H319:40;H335:39
104583,"Oils, capelin, oleins",297-106-4,93334-32-8,Not Classified,Notified C&L,1,Not classified:1
104589,"1,3-thiazolidin-2-one",474-200-5,2682-49-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,3,H319:2;H302:2;H315:1;H335:1
104590,(E)-4-decenal,265-741-6,65405-70-1,Aquatic Chronic 3,REACH registration C&L,1698,H412:1322;H319:374;H315:376;H335:42
104591,"1,1-bis(hexyloxy)hexane",251-631-5,33673-65-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1
104598,Methyl 2-cyano-2-propylpentanoate,613-941-2,66546-92-7,,Notified C&L,1,H302:1
104599,(Z)-1-(1-ethoxyethoxy)hex-3-ene,248-817-3,28069-74-1,Not Classified,Notified C&L,207,Not classified:158;H226:49
104603,"(1r,4r)-dimethyl cyclohexane-1,4-dicarboxylate",919-945-3,3399-22-2,Skin Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H412:1;H315:1
104604,Sanguinarine nitrate,225-276-1,4752-86-7,Acute Tox. 3,Notified C&L,2,H301:1;H302:1
104612,trisodium nitrilotriacetate,225-768-6,5064-31-3,Acute Tox. 4;Eye Irrit. 2;Carc. 2,Harmonised C&L,0,H319:0;H351:0;H302:0
104615,"2,3-dichloroquinoxaline",218-667-3,2213-63-0,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H301:47;H315:47;H319:47;H335:46;H331:1;H311:1
104617,(E)-Ethyl 4-oxo-but-2-enoate,438-470-8,,Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H318:1;H301:1;H314:1;H400:1;H317:1;H410:1
104618,Phenylmercury chloride,202-865-1,100-56-1,,Notified C&L,8,H373:8;H330:8;H310:8;H300:8;H400:8;H410:8
104619,4-hydroxyphenethyl alcohol,207-930-8,501-94-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,90,H319:89;H315:88;H335:88;H302:1
104620,"2-[[2-(acetyloxy)-3-(1,1-dimethyl-ethyl)-5-methylphenyl]methyl]-6-(1,1-dimethylethyl)-4-methylphenol",412-210-3,41620-33-1,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
104626,"3,6,9,12,15,18,21-heptaoxatritriacontanol",221-283-9,3055-97-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,278,H319:225;H315:225;H335:224;H318:50;H400:50;H302:51;Not classified:3;H411:1
104629,Dodecenylsuccinic anhydride,246-917-1,25377-73-5,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,744,H319:606;H412:449;H315:634;Not classified:97;H335:43;H318:37;H317:84;H334:31;H332:9;H411:1;H413:1
104637,"Oxalic acid, ammonium salt",238-135-4,14258-49-2,Acute Tox. 4;Acute Tox. 4,Notified C&L,3,H312:3;H302:3
104638,Chlorodimethylpentafluorophenylsilane,243-506-9,20082-71-7,Skin Corr. 1B,Notified C&L,44,H314:43;H225:1;H318:1;H290:1;H319:1;H315:1;H335:1
104645,"Octafluorotetrahydrothiophene 1,1-dioxide",255-641-0,42060-64-0,,Notified C&L,33,Not classified:33
104647,(3-Phenyl-1H-inden-1-ylidene)bis(tricyclohexylphosphine)ruthenium(IV) Dichloride Tetrahydrofuran Adduct,480-140-0,250220-36-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
104648,2-fluoro-6-nitrophenol,216-199-4,1526-17-6,,Notified C&L,6,H319:6;H315:6;H302:6;H335:5;H332:1;H312:1
104650,"Formic acid, compound with 2,2',2''-nitrilotris[ethanol] (1:1)",246-463-4,24794-58-9,Not Classified,Notified C&L,99,Not classified:99
104654,6-chloro-m-anisidine,219-277-6,2401-24-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:44;H302:39;H335:39;H319:44;H312:39;H373:4;H301:6;H311:6;H332:1;H331:2
104656,1-nitrobutane,210-980-3,627-05-4,Flam. Liq. 3,Notified C&L,38,H226:38
104658,"(1R)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-ethanol",252-744-2,35836-73-8,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,48,H315:48;H302:48;H319:48;H317:4;H411:4;H335:44
104669,"2-[2-(2,3-dihydro-2-methyl-1H-indol-1-yl)vinyl]-1,3,3-trimethyl-3H-indolium chloride",228-800-7,6359-50-8,Acute Tox. 3;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,54,H301:39;H318:35;H400:39;H410:39;H315:33;Not classified:15;H319:4
104671,"Lanolin, oxidized, bisulfited, sodium salt",307-958-1,97808-39-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,29,H319:29;H315:29
104676,"2-butoxyethyl 2,4-dichlorophenoxyacetate",217-680-1,1929-73-3,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H400:42;H302:42;H317:42;H410:42
104678,"2,7-Naphthalenedisulfonic acid, 5-amino-4-hydroxy-3-[(4-nitrophenyl)azo]-, diazotized, coupled with diazotized 2-amino-4,6-dinitrophenol, diazotized 4-amino-5-hydroxy-2,7-naphthalenedisulfonic acid, diazotized 4-nitrobenzenamine and resorcinol, sodium salts",291-641-7,90459-01-1,Aquatic Chronic 3,Notified C&L,33,H412:33
104679,1-bromohexane,203-850-2,111-25-1,Flam. Liq. 3;Skin Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,98,H411:41;H315:94;H226:97;H335:88;H319:88
104688,"Methyl 4-[[(2,5-dichlorophenyl)amino]carbonyl]-2-[[2-hydroxy-3-[[(2-methoxyphenyl)amino]carbonyl]-1-naphthyl]azo]benzoate",263-272-1,61847-48-1,Not Classified,REACH registration C&L,205,Not classified:201;H317:4
104689,Neodymium trifluoride,237-253-3,13709-42-7,Not Classified,REACH registration C&L,49,Not classified:1;H315:47;H302:46;H335:47;H319:47;H332:45;H312:46;H413:3;H331:1;H314:1
104691,dicyclopentyldimethoxysilane,404-370-8,126990-35-0,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H318:0;H315:0;H400:0;H410:0
104696,"Tetraphenylphosphonium, Trihydrogen-bis(methylenediphenolate",484-270-9,318276-52-7,Acute Tox. 4;Eye Dam. 1,Notified C&L,2,H318:2;H302:2
104697,2-chloro-3-fluoroaniline,244-366-1,21397-08-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H315:3;H335:3;H302:1;H332:1;H312:1
104698,2-methyl-5-(2-methyl-3-methylenebicyclo[2.2.1]hept-2-yl)pent-2-enyl butyrate,266-800-9,67633-98-1,Not Classified,Notified C&L,88,Not classified:88
104701,Disperbyk 160,601-284-4,113834-89-2,Not Classified,Notified C&L,33,Not classified:33
104704,Silver iodate,232-039-6,7783-97-3,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,64,H319:64;H315:64;H272:64;H335:64
104708,"p,p'-(2-pyridylmethylene)bisphenol",210-039-7,603-41-8,Not Classified,REACH registration C&L,7,Not classified:6;H302:1
104711,Tetra(isobutyl)thioperoxydicarbamic acid,221-312-5,3064-73-1,Aquatic Chronic 4,REACH registration C&L,26,H413:4;H302:15;Not classified:7;H412:1;H317:1
104712,"Sodium (E,E)-hexa-2,4-dienoate",231-819-3,7757-81-5,Eye Irrit. 2,Notified C&L,16,H319:13;Not classified:3
104715,"Methyl 4-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoate",239-889-7,15790-15-5,Not Classified,Notified C&L,2,Not classified:2
104718,(S)-N-[(Diethylamino)methyl]-.alpha.-ethyl-2-oxo-1-pyrrolidineacetamide L-(+)-tartrate,700-272-7,754186-36-2,Not Classified,REACH registration C&L,2,Not classified:1;H301:1;H371:1;H331:1;H311:1;H228:1
104719,"Cyclododeca-1,5,9-triene",225-533-8,4904-61-4,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Carc. 2;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,146,H315:3;H226:3;H304:146;H361:3;H351:3;H400:143;H410:146
104720,2-aminobutyric acid,201-296-6,80-60-4,Eye Irrit. 2,Notified C&L,55,H319:55
104723,"2,3-dihydroxypropyl 4-hydroxybenzoate",298-149-1,93778-15-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
104724,"Hydrocarbons, C9-unsatd., polymers with phenol",615-277-9,71302-91-5,Not Classified,Notified C&L,20,Not classified:15;H302:5
104729,"Bentonite, acid-leached",274-324-8,70131-50-9,Not Classified,REACH registration C&L,199,Not classified:199
104730,"Fatty acids, C16-18, 2-octyldodecyl esters",306-232-1,96690-38-9,Not Classified,REACH registration C&L,2,Not classified:2
104733,"4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, sodium salt (1:1), (2S,3S,5R)-",685-629-4,89785-84-2,Skin Sens. 1;Resp. Sens. 1,Notified C&L,2,H334:2;H317:2
104736,4-[(1-oxoallyl)oxy]butyl acetoacetate,235-885-4,13025-07-5,Not Classified,Notified C&L,11,Not classified:11
104737,"Phosphonic acid, reaction products with maleic anhydride, sodium salts",605-900-2,180513-31-9,Not Classified,Notified C&L,7,Not classified:5;H411:2;H317:2
104741,"[4-[[4-(dimethylamino)phenyl][4-(methylamino)phenyl]methylene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium hydroxide",306-577-8,97337-83-2,Eye Dam. 1;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H318:2;H302:2;H351:2;H400:2;H410:2
104742,imazamox (ISO);(RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid,601-305-7,114311-32-9,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
104743,"methyl (2E)-{2-[(2,5-dimethylphenoxy)methyl]phenyl}(methoxyimino)ethanoate",461-290-6,167374-38-1,Skin Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,84,H372:84;H400:84;H317:84;H410:84
104744,"3,4,5-trimethoxyaniline",246-154-4,24313-88-0,Skin Irrit. 2;STOT SE 3,Notified C&L,48,H315:44;H335:43;H312:7;H332:7;H302:7;H319:6
104745,Octanol,249-405-6,29063-28-3,Eye Irrit. 2,Notified C&L,8,H319:8
104746,"1(4H)-Naphthalenone, 8-aminodibromo-5-hydroxy-4-imino",602-259-0,12222-74-1,Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H319:1;H400:1;H317:1;H410:1
104747,diethyldimethylammonium hydroxide,419-400-5,95500-19-9,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A,Harmonised C&L,0,H312:0;H314:0;H302:0
104749,"N,N',N''-triphenyl-1,3,5-triazine-2,4,6-triamine",217-822-2,1973-05-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
104757,Propionamide,201-172-1,79-05-0,Eye Irrit. 2,REACH registration C&L,44,H319:4;H302:40
104758,"Siloxanes and Silicones, Me 3,3,3-trifluoropropyl",613-151-8,63148-56-1,Not Classified,Notified C&L,495,Not classified:452;H319:42;H315:42;H335:42;H411:1
104760,5-phenylvaleric acid,218-872-8,2270-20-4,,Notified C&L,6,H319:6;H315:6;H335:5
104761,"3,3-bis(2-methyl-1-octyl-1H-indol-3-yl)phthalide",256-524-7,50292-95-0,Not Classified,Notified C&L,94,Not classified:93;H319:1;H315:1;H335:1
104763,"Dodecylbenzenesulphonic acid, compound with ethylenediamine",267-919-9,67952-66-3,,Notified C&L,1,Not classified:1
104765,"hexazinone (ISO);3-cyclohexyl-6-dimethylamino-1-methyl-1,2,3,4-tetrahydro-1,3,5-triazine-2,4-dione",257-074-4,51235-04-2,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H319:0;H400:0;H302:0;H410:0
104766,"Octahydro-7,7,8,8-tetramethyl-2,3b-methano-3bH-cyclopenta[1,3]cyclopropa[1,2]benzene-4-methyl acetate",261-579-5,59056-62-1,Not Classified,Notified C&L,97,Not classified:88;H411:9
104769,Procaine hydrochloride,200-077-2,51-05-8,Acute Tox. 3,REACH registration C&L,154,H301:153;H317:136;H370:35;H360:35;H319:37;H330:2;H311:2;H334:2;H315:2;Not classified:1;H335:1
104772,2-methyl-3-propylpyrazine,240-121-8,15986-80-8,Not Classified,Notified C&L,134,Not classified:91;H319:43;H315:43;H335:42
104777,"2,4,6-tri-n-propyl-2,4,6-trioxo-1,3,5,2,4,6-trioxatriphosphorinane",422-210-5,68957-94-8,Skin Corr. 1B,Harmonised C&L,0,H314:0
104779,"4-ethoxybenzene-1,3-diammonium sulphate",268-164-8,68015-98-5,,Notified C&L,18,H315:10;H302:18;H319:10;H351:10;H411:10;H341:10
104781,"Phosphoric acid, C14-18 and C16-18-unsatd. alkyl esters, sodium salts",268-603-3,68130-75-6,Skin Irrit. 2,Notified C&L,1,H315:1
104782,"Fatty acids, C8-18 and C18-unsatd., Me esters",267-014-9,67762-37-2,Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,96,H411:1;H400:8;Not classified:88
104783,"L-Threonine, N-coco acyl derivs., monosodium salts",292-282-9,90583-79-2,Not Classified,REACH registration C&L,3,Not classified:3
104787,3-Amino-5-nitrobenz[d]isothiazole,617-562-3,84387-89-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
104788,p-methoxybenzenesulphonyl hydrazide,217-769-5,1950-68-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
104789,Hexasodium tetraphosphate,239-073-0,14986-84-6,Not Classified,Notified C&L,1,Not classified:1
104791,3-benzyloxy-2-pyridylamine,245-983-9,24016-03-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:45
104796,3-methoxypropan-1-ol,433-230-9,1589-49-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,4,H319:3;H315:3;H226:4
104797,"Phosphoric acid, mono- and di-C12-14-alkyl esters",308-020-4,97808-97-4,Skin Corr. 1B,Notified C&L,34,H314:33;H302:2;Not classified:1
104798,"Propanoic acid, 2-hydroxy-, C12-15-alkyl esters",300-338-1,93925-36-1,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,10,H319:4;H411:4;H400:4;Not classified:6
104800,"2-Oxazolidinone, 3-(2-hydroxyethyl)-",468-930-3,3356-88-5,Eye Irrit. 2,Notified C&L,85,H319:85;H315:1;H302:1;H335:1
104803,Sucrose dipalmitate,247-147-9,25637-97-2,Not Classified,Notified C&L,38,Not classified:38
104804,"(3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1-oxodecahydro-3a,9-propanocyclopenta[8]annulen-8-yl[(methylsulfonyl)oxy]acetate",700-396-1,60924-38-1,Acute Tox. 4,Notified C&L,1,H302:1
104806,4-pentylphenyl 4-propylbenzoate,256-684-8,50649-60-0,Eye Dam. 1;Aquatic Chronic 4,Notified C&L,39,H413:39;H318:38;Not classified:1
104817,Diphenyl ditelluride,250-982-1,32294-60-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H315:39;H302:39;H335:38;H319:39;H332:39;H312:39;H301:1;H331:1;H311:1
104822,Palladium dichloride,231-596-2,7647-10-1,Met. Corr. 1;Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,376,H318:266;H290:272;H302:101;H400:96;H317:309;H410:96;H319:68;H315:67;H335:58;H301:38;H314:5;H312:4;H332:1
104824,Melarsoprol,207-793-4,494-79-1,Acute Tox. 3;Acute Tox. 3;Aquatic Chronic 1,Notified C&L,2,H301:2;H331:2;H410:2
104825,"(S)-3-[5-(4-Fluorophenyl)-1,5-dioxopentyl]-4-phenyloxazolidin-2-one",480-320-9,,Not Classified,REACH registration C&L,2,Not classified:2
104826,"Glycine, N-[2-[(2-hydroxyethyl)amino]ethyl]-, N'-coco acyl derivs., monosodium salts",263-164-4,61791-32-0,Eye Dam. 1,Notified C&L,37,H318:35;Not classified:1;H319:1
104829,Isopentyltriphenylphosphonium bromide,248-966-4,28322-40-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:44;H302:1;H332:1;H312:1
104830,"Ferrate(1-), bis[4-[(5-chloro-2-hydroxyphenyl)azo]-3-hydroxy-N-phenyl-2-naphthalenecarboxamidato(2-)]-, ammonium sodium",601-380-6,115706-73-5,Not Classified,Notified C&L,3,Not classified:3
104836,N-[3-(dimethoxymethylsilyl)-2-methylpropyl]ethylenediamine,245-642-4,23410-40-4,Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,24,H318:24;H302:24;H317:24;H411:22
104839,"Lithium 3,5-diiodosalicylate",211-496-5,653-14-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:43
104840,Sulmazole,277-406-1,73384-60-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H302:38;H335:38
104843,1-chloro-2-iodobenzene,210-423-4,615-41-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H315:47;H335:46;H312:1;H332:1;H302:1
104845,"Tetrasodium 4-amino-5-hydroxy-6-[[2-methoxy-5-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]azo]-3-[[4-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]azo]naphthalene-2,7-disulphonate",300-644-5,93951-21-4,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,55,H334:42;H317:42;Not classified:13
104847,trans-p-(4-propylcyclohexyl)phenetole,279-633-1,80944-44-1,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
104849,"2,2'-dimethyl-4,4'-bipyridine",211-924-0,712-61-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H315:38;H302:38;H335:38
104856,R-(+)-α-methylbenzyl isocyanate,251-485-2,33375-06-3,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,48,H315:47;H330:41;H335:46;H319:47;H334:46;H302:4;H331:5;H317:1;H314:1;H301:1;H311:1
104858,Sulfuric acid monododecyl ester sodium salt (1:1),603-752-3,1335-72-4,Skin Irrit. 2;Eye Dam. 1,Notified C&L,52,H318:52;H315:52
104860,"Fatty acids, tall-oil, manganese salts",232-445-3,8030-70-4,STOT RE 2,REACH registration C&L,18,H373:2;H413:7;Not classified:7;H315:2
104864,Decyl hydrogen phthalate,246-304-9,24539-60-4,Acute Tox. 4,Notified C&L,1,H302:1
104867,"1,2-dimethyl-3,5-diphenylpyrazolium methylsulphate;difenzoquat methyl sulfate",256-152-5,43222-48-6,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H302:0;H410:0
104870,6-nitrobenzothiazol-2-amine,228-513-7,6285-57-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H315:44;H302:43;H335:43;H319:44;H332:43;H312:43;H301:1;H331:1;H311:1
104871,Sodium feredetate,239-802-2,15708-41-5,Not Classified,REACH registration C&L,433,Not classified:246;H319:187;H315:185;H335:185;H302:1
104872,2-(3-chloropropoxy)-1-methoxy-4-nitrobenzene,618-883-1,92878-95-0,Not Classified,REACH registration C&L,3,Not classified:3
104873,"3-(tert-butylamino)propane-1,2-diol",245-190-8,22741-52-2,Not Classified,Notified C&L,1,Not classified:1
104874,"Nonapotassium hydrogen [[(phosphonomethyl)imino]bis[ethane-2,1-diylnitrilobis(methylene)]]tetrakisphosphonate",300-051-1,93919-68-7,Not Classified,Notified C&L,2,Not classified:2
104876,Whey,295-890-2,92129-90-3,Not Classified,Notified C&L,88,Not classified:88
104877,(E)-oct-5-en-2-one,242-810-9,19093-20-0,Flam. Liq. 3,Notified C&L,88,H226:88
104884,"2,6-diaminotoluene-4-sulphonic acid",202-649-7,98-25-9,Not Classified,Notified C&L,9,Not classified:9
104885,diphenyl(4-phenylthiophenyl)sulfonium hexafluoroantimonate,403-500-0,159120-95-3,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H317:0;H410:0
104886,"(±)-4-(1,2-dihydroxyethyl)pyrocatechol",249-260-9,28822-73-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
104888,Methyl 3-oxovalerate,250-184-3,30414-53-0,Not Classified,REACH registration C&L,7,Not classified:4;H319:3;H315:3;H335:3
104890,"Tetrabutylammonium, salt with 4-methylbenzenesulphonic acid (1:1)",230-548-8,7182-86-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
104892,Gold trinitrate,236-687-0,13464-77-2,Not Classified,Notified C&L,1,Not classified:1
104893,4-Benzyloxy-1-butanol,610-249-2,4541-14-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
104895,"8,9,10-trinorborna-2,5-diene",204-472-0,121-46-0,Skin Corr. 1;Eye Dam. 1,REACH registration C&L,76,H318:4;H314:4;H225:72;H341:1;Not classified:2;H315:1;H302:1;H319:1;H411:1
104896,"Oxidase, d-amino acid",232-563-5,9000-88-8,Resp. Sens. 1,Notified C&L,2,H334:2
104897,"2-(2-bromoethyl)-1,3-dioxolane",242-551-1,18742-02-4,Acute Tox. 4;Skin Irrit. 2,REACH registration C&L,52,H315:52;H302:3;H301:40;H319:49;H335:48;H341:1
104899,Norethisterone acetate,200-132-0,51-98-9,Carc. 2,Notified C&L,113,H351:83;H350:29;H360:72;H362:25;H400:24;H410:24;H302:18;H332:17;H312:17;H334:1;H371:1;H361:1
104901,"2,2,2-trichloro-1-phenylethyl acetate",201-972-0,90-17-5,Aquatic Chronic 3,REACH registration C&L,1635,H412:1388;H315:1385;Not classified:243;H319:4
104902,"5-chloro-1,3-benzodioxole",244-081-2,20850-43-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;Carc. 2,Notified C&L,1,H315:1;H330:1;H335:1;H301:1;H319:1;H351:1;H311:1
104903,p-(tert-butyl)-alpha-chlorotoluene,243-228-8,19692-45-6,Skin Corr. 1B;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:39;H314:44;H335:39;H318:1
104905,"Amides, tallow, hydrogenated, N-[(dimethylamino)propyl]",273-783-1,69013-24-7,Skin Irrit. 2;Eye Dam. 1,Notified C&L,11,H318:7;H315:8;Not classified:3;H319:1
104908,Methyl DL-serinate hydrochloride,227-047-1,5619-04-5,Eye Dam. 1,REACH registration C&L,199,H318:158;H319:41;H315:41;H335:41
104909,Benziodarone,200-695-2,68-90-6,Acute Tox. 3,Notified C&L,1,H301:1
104910,Tetrahexylammonium hydrogen sulphate,251-069-0,32503-34-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
104915,4-hexyloxyaniline,254-696-8,39905-57-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H315:38;H302:38;H335:38;H319:38;H400:38;H332:38;H312:38
104916,benzthiazuron (ISO);1-benzothiazol-2-yl-3-methylurea,217-685-9,1929-88-0,Acute Tox. 4,Harmonised C&L,0,H302:0
104920,3-fluoropyridine,206-755-4,372-47-4,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,58,H225:58;H315:56;H319:56;H335:55;H312:1;H332:1;H302:1
104926,2-methoxyphenylacetic acid,202-231-4,93-25-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H315:44;H335:43;H318:1;Not classified:1
104927,3-propyltoluene,214-040-3,1074-43-7,Aquatic Chronic 2,Notified C&L,39,H411:38;H319:1;H315:1;H226:1
104928,"7-methyl-1H-indole-2,3-dione",214-431-9,1127-59-9,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H319:38;H302:38;Not classified:1
104931,ammonium pentaborate tetrahydrate,601-709-3,12046-04-7,Not Classified,Notified C&L,2,Not classified:1;H361:1
104932,glyoxylic acid ...%,206-058-5,298-12-4,Eye Dam. 1;Skin Sens. 1B,Harmonised C&L,0,H318:0;H317:0
104935,N-acetyl-D-valine,241-860-9,17916-88-0,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H317:38;H335:38
104936,C.I. Acid Orange 78,602-536-6,12234-92-3,Aquatic Chronic 3,Notified C&L,83,H412:83
104938,"Dec-1-ene, dimers, hydrogenated",500-228-5,68649-11-6,Asp. Tox. 1;Acute Tox. 4,REACH registration C&L,992,H304:986;H332:936;Not classified:5;H312:1;H319:1;H302:1
104944,3-(trichlorosilyl)propyl methacrylate,230-878-2,7351-61-3,Skin Corr. 1B,Notified C&L,44,H314:44;H335:6;H318:1
104955,Bis(acetato-O-)triphenylantimony,216-262-6,1538-62-1,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,39,H411:38;H332:38;H302:38;H301:1;H331:1;H311:1
104957,Dichlorotetrakis(pyridine)rhodium chloride,237-929-8,14077-30-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
104959,Ammonium undecafluorohexanoate,244-479-6,21615-47-4,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,3,H318:3;H314:1;H302:1;H317:1
104962,"(S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol",607-117-1,225920-05-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
104963,"4-chloro-3,5-dinitro-α,α,α-trifluorotoluene",206-889-3,393-75-9,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,103,H315:63;H302:103;H335:61;H319:62;H311:56;H310:46;H332:1;H317:1;H410:2
104966,"Tetrasodium 4,4'-bis[[4-anilino-6-(p-sulphonatoanilino)-1,3,5-triazin-2-yl]amino]stilbene-2,2'-disulphonate",251-892-5,34233-64-2,Not Classified,Notified C&L,31,Not classified:31
104967,1-[2-(2-methoxy-1-methylethoxy)-1-methylethoxy]propan-2-ol,243-734-9,20324-33-8,Not Classified,Notified C&L,6,Not classified:6
104968,4-phenylpiperidine,212-243-1,771-99-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:48;H315:48;H335:47;H312:1;H332:1;H302:1
104970,"fenazaflor (ISO);phenyl 5,6-dichloro-2-trifluoromethylbenzimidazole-1-carboxylate",238-134-9,14255-88-0,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H312:0;H400:0;H302:0;H410:0
104973,Heptyl undec-10-enoate,268-850-7,68141-27-5,Not Classified,REACH registration C&L,143,Not classified:143
104975,Bromopentacarbonylmanganese,238-522-8,14516-54-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,42,H312:38;H332:38;H302:38;H301:4;H331:4
104977,"1,1,1,5,5,5-hexamethyl-3-[(trimethylsilyl)oxy)-3-vinyltrisiloxane",226-342-2,5356-84-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,61,H319:39;H315:39;H335:38;H413:22
104978,N-piperidylamine,218-666-8,2213-43-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:39;H315:39;H226:45;H335:38;H314:6;H318:1;H302:1;H332:1;H312:1
104981,"Propane-1,2-diyl diacetate",210-817-6,623-84-7,Not Classified,REACH registration C&L,2600,Not classified:2594;H319:6;H312:1;H315:1;H335:1
104984,3-bromopiperidin-2-one,252-023-2,34433-86-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
104986,"4,5-dichlorophthalic anhydride",213-386-2,942-06-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39
104987,propionyl chloride,201-170-0,79-03-8,Flam. Liq. 2;Skin Corr. 1B,Harmonised C&L,0,H225:0;H314:0
104990,"Butanedioic acid, 1-[2-[(1-oxo-2-propen-1-yl)oxy]ethyl] ester",478-130-6,,Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1;Resp. Sens. 1;STOT SE 3,REACH registration C&L,3,H302:3;H335:3;H314:3;H317:3;H334:3
104991,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-alanine,252-660-6,35661-39-3,Not Classified,Notified C&L,9,Not classified:8;H319:1;H315:1;H335:1
104995,di-n-butylamine,203-921-8,111-92-2,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H312:0;H332:0;H302:0;H226:0
105000,Tris[4-(diethylamino)phenyl]ammoniumyl hexafluoroantimonate(1-),255-405-7,41494-34-2,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,38,H411:38;H332:38;H302:38
105002,"Oligomerisation products of 2-(chloromethyl)oxirane and 2-ethyl-2-(hydroxymethyl)propane-1,3-diol",922-223-0,,Skin Sens. 1,Notified C&L,1,H317:1
105003,5-nitro-o-toluic acid,217-829-0,1975-52-6,Acute Tox. 4;Skin Sens. 1,Notified C&L,44,H302:38;H317:38;H319:6;H315:6;H335:5
105007,"Styrax benzoin, ext.",284-557-7,84929-79-3,Not Classified,Notified C&L,120,Not classified:62;H317:39;H319:19;H315:19;H225:2;H412:1;H302:1;H400:1;H410:1
105009,(9-ethyl-9H-carbazol-3-yl)ammonium chloride,228-072-0,6109-97-3,Acute Tox. 3,Notified C&L,38,H301:38
105014,Bis(triphenylsilyl) chromate,216-612-8,1624-02-8,Acute Tox. 3;Skin Sens. 1;Carc. 1A;Repr. 2;Aquatic Chronic 1,REACH registration C&L,97,H361:57;H350:97;H317:97;H311:57;H410:97;H400:38
105015,Codeine phosphate,200-137-8,52-28-8,Acute Tox. 3;Skin Sens. 1;Resp. Sens. 1;Repr. 2,Notified C&L,45,H301:43;H334:28;H361:26;H317:29;H360:9;H412:2;H331:4;H311:3;H330:1;H336:3;H302:2;H332:1;H362:4;H318:1
105018,Trimethylsilylcarbonitrile,231-657-3,7677-24-9,Flam. Liq. 2;Acute Tox. 2;Acute Tox. 2;Acute Tox. 1,Notified C&L,79,H225:79;H300:79;H330:79;H310:79;H410:39;H400:11;Not classified:2;H315:1;H319:1
105021,"2,4,6-trinitrobenzenesulphonic acid",219-717-7,2508-19-2,Expl. 1.1;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1,Notified C&L,76,H301:39;H314:40;H201:40;H317:39;Not classified:36;H318:1;H302:1;H332:1;H312:1
105023,trisodium bis(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)chromate(1-),400-810-8,106084-79-1,Muta. 2,Harmonised C&L,0,H341:0
105027,4'-hydroxy-3'-methoxyacetophenone,207-854-5,498-02-2,Not Classified,Notified C&L,140,Not classified:92;H319:48;H315:48;H335:47
105029,sodium (1-(5-(4-(4-anilino-3-sulphophenylazo)-2-methyl-5-methylsulphonamidophenylazo)-4-hydroxy-2-oxido-3-(phenylazo)phenylazo)-5-nitro-4-sulphonato-2-naphtholato)iron(II),401-220-3,,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H332:0
105033,Methyl 3-pyridyl ketone,206-496-7,350-03-8,Acute Tox. 3;Skin Irrit. 2,REACH registration C&L,1649,H301:1647;H315:21;H319:7;H300:2;H335:1;H331:1;H311:1
105036,4-iodobenzoyl chloride,216-974-7,1711-02-0,Skin Corr. 1B,Notified C&L,46,H314:46;H318:2;H290:1
105039,Nonan-4-one,224-770-4,4485-09-0,Eye Irrit. 2,Notified C&L,38,H319:38
105040,"2-Propenoic acid, C12-14-alkyl esters",282-516-8,84238-60-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,83,H319:83;H411:83;H315:83;H335:83
105041,"2,5-dihydro-2,2,4-trimethylthiazole",239-761-0,15679-23-9,Acute Tox. 4,Notified C&L,10,H302:10
105042,2-(methylthio)propionic acid,261-450-3,58809-73-7,Not Classified,Notified C&L,89,Not classified:88;H314:1;H302:1;H335:1
105046,"4'-heptyl[1,1'-biphenyl]-4-carbonitrile",255-229-0,41122-71-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H315:42;H302:44;H335:42;H319:42;H332:43;H312:43;H413:1;Not classified:1
105047,"4-hydroxy-3,5-diiodophenylacetic acid",217-753-8,1948-39-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H302:1;H335:1;H319:1;H332:1;H312:1
105049,"(Z)-2-(8-heptadecenyl)-4,5-dihydro-1H-imidazole-1-ethanol",244-501-4,21652-27-7,Skin Corr. 1B,Notified C&L,390,H314:301;Not classified:89;H400:60;H302:52;H410:86;H318:30;H360:17;H317:17;H335:17;H290:13
105050,"Residues (petroleum), hydrocracked;Heavy Fuel oil;[A complex combination of hydrocarbons produced as the residual fraction from distillation of the products of a hydrocracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C",265-076-1,64741-75-9,Carc. 1B,Harmonised C&L,0,H350:0
105056,3-chloro-N-methylbenzylamine,254-343-8,39191-07-6,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,39,H318:39;H315:39;H302:39;H226:39;H335:1;H412:1
105058,"[[N,N',N'',N'''-[29H,31H-phthalocyaninetetrayltetrakis[methylenethio[(dimethylamino)methylidyne]]]tetrakis[dimethylammoniumato]](2-)-N29,N30,N31,N32]copper(4+) tetrachloride",251-705-7,33864-99-2,Not Classified,Notified C&L,2,Not classified:2
105061,"1,3-Difluor-5-(trans-4-propylcyclohexyl)-benzene",604-405-9,144261-13-2,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
105062,Glucose,200-075-1,50-99-7,Not Classified,Notified C&L,898,Not classified:897;H320:1
105064,"Silanamine, 1,1,1-trimethyl-N-(trimethylsilyl)-, reaction products with ammonia, octamethylcyclotetrasiloxane and silica",273-072-6,68937-51-9,Not Classified,Notified C&L,15,Not classified:15
105067,3-[C13-(branched)-alkyloxy]propionitrile,700-399-8,947522-81-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Acute Tox. 4;Carc. 1B;Aquatic Acute 1,Notified C&L,1,H315:1;H302:1;H350:1;H400:1;H332:1;H317:1;H312:1
105068,Quinolin-6-ol,209-454-6,580-16-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38;H302:1;H332:1;H312:1
105071,cyclohexyl acrylate,221-319-3,3066-71-5,Skin Irrit. 2;STOT SE 3;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H315:0;H335:0
105076,3-Amino-4-methylpyridine,608-968-1,3430-27-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,45,H318:38;H315:44;H302:39;H335:44;H301:6;H319:6;H311:6;H312:1;H314:1
105077,"1,2-benzenedicarboxylic acid;di-C",276-158-1,71888-89-6,Repr. 1B,Harmonised C&L,0,H360:0
105081,"Isooctadecanoic acid, reaction products with tetraethylenepentamine",272-225-4,68784-17-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1013,H319:973;H315:847;Not classified:27;H413:13;H412:8;H317:9
105085,Potassium O-ethyl dithiocarbonate,205-439-3,140-89-6,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,85,H315:82;H302:83;H335:78;H319:83;H312:5;H228:43;H332:40;Not classified:2;H252:1
105092,2-aminoresorcinol hydrochloride,211-210-9,634-60-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
105101,(tetrahydro-2-furyl)methyl butyrate,218-710-6,2217-33-6,Acute Tox. 4,Notified C&L,1445,H302:1445;H319:134;H315:134
105103,"2,6-dimethylpyridine--borane",223-645-1,3999-42-6,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H318:38;H314:38
105105,"Trisodium 5-[(6,8-disulphonato-2-naphthyl)azo]salicylate",229-306-4,6471-07-4,Not Classified,Notified C&L,2039,Not classified:2039
105108,"O,O-diethyl methylphosphonite",239-805-9,15715-41-0,Flam. Liq. 3;Acute Tox. 4,Notified C&L,44,H302:39;H226:44;H315:5;H330:5;H335:4;H301:5;H319:5;H311:5;H336:1
105111,"2,6-dinitro-p-toluidine",229-004-2,6393-42-6,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;STOT RE 2;Aquatic Chronic 2,Notified C&L,38,H373:38;H315:38;H335:38;H301:38;H319:38;H331:38;H311:38;H411:38
105113,"Fuel gases, coke-oven",266-015-1,65996-81-8,Flam. Gas 1;Press. Gas (Comp.);Acute Tox. 3;Carc. 1A;Repr. 1A;STOT RE 1;Aquatic Acute 1,Notified C&L,32,H372:23;H360:32;H220:32;H350:32;H331:23;H400:23;H280:26;H373:9;H340:11;H332:9
105115,Oxytetracycline,201-212-8,79-57-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,203,H312:141;H332:141;H302:141;H400:36;H360:35;H317:35;H410:56;H315:20;H335:20;H361:25;H319:21;H362:21;Not classified:1;H301:1
105116,Monoethanolamine oleate,218-878-0,2272-11-9,Eye Irrit. 2,REACH registration C&L,188,H319:123;Not classified:42;H302:26;H318:23;H315:7;H412:1
105120,"Octene, hydroformylation products",271-250-8,68527-05-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,118,H319:114;H315:118;H411:5;H225:1;H401:1;H317:1
105124,N-acetyl-D-alanine,243-066-8,19436-52-3,Not Classified,Notified C&L,1,Not classified:1
105125,O-benzylhydroxylamine hydrochloride,220-249-0,2687-43-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,8,H319:7;H315:7;H335:7;Not classified:1
105126,"3-nitro-1,2,4-triazole",246-468-1,24807-55-4,,Notified C&L,7,H319:7;H315:7;H335:6
105127,"Hexan-1-ol, ethoxylated",500-077-5,31726-34-8,Acute Tox. 4;Eye Dam. 1,Notified C&L,252,H318:144;H302:197;H319:108;H315:107;Not classified:31;H411:1
105128,"7-(diethylamino)-3-(5-phenyl-1,3,4-thiadiazol-2-yl)-2-benzopyrone",263-433-6,62143-26-4,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 1,Notified C&L,1,H315:1;H330:1;H301:1;H319:1;H311:1
105132,"Cymbopogon martini motia, ext.",294-453-3,91722-54-2,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1400,H412:1400;H318:1400;H317:1400;H315:114
105134,"(7aR,cis)3,4,7a,9,10,10a-hexahydro-5-methoxy-1H,12H-furo[3',2':4,5]furo[2,3-h]pyrano[3,4-c]chromene-1,12-dione",230-643-4,7241-98-7,Acute Tox. 1;Acute Tox. 1;Acute Tox. 2;Carc. 1B,Notified C&L,3,H350:3;H300:3;H330:3;H310:3
105135,3-(methylthio)propanol,208-004-6,505-10-2,Not Classified,Notified C&L,165,Not classified:91;H319:74;H315:74;H335:72
105138,Sodium bis(2-hydroxyethyl) 5-sulphonatoisophthalate,245-987-0,24019-46-3,Not Classified,Notified C&L,1,Not classified:1
105139,2-deoxy-D-galactose,217-765-3,1949-89-9,Not Classified,Notified C&L,8,Not classified:8
105148,"5-Chloro-6-(2,3-dichlorophenoxy)-2-(methylthio)-1H- benzimidazole",614-728-7,68786-66-3,,Notified C&L,79,Not classified:41;H373:35;H302:2;H410:1;H312:1;H332:1
105149,"Quaternary ammonium compounds, di-C14-18-alkyldimethyl, chlorides",268-072-8,68002-59-5,Eye Dam. 1;Aquatic Chronic 1,Notified C&L,84,H318:71;H410:84;H302:21;H335:21;H314:21;H400:43;H315:16
105151,(η6-benzene)tricarbonylchromium,235-146-6,12082-08-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H312:38;H332:38;H302:38
105152,4'-chloropropiophenone,228-511-6,6285-05-8,,Notified C&L,5,H319:5;H315:5;H335:1
105153,Methyl 5-acetylsalicylate,240-532-2,16475-90-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
105155,"penconazole (ISO);1-[2-(2,4-dichlorophenyl)pentyl]-1H-1,2,4-triazole",266-275-6,66246-88-6,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H400:0;H361:0;H302:0;H410:0
105156,"Quaternary ammonium compounds, N,N,N'-tris(hydroxyethyl)-N,N'-dimethyl-N'-tallow alkyltrimethylenedi-, bis(Me sulfates) (salts)",297-495-0,93572-63-5,Not Classified,Notified C&L,35,Not classified:31;H411:4
105160,p-phenylcinnamic acid,235-888-0,13026-23-8,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,42,H319:42;H411:38;H302:38;H315:4;H335:4
105162,"1',3'-dihydro-8-methoxy-1',3',3'-trimethyl-6-nitrospiro[2H-1-benzopyran-2,2'-[2H]indole]",216-103-0,1498-89-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
105164,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with bicyclo[2.2.1]heptanebis(methylamine)",500-326-8,146277-66-9,Not Classified,Notified C&L,1,Not classified:1
105169,Undecylcyclohexane,258-976-0,54105-66-7,Asp. Tox. 1,Notified C&L,1,H304:1
105171,4-amino-5-ethyl-1-(2-methoxyethyl)-1H-Pyrazole-3-carboxamide,438-910-9,,Aquatic Chronic 3,Notified C&L,1,H412:1
105172,C.I. Acid Green 80,602-030-5,12219-98-6,Not Classified,Notified C&L,1,Not classified:1
105173,Methyl hydrogen fumarate,220-412-6,2756-87-8,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;STOT SE 3,REACH registration C&L,135,H318:101;H315:5;H335:4;H317:3;H312:3;Not classified:33;H319:1;H302:1
105175,4-[(1-Pyrrolidinylsulfonyl)methyl]aniline,608-876-1,334981-10-1,Not Classified,Notified C&L,3,Not classified:2;H319:1;H315:1
105176,[No public or meaningful name is available],451-020-5,,Not Classified,Notified C&L,1,Not classified:1
105179,"β-D-Glucopyranoside, 2-(3,4-dihydroxyphenyl)ethyl O-6-deoxy-α-L-mannopyranosyl-(1.fwdarw.3)-O-[β-D-glucopyranosyl-(1.fwdarw.6)]-, 4-[3-(3,4-dihydroxyphenyl)-2-propenoate]",617-397-7,82854-37-3,Not Classified,Notified C&L,2,Not classified:2
105180,"Fatty acids, C18-22, reaction products with diethanolamine and triethanolamine",294-981-4,91771-86-7,Not Classified,Notified C&L,1,Not classified:1
105183,"1,3-dioxane",208-005-1,505-22-6,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,42,H225:42;H312:38;H332:38;H302:38;H315:4;H319:1
105188,2-propylisonicotinamide,279-634-7,80944-48-5,,Notified C&L,1,H302:1
105190,"Magnesium, bromo-1-propynyl-",605-372-3,16466-97-0,Water-react. 2;Skin Corr. 1B,Notified C&L,42,H261:39;H314:42;H225:3;H260:2;H302:1;H335:1;H351:1;H318:1
105191,"sodium (5Z,13E,15S)-6,9α-epoxy-11α,15-dihydroxyprosta-5,13-dien-1-oate",263-273-7,61849-14-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H312:38;H332:38;H302:38;H300:1
105192,C.I. Disperse Yellow 39,602-641-7,12236-29-2,Acute Tox. 4,Notified C&L,38,H302:38
105194,"Esterification product of trimellic anhydride, pentaerythritol, fatty acids sunflower oil, fatty acid soybean oil and benzoic acid",921-544-3,,Not Classified,Notified C&L,71,Not classified:71
105199,"1,1'-[methylenebis(sulphonyl)]diethylene",221-909-0,3278-22-6,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,10,H318:9;H315:10;H301:7;H400:7;H317:9;H410:7;H300:2;H332:2;H312:2;H334:2;H319:1;H341:1
105201,β-amino-1H-indole-3-propanol,208-392-7,526-53-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
105205,Diammonium azelate,263-841-4,63075-84-3,Not Classified,Notified C&L,1,Not classified:1
105206,reaction mass of: 4-chloro-7-methylbenzotriazole sodium salt;4-chloro-5-methylbenzotriazole sodium salt;5-chloro-4-methylbenzotriazole sodium salt,427-730-6,202420-04-0,Skin Corr. 1B;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H314:0
105207,"1,1'-(chlorovinylidene)bis[4-chlorobenzene]",213-823-7,1022-22-6,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H400:41;H410:41
105210,"Onium compounds, morpholinium, 4-ethyl-4-soya alkyl, Et sulfates",263-167-0,61791-34-2,Skin Corr. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,465,H318:464;H314:5;H400:446;H410:447;H315:460;H302:461;H335:442;H317:442
105211,2-Amino-6-fluorobenzothiazole,609-034-6,348-40-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44;H302:2
105212,Methyl DL-valinate hydrochloride,227-048-7,5619-05-6,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
105214,"Sulfuric acid, mono(branched and linear C8-18 and C18-unsatd. alkyl) esters, ammonium salts",293-903-6,91648-41-8,Eye Irrit. 2,Notified C&L,1,H319:1
105217,"polyphosphoric acid, copper, sodium, magnesium, calcium, silver and zinc salt",416-850-4,,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
105220,Iodocyclopentane,216-311-1,1556-18-9,Flam. Liq. 3,Notified C&L,44,H226:43;H319:5;H315:5;H335:5;H225:1
105223,hydrochloric acid ... %;hydrogen chloride,231-595-7,7647-01-0,,,0,H331:0;H314:0;Not classified:0
105226,"Iron, compound with titanium (1:1)",234-673-9,12023-04-0,Not Classified,Notified C&L,1,Not classified:1
105228,Carboxyferrocene,215-040-6,1271-42-7,,Notified C&L,6,H319:6;H315:6;H335:6
105229,(E)-hex-3-enyl acetate,222-962-2,3681-82-1,Flam. Liq. 3,Notified C&L,1401,H226:1401
105230,4-anilino-1-benzylpiperidine-4-carbonitrile,213-533-0,968-86-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3,Notified C&L,39,H318:39;H315:39;H302:39;H335:39;H332:39;H312:38
105235,"4-chloro-N-ethylbenzene-1,2-diamine",263-558-6,62476-15-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2
105239,2-((4-(ethyl-(2-hydroxyethyl)amino)-2-methylphenyl)azo)-6-methoxy-3-methyl-benzothiazolium methylsulfate,411-100-2,136213-73-5,Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H373:0;H400:0;H317:0;H410:0
105241,(3-amino-1-hydroxypropylidene)bisphosphonic acid,254-905-2,40391-99-9,Acute Tox. 4,Notified C&L,21,H302:21;H370:1;H360:1;H335:1;H319:1
105242,"1,3-Propanediamine, N,N''-1,2-ethanediylbis-, polymer with (chloromethyl)oxirane and α-hydro-ω-hydroxypoly(oxy-1,2-ethanediyl), acetate (ester)",604-802-7,151552-30-6,,Notified C&L,1,Not classified:1
105243,"Amines, C12-14-tert-alkyl, reaction products with O,O-di-C1-14-alkyl hydrogen phosphorodithioate",276-159-7,71888-91-0,Flam. Liq. 3;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,2,H411:1;H317:1;H226:1;H413:1
105245,"(2S,3S)-2,3-Bis((4-methoxybenzoyl)oxy)succinic acid",606-247-6,191605-10-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
105246,"Dehydrogenase, 3α-hydroxy steroid",232-839-5,9028-56-2,Resp. Sens. 1,Notified C&L,1,H334:1
105251,4-(2-chloroethyl)benzoic acid,244-080-7,20849-78-9,,Notified C&L,6,H319:6;H315:6;H335:6
105253,"(3,4-dichlorophenyl)acetonitrile",221-743-9,3218-49-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46,H315:46;H302:40;H335:45;H319:46;H332:39;H312:40;H301:5;H331:5;H311:5
105254,"(RS)-1-(4-chloro-phenyl)-4,4-dimethyl-3-[1,2,4]triazol-1-ylmethyl-pentan-3-ol",600-834-0,107534-96-3,Acute Tox. 4;Repr. 2;Aquatic Chronic 2,Notified C&L,314,H411:280;H361:314;H302:314;H400:34;H410:34;H330:4
105256,ethyl 3-amino-3-phenylpropanoate,613-206-6,6335-76-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,39,H319:1;H315:1;H335:1;H412:38;H302:38
105257,4-methylbenzothiazol-2-ylamine,216-028-3,1477-42-5,Acute Tox. 3;Aquatic Chronic 2,REACH registration C&L,202,H301:2;H411:2;H302:200
105258,p-(trifluoromethoxy)phenyl isocyanate,252-328-0,35037-73-1,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1C;Skin Sens. 1A;Eye Dam. 1;Acute Tox. 1;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,46,H318:2;H302:45;H330:2;H335:45;H412:2;H314:2;H317:2;H311:3;H315:44;H319:44;H332:43;H312:39;H334:4;H301:1;H331:1
105260,2-iodoaniline,210-426-0,615-43-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,50,H315:49;H302:48;H335:48;H332:48;H312:48;H319:10;Not classified:2
105264,Vanadium diboride,234-509-6,12007-37-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H312:38;H332:38;H302:38
105266,"2,4-Bis(2,4-dimethylphenyl)-6-(2-hydroxy-4-n-octyloxyphenyl)-1,3,5-triazine",608-067-3,2725-22-6,Not Classified,Notified C&L,39,Not classified:26;H411:12;H319:1;H315:1
105270,Triphenylphosphine,210-036-0,603-35-0,Acute Tox. 4;Skin Sens. 1B;STOT RE 2,REACH registration C&L,1209,H373:282;H302:1173;H317:1201;H372:155;H318:141;H413:756;H410:42;H319:41;H315:21;H335:13;H400:20;Not classified:16;H301:6;H411:5;H412:1;H332:1;H331:1;H311:1
105273,"1,3 Butadiene/styrene copolymers",618-370-2,9003-55-8,Not Classified,Notified C&L,366,Not classified:281;H412:36;H317:36;H350:8;H340:8;H319:8;H332:1;H315:1;H335:1
105275,"1-Butoxy-2,3-difluoro-4-(4-pentylcyclohex-1-en-1-yl)benzene",926-964-0,,Not Classified,Notified C&L,1,Not classified:1
105276,Aluminium sodium thiosilicate green,215-711-3,1345-00-2,Not Classified,Notified C&L,3,Not classified:3
105282,"4(3H)-Pyrimidinone, 2,5-diamino-6-hydroxy-, hydrochloride (1:1)",611-428-8,56830-58-1,Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1
105283,(iodomethyl)trimethylammonium iodide,254-611-4,39741-91-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,42,H318:38;H315:42;H302:38;H335:42;H319:4
105288,"Poly(oxy-1,2-ethanediyl), .alpha.,.alpha.'-1,6-hexanediylbis[.omega.- hydroxy]- (3-EO)",610-830-0,52365-03-4,Acute Tox. 4;Acute Tox. 4,Notified C&L,22,H332:22;H302:22
105289,Ethyl (E)-oct-2-enoate,230-913-1,7367-82-0,Not Classified,Notified C&L,139,Not classified:138;H319:1;H315:1
105292,"Fatty acids, tallow, hydrogenated, aluminum salts",294-788-5,91770-05-7,Not Classified,Notified C&L,9,Not classified:9
105298,Chlorophenylmagnesium,202-868-8,100-59-4,Flam. Liq. 2;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,71,H225:32;H318:3;H314:71
105299,"Sodium 1,2-bis(pentyloxycarbonyl)ethanesulphonate",213-085-6,922-80-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,255,H319:128;H315:250;H318:122;Not classified:5
105300,"Sodium 4-amino-5-hydroxy-3-(4-nitrophenylazo)-6-(phenylazo)naphthalene-2,7-disulphonate",213-903-1,1064-48-8,Skin Sens. 1B,REACH registration C&L,231,H317:126;H372:95;H319:87;H315:61;H335:54;Not classified:32;H302:2
105301,"Honey, ext.",293-255-4,91052-92-5,Not Classified,Notified C&L,147,Not classified:147
105305,"5-hydroxy-7,11-dimethyldodec-10-en-3-one",272-984-1,68922-12-3,Flam. Liq. 3,Notified C&L,25,H226:25
105306,"6,9-bis(hexadecyloxymethyl)-4,7-dioxanonane-1,2,9-triol",411-450-6,143747-72-2,Aquatic Chronic 4,Harmonised C&L,0,H413:0
105310,"Castor oil, sodium salt",306-231-6,96690-37-8,Not Classified,Notified C&L,1,Not classified:1
105311,Phthalylsulfathiazole,201-627-4,85-73-4,Aquatic Chronic 3,REACH registration C&L,4,H412:1;Not classified:3
105312,"N,N',N''-methylidynetrisformamide",225-317-3,4774-33-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
105314,"Methyl N,N,N-trimethyl-4-[(4,7,7-trimethyl-3-oxobicyclo[2.2.1]hept-2-ylidene)methyl]anilinium sulphate",258-190-8,52793-97-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,40,H319:40;H315:38;H411:1
105321,"1,1-bis(2,2-dimethylpropoxy)-N,N,N-trimethylamine",225-536-4,4909-78-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H226:38;H335:38
105324,Ethanesulphonic acid,209-843-0,594-45-6,Met. Corr. 1;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1;Eye Dam. 1;STOT SE 3,REACH registration C&L,58,H318:12;H290:8;H302:47;H335:8;H314:58;H312:8;Not classified:1
105325,"Cyclohexane, oxidized, distillates",308-380-2,97952-85-7,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3;STOT SE 3,Notified C&L,1,H318:1;H315:1;H336:1;H226:1;H335:1;H332:1
105326,3-nitro-p-toluidine,204-314-0,119-32-4,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,85,H373:82;H372:4;H301:83;H331:84;H311:85;H411:82;H330:1;H315:1;H319:1
105329,Cyclohexyldiethylamine,202-087-2,91-65-6,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,61,H302:60;H226:61;H314:61;H332:38;H312:38;H330:22;H310:22;H318:1
105335,2-methoxyphenyl acetate,210-350-8,613-70-7,Not Classified,Notified C&L,115,Not classified:89;H315:26;H319:1;H335:1
105337,Diethyl dimethylmalonate,216-582-6,1619-62-1,Acute Tox. 4,Notified C&L,41,H302:41
105338,Ethoxydimethylvinylsilane,226-341-7,5356-83-2,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H225:43;H315:43;H319:43;H335:42
105341,"Alkenes, C8-10, hydroformylation products, distn. lights, sulfonated, ammonium salts",310-175-8,122117-05-9,Not Classified,Notified C&L,1,Not classified:1
105348,"1,4-benzodioxan-6-ylamine",244-718-4,22013-33-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H315:42;H302:46;H335:40;H319:41;H332:46;H312:42;H311:5;H301:1;H331:1
105354,C.I. dDisperse Blue 35,602-260-6,12222-75-2,Skin Sens. 1,Notified C&L,38,H317:38
105355,2-isopropyl-1H-imidazole,253-286-6,36947-68-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,100,H319:99;H315:100;H335:98;H302:9;H312:9;H301:1;H318:1
105357,"(2S,4S,5S,7S)-5-Amino-N-(2-carbamoyl-2-methylpropyl)-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanamide",605-672-4,173334-57-1,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H400:33;H317:33;H410:33;H412:9
105358,"3-[(2E)-2-benzylidenehydrazino]-4-sulfonatobenzoate, disodium salt",601-577-7,118969-29-2,Skin Sens. 1,Notified C&L,1,H317:1
105359,"3-amino-4-hydroxy-N,N-dimethylbenzenesulphonamide",246-548-6,24962-75-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
105360,"(2Z)-but-2-ene-1,4-diyl diacetate",607-674-0,25260-60-0,Not Classified,REACH registration C&L,41,Not classified:1;H319:39;H315:40;H335:39
105365,2-[2-(trifluoromethyl)phenyl]acetamide,252-209-3,34779-65-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
105366,Lanthanum fluoride,237-252-8,13709-38-1,Not Classified,REACH registration C&L,21,Not classified:11;H315:8;H302:8;H335:8;H319:8;H332:8;H312:8;H413:3;H300:1;H310:1
105370,"(2S)-2-Amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid",609-918-1,41372-08-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,5,H319:2;H315:2;H302:2;H335:2;H412:1;H372:1;H361:1
105372,12-bromododecanoic acid,277-401-4,73367-80-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H315:1;H335:1;Not classified:1
105373,Producto P0310,476-880-9,,Not Classified,REACH registration C&L,2,Not classified:2
105374,AS Violet,480-210-0,,Not Classified,Notified C&L,1,Not classified:1
105381,"Phenol, 4,4'-(4,5,6,7-tetrabromo-1,1-dioxido-3H-2,1-benzoxathiol-3-ylidene)bis[2,6-dibromo-, monosodium salt",600-863-9,108321-10-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
105382,Trimethylacetic anhydride,216-263-1,1538-75-6,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,46,H314:45;H226:40;H318:2;H315:1;H302:1;H335:1;H319:1;H317:1
105383,[No public or meaningful name is available],469-290-8,,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H302:1;H226:1;H412:1;H314:1;H317:1
105384,"1,1,2-trichloropropane",209-951-8,598-77-6,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3,Notified C&L,1,H331:1;H302:1;H226:1
105385,"Residual oils (petroleum), oxidized, calcium salts",271-641-3,68603-14-5,Not Classified,Notified C&L,126,Not classified:126
105388,"Tar acids, xylenol fraction;Distillate Phenols;[The fraction of tar acids, rich in 2,4- and 2,5-dimethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]",284-895-5,84989-06-0,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
105390,Methyl 1-methyl-5-(4-methylbenzoyl)-1H-pyrrole-2-acetate,251-480-5,33369-52-7,Not Classified,REACH registration C&L,1,Not classified:1
105393,4-isopropylbenzyl alcohol,208-640-4,536-60-7,Acute Tox. 4,Notified C&L,1685,H302:1685;H315:44;H319:6;H335:5
105395,Benzyl hydrogen β-L-aspartate,218-541-8,2177-63-1,Not Classified,Notified C&L,3,Not classified:2;H319:1;H315:1;H335:1
105399,Febantel,261-205-0,58306-30-2,Acute Tox. 4,Notified C&L,105,H302:105;H400:62;H410:62;H360:27;H312:1
105402,Poly(methylhydrosiloxane),613-152-3,63148-57-2,Not Classified,Notified C&L,264,Not classified:262;H319:2;H315:1;H335:1
105405,"Acetamide, N-(2,4-dinitrophenyl)-, reaction products with 1-methyl-2,4-dinitrobenzene and sodium sulfide (Na2(Sx)), leuco derivatives",288-896-1,85940-08-5,Not Classified,REACH registration C&L,39,Not classified:39
105406,(chloromethyl)pentamethylbenzene,207-608-7,484-65-1,Skin Corr. 1B;Eye Dam. 1,Notified C&L,44,H318:39;H314:44;H290:1;H335:1
105408,p-toluoyl chloride,212-864-8,874-60-2,Skin Corr. 1B;STOT SE 3,REACH registration C&L,94,H314:92;H335:8;Not classified:2;H318:3;H290:1;H411:1;H341:1
105412,"4,4'-trimethylenedi(piperidine-1-propiononitrile)",242-022-5,18136-00-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H315:39;H302:38;H335:39;H319:39;H332:38;H312:38
105414,2-nitrophenol,201-857-5,88-75-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,291,H302:287;H400:240;H332:241;H410:240;H312:240;H315:44;H335:39;H412:46;H319:44;H373:5;Not classified:2
105421,1-ethylnaphthalene,214-432-4,1127-76-0,Aquatic Chronic 2,Notified C&L,23,H411:20;Not classified:3
105423,Trisodium hexakis(nitrito-N)iridate,301-548-6,94022-51-2,,Notified C&L,4,H319:4;H315:4;H335:4
105424,Potassium hydrogencarbonate,206-059-0,298-14-6,Not Classified,REACH registration C&L,389,Not classified:232;H319:156;H335:156;H312:1;H332:1;H302:1
105427,"4-chloro-3,5-dinitrobenzonitrile",217-686-4,1930-72-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H315:43;H302:43;H335:42;H319:43;H332:43;H312:43;H373:1;H331:1;H311:1
105430,butyl 2-{[3-(trifluoromethyl)phenyl]amino}benzoate,614-050-1,67330-25-0,Acute Tox. 4,REACH registration C&L,3,H302:3
105433,"2,4-Bis(trifluoromethyl)phenylboronic Acid (contains varying amounts of Anhydride)",604-892-8,153254-09-2,,Notified C&L,5,H319:5;H315:5;H335:4
105438,5-chloro-1H-indole-3-ethylamine monohydrochloride,213-387-8,942-26-7,,Notified C&L,8,H319:8;H315:8;H335:7
105439,"1-(2,6-xylyl)thiourea",229-005-8,6396-76-5,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,46,H319:41;H302:40;H301:5;H315:2;H335:2;H332:1;H312:1
105441,Allylpentafluorobenzene,217-083-6,1736-60-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H226:46;H335:45
105443,N-butyrylalanine,611-909-2,59875-04-6,Eye Dam. 1,Notified C&L,1,H318:1
105448,"(1S,6S,7R,8R,8aR)-1,6,7,8-Tetrahydroxyindolizidine",616-743-4,79831-76-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H312:39;H332:39;H302:39
105455,Modified chlorinated polyolefin with maleic anhydride,614-659-2,68609-36-9,Not Classified,Notified C&L,42,Not classified:41;H317:1
105456,"Ethyl 4,4,4-trichloro-3-oxobutyrate",223-041-8,3702-98-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
105457,"17-α,21-dihydroxypregna-4,9(11)-diene-3,20-dione 21-acetate",231-812-5,7753-60-8,Not Classified,REACH registration C&L,2,Not classified:2
105460,2-chloro-α-methylbenzyl alcohol,236-868-4,13524-04-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2
105462,"(3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone",444-350-6,133413-70-4,Eye Irrit. 2;Aquatic Chronic 4,Harmonised C&L,0,H319:0;H413:0
105469,"Oils, capelin, stearins",297-108-5,93334-33-9,Not Classified,Notified C&L,1,Not classified:1
105471,Bis(2-pyridyl) ketone,243-067-3,19437-26-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:41
105475,Octamethylsilanetetramine,216-611-2,1624-01-7,Flam. Liq. 3;Water-react. 2;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,67,H302:67;H226:45;H314:67;H261:65;H332:41;H312:67;H225:22;H331:22;H318:1
105477,"Disodium 7,7'-(carbonyldiimino)bis(4-hydroxynaphthalene-2-sulphonate)",243-735-4,20324-87-2,Not Classified,REACH registration C&L,128,Not classified:128
105481,Phenetole,203-139-7,103-73-1,Flam. Liq. 3,REACH registration C&L,51,H226:51
105484,"1,6-anhydro-β-D-glucose",207-855-0,498-07-7,Not Classified,Notified C&L,3,Not classified:3
105486,"2-Propenoic acid, 2-methyl-, methyl ester, polymer with 1,3-butadiene, ethenylbenzene and 2-propenenitrile",618-462-2,9010-94-0,Not Classified,Notified C&L,58,Not classified:58
105490,Diazidodimethylsilane,225-318-9,4774-73-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
105491,"(butylamine)[[2,2'-thiobis[4-(1,1,3,3-tetramethylbutyl)phenolato]](2-)-O,O',S]nickel",238-523-3,14516-71-3,Skin Sens. 1A,REACH registration C&L,102,H317:21;H312:41;H332:41;H302:41;H413:17;H410:18;Not classified:7;H400:3;H350:1;H334:1;H372:1
105495,Bromophenylmagnesium,202-867-2,100-58-3,Skin Corr. 1B,Notified C&L,72,H314:72;H225:28;H336:4;H302:5;H261:4;H224:5;H260:2;H332:1;H312:1;H318:2;H373:1;H340:1;H335:2;H350:1;H351:1
105496,"2,4-dimethylpent-1-ene",218-665-2,2213-32-3,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,43,H225:43;H304:38;H315:4;H319:4;H335:4
105502,5-tert-butylpyrazol-3-ylamine,450-360-1,82560-12-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H370:1;H335:1;H225:1;H301:1;H331:1;H311:1
105505,Pentapotassium pentasodium bis(triphosphate),246-156-5,24315-83-1,Not Classified,Notified C&L,4,Not classified:4
105509,2-amino-4-chloro-5-nitrophenol,228-760-0,6358-07-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,73,H315:39;H302:71;H335:71;H319:72;H332:71;H312:71;H411:33;Not classified:1
105516,"Strawberry, Fragaria vesca, ext.",284-556-1,84929-78-2,Flam. Liq. 2,Notified C&L,1316,H225:1287;H226:29;H319:2
105518,"Rose, Rosa bourboniana, ext.",307-515-2,97660-07-6,Skin Irrit. 2,Notified C&L,25,H315:25
105519,4-nitro-o-toluic acid,217-828-5,1975-51-5,Acute Tox. 4;Skin Sens. 1,Notified C&L,47,H302:40;H317:38;H319:7;H315:7;H335:7;H312:1;H332:1
105520,3-quinolylamine,209-455-1,580-17-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,45,H319:45;H315:45;H302:5;H335:5;H332:5;H312:5;H341:1
105521,Potassium tetrafluoroborate,237-928-2,14075-53-7,Not Classified,REACH registration C&L,90,Not classified:41;H413:22;H319:25;H315:24;H335:25;H314:3;H372:1
105522,2-Chloro-1-fluoro-4-(trifluoromethyl)benzene,616-586-1,78068-85-6,,Notified C&L,8,H319:8;H315:8;H226:4;H335:7
105525,"1,3- AND 1,4-CYCLOHEXANDICARBOXYALDEHYDE",482-020-3,,Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,25,H318:25;H302:25;H335:25;H412:23;H317:25;H315:2;H225:2;H304:2;H411:2
105526,"Hydrogen 1-(3-sulphonatopropyl)-2-[2-[[1-(3-sulphonatopropyl)naphtho[1,2-d]thiazolin-2-ylidene]methyl]but-1-enyl]naphtho[1,2-d]thiazolium, compound with triethylamine",245-498-2,23216-67-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:40
105533,Captopril,263-607-1,62571-86-2,Skin Sens. 1;Repr. 1A,Notified C&L,135,H360:84;H317:131;H361:47;H318:32;H319:4;H315:4;H335:5;H362:2;H412:1;H312:1;H332:1;H302:2
105536,Parbendazole,238-133-3,14255-87-9,Acute Tox. 4;Repr. 2,Notified C&L,39,H361:39;H302:39
105537,"2,5-dichloro-4-nitrophenol",227-439-2,5847-57-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3;Aquatic Chronic 4,Notified C&L,1,H315:1;H302:1;H335:1;H319:1;H413:1
105538,5-aminopentan-1-ol,219-718-2,2508-29-4,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,Notified C&L,130,H318:84;H314:129;H302:128;Not classified:1
105540,Sulbentine,206-497-2,350-12-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H315:38;H302:38;H335:38;H319:38;H400:38
105541,2-fluoronicotinic acid,206-888-8,393-55-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44
105543,Cyclobarbital,200-138-3,52-31-3,Acute Tox. 4,Notified C&L,1,H302:1
105544,"(1S)-1-(2-chlorophenyl)-N-methyl-2-oxocyclohexanaminium (2R,3R)-3-carboxy-2,3-dihydroxypropanoate",925-303-3,199468-20-7,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,1,H332:1;H302:1
105545,Histidine hydrochloride,213-754-2,1007-42-7,Not Classified,Notified C&L,1,Not classified:1
105556,"4'-hexyl[1,1'-biphenyl]-4-carbonitrile",255-228-5,41122-70-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H315:39;H302:39;H335:38;H319:39;H332:39;H312:39;Not classified:1;H400:1;H410:1
105557,"6-chloro-α,α,α-trifluoro-m-toluidine",204-475-7,121-50-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,138,H315:96;H302:133;H335:38;H319:95;H332:133;H312:133;H411:91;H301:4;H330:3;H311:4;H331:1
105558,4-tert-butylbenzoyl chloride,216-973-1,1710-98-1,Skin Corr. 1B,Notified C&L,43,H314:43
105559,Indol-3-ylglyoxylic acid,216-029-9,1477-49-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
105560,"Naphtha (petroleum), light thermal cracked;Low boiling point thermally cracked naphtha;[A complex combination of hydrocarbons from distillation of products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C",265-075-6,64741-74-8,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
105567,2-ethyl-2-methylsuccinonitrile,224-035-8,4172-97-8,Not Classified,Notified C&L,1,Not classified:1
105568,CARBAMATED DIOL,470-100-0,,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,1,H413:1;H332:1
105572,Bis(2-chloroethoxy)methane,203-920-2,111-91-1,Acute Tox. 3;Acute Tox. 4;Acute Tox. 2;STOT SE 1;STOT RE 2,REACH registration C&L,106,H373:77;H370:64;H330:77;H301:105;H312:78;Not classified:1
105573,N-benzylidene-p-toluidine,218-879-6,2272-45-9,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38,H413:38;H302:38
105575,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-3-phenyl-L-alanine,252-661-1,35661-40-6,Not Classified,Notified C&L,8,Not classified:7;H312:1;H332:1;H302:1;H335:1
105578,Quinuclidin-3-yl acetate hydrochloride,228-071-5,6109-70-2,Acute Tox. 3;Acute Tox. 3,Notified C&L,39,H301:39;H311:38
105589,4-[2-[4-[benzylmethyl(ethyl)amino]phenyl]vinyl]-1-(2-hydroxyethyl)pyridinium acetate,281-468-5,83950-14-5,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1,REACH registration C&L,45,H318:12;H315:12;H302:12;H400:2;H317:2;Not classified:33;H412:10
105590,"3-Cyclohexene-1-carboxylic acid, 2,6,6-trimethyl-, methyl ester, (1R,2S)-rel-",619-523-6,540734-22-3,Aquatic Chronic 3,Notified C&L,37,H412:37
105591,"1,3,5-trichloro-2,4-dinitrobenzene",228-510-0,6284-83-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,2,H315:2;H302:2;H319:2;H332:2;H312:2
105596,4-chloro-γ-ethoxybenzenebutyronitrile,230-093-5,6940-87-0,Acute Tox. 3,Notified C&L,38,H301:38
105599,"1,5-dihydroxy-4-nitro-8-(phenylamino)anthraquinone",221-318-8,3065-87-0,Skin Sens. 1,Notified C&L,33,H317:22;Not classified:11
105606,"3,3',3''-(trioxo-1,3,5-triazinetriyl)tri(propionic acid)",220-803-1,2904-41-8,Skin Irrit. 2;STOT SE 3,Notified C&L,28,H315:27;H335:26;Not classified:1;H319:1
105613,2-tert-butylhydroquinone,217-752-2,1948-33-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2676,H315:646;H302:2510;H319:1120;H400:899;H317:804;H410:307;H312:710;H335:229;Not classified:137;H341:29;H371:24;H411:1;H412:1
105617,"1-benzo-2-oxa-1,3-diazole oxide",207-559-1,480-96-6,Not Classified,REACH registration C&L,46,Not classified:4;H319:42;H315:42;H335:40;H312:1;H302:1
105619,"5-(3,5-dinitro-2-hydroxyphenylazo)-6-hydroxy-m-methylacetanilide",228-884-5,6370-46-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
105621,"2,4-Dichloro-6,7-dimethoxyquinazoline",608-117-4,27631-29-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:46;H315:46;H335:45;H302:1
105622,"Quaternary ammonium compounds, trimethyltallow alkyl, chlorides",232-447-4,8030-78-2,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Acute 1,Notified C&L,274,H400:265;H318:115;H314:180;H302:162;H319:73;H315:86;H335:93;H301:20;H410:35;H312:33;H332:13;Not classified:6;H225:1;H331:1;H311:1
105634,"2,2-dimethyl-3-(m-tolyl)propanal",440-720-6,,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1,H315:1;H302:1;H319:1;H317:1;H411:1
105640,"Tar oils, coal;Carbolic Oil;[The distillate from high temperature coal tar having an approximate distillation range of 130°C to 250°C (266°F to 410°F). Composed primarily of naphthalene, alkylnaphthalenes, phenolic compounds, and aromatic nitrogen bases.]",266-016-7,65996-82-9,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
105641,C12-C16 n-alkanes,920-008-6,,Asp. Tox. 1;STOT SE 3;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,3,H372:3;H304:3;H336:3;H411:3
105642,Iron(2+) di-L-ascorbate,246-469-7,24808-52-4,Not Classified,Notified C&L,1,Not classified:1
105644,Ephedrine hydrochloride,200-074-6,50-98-6,Acute Tox. 4,REACH registration C&L,112,H302:112;H362:1;H360:1
105645,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[[4-methoxy-6-[(2-sulfoethyl)amino]-1,3,5-triazin-2-yl]amino]-, sodium salt, compd. with 2-aminoethanesulfonic acid monosodium salt and 2,2'-iminobis[ethanol]",285-982-0,85169-39-7,Not Classified,Notified C&L,1,Not classified:1
105647,"5-amino-1-(2,6-dichloro-α,α,α-trifluoro-p-tolyl)-4-ethylsulfinylpyrazole-3-carbonitrile",605-936-9,181587-01-9,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,195,H373:195;H400:195;H410:195
105651,"2,6-bis[[bis(2-hydroxyethyl)amino]methyl]-4-nonylphenol",243-500-6,20073-51-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,35,H318:4;H315:30;H302:4;H400:4;H317:4;H410:4;H319:26;Not classified:5
105652,"Ethane- 1,2-diol, propoxylated",500-078-0,31923-84-9,Not Classified,REACH registration C&L,24,Not classified:5;H319:17;H315:17;H302:19
105656,"Toluene-2,3-diamine",220-248-5,2687-25-4,Acute Tox. 3;Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Muta. 2;Carc. 1B;Repr. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,237,H373:117;H301:199;H361:117;H319:237;H350:194;H332:198;H317:194;H312:237;H411:194;H341:117;H315:43;H302:38;H335:42
105660,"Pyridine-2,6-dicarbaldehyde",226-589-6,5431-44-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:41;H302:3;H332:3;H312:3
105662,3-nitropropionic acid,208-003-0,504-88-1,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H301:39;H315:38;H319:38;H335:38;H311:1
105663,"Bis(η2-ethylene)(pentane-2,4-dionato-O,O')rhodium",235-147-1,12082-47-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
105664,2-methyl-5-nitro-1H-imidazole-1-propanol monohydrochloride,274-285-7,70028-95-4,Not Classified,REACH registration C&L,40,Not classified:2;H302:38
105667,"Quaternary ammonium compounds, coco alkyltrimethyl, Me sulfates",268-073-3,68002-60-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,69,H318:43;H315:42;H302:69;H290:22;H314:26;H400:5
105669,"triazophos (ISO);O,O-diethyl-O-1-phenyl-1H-1,2,4-triazol-3-yl phosphorothioate",245-986-5,24017-47-8,Acute Tox. 3;Acute Tox. 4;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H301:0;H331:0;H400:0;H410:0;H312:0
105671,"N'-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxysuccinamide monohydrochloride",217-767-4,1950-39-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,REACH registration C&L,3,H315:2;H335:2;H319:2;H317:2;H334:2;Not classified:1
105673,Disodium 5-sulphido-1H-tetrazole-1-methanesulphonate,266-274-0,66242-82-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H315:39;H335:39;Not classified:1
105675,Xenon difluoride,237-251-2,13709-36-9,Ox. Sol. 2;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 2,Notified C&L,116,H301:112;H314:116;H330:112;H272:93;H271:23;H318:2;H412:2;H332:2;Not classified:1
105679,"Quaternary ammonium compounds, (C16-18 and C18-unsatd. alkyl)trimethyl, chlorides",268-074-9,68002-61-9,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,6,H318:6;H302:6;H314:6;H400:6;H410:6
105681,"Trisodium [3-hydroxy-4-[(2-hydroxy-5-sulphophenyl)azo]naphthalene-2,7-disulphonato(5-)]chromate(3-)",288-810-2,85896-33-9,Not Classified,Notified C&L,12,Not classified:12
105684,1-aminocyclohexane-1-carboxylic acid,220-411-0,2756-85-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,61,H318:55;H315:60;H319:5;H335:5;H312:1;H332:1;H302:1
105685,"1,4-Benzenedicarboxylic acid, dimethyl ester, manuf. of, by-products from",273-521-6,68988-22-7,Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H317:2
105686,"2H-1-Benzopyran-5-methanol, 2-cyclopropyl-7,8-dimethoxy-",617-580-1,845276-38-2,Acute Tox. 4,REACH registration C&L,2,H302:2
105687,"1',3'-dihydro-1',3',3'-trimethyl-6-nitrospiro[2H-1-benzopyran-2,2'-[2H]indole]",216-102-5,1498-88-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
105693,"2-Propenoic acid, 2-hydroxypropyl ester, polymer with chloroethene and ethenyl acetate",609-941-7,41618-91-1,Not Classified,Notified C&L,74,Not classified:74
105700,"Sodium 2,4-diamino-5-(4-(2-sulfoxyethanesulfonyl)phenylazo)benzenesulfonate",461-870-9,,Not Classified,REACH registration C&L,1,Not classified:1
105706,"Phenol, polymer with 3A,4,7,7A-tetrahydro-4,7-methano-1H-indene, glycidyl ether; Epoxy resin",601-602-1,119345-05-0,Skin Sens. 1,Notified C&L,84,H317:75;Not classified:9
105709,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[[4-[(2-hydroxyethyl)amino]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-, sodium salt (1:2)",602-364-1,12224-06-5,,Notified C&L,1,Not classified:1
105710,5-{4-[(3-chloro-4-{[(3-fluorophenyl)methyl]oxy}phenyl)amino]-6-quinazolinyl}-2-furancarbaldehyde mono(4-methylbenzenesulfonate),929-151-9,,Not Classified,REACH registration C&L,2,Not classified:2
105714,"O,O-dimethyl thiophosphonate",227-674-0,5930-72-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H226:38;H335:38
105715,"Fatty acids, C14-18 and C18-unsatd., branched and linear, Me esters",286-065-8,85186-80-7,Not Classified,REACH registration C&L,8,Not classified:8
105716,{[2-(trifluoromethyl)benzoyl]amino}methyl acetate,619-484-5,895525-72-1,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 4,REACH registration C&L,37,H413:4;H302:4;H317:4;Not classified:33
105718,Triphenylstibine,210-037-6,603-36-1,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,196,H411:186;H332:187;H302:144;H301:52;H330:9;H335:9;H319:9;H311:9
105721,"2-Acetyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino(2,1-a)isochinolin-4-one",470-180-7,,Acute Tox. 4;Skin Sens. 1,REACH registration C&L,1,H302:1;H317:1
105722,β-indol-3-ylethanol,208-393-2,526-55-6,Not Classified,Notified C&L,4,Not classified:2;H319:2;H315:2;H335:2;H302:1
105725,Dipotassium tetrahydrogen [nitrilotris(methylene)]trisphosphonate,223-643-0,3998-50-3,Met. Corr. 1,Notified C&L,1,H290:1
105727,"2-Propenenitrile, polymer with ethenylbenzene",618-369-7,9003-54-7,Not Classified,Notified C&L,240,Not classified:164;H302:76
105735,potassium hydrogensulphate,231-594-1,7646-93-7,Skin Corr. 1B;STOT SE 3,Harmonised C&L,0,H314:0;H335:0
105736,"4,10-dibromodibenzo[def,mno]chrysene-6,12-dione",224-481-3,4378-61-4,Not Classified,REACH registration C&L,237,Not classified:237
105740,2-[3-(methylamino)propyl]-1H-benzimidazole,425-760-4,64137-52-6,Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H318:0
105742,3-bis(N-n-butyl)aminopropiononitrile,247-211-6,25726-99-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,22,H319:22;H315:22;H335:22
105743,1-benzyl-4-(cyclohexylamino)piperidine-4-carbonitrile,213-532-5,968-85-4,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H301:38;H315:38;H319:38;H335:38
105744,"Distillates (coal-petroleum), condensed-ring arom;[The distillate from a mixture of coal and tar and aromatic petroleum streams having an approximate distillation range of 220 °C to 450 °C (428 °F to 842 °F). Composed primarily of 3- to 4-membered condensed ring aromatic hydrocarbons.]",269-159-3,68188-48-7,Carc. 1B,Harmonised C&L,0,H350:0
105748,"Phosphorodithioic acid, mixed O,O-bis(sec-Bu and 1,3-dimethylbutyl) esters, zinc salts",272-238-5,68784-31-6,Eye Dam. 1;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,465,H411:7;H318:448;H401:4;H315:441;Not classified:17
105751,Bis(isopropyl) thioperoxydicarbonate,203-319-5,105-65-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,77,H319:40;H315:76;H335:40;H302:36;H317:36;Not classified:1
105752,"Resin acids and Rosin acids, maleated, potassium salts",287-094-9,85409-27-4,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,6,H411:2;H318:2;H317:2;Not classified:4
105755,Bromhexine,222-684-1,3572-43-8,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H400:2;H410:2
105757,"2,6-dichloro-3-pyridylamine",263-559-1,62476-56-6,Acute Tox. 3;Skin Sens. 1;Eye Dam. 1,Notified C&L,47,H301:39;H318:38;H317:38;H315:8;H302:5;H335:6;H319:8;H332:5;H312:5;H331:1;H311:1
105758,1-ethoxydecane,614-340-8,68154-97-2,Not Classified,Notified C&L,564,Not classified:233;H318:148;H302:117;H319:114;H400:69;H411:22;H315:22;H410:13
105764,"2,2,4,4,6,6-hexamethyl-1,3,5-trithiane",212-582-5,828-26-2,Not Classified,Notified C&L,131,Not classified:79;H319:52;H315:51;H335:51
105769,4-nitrochalcone,214-949-5,1222-98-6,,Notified C&L,7,H319:6;H315:6;H335:5;H351:1;H400:1;H410:1
105771,3-Amino-2-methylbenzoic Acid,610-787-8,52130-17-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
105774,"Benzenepropanoyl chloride, alpha-methylene",925-602-9,,Acute Tox. 4;Skin Corr. 1B;STOT SE 3,Notified C&L,1,H314:1;H302:1;H335:1
105776,"reaction mass of: N,N-di(hydrogenated alkyl C",413-800-3,87787-81-3,Aquatic Chronic 4,Harmonised C&L,0,H413:0
105780,3-methyl-2-(pentyloxy)cyclopent-2-en-1-one,272-985-7,68922-13-4,Not Classified,Notified C&L,88,Not classified:88
105781,"1,3,3-trimethyl-2-[2-(1-methyl-2-phenyl-1H-indol-3-yl)vinyl]-3H-indolium dihydrogen phosphate",252-327-5,35033-71-7,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,2,H411:2;H318:2;H302:2
105782,N-benzylmethacrylamide,221-744-4,3219-55-4,Acute Tox. 4,Notified C&L,38,H302:38
105784,Magnesium bromide,232-170-9,7789-48-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:43;H315:43;H335:43;Not classified:4
105785,"1,2-diiodobenzene",210-425-5,615-42-9,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,46,H318:38;H315:45;H335:40;H319:7;H314:1
105786,"2-isopropenyl-4-isopropyl-1-methyl-1-vinylcyclohexane, didehydro derivative",272-459-7,68845-33-0,Asp. Tox. 1,Notified C&L,51,H304:51
105787,"Ethylenediamine, salt with phosphoric acid",238-914-9,14852-17-6,Skin Sens. 1,REACH registration C&L,79,H317:23;Not classified:56
105789,Coumarin,202-086-7,91-64-5,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,2843,H412:220;H302:2515;H317:2616;H373:290;H301:202;H331:87;H311:89;H411:87;H351:53;Not classified:45;H300:36;H318:8;H315:8;H330:2;H335:2;H341:2;H319:1;H312:1
105790,"Chromium alloy, base, Cr,C,Fe,N,Si (Ferrochromium)",601-052-2,11114-46-8,Not Classified,Notified C&L,2,Not classified:2
105796,5-bromo-2'-deoxycytidine,213-824-2,1022-79-3,Carc. 2,Notified C&L,38,H351:38
105798,"3,3',4',5-tetrahydroxy-7-methoxyflavone",201-974-1,90-19-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:39;H315:39;H335:39;Not classified:2
105804,"8-β-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one",222-963-8,3681-93-4,Not Classified,Notified C&L,2,Not classified:2
105808,"3-amino-5-hydroxynaphthalene-2,7-disulphonic acid, sodium salt",258-843-7,53891-22-8,Eye Irrit. 2,Notified C&L,9,H319:9
105811,Vinylferrocene,215-041-1,1271-51-8,Flam. Sol. 1,Notified C&L,41,H228:41
105813,BISPHENOL TMC,404-140-7,,Aquatic Chronic 1,Notified C&L,3,H410:3
105815,"2,6-di-tert-butyl-4-methylpyridine",253-834-4,38222-83-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:43;H315:43;H302:39;H335:42;H312:1;H332:1
105816,1-(4-fluorophenyl)cyclohexanecarbonitrile,275-515-9,71486-43-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H302:1;H335:1;H319:1;H312:1
105823,4-phenoxyphenol,212-611-1,831-82-3,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2A;STOT SE 3,REACH registration C&L,207,H315:207;H302:166;H335:206;H319:207;H317:160;H332:1;H312:1
105825,Antazoline hydrochloride,219-719-8,2508-72-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,41,H315:40;H302:41;H335:39;H319:40;H332:40;H312:40
105826,1-butyl-5-carboxypentyl 6-decenoate,286-864-1,85392-06-9,Skin Irrit. 2,Notified C&L,897,H315:897
105828,3-methylbutan-2-ol,209-950-2,598-75-4,Acute Tox. 4;STOT SE 3,Notified C&L,1471,H332:1460;H335:1467;H226:185;H331:10;H319:1
105829,"Butanoic acid, 4-amino-4-oxo-3-sulfo-, N-tallow alkyl derivs., disodium salts",288-337-1,85711-75-7,Eye Dam. 1,Notified C&L,1,H318:1
105830,"Alcohols, C6-12",271-642-9,68603-15-6,Not Classified,Notified C&L,265,Not classified:158;H319:98;H315:107;H400:97;H410:14
105832,Barium hexafluorosilicate,241-189-1,17125-80-3,Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H302:38
105833,2-nitro-p-cresol,204-315-6,119-33-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,51,H319:51;H315:51;H335:50;H312:4;H412:1
105834,"Protein hydrolyzates, milk",296-575-2,92797-39-2,Not Classified,REACH registration C&L,50,Not classified:50
105836,1-methylpyridinium chloride,231-658-9,7680-73-1,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H301:1;H315:1;H319:1
105837,"Silicic acid, calcium salt",215-710-8,1344-95-2,Not Classified,REACH registration C&L,851,Not classified:418;H319:433;H335:341;H315:20
105838,"Alcohols, C8-18",271-359-0,68551-07-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,33,H319:31;H315:31;Not classified:2
105840,2-ethylhexyl 12-hydroxyoctadecanoate,249-793-7,29710-25-6,Not Classified,REACH registration C&L,128,Not classified:128
105841,4-methoxy-2-methylbutane-2-thiol,301-977-9,94087-83-9,Flam. Liq. 3;Acute Tox. 4,Notified C&L,1440,H302:1322;H226:1440;H319:2;H315:2;H335:2
105842,"Reaction product of 4,4'-methylenediphenyl diisocyanate (MDI) (CAS: 101-68-8) and Cyclohexylamine (108-91-8)",923-378-7,,Not Classified,Notified C&L,1,Not classified:1
105845,Sodium bis[4-hydroxy-3-[(2-hydroxy-1-naphthyl)azo]benzenesulphonamidato(2-)]cobaltate(1-),261-204-5,58302-43-5,Not Classified,REACH registration C&L,145,Not classified:128;H319:13;H412:4
105846,Dimethametryn,245-337-6,22936-75-0,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H400:89;H317:89;H410:89
105848,(diethylamino)acetone,216-583-1,1620-14-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H226:38;H335:38
105851,"1-amino-6,7-dichloroanthraquinone",226-340-1,5355-88-4,Eye Irrit. 2;Resp. Sens. 1,Notified C&L,38,H319:38;H334:38
105852,"[1,3-phenylenebis(1-methylethylidene)]bis[tert-butyl] peroxide",218-664-7,2212-81-9,Org. Perox. D;Aquatic Chronic 4,REACH registration C&L,4,H242:4;H413:4
105853,"2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoic acid",220-785-5,2898-84-2,Aquatic Chronic 2,Notified C&L,121,H411:83;H301:38;H400:38
105856,BUCHU OIL (TREATT NATURAL),614-699-0,68650-46-4,Flam. Liq. 3;Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,107,H411:42;H317:106;H302:104;H226:38;H315:66;H304:67;H410:63;H400:26;Not classified:1
105859,Methyl (E)-oct-2-enoate,230-912-6,7367-81-9,Not Classified,Notified C&L,2,Not classified:2
105860,Anabasine,207-791-3,494-52-0,,Notified C&L,7,H411:5;H300:5;H310:5;H301:1;Not classified:1
105862,"(-)-2,2-dimethyl-4,5-((diphenylphosphino)dimethyl)dioxolane",250-984-2,32305-98-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
105863,"3,5-dimethylanisole",212-865-3,874-63-5,,Notified C&L,1,H301:1;H331:1;H311:1
105866,"Pyrrolidine, 1-[[(4-hydrazinylphenyl)methyl]sulfonyl]-, hydrochloride (1:1)",608-877-7,334981-11-2,Not Classified,Notified C&L,1,Not classified:1
105867,"Bis[(2,3,5,6-η)-bicyclo[2.2.1]hepta-2,5-diene]di-μ-chlorodirhodium",235-510-4,12257-42-0,,Notified C&L,7,H319:6;H315:6;H335:5;H413:2;H302:1;H332:1;H312:1
105868,"2,2-dimethoxy-1,2-diphenylethan-1-one",246-386-6,24650-42-8,Acute Tox. 4;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,3356,H373:2188;H412:2149;H302:2187;H400:1154;H410:1181;H317:290;Not classified:12;H314:9;H411:4;H334:1;H226:1
105871,3-(1-naphthyl)acrylic acid,235-887-5,13026-12-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H302:38;H335:42
105875,"Propane-1,2,3-triyl trinonan-1-oate",204-791-5,126-53-4,Not Classified,REACH registration C&L,9,Not classified:9
105881,Magnesium succinate,209-121-5,556-32-1,Not Classified,Notified C&L,2,Not classified:1;H318:1
105883,Cyano(3-phenoxyphenyl)methyl 2-[4-difluoromethoxy)phenyl]-3-methylbutyrate,274-322-7,70124-77-5,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 4;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,125,H373:83;H330:86;H226:83;H301:125;H400:122;H410:122;H312:121;H331:39;H315:1;H319:1
105884,"Titanium tetra(octanolate), branched and linear",281-199-3,83897-91-0,Eye Irrit. 2,REACH registration C&L,60,H319:54;H315:56;H226:4;Not classified:2
105885,Methyl oxoacetate,213-084-0,922-68-9,Not Classified,Notified C&L,3,Not classified:2;H319:1;H315:1;H226:1;H335:1
105887,Hexamethonium hydroxide,611-300-1,556-81-0,Skin Corr. 1B,Notified C&L,42,H314:42;H318:4
105894,2-[[(3-methylphenyl)amino]carbonyl]benzoic acid,201-626-9,85-72-3,Eye Irrit. 2;Aquatic Acute 1,Notified C&L,38,H319:38;H400:38
105895,"2-(1-amino-1-methylethyl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide",465-070-0,,Aquatic Chronic 2,REACH registration C&L,1,H411:1
105897,"Ethyl N-(2-ethoxy-1,2-dihydroquinoline)carboxylate",240-418-2,16357-59-8,Acute Tox. 4;Skin Irrit. 2,Notified C&L,82,H315:81;H302:74;H319:10;H335:9;H332:2;H312:3;Not classified:1
105898,1-nitrocyclohex-1-ene,219-883-0,2562-37-0,Eye Irrit. 2,Notified C&L,39,H319:39
105899,Isohexadecyl 12-[(1-oxooctadecyl)oxy]octadecanoate,306-621-6,97338-28-8,Aquatic Chronic 1,REACH registration C&L,6,H410:2;Not classified:4
105900,Sodium calcium edetate,200-529-9,62-33-9,Not Classified,REACH registration C&L,239,Not classified:192;H319:45;H315:45;H335:45;H318:4
105903,"Disodium 4-hydroxy-3-[[4'-[(2-hydroxynaphthyl)azo]-2,2'-dimethyl[1,1'-biphenyl]-4-yl]azo]naphthalene-2,7-disulphonate",223-040-2,3701-40-4,Not Classified,Notified C&L,2,Not classified:2
105905,"4-phenyl-1,3-dioxane",212-244-7,772-00-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H302:39;H335:43
105907,"4,4'-(1-{4-[1-(4-hydroxyphenyl)-1-methylethyl]phenyl}ethylidene)diphenol",425-600-3,110726-28-8,Aquatic Chronic 4,Harmonised C&L,0,H413:0
105912,"(1S,2R,18R,19R,22S,25R,28R,40S)-48-{[(4S,5S,6R)-3-{[(4S,5R,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-22-(carbamoylmethyl)-47,49-dichloro-2,18,32,35,37-pentahydroxy-19-[(2R)-4-methyl-2-(methylazaniumyl)pentanamido]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2^{3,6}.2^{14,17}.1^{8,12}.1^{29,33}.0^{10,25}.0^{34,39}]pentaconta-3,5,8(48),9,11,14,16,29,31,33(45),34,36,38,46,49-pentadecaene-40-carboxylate hydrochloride",604-193-8,1404-93-9,Skin Sens. 1,Notified C&L,119,H317:116;H319:18;H315:17;H335:18;H302:1;H332:1;H312:1;H360:1;Not classified:2;H334:3
105915,Methyl 3-phenyl-DL-alaninate hydrochloride,227-049-2,5619-07-8,,Notified C&L,7,H319:7;H315:7;H335:7
105916,"Siloxanes and Silicones, Me Ph",613-153-9,63148-58-3,,Notified C&L,44,Not classified:44
105917,"3-Quinolinecarboxylic acid, 7-[6-(benzoylmethylamino)-5-methyl-3-pyridinyl]-1-cyclopropyl-1,4-dihydro-8-methyl-4-oxo-, ethyl ester",610-204-7,446299-90-7,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H400:2;H410:2
105918,"29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32 copper",205-685-1,147-14-8,Not Classified,REACH registration C&L,2121,Not classified:2075;H413:31;H317:30;H412:9;H400:4;H410:5;H319:1;H315:1
105919,4-chloro-3-(3-methyl-5-oxo-2-pyrazolin-1-yl)benzenesulphonic acid,201-858-0,88-76-6,Skin Sens. 1,Notified C&L,70,H317:39;H314:32
105925,"sodium 4,4-dimethyl-2,5-dioxoimidazolidin-1-ide",476-160-4,,Not Classified,REACH registration C&L,4,Not classified:4
105927,2-chloroethyl chloroformate,210-982-4,627-11-2,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,46,H301:4;H315:4;H319:4;H335:3;H331:40;H314:42;H318:2;H330:3;H226:2;H350:1;H411:1;H311:1
105929,3-ethoxypropiononitrile,218-393-4,2141-62-0,,Notified C&L,5,H319:5;H315:5;H335:4
105932,Tofenacin hydrochloride,234-011-9,10488-36-5,,Notified C&L,1,H302:1
105940,"calcium 2,2,bis[(5-tetrapropylene-2-hydroxy)phenyl]ethanoate",421-670-4,,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H315:0;H400:0;H410:0
105950,2-(o-tolylazo)-p-cresol,228-881-9,6370-43-0,,Notified C&L,1,Not classified:1
105952,"Naphthalene-1,8-sultone",201-468-0,83-31-8,Skin Irrit. 2,Notified C&L,39,H315:39
105953,Potassium 2-(4-chloro-2-methylphenoxy)propionate,217-683-8,1929-86-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H318:2;H315:2;H302:2;H400:2;H410:2
105954,Pindolol,236-867-9,13523-86-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:39;H315:39;H302:38;H335:39;H301:4;H412:1;H331:1;H311:1
105955,Lead divanadium hexaoxide,233-248-5,10099-79-3,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H373:42;H360:42;H302:42;H400:42;H332:42;H410:42
105956,Rape oil,232-299-0,8002-13-9,Not Classified,Notified C&L,537,Not classified:537
105957,Ethyl 2-acetylheptanoate,246-157-0,24317-94-0,Not Classified,Notified C&L,88,Not classified:88
105962,"9-fluoro-11β,17,21-trihydroxy-16α-methylpregna-1,4-diene-3,20-dione 21-(3,3-dimethylbutyrate)",246-389-2,24668-75-5,Acute Tox. 4;Repr. 1B;STOT RE 2;Aquatic Chronic 1,Notified C&L,17,H373:17;H360:17;H332:17;H410:17
105963,Oxybis(1-methylethylene) tetraphenyl diphosphite,279-498-9,80584-85-6,Not Classified,Notified C&L,6,Not classified:4;H319:2;H315:2
105964,"dinex (ISO);2-cyclohexyl-4,6-dinitrophenol",205-042-5,131-89-5,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H301:0;H331:0;H400:0;H311:0;H410:0
105969,sec-butyl 3-methyl-2-butenethioate,251-938-4,34322-09-3,Not Classified,Notified C&L,88,Not classified:88
105971,"Fatty acids, C5-9, esters with pentaerythritol",270-290-3,68424-30-6,Not Classified,Notified C&L,449,Not classified:449
105972,"5-[(3-carboxy-5-methyl-4-oxo-2,5-cyclohexadien-1-ylidene)[4-(dimethylamino)phenyl]methyl]-3-methylsalicylic acid",245-497-7,23216-52-6,Not Classified,Notified C&L,8,Not classified:8
105973,"2'-anilino-6'-[ethyl(p-tolyl)amino]-3'-methylspiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one",261-618-6,59129-79-2,Not Classified,Notified C&L,7,Not classified:7
105974,Benzathine benzylpenicillin,216-260-5,1538-09-6,Acute Tox. 4;Resp. Sens. 1,Notified C&L,45,H334:43;H302:43;H317:3;H341:1;Not classified:1
105977,"Benzenamine, 2-bromo-6-fluoro-4-methyl-",605-996-6,18349-09-2,Acute Tox. 4;Skin Corr. 1B,Notified C&L,38,H314:38;H302:38
105981,"N,N-bis(2-hydroxyethyl)isooctadecan-1-amide",258-193-4,52794-79-3,Not Classified,Notified C&L,36,Not classified:36
105983,Quinolin-3-ol,209-456-7,580-18-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,4,H315:4;H302:3;H335:3;H319:4;H332:2;H312:2
105984,"2,2'-(1,3,4-oxadiazole-2,5-diyl)bis[1-aminoanthraquinone]",258-029-1,52591-25-0,Not Classified,Notified C&L,15,Not classified:15
105985,3-Bromo-N-methylaniline,613-950-1,66584-32-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H315:2;H302:2;H335:2;H319:2;H332:2;H312:2
105986,"D-chiro-Inositol, 3-O-[2-amino-4-[(carboxyiminomethyl)amino]-2,3,4,6-tetradeoxy-α-D-arabino-hexopyranosyl]-, hydrochloride (1:1)",606-307-1,19408-46-9,,Notified C&L,45,Not classified:45
105987,"Rosemary, Rosmarinus officinalis, ext., sulfurized, gold salt",307-516-8,97660-08-7,Not Classified,Notified C&L,1,Not classified:1
105993,"2,3-naphthylenediamine",212-241-0,771-97-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H302:44;H335:44;H332:4;H312:4;H351:1;H350:1
105995,N-(aminocarbonyl)benzenesulphonamide,252-441-5,35207-08-0,Acute Tox. 4,Notified C&L,38,H302:38
105996,Iron succinate,233-082-3,10030-90-7,Not Classified,Notified C&L,1,Not classified:1
105997,Benzoylformic acid,210-278-7,611-73-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:46;H315:46;H335:45;H302:1
105998,3-ethyl-2-[3-(3-ethyl-3H-benzothiazol-2-ylidene)-2-methylprop-1-enyl]benzothiazolium iodide,221-317-2,3065-79-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H312:38;H332:38;H302:38
105999,sodium benzoyloxybenzene-4-sulfonate,405-450-5,66531-87-1,Skin Sens. 1,Harmonised C&L,0,H317:0
106000,"3,3'-[(2-chloro-5-methyl-p-phenylene)bis[imino(1-acetyl-2-oxoethylene)azo]]bis[4-chloro-N-[2-(4-chlorophenoxy)-5-(trifluoromethyl)phenyl]benzamide]",279-356-6,79953-85-8,Not Classified,REACH registration C&L,182,Not classified:182
106001,2-fluorobenzoyl chloride,206-887-2,393-52-2,Skin Corr. 1B;STOT SE 3,Notified C&L,50,H314:50;H335:42;H318:1;H290:1
106003,HSY-2701,446-420-1,,Not Classified,Notified C&L,9,Not classified:9
106004,Yohimbine hydrochloride,200-600-4,65-19-0,Acute Tox. 2;Acute Tox. 3;Acute Tox. 3,Notified C&L,112,H300:97;H311:107;H331:109;H301:14;H372:9;H330:1;H373:1
106007,Diethyl fumarate,210-819-7,623-91-6,Acute Tox. 4,Notified C&L,315,H302:309;H318:41;H315:41;H335:41;H373:22;Not classified:6;H371:2;H317:2;H312:2;H332:2;H334:1
106008,"Methyl 2,3,4,5-tetrachloro-6-cyanobenzoate",226-344-3,5358-06-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,88,H319:83;H411:83;H315:83;H317:83;Not classified:5
106010,Lazurite,215-111-1,1302-83-6,Not Classified,Notified C&L,127,Not classified:127
106011,"1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one",220-781-3,2898-08-0,,Notified C&L,2,H319:2;H315:2;H335:2;H302:1;H332:1;H312:1
106012,"5-(diisopropylamino)-2-[[4-(dimethylamino)phenyl]azo]-3-methyl-1,3,4-thiadiazolium methyl sulphate",281-589-3,83969-12-4,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,39,H373:2;H318:38;H315:2;H301:39;H400:36;H317:2;H410:36;H411:3
106013,C.I. Disperse Blue 73,602-263-2,12222-78-5,Not Classified,Notified C&L,4,Not classified:4
106014,"Benzene, mono-C15-36-branched alkyl derivs., C24-rich",290-544-7,90171-05-4,Aquatic Chronic 4,Notified C&L,63,H413:63
106018,Zirconium ditelluride,250-988-4,32321-65-6,,Notified C&L,4,H332:4;H302:4
106019,"1-(2-chloroimidazo[[]1,2-a]pyridin-3-ylsulphonyl)-3-(4,6-dimethoxypyrimidin-2-yl)urea",602-788-7,122548-33-8,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,157,H400:157;H410:157
106020,"1-[2,4-dichloro-beta-[(5-bromo-2-chloro-3-thenyl)-oxy]phenethyl]imidazole; hydrochloride",925-330-0,,Acute Tox. 4;Skin Sens. 1;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H302:2;H361:2;H400:2;H317:2;H410:2
106023,Piperazine-1-carbaldehyde,231-813-0,7755-92-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,45,H318:39;H315:44;H302:39;H335:43;H319:5;Not classified:1
106027,3-[[2-[(2-aminoethyl)amino]ethyl]amino]propiononitrile,227-280-9,5760-73-6,Not Classified,Notified C&L,1,Not classified:1
106029,Lanosterol,201-214-9,79-63-0,Not Classified,Notified C&L,1,Not classified:1
106032,"1H-Pyrazole-5-carboxamide,4-amino-1-methyl-3-propyl-, hydrochloride",607-432-4,247584-10-7,Not Classified,Notified C&L,2,Not classified:2
106033,"Hydropolysulfide, carbonothioylbis-, disodium salt",603-285-5,128578-22-3,Aquatic Chronic 3,Notified C&L,21,H412:21
106034,diammonium tetrachloroplatinate,237-499-1,13820-41-2,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0,H318:0;H315:0;H301:0;H317:0;H334:0
106035,Cationic hydroxyethyl cellulose,618-826-0,92183-41-0,Not Classified,Notified C&L,104,Not classified:89;H411:15
106036,6-Fluorochromone-2-carboxylic Acid,619-404-9,99199-59-4,,Notified C&L,6,H319:6;H315:6;H335:5
106037,o-(trifluoromethyl)phenylthiourea,217-084-1,1736-71-6,,Notified C&L,6,H301:4;H319:2;H315:2;H335:2;H302:1;H332:1;H312:1
106038,Platinum tetrabromide,273-151-5,68938-92-1,,Notified C&L,4,H314:4
106039,(carboxymethyl)trimethylammonium D-glucuronate,252-025-3,34437-34-8,Not Classified,Notified C&L,1,Not classified:1
106040,Vitamin E,215-798-8,1406-18-4,Not Classified,Notified C&L,190,Not classified:189;H319:1;H315:1
106044,"Naphthalene-1,3,6-trisulphonic acid, sodium salt",243-068-9,19437-42-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
106050,(Z)-1-bromooctadec-9-ene,228-074-1,6110-53-8,Acute Tox. 4,Notified C&L,38,H302:38
106052,"Alkenes, C>10 α-, oxidized, calcium salts",271-252-9,68527-07-1,Not Classified,Notified C&L,33,Not classified:33
106053,"Acetic acid, 2-chloro-, dodecyl ester",613-168-0,6316-04-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,2,H319:2;H315:2;H302:2
106055,3-(Hydroxymethyl)-1-hexene,605-987-7,1830-48-4,Flam. Liq. 3,REACH registration C&L,2,H226:2;H314:1;H302:1
106056,"Fatty acids, C18-unsatd., dimers, compds. with coco alkylamines",614-682-8,68647-95-0,Skin Irrit. 2;Skin Sens. 1B;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,73,H373:23;H315:45;H400:23;H317:45;H410:23;H412:50
106057,"reaction mass of: 3,7,11-trimethyl-cis-6,10-dodecadienal;3,7,11-trimethyl-trans-6,10-dodecadienal",425-910-9,32480-08-3,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H315:0;H400:0;H410:0
106059,"2,3,5-triiodobenzoic acid",201-859-6,88-82-4,Acute Tox. 4,Notified C&L,45,H302:45;H319:6;H315:6;H335:5;H332:1;H312:1
106060,Diphenylpyraline,205-686-7,147-20-6,,Notified C&L,1,H302:1
106062,3-phenoxypropionyl chloride,248-961-7,28317-96-6,Acute Tox. 4;Skin Corr. 1B;STOT SE 3,Notified C&L,1,H314:1;H302:1;H335:1
106065,(±)-menthyl acetate,249-409-8,29066-34-0,Aquatic Chronic 2,Notified C&L,315,H411:315
106068,Ammonium sodium vanadium oxide,254-463-0,39455-80-6,Acute Tox. 3;Eye Irrit. 2;Acute Tox. 3;Repr. 2;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,5,H372:1;H301:3;H361:1;H319:4;H331:1;H411:1;H315:3;H335:3;H332:2;Not classified:1;H330:1;H300:1
106070,4-(trifluoromethyl)benzylic alcohol,206-494-6,349-95-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H315:47;H335:45
106071,"1-Butanesulfonic acid, 4-hydroxy-",608-029-6,26978-64-3,,Notified C&L,1,H314:1
106072,"Distillates (petroleum), light hydrocracked;Cracked gasoil;[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C",265-078-2,64741-77-1,Carc. 2,Harmonised C&L,0,H351:0
106085,Lithium stearate,224-772-5,4485-12-5,Not Classified,REACH registration C&L,222,Not classified:222
106087,4-morpholinoacetophenone,254-698-9,39910-98-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
106088,"trans,trans-4-((E)-propen-1-yl)-4'-propyl-bicyclohexane",608-148-3,279246-65-0,Not Classified,REACH registration C&L,1,Not classified:1
106089,"3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodec-1-ene",244-503-5,21652-58-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44;H302:1;H332:1;H312:1;H226:1
106090,N-(2-methoxyphenyl)acetamide,202-233-5,93-26-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H302:39;H335:38
106091,"reaction mass of: 4-[[bis-(4-fluorophenyl)methylsilyl]methyl]-4H-1,2,4-triazole;1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H-1,2,4-triazole",403-250-2,,Acute Tox. 4;Carc. 2;Aquatic Chronic 2;Repr. 1B,Harmonised C&L,0,H351:0;H360:0;H302:0;H411:0
106093,[[2-Methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]acetic acid,602-947-0,123599-82-6,Eye Irrit. 2,Notified C&L,1,H319:1
106097,"Poly(oxy-1,2--ethanediyl), .alpha.-sulfo-.omega.-[4-nonyl-2-(1-propenyl)phenoxy]-,branched, ammonium salts",604-803-2,151574-14-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,15,H319:15;H315:15
106098,2-(4-amino-3-nitroanilino)ethanol,246-521-9,24905-87-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,5,H319:4;H315:4;H317:2;H335:1;H302:1
106101,"Fatty acids, lard",294-983-5,91771-87-8,Not Classified,Notified C&L,1,Not classified:1
106102,"Benzenamine, 4-iodo-2,6-dimethyl-",473-420-9,,Aquatic Chronic 2,REACH registration C&L,1,H411:1
106105,"[(2-Hydroxyethylsulfamoyl)(sulfamoyl)sulfophthalocyaninato]copper(II),mixed isomers, sodium salt",428-120-2,,Eye Dam. 1,Notified C&L,1,H318:1
106106,"1-[2-[(2-chlorothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole; sulfate (2:1)",928-355-5,,Acute Tox. 4;Skin Sens. 1;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H302:2;H361:2;H400:2;H317:2;H410:2
106110,"2,3-Difluor-1-propoxy-4-[trans-4-(trans-4-propylcyclohexyl)- cyclohexyl]-benzene",610-336-5,473257-14-6,Not Classified,REACH registration C&L,1,Not classified:1
106112,Lactulose,225-027-7,4618-18-2,Not Classified,Notified C&L,9,Not classified:9
106115,Propyl acrylate,213-120-5,925-60-0,,Notified C&L,5,H319:5;H315:5;H226:5;H335:5;H411:1
106118,α-phenyl-1H-benzimidazole-2-methanol,200-073-0,50-97-5,Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,1,H412:1;H317:1
106119,"4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octane",421-750-9,57280-22-5,Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H319:0;H317:0
106122,2-(ethoxymethyl)oxolane,423-630-1,,Skin Corr. 1B;Repr. 2,REACH registration C&L,3,H319:3;H314:3;H361:3;H226:3
106123,"Calcium bis(dodecylbenzenesulphonate), branched",274-654-2,70528-83-5,Skin Irrit. 2;Eye Dam. 1,Notified C&L,294,H318:231;H315:232;H411:77;Not classified:62;H302:35;H319:1;H412:1
106124,3-chloro-2-(chloromethyl)-2-methylpropionic acid,266-644-1,67329-11-7,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H318:38;H314:38
106128,"Distillates (coal tar), pitch;Heavy Anthracene Oil;[The oil obtained from condensation of the vapors from the heat treatment of pitch. Composed primarily of two- to four-ring aromatic compounds boiling in the range of 200 °C to greater than 400 °C (392 °F to greater than 752 °F).]",309-855-7,101316-49-8,Carc. 1B,Harmonised C&L,0,H350:0
106130,"1H-Imidazole, 4,5-dihydro-, 2-nortall-oil alkyl derivs.",263-169-1,61791-36-4,Skin Corr. 1B,Notified C&L,22,H314:20;H319:1;H315:1;Not classified:1
106134,"2,4,6-tris(2-pyridyl)-s-triazine",222-965-9,3682-35-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44;H302:1;H332:1;H312:1
106136,3-nitrobenzenesulphonyl chloride,204-476-2,121-51-7,Skin Corr. 1B,Notified C&L,57,H314:57;H318:1;H290:1
106139,2-butyl-3-methylpyrazine,240-126-5,15987-00-5,Not Classified,Notified C&L,90,Not classified:90
106144,Theophyllin-7-ylacetic acid,211-490-2,652-37-9,Not Classified,REACH registration C&L,63,Not classified:11;H319:50;H315:50;H335:49;H302:10
106145,3-(2-chloro-6-fluorophenyl)-5-methylisoxazole-4-carboxylic acid,223-486-8,3919-74-2,,Notified C&L,6,H319:5;H315:5;H335:5;H302:1
106148,Triphenylbismuth,210-033-4,603-33-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,47,H312:41;H332:41;H302:45;H373:2;H319:1;H315:1;Not classified:1
106150,"Extracts, coal tar oil alk.;Alkaline Extract;[The extract from coal tar oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]",266-017-2,65996-83-0,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
106152,2-(benzylmethylamino)ethyl acetoacetate,259-197-9,54527-65-0,Not Classified,REACH registration C&L,3,Not classified:1;H319:2;H315:2;H302:2;H335:2
106156,"Betaines, coco alkyldimethyl",270-329-4,68424-94-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,611,H318:541;H315:589;H319:57;H400:42;Not classified:6;H412:5;H314:4
106158,"Humic acids, sodium salts",268-608-0,68131-04-4,Not Classified,REACH registration C&L,117,Not classified:116;H315:1;H317:1
106164,(R)-3-Aminopentaneitrile,639-991-5,400090-60-0,Eye Dam. 1;Acute Tox. 4,Notified C&L,34,H318:34;H332:34
106168,"1-deoxy-1-(methylamino)-D-glucitol 3-(acetylamino)-5-(acetylmethylamino)-2,4,6-triiodobenzoate",230-641-3,7241-11-4,Skin Sens. 1,Notified C&L,38,H317:38
106169,3-Aminophenylacetic acid,604-350-0,14338-36-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:40
106171,"Sulfuric acid, reaction products with aniline, aniline hydrochloride and nitrobenzene, sodium salts",309-930-4,101357-32-8,Not Classified,Notified C&L,111,Not classified:103;H319:6;H334:2;H317:2;H312:2;H332:2;H302:2
106172,[(methylethylene)bis(oxy)]dipropanol,246-466-0,24800-44-0,Not Classified,REACH registration C&L,1113,Not classified:662;H319:451;H315:451;H335:450
106174,"Formaldehyde, oligomeric reaction products with aniline and phosgene",500-079-6,32055-14-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,REACH registration C&L,191,H373:182;H315:191;H335:191;H319:191;H351:182;H332:191;H317:191;H334:191
106175,"Hydrogen [4-[[4-(diethylamino)-o-tolyl][4-[ethyl(3-sulphonatobenzyl)amino]phenyl]methylene]cyclohexa-2,5-dien-1-ylidene](ethyl)(3-sulphonatobenzyl)ammonium, sodium salt",227-511-3,5863-46-7,Aquatic Chronic 2,REACH registration C&L,18,H411:11;Not classified:7
106180,"Fatty acids, C12-20 and C12-20-unsatd., sodium salts",292-860-0,91001-86-4,Not Classified,Notified C&L,1,Not classified:1
106181,"Bis[[2-(3,5-dihydroxyphenyl)-2-oxoethyl]isopropylammonium] sulphate",303-491-2,94200-15-4,Not Classified,Notified C&L,1,Not classified:1
106182,"Dichloro[(1,2,5,6-η)-cycloocta-1,5-diene]platinum",235-144-5,12080-32-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H315:48;H335:46;H302:2;H332:2;H312:2;H413:1;H317:1;H334:1;H228:1
106188,"Dihydrogen 3-[[4-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-2-sulphonatophenyl]amino]-7-[ethyl[(3-sulphonatophenyl)methyl]amino]-5-(4-methoxy-3-sulphonatophenyl)phenazinium, disodium salt",281-347-7,83929-55-9,Not Classified,Notified C&L,1,Not classified:1
106190,"Rosin, reaction products with triethanolamine",268-070-7,68002-57-3,Not Classified,Notified C&L,13,Not classified:13
106194,4-hydroxy-3-methoxybenzyl alcohol,207-852-4,498-00-0,Not Classified,Notified C&L,136,Not classified:80;H319:56;H315:55;H335:54
106199,"1,4-dithiane",208-007-2,505-29-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:41;H335:41
106203,4-butoxybenzoyl chloride,251-703-6,33863-86-4,Skin Corr. 1B;STOT SE 3,Notified C&L,42,H314:42;H335:38
106209,"Phenol, 2,4-dinitro-, sulfurized, leuco derivatives",266-273-5,66241-11-0,Not Classified,REACH registration C&L,62,Not classified:62
106215,3-(butylphenylamino)propiononitrile,263-275-8,61852-40-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H315:1;H302:1;H319:1;H332:1;H312:1
106223,"1,10-diiododecane",240-415-6,16355-92-3,Not Classified,REACH registration C&L,45,Not classified:2;H319:43;H315:43;H335:42
106226,[trans(trans)]-4-(4-pentylcyclohexyl)-4'-(4-propylcyclohexyl)biphenyl,279-636-8,80955-71-1,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
106232,5-bromo-4-chloroindol-3-yl-β-D-galactopyranoside,230-640-8,7240-90-6,,Notified C&L,10,H312:8;H332:8;H302:8;Not classified:2
106236,"Benzenesulfonic acid, dodecyl-, compd. with 1,1'-iminobis[2-propanol] (1:1)",614-005-6,66989-21-7,,Notified C&L,1,Not classified:1
106237,"Stannane, dioctyl-, bis(coco acyloxy) derivs.",293-901-5,91648-39-4,Repr. 2;STOT RE 1;Aquatic Chronic 4,Notified C&L,1,H372:1;H413:1;H361:1
106241,"4-amino-2,6-dichlorophenol",227-671-4,5930-28-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44;H302:1
106242,2-methylquinoline,202-085-1,91-63-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Muta. 2;Aquatic Chronic 3,REACH registration C&L,375,H315:10;H302:375;H412:5;H319:334;H312:375;H341:6;H335:4;H371:1
106243,"4-amino-5-hydroxynaphthalene-2,7-disulphonic acid",201-975-7,90-20-0,Not Classified,REACH registration C&L,45,Not classified:2;H314:39;H319:4;H315:4;H335:4
106249,Cyproheptadine hydrochloride,213-535-1,969-33-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 2,Notified C&L,98,H315:97;H302:53;H335:95;H361:52;H319:97;H301:44;Not classified:1
106250,1-(cyanoacetyl)pyrrolidine,238-096-3,14227-95-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,43,H312:38;H332:38;H302:43;H319:5;H315:5;H335:5
106254,Bis(η6-benzene)chromium,215-042-7,1271-54-1,Flam. Sol. 1,Notified C&L,42,H228:38;H250:4;H252:4
106255,4-hydroxy-3-nitrosonaphthalene-1-sulphonic acid,222-964-3,3682-32-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;STOT RE 2,Notified C&L,43,H312:39;H373:38;H332:39;H302:39;H319:5;H315:5;H335:4
106257,"[1,3,8,10-tetrahydro-1,3,8,10-tetraoxoanthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-2,9-diyl]di-m-phenylene bis(thiocyanate)",267-761-0,67923-45-9,Not Classified,Notified C&L,6,Not classified:6
106258,4-chloro-γ-(1-methylethoxy)benzenebutyronitrile,230-095-6,6940-91-6,Acute Tox. 4,Notified C&L,38,H302:38
106263,1-Methyl-1H-pyrazol-5-ol,608-897-6,33641-15-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,45,H318:38;H315:40;H302:38;H335:38;Not classified:5;H319:2
106274,Bis(3-methoxybutyl) peroxydicarbonate,257-773-4,52238-68-3,Flam. Liq. 2;Org. Perox. D;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 2;STOT RE 2,Notified C&L,2,H373:2;H315:2;H336:2;H225:2;H304:2;H361:2;H319:2;H242:2
106277,Trifluorooxovanadium,237-250-7,13709-31-4,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,Notified C&L,43,H318:38;H302:38;H314:43;H332:38;H312:38;H301:5;H330:4;H311:5;H331:1
106282,4-Ethyl-3'-fluorbiphenyl,918-150-9,,Not Classified,REACH registration C&L,1,Not classified:1
106285,"4,5-diaminopyrimidine",237-339-0,13754-19-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,64,H319:64;H315:64
106288,"thionyl chloride, reaction products with 1,3,4-thiadiazol-2,5-dithiol, tert-nonanethiol and C",404-820-3,,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H315:0;H317:0
106291,"Waste solids, cerium mischmetal-manufg.",284-897-6,84989-08-2,Not Classified,Notified C&L,2,Not classified:2
106293,3-methylcyclopentadecan-1-ol,263-436-2,62151-56-8,Not Classified,Notified C&L,88,Not classified:88
106302,Oleic anhydride,246-522-4,24909-72-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,83,H319:60;H315:60;H335:59;Not classified:23
106304,Aminomethanesulphonic acid,237-649-6,13881-91-9,Skin Corr. 1B,Notified C&L,44,H314:44;H318:1
106306,"diethyl [2-(2,4-difluorophenyl)prop-2-en-1-yl]malonate",619-693-1,159276-62-7,Not Classified,REACH registration C&L,2,Not classified:2
106307,"29H,31H-Phthalocyanine, 1,8,15,22-tetrakis(3-methyl-1-piperidinyl)-",606-777-8,214710-35-7,Aquatic Chronic 4,Notified C&L,84,H413:83;Not classified:1
106312,Tridecan-1-yl dihydrogen phosphate,225-850-1,5116-94-9,Skin Corr. 1C;Eye Dam. 1,Notified C&L,452,H318:445;H314:445;Not classified:7
106314,C.I. Acid Black 168,602-710-1,12238-87-8,Not Classified,Notified C&L,1,Not classified:1
106315,"2,3-diethyl-5-methylpyrazine",242-024-6,18138-04-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1451,H312:1287;H332:1287;H302:1287;Not classified:89;H319:75;H315:75;H335:74;H226:1
106321,azido(trioctyl)stannane,604-973-8,154704-56-0,Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H300:2;H400:2;H410:2
106325,"2-ethylhexyl 3,5,5-trimethylhexanoate",275-073-7,70969-70-9,STOT RE 2,REACH registration C&L,8,H373:5;Not classified:3
106328,(3-Chloro-4-fluoro-phenyl)-{6-nitro-7-[(S)-(tetrahydro-furan-3-yl)oxy]-quinazolin-4-yl}-amine,925-395-5,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
106329,Titanium carbide,235-120-4,12070-08-5,Not Classified,REACH registration C&L,25,Not classified:18;H228:7
106332,Vanadium tetrahydroxide,248-401-1,27318-03-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H315:1;H332:1;H302:1
106335,"Fatty acids, C8-18 and C18-unsatd., magnesium salts",267-011-2,67762-33-8,Not Classified,Notified C&L,1,Not classified:1
106339,"Exo-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl propionate",220-410-5,2756-56-1,Not Classified,REACH registration C&L,297,Not classified:259;H319:38;H315:38;H335:38
106340,N-(N-glycylglycyl)glycine,209-122-0,556-33-2,Not Classified,Notified C&L,2,Not classified:1;H318:1;H314:1;H400:1;H317:1
106342,Methyl propiolate,213-083-5,922-67-8,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,53,H225:53;H315:52;H319:52;H335:50
106346,α-methylpiperazine-1-ethanol,214-042-4,1074-54-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
106350,Nitrocyclopentane,219-884-6,2562-38-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:39;H315:39;H335:39;H332:5;H302:5;H312:1
106352,Bismuth manganese oxide (BiMn2O5),602-494-9,12232-96-1,Not Classified,Notified C&L,2,Not classified:2
106353,(oxan-4-yl)methanol,604-599-5,14774-37-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H319:3;H315:3;H335:2;Not classified:1
106354,"3,4-dihydroxyphenethylmethylammonium chloride",200-528-3,62-32-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
106355,4-amino-2-nitrophenol,204-316-1,119-34-6,Acute Tox. 4,Notified C&L,46,H302:46;H318:6;H315:6;H335:5;H312:4;H341:5;H411:1
106365,4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide,448-010-8,,Repr. 2;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,1,H373:1;H411:1;H361:1
106366,"1,1,3,3-tetramethylbutyl peroxyneodecanoate",257-077-0,51240-95-0,Org. Perox. D;Asp. Tox. 1;Skin Irrit. 2;Repr. 1B,REACH registration C&L,6,H242:6;H304:2;H315:6;H360:2
106367,"1,4-bis(mesitylamino)anthraquinone",204-155-7,116-75-6,Not Classified,REACH registration C&L,2417,Not classified:2417
106375,2-Chloro-5-fluorobenzyl Bromide,617-259-6,81778-09-8,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,40,H225:39;H314:40;H318:1;H290:1
106378,N2-trityl-L-arginine,253-943-7,38453-62-2,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H301:38;H315:38;H319:38;H335:38
106380,"3,5-difluoroaniline",206-752-8,372-39-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,46,H312:41;H332:41;H302:45;H373:4;H315:7;H319:7;H331:5;H311:5;H335:2;H301:1
106382,"Protein hydrolyzates, liver",293-485-5,91079-94-6,Not Classified,Notified C&L,1,Not classified:1
106383,Aluminium selenide,215-110-6,1302-82-5,,Notified C&L,4,H373:4;H301:4;H331:4;H400:4;H410:4
106385,4-methyl-N-(methylsulfonyl)benzenesulfonamide,415-040-8,14653-91-9,Acute Tox. 4;Eye Dam. 1;STOT SE 3,Harmonised C&L,0,H318:0;H302:0;H335:0
106387,"disodium 4-[2-(2,4-dichlorophenoxy)acetamido]-5-hydroxy-6-{(E)-[2-(2-methylphenoxy)phenyl]diazenyl}naphthalene-1,7-disulfonate",435-970-8,,Eye Dam. 1,REACH registration C&L,1,H318:1
106389,"7-chloro-2,3-dihydro-1-methyl-5-phenyl-1H-benzo-1,4-diazepine monohydrochloride",220-782-9,2898-11-5,Acute Tox. 4;STOT SE 3;Repr. 2;Lact.,REACH registration C&L,2,H362:2;H336:2;H361:2;H302:2
106390,2-methoxybenzoyl chloride,244-477-5,21615-34-9,Skin Corr. 1B;STOT SE 3,Notified C&L,45,H314:45;H335:38;H318:1;H290:1
106391,Bis[(p-aminophenyl)dimethylammonium] oxalate,263-723-2,62778-12-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H315:40;H302:38;H335:38;H319:40;H332:38;H317:38;H312:38;H300:2
106393,"1,3,5-tri(2-furyl)-2,4-diazapenta-1,4-diene",207-790-8,494-47-3,Acute Tox. 4,Notified C&L,38,H302:38
106396,1'-acetonaphthone,213-384-1,941-98-0,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,332,H412:283;H302:332;H317:233;H319:41;H315:77;H335:39;H413:1
106398,"α,α,α,4-tetrafluoro-o-toluidine",206-886-7,393-39-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H315:47;H302:47;H335:42;H319:47;H332:47;H312:43;H311:4;H227:1;H412:1;H402:1
106400,Butoxydibutylchlorostannane,238-131-2,14254-22-9,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,13,H301:13;H318:13;H315:13;H335:13
106401,N-(2-hydroxy-5-methylphenyl)acetamide,228-934-6,6375-17-3,Eye Irrit. 2,Notified C&L,44,H319:44;H315:5;H335:4
106408,Bambermycin,234-246-7,11015-37-5,Aquatic Chronic 4,Notified C&L,1,H413:1
106410,"Beeswax, ext.",293-377-8,91078-93-2,Flam. Liq. 3,Notified C&L,114,H226:87;Not classified:27
106413,"Tetrasodium 6,13-dichloro-3,10-bis[[4-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]sulphonatophenyl]amino]triphenodioxazinedisulphonate",272-521-3,68867-63-0,Not Classified,Notified C&L,1,Not classified:1
106419,"Lupine, L. albus, ext.",282-001-8,84082-55-3,Not Classified,REACH registration C&L,23,Not classified:23
106420,"Alcohols, C12-18, distn. residues",271-643-4,68603-16-7,Not Classified,Notified C&L,33,Not classified:33
106423,"Fatty acids, tallow, calcium lithium salts",307-955-5,97808-36-1,Not Classified,Notified C&L,1,Not classified:1
106424,"Poly(oxy-1,2-ethanediyl), alpha-phenyl-omega-hydroxy-, phosphate",609-691-9,39464-70-5,Eye Irrit. 2,REACH registration C&L,86,H319:1;H318:84;H315:83;H314:1
106431,"Benzene-1,2,4-triyltriamine dihydrochloride",210-428-1,615-47-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H302:43;H335:43;H332:1;H312:1
106432,"Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, chlorosulfonyl derivs., reaction products with 2-[(4-aminophenyl)amino]-5-nitrobenzenesulfonic acid, sodium salts",277-403-5,73378-63-9,Not Classified,REACH registration C&L,51,Not classified:10;H412:39;H319:2;H413:2
106435,3-CYCLOPENTENE-1-CARBOXYLIC ACID,616-404-0,7686-77-3,,Notified C&L,8,H319:6;H315:7;H335:6;H318:1;H290:1;H314:1
106436,Lead acetate,239-379-4,15347-57-6,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,83,H373:83;H360:83;H302:83;H400:83;H332:83;H410:83
106440,Thiotepa,200-135-7,52-24-4,Acute Tox. 2;Carc. 1B,Notified C&L,51,H350:51;H300:50;H315:10;H360:11;H340:13;H335:10;H319:10;H361:2;H330:1;H310:1;H317:1;H334:1;H301:1;H331:1;H311:1
106441,2-butyloctanoic acid,248-570-1,27610-92-0,Not Classified,REACH registration C&L,55,Not classified:3;H319:39;H315:39;H335:39;H412:13
106442,4-isopropylbenzoic acid,208-642-5,536-66-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:45;H302:2;H332:2;H312:2
106446,"Sulphurous acid, gold sodium salt",249-098-9,28600-35-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
106447,"Phenol, 4,4'-(1-methylethylidene)bis[2,6-dibromo-, polymer with 2,2'-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bis[oxirane]",608-684-8,31942-06-0,,Notified C&L,1,H319:1;H411:1;H315:1;H317:1
106449,N-ethyltetrahydrofurfurylamine,230-543-0,7179-86-4,Flam. Liq. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H315:1;H335:1;H227:1
106452,1-(2-aminoethyl)imidazolidin-2-one,228-491-9,6281-42-1,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,447,H318:445;H314:445;H317:442;H319:1;H315:2;H335:2
106454,"(2,4,6-trioxotriazine-1,3,5(2H,4H,6H)-triyl)tris(methyl-m-phenylene) isocyanate",247-840-6,26603-40-7,Skin Sens. 1;Eye Irrit. 2,Notified C&L,59,H319:25;H317:54;Not classified:5
106456,"6-Bromo-4,4-dimethylthiochroman",601-162-0,112110-44-8,Aquatic Chronic 4,Notified C&L,3,H413:3
106458,3-(2-furyl)methacrylaldehyde,212-866-9,874-66-8,Acute Tox. 4,Notified C&L,1636,H302:1598;H318:38;H315:42;H335:42;H319:4
106461,"2,5-dimethoxybenzoyl chloride",241-863-5,17918-14-8,Skin Corr. 1B,Notified C&L,1,H314:1
106462,"α,α,α-trifluoro-o-cresol",207-148-7,444-30-4,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3,Notified C&L,79,H318:39;H315:41;H302:42;H335:40;H332:42;H312:42;H228:38;Not classified:33;H314:5;H319:2;H301:1;H331:1;H311:1
106463,"2-chloro-3,5-dinitropyridine",219-937-3,2578-45-2,Acute Tox. 2,Notified C&L,54,H300:52;H319:8;H315:8;H335:6;H332:1;H312:1;H301:2;H331:1;H311:1
106464,3-methyl-2-pentylcyclopent-2-enone,214-434-5,1128-08-1,Eye Irrit. 2,Notified C&L,1634,H319:1288;Not classified:346;H315:1
106466,m-nitrobenzenesulphonamide,204-477-8,121-52-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39;H302:1
106475,"2,4,6-trihydroxybenzoic acid",201-467-5,83-30-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
106476,"Resin acids and Rosin acids, fumarated, compds. with triethanolamine",293-625-5,91081-22-0,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 4,REACH registration C&L,6,H319:2;H413:2;H317:2;Not classified:4
106478,"3,3',3'',5,5',5''-hexa-tert-butyl-α,α',α''-(mesitylene-2,4,6-triyl)tri-p-cresol",216-971-0,1709-70-2,Not Classified,REACH registration C&L,436,Not classified:183;H413:156;H312:56;H412:55;H319:41;H315:41;H302:46;H335:41;H332:1
106479,"1,1,2,2-tetrafluoro-2-[1,2,2-trifluoro-1-(trifluoromethyl)-2-[(trifluorovinyl)oxy]ethoxy]ethanesulphonyl fluoride",240-249-4,16090-14-5,,Notified C&L,3,Not classified:2;H336:1
106481,"3,6-diazaoctane-1,8-diamine tetrahydrochloride",225-604-3,4961-40-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 2,Notified C&L,40,H319:40;H351:38;H315:40;H335:38;H361:1
106482,"(2β,3α,5α,16β,17β)-2,16-dipiperidin-1-ylandrosta-3,17 diol",236-866-3,13522-16-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
106488,diamminediisocyanatozinc,401-610-3,122012-52-6,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1;Aquatic Acute 1,Harmonised C&L,0,H318:0;H302:0;H400:0;H317:0;H334:0
106491,"2,6-dichloro-N-(2,6-dimethylphenyl)hexanamide",600-476-5,1037184-07-8,,Notified C&L,2,H228:1;H302:1;H319:1;H315:1;H335:1
106493,"α,α,β,β-tetrafluoro-m-methylphenetole",217-085-7,1737-10-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
106494,"1,2,3,4-tetrahydrocarbazole",213-385-7,942-01-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,134,H319:134;H315:134;H335:133
106497,"Carbamic acid, N-[(1S)-1-(2R)-2-oxiranyl-2-phenylethyl]-, 1,1-dimethylethyl ester",619-374-7,98760-08-8,Not Classified,Notified C&L,4,Not classified:3;H319:1;H316:1
106500,"3,3',3'',3'''-[[(3-hydroxypropyl)imino]bis(ethylenenitrilo)]tetrapropanol",243-069-4,19437-46-8,Not Classified,Notified C&L,1,Not classified:1
106504,"3-methoxyoestra-1,3,5(10)-trien-17-one",216-613-3,1624-62-0,Carc. 2;Repr. 1A;Lact.;Aquatic Chronic 1,REACH registration C&L,43,H362:2;H351:42;H360:2;H410:2;H312:39;H332:39;H302:40;H361:1
106506,3-({6-[(2-cyanoethyl)amino]hexyl}amino)propanenitrile,700-129-9,2004-62-8,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H318:1;H317:1
106507,Xipamide,238-216-4,14293-44-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:39;H315:39;H335:39;H302:7;H332:3;H312:2;H412:1;Not classified:1
106509,4-(2-Aminoethyl) benzenesulfonylfluoride hydrochloride,608-547-2,30827-99-7,Skin Corr. 1B,Notified C&L,58,H314:57;H318:3;H290:1;H319:1;H315:1;H335:1
106510,"Fatty acids, C5-10, esters with pentaerythritol",270-291-9,68424-31-7,Not Classified,REACH registration C&L,589,Not classified:589
106513,"6'-(diethylamino)-2'-[(dimethylphenyl)amino]-3'-methylspiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one",276-629-1,72389-80-1,Not Classified,Notified C&L,92,Not classified:85;H413:7
106518,Hexadecyl 2-ethylhexanoate,261-619-1,59130-69-7,Not Classified,REACH registration C&L,186,Not classified:186
106519,"3,3'-dimethoxybiphenyl-4,4'-ylenediammonium dichloride",243-737-5,20325-40-0,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Carc. 1B,REACH registration C&L,83,H350:82;H318:39;H314:39;H302:83;H351:1;H341:1
106520,"Oils, fish, hydrogenated",293-379-9,91078-95-4,Not Classified,Notified C&L,1,Not classified:1
106521,"L-aspartic acid, compound with L-arginine (1:1)",231-656-8,7675-83-4,Not Classified,Notified C&L,5,Not classified:4;H302:1
106523,PURAM,434-000-0,,,,0,No data
106526,"fatty acids, tall-oil, reaction products with iminodiethanol and boric acid",400-160-5,,Skin Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H315:0
106535,2-(6-Methoxy-naphthalen-2-yl)-propionyl chloride,610-612-5,51091-84-0,Eye Irrit. 2,Notified C&L,38,H319:38
106537,"(R*,R*)-(±)-2,3-dibromobutane-1,4-diol",217-750-1,1947-58-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
106538,"Extract oils (coal), coal tar residual pyrolysis oils, naphthalene oil, distn. residues;Redistillates;[Residue from the distillation of dephenolated and debased methylnaphthalene oil (from bituminous coal tar and pyrolysis residual oils) with a boiling range of 240°C to 260°C (464°F to 500°F). Composed primarily of substituted dinuclear aromatic and heterocyclic hydrocarbons.]",310-171-6,122070-80-8,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
106539,"2-[2-[4-(diethylammonio)phenyl]vinyl]-1,3,3-trimethyl-3H-indolium oxalate",281-588-8,83969-11-3,Acute Tox. 2;Eye Dam. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,3,H318:2;H330:2;H300:2;H400:2;H410:2;Not classified:1
106540,Fluorocyclohexane,206-754-9,372-46-3,,Notified C&L,7,H225:7;H315:1;H319:1;H335:1
106544,"Starch, polymer with 2-hydroxy-2-propenoic acid monosodium salt, graft",606-724-9,212080-59-6,Not Classified,Notified C&L,31,Not classified:31
106547,Diammonium tetrachloropalladate,237-498-6,13820-40-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H315:44;H302:40;H335:42;H319:43;H332:39;H312:39;H318:2;H290:1
106548,"4-isopropylamino-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one",222-791-3,3615-24-5,Not Classified,Notified C&L,1,Not classified:1
106553,"4,7-Octadienoic acid, methyl ester, (4E)-",422-840-0,189440-77-5,Not Classified,Notified C&L,36,Not classified:36
106559,2-(3-bromophenoxy)tetrahydro-2H-pyran,429-030-6,57999-49-2,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H317:0
106561,"Dodecene, hydroformylation products",271-251-3,68527-06-0,Skin Corr. 1B,Notified C&L,52,H314:52
106563,Bromo(1-methylpropyl)magnesium,213-081-4,922-66-7,Water-react. 1;Skin Corr. 1B,Notified C&L,26,H260:26;H314:26
106566,"Fatty acids, vegetable-oil, monoesters with sorbitan",307-493-4,97659-86-4,Not Classified,Notified C&L,5,Not classified:5
106567,Diphenhydramine hydrochloride,205-687-2,147-24-0,Acute Tox. 4,Notified C&L,274,H302:272;H332:2;H362:2;H351:1;H360:1;H315:2;H335:1;H361:2;H319:1;H317:1
106568,Zinc divalerate,209-124-1,556-38-7,Not Classified,Notified C&L,1,Not classified:1
106569,Floxuridine,200-072-5,50-91-9,Acute Tox. 3,Notified C&L,49,H301:47;H360:4;H341:5;H312:1;H332:1;H302:2;H315:1;H319:1;H331:1;H311:1
106570,Quinolin-7-ol,209-457-2,580-20-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,5,H319:5;H315:5;H335:4;H302:2;H332:2;H312:2
106572,Di(N-succinimidyl) glutarate,616-716-7,79642-50-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
106573,3-nitro-o-toluic acid,217-826-4,1975-50-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
106577,Cyclododecyl formate,261-575-3,59052-82-3,Not Classified,Notified C&L,89,Not classified:55;H319:34
106579,"(2R,4S,5R)-3-N-Boc-2-(4-methoxyphenyl)-4-phenyl oxazolidine-5-carboxylic acid",605-008-3,155396-69-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H315:1;H335:1;H301:1;H331:1;Not classified:1
106582,Scleroglucan,254-464-6,39464-87-4,Not Classified,Notified C&L,60,Not classified:60
106583,"N,N-dimethylbenzamide",210-279-2,611-74-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,47,H319:47;H315:47;H302:47;H335:44
106585,N-[4-(trifluoromethyl)phenyl]acetamide,206-495-1,349-97-3,Acute Tox. 4,Notified C&L,43,H302:42;H315:1;H335:1;H301:1;H319:1;H331:1;H311:1
106588,2-ethoxythiazole,239-760-5,15679-19-3,Flam. Liq. 3;Acute Tox. 4,Notified C&L,151,H302:113;H226:140;H319:39;H315:39;H335:39;H332:1;H312:1
106589,"Distillates (petroleum), heavy hydrocracked;Baseoil - unspecified;[A complex combination of hydrocarbons from the distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers in the range of C",265-077-7,64741-76-0,Carc. 1B,Harmonised C&L,0,H350:0
106591,"1,3-dichloro-2-isocyanatobenzene",254-699-4,39920-37-1,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,44,H315:44;H335:44;H301:43;H319:44;H331:39;H311:39;H330:5;H334:5;H300:1
106593,Tetrahydro-6-(2-pentenyl)-2H-pyran-2-one,252-148-2,34686-71-0,Not Classified,Notified C&L,89,Not classified:88;H319:1;H315:1;H335:1
106594,Trisodium arsenate,236-682-3,13464-38-5,Acute Tox. 3;Acute Tox. 3;Carc. 1A;Aquatic Chronic 1,Notified C&L,1,H301:1;H350:1;H331:1;H410:1
106599,"1,1´-Bicyclohexyl, 4-[[(trans-4-pentylcyclohexyl)oxy]methyl]-4´-propyl-, (trans,trans)-",608-149-9,279246-66-1,Aquatic Chronic 4,Notified C&L,2,H413:2;Not classified:1
106604,3-ethylhexahydro-3-(3-hydroxyphenyl)-1-methyl-2H-azepin-2-one,275-622-0,71556-74-6,Not Classified,Notified C&L,1,Not classified:1
106606,"N,N'-hexane-1,6-diylbis(aziridine-1-carboxamide)",218-877-5,2271-93-4,Acute Tox. 3,Notified C&L,1,H301:1
106608,Potassium butanolate,223-646-7,3999-70-0,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;STOT SE 3;STOT SE 3;STOT SE 3;STOT SE 3,REACH registration C&L,2,H318:2;H302:2;H226:1;H335:1;H336:1;H314:2;H228:1
106611,3-fluorophthalic anhydride,211-491-8,652-39-1,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H315:48;H317:47;H335:47;H334:8
106612,"2,4-dihydro-4-[(5-hydroxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)methylene]-5-methyl-2-phenyl-3H-pyrazol-3-one",224-037-9,4174-09-8,,Notified C&L,46,Not classified:46
106613,"2,5-dimethylbenzene-1,4-diamine",229-003-7,6393-01-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,71,H315:71;H302:71;H335:70;H319:71;H332:71;H312:71
106614,"4-[trans-4-(trans-4-butylcyclohexyl)-cyclohexyl]-1-ethoxy-2, 3-difluorobenzene",610-337-0,473257-15-7,Not Classified,REACH registration C&L,1,Not classified:1
106625,"(1R,2R)-trans-2-Benzyloxy-cyclohexylamine",606-810-6,216394-06-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,76,H319:38;H315:38;H302:38;H335:38;H301:33;H411:33;H314:38
106630,"Fatty acids, C14-18 and C16-22-unsatd., sodium salts",292-861-6,91001-87-5,Not Classified,Notified C&L,1,Not classified:1
106634,N-(p-chlorophenyl)-p-toluenesulphonamide,220-801-0,2903-34-6,Acute Tox. 4,Notified C&L,38,H302:38
106637,Hydrazine tartrate,211-211-4,634-62-8,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,1,H315:1;H301:1;H319:1;H331:1;H311:1
106640,N-HYDROXYMETHYL 2-TRIFLUOROMETHYLBENZAMIDE,619-482-4,895525-70-9,,Notified C&L,2,H319:1;H315:1;H335:1;Not classified:1
106644,"Benzenamine, N-phenyl-, octyl derivs.",274-653-7,70528-82-4,Aquatic Chronic 2,Notified C&L,441,H411:441
106647,Nω-nitro-L-arginine,218-418-9,2149-70-4,Not Classified,Notified C&L,1,Not classified:1
106648,"7-[((4,6-dichloro-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-(4-((2-sulfoxy)ethyl)sulfonyl)phenylazo]naphthalene-2-sulfonic acid",407-050-6,117715-57-8,Skin Sens. 1,Harmonised C&L,0,H317:0
106653,2-[4-[(2-chloro-4-nitrophenyl)azo]-N-(2-cyanoethyl)anilino]ethyl benzoate,239-140-4,15087-68-0,Not Classified,Notified C&L,2,Not classified:2
106659,Substituted anthraquinone compound,474-180-8,,Aquatic Chronic 1,Notified C&L,1,H410:1
106661,"2-chloro-N-(2,6-dimethylphenyl)-N-(tetrahydro-2-oxo-3-furyl)acetamide",261-451-9,58810-48-3,Eye Irrit. 2,Notified C&L,127,H319:127
106662,Pentacadmium chloridetriphosphate,235-353-1,12185-64-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1,Notified C&L,1,H302:1;H400:1;H332:1;H410:1;H312:1
106663,2-hydroxy-3-[(1-oxodocosyl)oxy]propyltrimethylammonium chloride,274-033-6,69537-38-8,Skin Irrit. 2,Notified C&L,17,H315:17
106665,"Pyroligneous acids, reaction products with Et alc., distillates",232-449-5,8030-89-5,Flam. Liq. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1531,H225:1493;H319:1328;H336:1326;H351:49;H314:47;Not classified:36;H350:35;H335:2;H224:1;H226:1
106668,"2,4-difluorophenylacetic acid",279-709-4,81228-09-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H315:47;H335:46
106671,Crotonoyl chloride,234-010-3,10487-71-5,Flam. Liq. 3;Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,17,H318:16;H314:17;H226:17;H335:17
106672,Sodium 3-sulphonatopropyl acrylate,239-806-4,15717-25-6,Skin Sens. 1A;Aquatic Chronic 3,REACH registration C&L,1,H412:1;H317:1
106673,"1,2 Dichloroethane polymer with Ammonia",608-347-5,29320-38-5,Skin Sens. 1;Resp. Sens. 1,Notified C&L,148,H334:141;H317:141;Not classified:6;H302:1
106676,1-(2-hydroxy-3-sulphonatopropyl)pyridinium,223-485-2,3918-73-8,Not Classified,REACH registration C&L,75,Not classified:74;H319:1;H315:1;H335:1
106677,"Quaternary ammonium compounds, C14-18-alkyltrimethyl, bromides",270-328-9,68424-92-0,,Notified C&L,1,H319:1;H315:1;H335:1
106679,"2-(benzylmethylamino)ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylatemonohydrochloride",259-198-4,54527-84-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,47,H301:43;H331:38;H311:38;H411:4;H302:3;Not classified:1
106680,"Tar bases, coal, crude;Crude Tar Bases;[The reaction product obtained by neutralizing coal tar base extract oil with an alkaline solution, such as aqueous sodium hydroxide, to obtain the free bases. Composed primarily of such organic bases as acridine, phenanthridine, pyridine, quinoline and their alkyl derivatives.]",266-018-8,65996-84-1,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
106681,"2,2',6,6'-Tetrabromo-4,4'-isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane and acrylic acid",500-323-1,144952-43-2,Not Classified,Notified C&L,11,Not classified:11
106683,L-menthan-3-one,237-926-1,14073-97-3,Skin Irrit. 2;Skin Sens. 1B,REACH registration C&L,1554,H315:1436;H317:1435;H412:202;H302:12;H226:4;H319:5;Not classified:2
106684,"1-(3-hydroxy-1,1-diphenylpropyl)piperidinium methanesulphonate",229-953-2,6856-31-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H312:38;H332:38;H302:39
106687,"1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran;galaxolide;(HHCB)",214-946-9,1222-05-5,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
106692,Sodium 7-amino-4-hydroxynaphthalene-2-sulphonate,243-502-7,20074-69-5,Not Classified,Notified C&L,1,Not classified:1
106693,Triethoxy(3-isocyanatopropyl)silane,246-467-6,24801-88-5,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 1;Resp. Sens. 1,REACH registration C&L,190,H330:168;H302:165;H314:164;H317:38;H312:165;H334:153;H318:65;Not classified:22;H315:4;H310:3;H371:3;H300:3;H319:1
106699,Di-μ-chlorotetrakis(η2-ethylene)dirhodium,235-145-0,12081-16-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
106701,2-[2-[4-(diethylamino)phenyl]vinyl]-1-ethylpyridinium iodide,260-736-5,57439-27-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
106703,Hydroxyprogesterone,200-699-4,68-96-2,Aquatic Chronic 2,REACH registration C&L,42,H411:3;H360:39;H361:1
106706,"Disodium [4-amino-5-hydroxy-6-[(2-hydroxy-5-nitrophenyl)azo]naphthalene-1,7-disulphonato(4-)][2-[[2-hydroxy-5-sulphamoylphenyl]azo]-3-oxo-N-phenylbutyramidato]chromate(2-)",304-042-3,94233-12-2,Not Classified,Notified C&L,2039,Not classified:2039
106707,"Quaternary ammonium compounds, di-C14-18-alkyldimethyl, Me sulfates",268-071-2,68002-58-4,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,6,H318:6;H400:2;H410:6;H315:4
106710,"3,3'-(1,3-dioxo-1,3-digermoxanediyl)dipropionic acid",235-800-0,12758-40-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:3;H315:3;H335:1
106712,"pentapotassium 2-(4-{5-[1-(2,5-disulfophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-(2-pyrrolidinone-1-yl)-1,3-pentadienyl}-3-methylcarbamoyl-5-oxopyrazol-1-yl)benzene-1,4-disulfonate",430-210-1,,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
106729,O-ethyl dichlorothiophosphate,216-100-4,1498-64-2,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,38,H331:38;H314:38;H302:38;H311:38
106734,"Undecanoic acid, compound with 1-[(4-chlorophenyl)methyl]-2-(pyrrolidin-1-ylmethyl)-1H-benzimidazole (1:1)",263-276-3,61853-30-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,24,H312:24;H332:24;H302:24
106738,6-decenoic acid,286-862-0,85392-04-7,Skin Irrit. 2,Notified C&L,391,H315:389;Not classified:2
106741,"Phosphorous acid, tri-C12-14-alkyl esters",297-701-9,93686-48-7,Skin Sens. 1B,REACH registration C&L,2,H317:2
106743,"2-Propenenitrile, polymer with 1,3-butadiene and ethenylbenzene",618-371-8,9003-56-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,111,H319:38;H315:38;H302:38;H335:38;Not classified:71;H373:1;H350:1;H360:1
106744,5-METHYLHEXANOIC ACID,613-089-1,628-46-6,Eye Dam. 1,Notified C&L,47,H318:41;H314:6;H290:1;Not classified:1
106745,5-butylpyridine-3-carboxylic acid,208-643-0,536-69-6,Acute Tox. 4,Notified C&L,130,H302:129;H301:1
106748,"α, ω-dihydroxypoly(hex-5-en-1-ylmethylsiloxane)hoxysilane with (hydrolysis product of silica and methyltrimethoxysilane)iazole",408-160-7,125613-45-8,Aquatic Chronic 2,Harmonised C&L,0,H411:0
106750,Triphenylamine,210-035-5,603-34-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,47,H319:47;H315:47;H335:4
106751,"1H-Imidazole-1-ethanol, 4,5-dihydro, 2-(C7-17 alkyl) derivs.",930-775-9,1334421-90-7,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,87,H318:87;H302:87;H314:87;H400:87;H410:87
106753,"Sulphurous acid, gold potassium salt",249-099-4,28600-36-4,,Notified C&L,4,H314:4
106758,"Fatty acids, C14-22 and C16-22-unsatd., compds. with ethanolamine",286-067-9,85186-82-9,Not Classified,Notified C&L,1,Not classified:1
106762,2-(2-nitrovinyl)thiophene,212-867-4,874-84-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H318:38;H315:38;H302:39;H335:38
106767,"2-Butenedioic acid (2Z)-, polymer with methoxyethene, calcium sodium salt",613-024-7,62386-95-2,Not Classified,Notified C&L,1,Not classified:1
106772,m-formylbenzonitrile,246-549-1,24964-64-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:45;H302:8;H332:1;H312:1
106774,"1,3-dithiane",208-006-7,505-23-7,Not Classified,Notified C&L,2,Not classified:1;H319:1;H315:1;H302:1;H335:1
106777,"Tri(tridecyl) benzene-1,2,4-tricarboxylate",302-446-4,94109-09-8,Not Classified,REACH registration C&L,11,Not classified:8;H400:3;H410:3
106779,(±)-3-phenyllactic acid,212-580-4,828-01-3,,Notified C&L,4,H319:4
106780,4-(3-oxobutyl)phenyl acetate,222-682-0,3572-06-3,Not Classified,Notified C&L,237,Not classified:236;H319:1;H315:1;H335:1
106784,Bisisopropyl peroxydicarbonate,203-317-4,105-64-6,Org. Perox. B;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,12,H318:12;H241:6;H315:12;H302:4;H400:4;H242:6;H336:2;H411:4
106785,"(1S,2S)-trans-2-Benzyloxy-cyclohexylamine",606-811-1,216394-07-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:38;H315:38;H302:38;H335:38;H314:4
106786,5-Bromo-2-iodobenzonitrile,601-788-4,121554-10-7,,Notified C&L,6,H315:6;H302:5;H335:5;H319:6;H332:5;H312:5
106793,Ethyl L-histidinate dihydrochloride,300-174-0,93923-84-3,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
106795,"Undeca-1,3,5-triene",240-416-1,16356-11-9,Asp. Tox. 1;Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1464,H304:1464;H315:1438;H400:1438;H410:1463
106796,"Tar acids, 3,5-xylenol fraction;Distillate Phenols;[The fraction of tar acids, rich in 3,5-dimethylphenol, recovered by distillation of low-temperature coal tar acids.]",284-896-0,84989-07-1,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
106807,"3-bromo[1,1'-biphenyl]-4-ol",202-119-5,92-03-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
106809,5-chloro-2-(methylamino)benzophenone,213-822-1,1022-13-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,45,H319:44;H315:44;H335:43;H302:1
106810,6-methylquinoline,202-084-6,91-62-3,Acute Tox. 4,Notified C&L,1644,H302:1644;H315:44;H319:5;H341:4
106812,Bromocyclooctane,216-310-6,1556-09-8,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H302:38;H410:38
106818,"(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-Dodecahydro-4,6,9,11,12,12b-hexahydroxy-4a,8,13,13-tetramethyl-7,11-methano-5H-cyclodeca(3,4)benz(1,2-b)oxet-5-one 6,12b-diacetate, 12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine",608-826-9,33069-62-4,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3;Repr. 2;Aquatic Chronic 4,Notified C&L,227,H318:192;H315:196;H335:195;H361:161;H317:162;H413:118;H341:71;H334:44;H372:35;H360:63;H340:33;H301:4;H302:4;H332:3;H312:3;H319:6;H373:3;H351:7;H362:4;H331:2;Not classified:1;H311:2;H371:1;H350:1
106821,Manganese diiodide,232-201-6,7790-33-2,Repr. 1B,Notified C&L,45,H360:40;H302:4;H361:1
106822,"17-spiro(5,5-dimethyl-1,3-dioxan-2-yl)androsta-1,4-diene-3-one",421-050-3,13258-43-0,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
106824,"Fatty acids, animal, unsatd., Me esters",287-322-7,85480-42-8,Not Classified,Notified C&L,2,Not classified:2
106825,4-isopropyl-α-methylcinnamaldehyde,212-613-2,831-97-0,Skin Irrit. 2,Notified C&L,97,H315:97
106828,N-(3-amino-4-methylphenyl)acetamide,228-933-0,6375-16-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
106831,Stearoptenes,215-799-3,1406-57-1,Not Classified,Notified C&L,113,Not classified:113
106836,zinc chloride,231-592-0,7646-85-7,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H314:0;H302:0;H410:0
106838,Trisodium 2-[2-(4-nitro-2-sulphonatophenyl)vinyl]-5-[[4-[(4-sulphonatophenyl)azo]phenyl]azo]benzenesulphonate,277-992-9,74764-74-2,Not Classified,Notified C&L,1,Not classified:1
106841,"Fatty acids, C14-18 and C16-18-unsatd., magnesium salts",267-010-7,67762-32-7,Not Classified,Notified C&L,7,Not classified:7
106843,"1,3-bis(chloromethyl)-1,1,3,3-tetramethyldisiloxane",219-109-1,2362-10-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H315:48;H226:38;H335:43
106848,"4,4'-sulphonylbis[2-aminophenol]",231-428-8,7545-50-8,Skin Sens. 1;Eye Irrit. 2,Notified C&L,39,H319:39;H317:38;H315:1
106850,Hexaphenyldistannane,213-902-6,1064-10-4,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H301:42;H331:38;H400:42;H311:42;H410:42;H330:4
106851,"Hemoglobins, bovine",293-254-9,91052-91-4,Not Classified,Notified C&L,2,Not classified:2
106853,α-cyclopropylthiophene-2-methanol,262-532-1,60942-21-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
106858,"(3,5-dichlorophenyl)hydrazine monohydrochloride",264-109-7,63352-99-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H315:44;H302:44;H335:43;H319:44;H332:40;H312:40
106860,Choline glycerophosphate,248-962-2,28319-77-9,Not Classified,REACH registration C&L,4,Not classified:4
106861,"2-Propenoic acid, 2-methyl-, polymer with ethene and ethenyl acetate",607-923-3,26375-31-5,Not Classified,Notified C&L,61,Not classified:61
106864,Methyl salicylate,204-317-7,119-36-8,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,2511,H318:34;H302:2441;H319:589;H315:474;H361:90;H335:24;Not classified:8;H362:6;H360:6;H412:1;H317:1
106865,"Acetamide, N-(2,4-dinitrophenyl)-, reaction products with p-phenylenediamine, sodium sulfide (Na2(Sx)) and sulfur, leuco deriv.",288-897-7,85940-09-6,Not Classified,REACH registration C&L,39,Not classified:39
106873,"(6α,9α,11β,16α)-9-bromine-6-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione",923-618-0,,Acute Tox. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Repr. 1A,Notified C&L,1,H315:1;H360:1;H335:1;H319:1;H300:1;H332:1;H312:1
106874,Propylpyrazine,242-023-0,18138-03-9,Acute Tox. 4,Notified C&L,1414,H302:1374;H318:38;H315:40;H226:38;H335:39;H319:2
106877,Pyridoxal hydrochloride,200-602-5,65-22-5,,Notified C&L,8,H302:5;H319:2;H315:2;H335:2;Not classified:1
106878,Bis(trichloromethyl) carbonate,250-986-3,32315-10-9,Skin Corr. 1B;Acute Tox. 1,Notified C&L,54,H314:52;H330:52;H300:2;Not classified:2;H318:1
106880,N2-[(phenylmethoxy)carbonyl]-L-lysine,218-662-6,2212-75-1,Not Classified,Notified C&L,1,Not classified:1
106886,"2,2'-[[3-acetamido-4-[(2,4-dinitrophenyl)azo]phenyl]imino]diethyl diacetate",269-955-0,68391-47-9,Not Classified,Notified C&L,9,Not classified:9
106888,Medazepam,220-783-4,2898-12-6,Acute Tox. 4;STOT SE 3;Repr. 2;Lact.,Notified C&L,91,H362:90;H336:90;H361:90;H302:91
106896,"2-ethyl-2-[[(1-oxononyl)oxy]methyl]propane-1,3-diyl dinonan-1-oate",204-793-6,126-57-8,Not Classified,REACH registration C&L,466,Not classified:466
106898,"Fatty acids, C18-unsatd., dimers, methyl esters",500-225-9,68604-84-2,Not Classified,REACH registration C&L,8,Not classified:8
106899,[No public or meaningful name is available],472-480-3,,Aquatic Acute 3,Notified C&L,1,H412:1;Not classified:1
106905,"4-bromo-α,α,α-trifluoro-m-toluidine",206-885-1,393-36-2,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;STOT RE 2;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,47,H373:2;H315:47;H301:2;H319:47;H317:2;H401:2;H411:2;H302:45;H335:40;H332:45;H312:41;H311:4
106908,"Fatty acids, essential",234-245-1,11006-87-4,Not Classified,Notified C&L,17,Not classified:17
106910,2-nitrosulphanilic acid,211-920-9,712-24-3,Not Classified,Notified C&L,7,Not classified:7
106916,"Disodium [3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4-hydroxybenzenesulphonato(3-)][1-[[2-hydroxy-5-(phenylazo)phenyl]azo]-2-naphtholato(2-)]chromate(2-)",258-027-0,52587-68-5,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,2066,H411:2058;H317:12;Not classified:8
106918,"Benzene, 1-(dimethoxymethyl)-2-nitro-",606-589-6,20627-73-0,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,33,H411:33;H317:33
106922,(trimethylsilyl)methanol,221-746-5,3219-63-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:39;H315:39;H226:43;H335:38
106929,"(E)-[[](2-{[[]6-(2-chlorophenoxy)-5-fluoropyrimidin-4-yl]oxy}phenyl)(5,6-dihydro-1,4,2-dioxazin-3-yl)methylidene](methoxy)amine",609-207-6,361377-29-9,Skin Sens. 1;Aquatic Acute 1,Notified C&L,211,H400:211;H317:210;H410:17
106930,Ethyl 3-methyl-2-oxobutyrate,243-587-0,20201-24-5,Flam. Liq. 3,Notified C&L,40,H226:40;H319:1;H315:1;H335:1
106931,Cyclohexyl(methyl)amine,202-869-3,100-60-7,Flam. Liq. 3;Met. Corr. 1;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,130,H290:86;H318:85;H302:130;H226:130;H412:84;H314:130;H311:84;H331:39;H312:40;H332:5;Not classified:2
106935,Ethanesulphonyl chloride,209-842-5,594-44-5,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 2;STOT SE 3,REACH registration C&L,55,H330:47;H302:53;H335:3;H314:55;H312:5;H310:47;H318:1;H290:1;H332:1;H341:1;Not classified:2
106937,fluopyram (ISO);N-{2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]ethyl}-2-(trifluoromethyl)benzamide,619-797-7,658066-35-4,Aquatic Chronic 2,Harmonised C&L,0,H411:0
106938,"(3S)-TETRAHYDROFURAN-3-YL (1S,2R)-3-(((4-AMINOPHENYL)SULFONYL)(ISOBUTYL)AMINO)-1-BENZYL-2-(PHOSPHONOO XY)PROPYLCARBAMATE MONOCALCIUM SALT",607-123-4,226700-81-8,,Notified C&L,3,H315:1;H361:2;H351:2;H362:1;H373:1
106940,"1,1,2,3,3-pentamethyl-5-(2-methylprop-2-en-1-yl)octahydro-4H-inden-4-one",610-371-6,476332-63-5,Not Classified,REACH registration C&L,2,Not classified:2
106941,Dopamine hydrochloride,200-527-8,62-31-7,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,205,H400:197;H302:198;H410:196;H319:6;H315:6;H335:5;H411:1
106942,DS-1298A-E,430-520-7,,Not Classified,Notified C&L,1,Not classified:1
106943,Nicotine Polacrilex,619-191-2,96055-45-7,Acute Tox. 3;Acute Tox. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H301:1;H411:1;H319:1;H310:1
106945,Morphine hydrochloride,200-136-2,52-26-6,Acute Tox. 4;STOT SE 3,REACH registration C&L,8,H336:3;H302:5;H301:3;H361:2;H362:3;H331:3;H317:2;H334:3;H315:1;H319:1;H311:1;Not classified:1
106946,"Ivy, Hedera helix, ext.",282-000-2,84082-54-2,Not Classified,Notified C&L,9,Not classified:7;H302:1;H226:1
106953,Tetrahydrofurfuryl-2-methylamine,230-544-6,7179-94-4,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H315:1;H226:1;H335:1
106954,Propyl carbamate,210-984-5,627-12-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H302:38;H335:38
106956,"(1S,2S)-(+)-1,2-Cyclohexanediamine",606-765-2,21436-03-3,Skin Corr. 1B,Notified C&L,48,H314:48;H317:6;H318:2
106957,Amylase,232-567-7,9000-92-4,Resp. Sens. 1,Notified C&L,107,H334:105;H317:10;Not classified:2
106959,o-phenylenediacetonitrile,210-351-3,613-73-0,Acute Tox. 4,REACH registration C&L,53,H302:47;H312:39;H332:38;H301:6;H331:6;H311:6;H315:2;H319:2;H335:1
106960,"1,2-dichloro-4-(methylsulphonyl)benzene",253-942-1,38452-47-0,Eye Irrit. 2,Notified C&L,39,H319:39;H315:1;H302:1;H335:1;H332:1;H312:1
106961,"4-bromo-2-chloro-α,α,α-trifluorotoluene",207-149-2,445-01-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
106963,Acetylferrocene,215-043-2,1271-55-2,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Repr. 1B;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,212,H373:2;H360:2;H302:2;H332:2;H410:158;H228:7;H330:156;H310:157;H300:210;H400:156;H311:10;Not classified:1
106965,"[S-(E)]-3,4,5,6,9,10-hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione",241-864-0,17924-92-4,Skin Corr. 1B;Repr. 2,Notified C&L,43,H314:42;H361:41;H319:1;H315:1;H335:1
106969,Pyridoxine,200-603-0,65-23-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,50,H319:48;H315:48;H335:46;Not classified:2;H302:1
106978,"Ethyl 4,4,4-trifluoroacetoacetate",206-750-7,372-31-6,Flam. Liq. 3;Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,146,H412:143;H315:86;H226:145;H302:139;H225:1;H318:2;H319:1;H335:2
106979,"1,3,5-Triazine-2,4-diamine, 6-butyl-",608-728-6,3232-26-6,Not Classified,Notified C&L,1,Not classified:1
106982,Tetrahydro-4-methyl-2-phenyl-2H-pyran,303-662-1,94201-73-7,Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,146,H412:14;H315:146;H317:132;H319:56
106983,Prop-1-ynylbenzene,211-607-7,673-32-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
106984,methyl 4-oxocyclohexane-1-carboxylate,613-123-5,6297-22-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H319:1;H315:1;H335:1;Not classified:1
106985,salts of benzidine [,208-520-1,531-86-2,Acute Tox. 4;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H350:0;H400:0;H302:0;H410:0
106988,"1H,5H-Pyrazolo[1,2-a]pyrazol-1-one, 3-amino-6,7-dihydro-2-nitroso-",617-748-4,857035-96-2,STOT SE 3,REACH registration C&L,2,H335:2
106989,2-methyl-1-vinyl-1H-imidazole,220-664-7,2851-95-8,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H318:39;H315:38;H335:38;H314:1
106996,"1,1-diphenylbutane-1,4-diol",213-827-9,1023-94-5,Eye Irrit. 2,Notified C&L,38,H319:38
106997,Silver docosanoate,219-641-4,2489-05-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H312:1;H332:1;H302:1;H400:1;H410:1
107001,Tenonitrozole,223-282-9,3810-35-3,Acute Tox. 3;Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H301:1;H312:1;H334:1;H317:1
107003,Diethyl(methyl)(2-(3-methyl-2-phenylvaleryloxy)ethyl)ammonium bromide,201-977-8,90-22-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H312:39;H332:39;H302:39;H315:1;H319:1
107009,"2-Naphthalenesulfonic acid, polymer with formaldehyde, sodium salt",609-228-0,36290-04-7,Not Classified,Notified C&L,278,Not classified:237;H412:25;H312:16;H315:16;H319:16;H302:16
107019,Triethylammonium chloride,209-067-2,554-68-7,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,183,H319:135;H315:135;H335:134;Not classified:35;H318:13;H314:15;H302:6;H332:2;H312:2
107020,4-(4-methylpiperidyl)pyridine,279-638-9,80965-30-6,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,38,H315:38;H335:38;H301:38;H319:38;H331:38;H311:38
107021,6-ethoxybenzothiazol-2-ylamine,202-333-9,94-45-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H315:44;H302:43;H335:43;H319:44;H332:38;H312:38
107026,(Z)-octadec-9-enylammonium acetate,233-945-4,10460-00-1,Not Classified,Notified C&L,1,Not classified:1
107031,Kieserite (Mg(SO4).H2O),604-485-5,14567-64-7,Not Classified,Notified C&L,83,Not classified:83
107034,"α,α-bis[4-(dimethylamino)phenyl]-4-(methylphenylamino)naphthalene-1-methanol",215-408-6,1325-85-5,Not Classified,Notified C&L,1,Not classified:1
107035,Potassium ethyl 4-oxidobenzoate,253-048-1,36457-19-9,Not Classified,Notified C&L,3,Not classified:3
107036,"7-hydroxy-8-[[4-(phenylazo)phenyl]azo]naphthalene-1,3-disulphonic acid, compound with N,N'-di(o-tolyl)guanidine (1:2)",276-478-1,72208-29-8,Acute Tox. 4,Notified C&L,1,H302:1
107040,1-methyl-3-phenyl-5-[3-(trifluoromethyl)phenyl]-4-pyridone,261-916-6,59756-60-4,Acute Tox. 3;Aquatic Chronic 2,Notified C&L,146,H411:144;H311:129;H319:13;Not classified:1;H413:1
107041,Phenanthren-4-methanol,245-270-2,22863-79-2,Eye Irrit. 2,Notified C&L,38,H319:38
107043,"Isophthalic acid, oligomeric reaction products with 2,2-dimethylpropane-1,3-diol, 3-methylpentane- l,5-diol and phthalic anhydride",500-407-8,158885-20-2,Not Classified,Notified C&L,2,Not classified:2
107048,"Oils, apricot",615-861-3,72869-69-3,Flam. Liq. 3,Notified C&L,79,H226:53;Not classified:26
107052,Octan-4-one,209-655-9,589-63-9,Flam. Liq. 3,Notified C&L,42,H226:39;Not classified:3
107054,molinate (ISO);S-ethyl 1-perhydroazepinecarbothioate;S-ethyl perhydroazepine-1-carbothioate,218-661-0,2212-67-1,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Carc. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H373:0;H302:0;H361:0;H351:0;H400:0;H332:0;H317:0;H410:0
107056,"Benzoic acid, 4-iodo-2-methoxy-, methyl ester",604-637-0,148490-97-5,,Notified C&L,4,H319:4;H315:4;H335:4
107057,"[3aR-(3aα,4α,5β,6aα)]-hexahydro-4-(hydroxymethyl)-2-oxo-2H-cyclopenta[b]furan-5-yl benzoate",254-615-6,39746-00-4,Not Classified,Notified C&L,3,Not classified:3
107058,"2-[2-[4-[(2-chloroethyl)methylamino]phenyl]vinyl]-1,3,3-trimethyl-3H-indolium dihydrogen phosphate",281-586-7,83969-09-9,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 1,Notified C&L,10,H318:9;H302:9;H410:9;Not classified:1
107062,"5,5'-dimethoxy-3,3'-di-tert.-butyl-1,1'-biphenyl-2,2'-diol",604-200-4,14078-41-2,Carc. 2;Aquatic Chronic 4,REACH registration C&L,4,H351:1;H413:3;H315:2;H302:2;H335:2;H319:2;Not classified:1
107065,"Bicyclo(2.2.1)heptane-2,3-dicarboxylic acid, sodium salt (1:2), (1R,2R,3S,4S)-rel-",609-085-4,351870-33-2,Not Classified,Notified C&L,99,Not classified:99
107067,Tris[(2-hydroxyethyl)ammonium] citrate,244-599-9,21829-50-5,Not Classified,REACH registration C&L,2,Not classified:2
107075,"Formaldehyde, reaction products with m-phenylenediamine, sodium sulfide (Na2S) and sulfur",274-986-8,70892-34-1,Not Classified,REACH registration C&L,38,Not classified:38
107076,Methyl 4-fluoro-2-methoxybenzoate,606-563-4,204707-42-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H315:1;H335:1;H302:1
107077,1-(trimethylsilyl)pyrrolidine,239-149-3,15097-49-1,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,38,H225:38;H314:38
107079,fentin acetate (ISO);triphenyltin acetate,212-984-0,900-95-8,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 2;STOT SE 3;Carc. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H372:0;H318:0;H315:0;H330:0;H335:0;H301:0;H361:0;H351:0;H400:0;H311:0;H410:0
107081,Potassium 3-[(ethoxythioxomethyl)thio]propanesulphonate,298-984-1,93841-14-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,71,H312:57;H315:71;H319:71;H302:57;H350:1
107082,"N,N-dimethyloctadecenylamine",248-811-0,28061-69-0,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,444,H400:444;H314:444;H302:444;H410:2;H318:441;H317:441;H312:441
107083,Dibenzyl sulphoxide,210-668-7,621-08-9,Not Classified,REACH registration C&L,2,Not classified:2
107084,"(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaen-7-yl 4-(piperidin-1-yl)piperidine-1-carboxylate hydrochloride",600-054-0,100286-90-6,Acute Tox. 4,Notified C&L,40,H302:40
107086,Hydroquinidine hydrochloride,216-024-1,1476-98-8,Acute Tox. 4,Notified C&L,40,H302:40;H317:1
107100,1-(3-bromo-4-fluorophenyl)ethan-1-one,213-750-0,1007-15-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,135,H319:135;H315:135;H335:134
107101,"flufenacet (ISO);N-(4-fluorophenyl)-N-isopropyl-2-(5-trifluoromethyl-[1,3,4]thiadiazol-2-yloxy)acetamide",604-290-5,142459-58-3,Acute Tox. 4;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H373:0;H302:0;H400:0;H317:0;H410:0
107102,Methylsuccinic anhydride,223-870-5,4100-80-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
107103,"Pelargonium graveolens, ext., acetylated",295-811-1,92129-10-7,Not Classified,Notified C&L,1286,Not classified:1286
107110,"5-bromoindoline-2,3-dione",201-747-7,87-48-9,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,46,H318:46;H315:46;H335:45
107115,3-chloro-4-hydroxybenzoic acid,223-574-6,3964-58-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43;H302:1
107117,N-phenylmaleimide,213-382-0,941-69-5,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1,REACH registration C&L,134,H318:57;H315:127;H301:134;H400:125;H317:125;H330:68;H335:68;H319:74;H410:81;H331:3;H311:2;H370:1;H411:1
107118,4-nitro-3-(trifluoromethyl)aniline,206-884-6,393-11-3,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,115,H315:113;H335:112;H301:66;H319:113;H332:74;H312:69;H302:9;H311:5;Not classified:1
107123,"Benzenesulfonic acid, 4-chloro-2-[2-[4,5-dihydro-3-methyl-5-oxo-1-(3-sulfophenyl)-1H-pyrazol-4-yl]diazenyl]-5-methyl-, ammonium salt (1:2)",416-730-1,,Not Classified,REACH registration C&L,87,Not classified:87
107130,"1,2-dihydro-1,3-dimethyl-4-[(methylphenylhydrazono)methyl]-2-oxopyrimidinium chloride",284-487-7,84912-24-3,,Notified C&L,1,H319:1;H315:1
107132,"1,4-bis[(2,3-epoxypropoxy)methyl]cyclohexane",238-098-4,14228-73-0,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,556,H412:259;H315:272;H302:25;H317:555;H319:247;Not classified:1;H411:1
107134,"1,1',1'-nitrilotripropan-2-ol;triisopropanolamine",204-528-4,122-20-3,Eye Irrit. 2,Harmonised C&L,0,H319:0
107135,"3,4-dimethoxybenzylamine",227-287-7,5763-61-1,,Notified C&L,8,H314:8;H318:1;H312:1;H332:1;H302:1
107140,"1,2,3,4-tetrachlorobenzene",211-214-0,634-66-2,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,44,H400:39;H302:43;H410:39;H319:1;H413:1;H315:1;Not classified:1
107142,Menadione,200-372-6,58-27-5,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,70,H315:61;H302:65;H335:67;H319:70;H400:15;H317:2;H410:4;H361:9;H341:9
107143,2-methyl-2-(methyldithio)propionaldehyde,267-914-1,67952-60-7,Acute Tox. 4,Notified C&L,1373,H302:1363;Not classified:10
107144,Tributyl citrate,201-071-2,77-94-1,Not Classified,REACH registration C&L,348,Not classified:251;H318:83;H400:14
107145,Copper oxychloride,603-724-0,1332-40-7,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,132,H400:130;H332:91;H302:131;H410:124;H411:6;H314:1;Not classified:1;H315:1;H319:1
107147,"1,2,2,6,6-pentamethyl-4-piperidyl methacrylate",271-354-3,68548-08-3,Skin Irrit. 2;Aquatic Chronic 3,Notified C&L,4,H412:2;H315:3;Not classified:1;H319:1
107150,Pentaerythritoltetracyanoacetic ester,605-830-2,178671-69-7,Not Classified,REACH registration C&L,84,Not classified:84
107152,4-bromoheptane,213-653-3,998-93-6,,Notified C&L,4,H226:4
107156,"Fatty acids, C16-18 and C18-unsatd., Me esters, sulfonated, ammonium salts",608-255-5,288094-94-0,Skin Irrit. 2,Notified C&L,28,H315:28
107160,"Disodium 2-[[2,4-dihydroxy-3-[(4-nitrophenyl)azo]-5-[(4-sulphonatophenyl)azo]phenyl]azo]-5-nitrobenzenesulphonate",288-034-4,85631-85-2,Not Classified,Notified C&L,5,Not classified:4;H319:1
107161,"2-Propanone, 2,2',2''-[O,O',O''-(ethylsilylidyne)trioxime]",611-631-1,58190-57-1,STOT RE 2,REACH registration C&L,14,H373:14
107163,"2,4,6-trichlorophenylhydrazine",226-217-2,5329-12-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42;H302:5;H332:5;H312:5
107168,3-chloro-2-nitrobenzoic acid,225-313-1,4771-47-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44
107170,"1,1'-(3,3'-dimethoxy-4,4'-biphenylylene)bis[3,5-diphenylformazane]",245-567-7,23305-71-7,Carc. 1B,Notified C&L,38,H350:38
107171,(R)-(-)-1-aminopropan-2-ol,220-532-9,2799-16-8,Skin Corr. 1B,Notified C&L,51,H314:51;H318:2
107174,"1-(6-amino-1,3-benzodioxol-5-yl)ethan-1-one",249-131-7,28657-75-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43;H302:1
107178,"Safflower oil, polymd.",614-651-9,68607-59-0,Not Classified,Notified C&L,7,Not classified:7
107182,"2-(hydroxymethyl)-2-[[(1-oxooctadecyl)oxy]methyl]propane-1,3-diyl distearate",248-889-6,28188-24-1,,Notified C&L,35,Not classified:35
107185,"Cyclohexanone, 4-butyl-",612-100-7,61203-82-5,Not Classified,Notified C&L,1,Not classified:1
107193,Bromocresol purple,204-087-8,115-40-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,157,H319:150;H315:150;H335:149;Not classified:7
107197,"4,4'-vinylidenebis(N,N-dimethylaniline)",231-284-6,7478-69-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 1B,Notified C&L,38,H315:38;H302:38;H335:38;H319:38;H350:38;H332:38;H312:38
107199,2-nitrotoluene,201-853-3,88-72-2,Acute Tox. 4;Muta. 1B;Carc. 1B;Aquatic Chronic 2;Repr. 2,Harmonised C&L,0,H302:0;H340:0;H361:0;H350:0;H411:0
107201,"Naphthalene-2,3-diamine hydrochloride",279-558-4,80789-78-2,Acute Tox. 2;Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;Carc. 1B,Notified C&L,38,H315:38;H330:38;H335:38;H310:38;H319:38;H350:38;H300:38
107203,bromomethane;methylbromide,200-813-2,74-83-9,Press. Gas;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Muta. 2;STOT RE 2;Aquatic Acute 1;Ozone 1,Harmonised C&L,0,H373:0;H315:0;H335:0;H301:0;H319:0;H331:0;H400:0;H420:0;Not classified:0;H341:0
107207,"2,2,6,6-tetramethyl-4-substituted-piperidinyl-1-oxy",482-430-2,,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H302:1;H317:1
107209,Tetraisocyanatosilane,222-297-8,3410-77-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,1,H315:1;H302:1;H335:1;H319:1;H331:1
107212,Cycloheptanone,207-937-6,502-42-1,Flam. Liq. 3;Acute Tox. 4;Eye Dam. 1,REACH registration C&L,50,H318:42;H302:48;H226:49;H319:1;H332:1;Not classified:1
107213,"Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, polymer with 1,1'-methylenebis[4-isocyanatobenzene]",609-379-2,37278-61-8,Not Classified,Notified C&L,1,Not classified:1
107214,"Sodium [[4-[(4-amino-m-tolyl)[4-(phenylimino)cyclohexa-2,5-dien-1-ylidene]methyl]phenyl]amino]benzenesulphonate",263-438-3,62152-67-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:42
107217,Reaction product of Aminoguanidine bicarbonate and Tall Oil fatty acid,442-600-9,,Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,5,H315:5;H400:5;H317:5;H410:5
107220,Ethyldiisopropylamine,230-392-0,7087-68-5,Flam. Liq. 2;Acute Tox. 4;Eye Dam. 1;Acute Tox. 3;STOT SE 3,REACH registration C&L,2473,H318:2385;H302:2277;H335:2261;H225:2417;H331:2261;H301:141;H412:151;H314:207;H226:2;H413:1;H319:1;H224:1;Not classified:2;H332:1;H312:1
107221,"Oils, citronella, reaction products with acetone",614-786-3,68916-62-1,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,113,H411:113;H318:113;H315:113;H317:113
107223,"Sodium 2-[[[2,5-dichloro-4-[(2-methyl-1H-indol-3-yl)azo]phenyl]sulphonyl]amino]ethanesulphonate",273-402-9,68959-19-3,Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,32,H319:1;H317:1;Not classified:31
107227,"Tetrakis(acetato-O)[μ4-(3',6'-dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-2',4',5',7'-tetrayl)]tetramercury",259-075-5,54295-90-8,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H373:38;H330:38;H310:38;H300:38;H400:38;H410:38
107232,Dimethylphenylsilane,212-170-5,766-77-8,Flam. Liq. 3;Eye Dam. 1,Notified C&L,45,H318:38;H226:45;H319:3;H315:2;H335:1
107233,Aluminum zirconium pentachlorohydrate,605-691-8,173762-83-9,Not Classified,Notified C&L,3,Not classified:3
107234,"Methyl 3-[1-[difluoro[(trifluorovinyl)oxy]methyl]-1,2,2,2-tetrafluoroethoxy]-2,2,3,3-tetrafluoropropionate",264-518-0,63863-43-4,,Notified C&L,48,Not classified:48
107236,"Fatty acids, lanolin, potassium salts",297-618-8,93685-71-3,Not Classified,Notified C&L,1,Not classified:1
107238,"2-[2,4-bis(1,1-dimethyl-ethyl)phenoxy]-N-(2-hydroxy-5-methyl-phenyl)hexanamide",411-330-3,104541-33-5,Aquatic Chronic 4,Harmonised C&L,0,H413:0
107239,"Benzenaminium, N,N,N-trimethyl-, tetrafluoroborate(1-)",605-764-4,17594-95-5,Not Classified,Notified C&L,1,Not classified:1
107242,"2-(2,7-dichloro-6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid",200-968-6,76-54-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H315:40;H335:39;Not classified:1
107244,4-bromomethyl-7-methoxycoumarin,252-448-3,35231-44-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H315:38;H302:38;H335:38;H318:1;H290:1;H314:1
107245,Tridymite,239-487-1,15468-32-3,STOT RE 1,Notified C&L,244,H372:194;H350:20;H373:44;Not classified:6;H351:2
107246,"Alkanes, C5-8",309-852-0,101316-46-5,Asp. Tox. 1;Muta. 1B;Carc. 1B,Notified C&L,39,H350:38;H304:39;H340:38;H315:1;H336:1;H225:1;H411:1
107249,"3-(diaryl)[1,3,5]triazin-2yl)-5-(alkoxy substituted)-phenol",440-520-9,,Not Classified,REACH registration C&L,85,Not classified:85
107253,"2-Bromo-4,5-difluorophenol",605-435-5,166281-37-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H315:47;H335:46;H302:1
107259,"[(3S,5R)-5-(2,4-difluorophenyl)-5-(iodomethyl)tetrahydrofuran-3-yl]methyl 2-methylpropanoate",600-541-8,1042398-26-4,Not Classified,REACH registration C&L,13,Not classified:3;H317:10
107261,Sodium (R)-12-hydroxyoleate,226-191-2,5323-95-5,,Notified C&L,47,Not classified:47
107263,3-(aminosulphonyl)-4-chlorobenzoyl chloride,274-288-3,70049-77-3,Skin Sens. 1A,REACH registration C&L,14,H318:3;H341:3;H302:3;H317:3;H319:9;H315:9;Not classified:2
107272,Halcinonide,221-439-6,3093-35-4,Repr. 2,Notified C&L,40,H361:40;H341:1;H372:1
107274,Trichloro(dichloromethyl)silane,216-315-3,1558-24-3,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,38,H314:38;H226:38
107279,4-nitrobenzaldehyde hydrazone,228-631-9,6310-10-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
107280,Butyl oleate,205-559-6,142-77-8,Not Classified,Notified C&L,400,Not classified:227;H319:173;H315:173;H335:151
107281,"hexamethylene diacrylate;hexane-1,6-diol diacrylate",235-921-9,13048-33-4,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H319:0;H315:0;H317:0
107285,"(S)-1,1-diphenyl-1,2-propanediol",443-220-6,46755-94-6,Aquatic Chronic 3,Harmonised C&L,0,H412:0
107288,Dilithium succinate,240-248-9,16090-09-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,26,H319:26;H315:26;H302:26
107290,"Thieno[3,2-c]pyridine-5(4H)-acetic acid, α-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (αS)-",601-269-2,113665-84-2,Lact.,Notified C&L,1,H362:1
107292,Disodium 5(or 8)-(3-methyl-4-(4-methylphenylsulphonyloxy)phenylazo)-8(or 5)-4-(4-nitro-2-sulphophenylamino)phenylazo)naphthalene-2-sulphonate,232-328-7,8003-88-1,,Notified C&L,44,Not classified:40;H319:4
107294,4-methylnonan-4-ol,245-648-7,23418-38-4,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H315:38;H335:38
107299,"Butane, 1-bromo-2-methyl-",600-538-1,10422-35-2,,Notified C&L,5,H319:5;H315:5;H226:5;H335:5
107300,3-methylthiopropyl isothiocyanate,208-020-3,505-79-3,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1446,H315:1416;H330:1391;H335:1393;H301:1342;H319:1440;H400:1286;H311:1391;H410:1311;H302:56;H312:5;H314:5;H332:6
107304,Chenodeoxycholic acid,207-481-8,474-25-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,10,H319:5;H315:5;H335:2;H312:2;H332:2;H302:2;H361:3;Not classified:1;H334:1;H317:1
107305,4-allyl-2-methoxyphenyl acetate,202-235-6,93-28-7,Acute Tox. 4;Skin Sens. 1B,REACH registration C&L,1665,H302:1665;H317:6;H315:42;H318:1;H319:1;H335:1
107306,sodium methyl [(4-aminophenyl)sulphonyl]carbamate; sodium methyl (EZ)-sulfanilylcarbonimidate; asulam-sodium,218-953-8,2302-17-2,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H317:0;H410:0
107307,pentane,203-692-4,109-66-0,Flam. Liq. 2;Asp. Tox. 1;STOT SE 3;Aquatic Chronic 2,Harmonised C&L,0,H225:0;H411:0;H304:0;H336:0
107309,"Sulfonic acids, animal-oil, ammonium salts",298-739-9,93821-52-4,Not Classified,Notified C&L,1,Not classified:1
107310,"2,2-methylenesuccinyl dichloride",217-689-0,1931-60-8,Skin Corr. 1B;STOT SE 3,Notified C&L,38,H314:38;H335:38
107315,"2-Propanol, 1,1'-iminobis-, N-coco alkyl derivs.",271-130-5,68516-06-3,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,33,H400:33;H314:33;H302:33;H410:33
107319,[No public or meaningful name is available],619-913-6,68606-80-4,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H315:1;H400:1;H410:1
107322,"Silicic acid, aluminum magnesium salt",215-478-8,1327-43-1,Not Classified,Notified C&L,70,Not classified:48;H335:22;H315:8;H302:8;H331:8;H400:8;H332:8;H311:8
107323,"5,6,7,8,10,10-hexachloro-3a,4,4a,5,8,8a,9,9a-octahydro-5,8-methanonaphtho[2,3-c]furan-1,3-dione",217-229-9,1782-06-5,Acute Tox. 3;Skin Irrit. 2;STOT SE 3,Notified C&L,38,H301:38;H315:38;H335:38
107325,"4,6-bis(phenylazo)-o-cresol",227-436-6,5844-01-9,Not Classified,Notified C&L,7,Not classified:7
107326,"Phosphorodithioic acid, mixed O,O-bis(2-ethylhexyl and iso-Bu and pentyl) esters, zinc salts",273-527-9,68988-45-4,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,3,H411:3;H318:3;H315:3
107327,"[4-[bis[4-(dimethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]dimethylammonium acetate",267-847-8,67939-65-5,Acute Tox. 4;Eye Irrit. 2;Carc. 2;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,205,H302:158;H361:2;H319:4;H351:102;H400:155;H410:155;H318:153;Not classified:47;H412:3;H350:1;H341:1
107329,"2,4-dihydroxy-3-methylbenzoic acid",700-279-5,4707-49-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H319:38;H302:38;Not classified:1
107332,Creosote oil;[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic hydrocarbons and may contain appreciable quantities of tar acids and tar bases. It distills at the approximate range of 200°C to 325°C (392°F to 617°F).],263-047-8,61789-28-4,Carc. 1B,Harmonised C&L,0,H350:0
107333,"Dihydro-3,3-dimethyl-2H-pyran-2,6(3H)-dione",220-922-9,2938-48-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
107336,Benzyltoluene,248-654-8,27776-01-8,Asp. Tox. 1;Skin Irrit. 2;Aquatic Chronic 4,REACH registration C&L,77,H413:76;H304:77;H315:77;H400:1;H332:1;H410:1
107343,Thiosultap disodium,610-797-2,52207-48-4,Acute Tox. 3;Acute Tox. 3,Notified C&L,38,H301:38;H311:38
107345,"Alfalfa, ext.",281-984-0,84082-36-0,Eye Irrit. 2,REACH registration C&L,100,H319:10;Not classified:89;H226:1
107346,Tetraammonium dihydrogen [nitrilotris(methylene)]trisphosphonate,301-421-5,94021-27-9,Not Classified,Notified C&L,1,Not classified:1
107347,Sodium iopodate,214-945-3,1221-56-3,Eye Dam. 1,Notified C&L,24,H318:24
107349,"Oils, lard, oxidized, sulfited, sodium salts",297-185-5,93348-42-6,Not Classified,Notified C&L,78,Not classified:48;H319:30;H315:30
107350,"Chromium, 2-hydroxy-3,5-dinitrobenzenediazonium-4(or 5)-hydroxy-1-naphthalenesulfonic acid coupling products 3-hydroxy-4-[(1-hydroxy-2-naphthalenyl)azo]-1-naphthalenesulfonate sodium complex",294-080-6,91672-71-8,Skin Irrit. 2,Notified C&L,1,H315:1
107351,5-Fluoro-2-methyl-1H-indole,609-764-5,399-72-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:45
107352,"Lignosulfonic acid, calcium salt, polymer with N-cyanoguanidine, formaldehyde and sodium lignosulfonate",619-154-0,95649-13-1,,Notified C&L,33,Not classified:33
107357,"Tetrahydro-1H-cyclopenta[c]furan-1,3(3aH)-dione",227-286-1,5763-49-5,Acute Tox. 4;Eye Dam. 1,Notified C&L,39,H318:39;H302:39;H315:1;H335:1
107359,"1,1-dichloro-3,3-dimethylbutan-2-one",245-111-7,22591-21-5,Acute Tox. 4;Acute Tox. 3,Notified C&L,1,H331:1;H302:1
107361,"Ashes (residues), cenospheres",300-212-6,93924-19-7,Not Classified,Notified C&L,36,Not classified:36
107362,Nonan-1-oic anhydride,216-854-4,1680-36-0,Skin Corr. 1B;Eye Dam. 1,Notified C&L,39,H318:39;H314:39;H290:1
107364,"6-hydroxy-3,4-dimethyl-2-pyridone",283-141-2,84540-47-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,73,H319:60;H315:52;H335:52;Not classified:13;H317:2
107370,Cerium trihydroxide,239-881-3,15785-09-8,Not Classified,Notified C&L,2,Not classified:2
107372,Ethyl 3-ethoxy-2-butenoate,213-652-8,998-91-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
107373,Diisopropylbenzene,246-835-6,25321-09-9,Skin Irrit. 2;Aquatic Chronic 4,Notified C&L,167,H413:160;H315:164;H319:4;H411:3;H335:3;H400:2;H336:1;H410:3;H304:1;H373:1
107374,"29H,31H-phthalocyanine",209-378-3,574-93-6,Not Classified,REACH registration C&L,102,Not classified:98;H319:4;H315:4;H335:4
107375,Disopyramide,223-110-2,3737-09-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,42,H312:1;H332:1;H302:42;H361:38
107379,Hydrastine,204-233-0,118-08-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H312:39;H332:39;H302:39
107384,"Soybean oil, ester with triethanolamine",271-408-6,68554-75-6,,Notified C&L,60,H319:60;H315:60
107386,Isopentyl cinnamate,231-931-2,7779-65-9,Not Classified,Notified C&L,293,Not classified:293
107389,4-chlorobenzophenone,205-160-7,134-85-0,Not Classified,REACH registration C&L,45,Not classified:42;H319:2;H315:2;H335:2;H411:1
107391,"Resin acids and Rosin acids, maleated, mixed esters with diethylene glycol, glycerol and phthalic anhydride",293-628-1,91081-25-3,Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,1,H319:1;H413:1;H317:1
107392,"Bisbenzimidazo[2,1-a:1',2'-b']anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-6,11-dione",611-220-7,55034-79-2,Not Classified,Notified C&L,122,Not classified:83;H319:39;H315:39;H335:39
107393,sodium 5-n-butylbenzotriazole,404-450-2,118685-34-0,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H314:0;H302:0;H317:0
107394,"Disodium naphthalene-1,5-disulphonate",216-732-0,1655-29-4,Not Classified,REACH registration C&L,8,Not classified:7;H319:1;H315:1;H335:1
107396,3-bromo-4-fluorobenzoic acid,213-751-6,1007-16-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H315:47;H335:46
107398,"Fatty acids, C16-18, mixed esters with adipic acid and pentaerythritol",307-372-6,97615-85-5,Not Classified,Notified C&L,50,Not classified:50
107399,Tolazoline,200-448-9,59-98-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,128,H315:128;H302:128;H335:127;H319:128;H332:128;H312:128
107402,2-methylallyl acetate,212-471-1,820-71-3,Flam. Liq. 3,Notified C&L,1,H226:1
107404,"Shallot, ext.",296-057-6,92202-24-9,Flam. Liq. 3,Notified C&L,1,H226:1
107405,Diethyl (hydroxymethyl)phosphonate,221-391-6,3084-40-0,Not Classified,Notified C&L,41,Not classified:34;H319:7;H315:6;H335:5
107406,Nonanal,204-688-5,124-19-6,Aquatic Chronic 3,REACH registration C&L,1810,H412:1674;H319:360;H315:373;Not classified:82;H335:44;H411:2;H317:2
107407,"2,5-Furandione, dihydro-, mono-C15-20-alkenyl derivs.",272-221-2,68784-12-3,Skin Sens. 1B,REACH registration C&L,181,H317:176;H412:20;Not classified:5
107410,Quinolin-2-amine,209-458-8,580-22-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,42,H318:38;H315:42;H302:40;H335:41;H319:4
107411,Pilocarpine hydrochloride,200-212-5,54-71-7,Acute Tox. 2;Acute Tox. 2,Notified C&L,121,H300:79;H330:118;H301:41;H361:1;H411:1;H331:1
107413,Ethyl 3-bromobenzoate,246-223-9,24398-88-7,,Notified C&L,3,H312:1;H332:1;H302:1;H319:1;H315:1;H335:1;Not classified:1
107415,"5-[(7-amino-1-hydroxy-3-sulpho-2-naphthyl)azo]-8-[[4-(phenylazo)-6-sulpho-1-naphthyl]azo]naphthalene-2-sulphonic acid, sodium salt",286-594-4,85283-66-5,Not Classified,Notified C&L,2,Not classified:2
107419,"1,2,3-Propanetricarboxylic acid, 2-hydroxy-, tripotassium salt, monohydrate",612-062-1,6100-05-6,Not Classified,Notified C&L,127,Not classified:127
107422,"methyl-2,4-dichlorophenylethanoate",611-334-7,55954-23-9,Not Classified,Notified C&L,5,Not classified:4;H319:1;H315:1;H335:1
107423,Calcium naphthyl phosphate,274-738-9,70675-10-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
107424,[[]diamino(sulfanylidene)-lambda5-phosphanyl](propyl)amine,618-780-1,916809-14-8,Eye Irrit. 2;Repr. 2,REACH registration C&L,100,H319:100;H361:100;H335:16
107430,4-(2-carboxyvinyl)benzoic acid,243-220-4,19675-63-9,,Notified C&L,4,H319:4;H315:4;H335:4
107434,Chloro-o-tolylmagnesium,251-709-9,33872-80-9,Flam. Sol. 1;Skin Corr. 1B,Notified C&L,64,H314:64;H228:38;H225:26
107436,"1-Butanaminium, N,N,N-tributyl-, salt with 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis[phenol] (1:1)",607-717-3,253873-59-5,Not Classified,Notified C&L,1,Not classified:1
107439,DOCOSANEDIOIC ACID,624-095-9,505-56-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
107443,Ethyl 2-hydroxy-2-methylpropionate,201-290-3,80-55-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:45;H315:41;H226:46;H335:44
107444,Ethyl 1-methylcyclopropanecarboxylate,275-461-6,71441-76-4,Flam. Liq. 3,Notified C&L,38,H226:38
107445,"N,N'-(3,3'-dimethylbiphenyl-4,4'-ylene)di(acetoacetamide)",202-111-1,91-96-3,Aquatic Chronic 2,REACH registration C&L,36,H411:1;Not classified:35
107449,"4,4'-Methylenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane",500-108-2,42423-25-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,157,H319:77;H315:77;H317:133;H411:74;Not classified:24
107455,Sodium 4-chlorobenzenesulphonate,225-900-2,5138-90-9,Eye Dam. 1;STOT SE 3,Notified C&L,39,H318:38;H335:38;H319:1
107457,"4-amino-N,N-dimethylbenzenesulphonamide",216-970-5,1709-59-7,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
107460,"1,3-oxazolidine",610-533-6,504-76-7,Skin Corr. 1B,Notified C&L,2,H314:2;H226:1
107461,"Formaldehyde, polymer with 4-(1,1-dimethylethyl)phenol, 2-methyloxirane and oxirane",608-514-2,30704-64-4,Not Classified,Notified C&L,61,Not classified:61
107465,"Oxirane, 2-methyl-, polymer with oxirane, monomethyl ether",618-595-6,9063-06-3,Not Classified,Notified C&L,12,Not classified:11;H412:1
107468,"Hydrogen -1-(3-sulphonatopropyl)-2-[[3-(3-sulphonatopropyl)-3H-benzothiazol-2-ylidene]methyl]naphtho[1,2-d]thiazolium, compound with triethylamine",262-407-1,60760-42-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
107470,"α,α-bis[4-(diethylamino)phenyl]-4-(ethylamino)naphthalene-1-methanol",215-409-1,1325-86-6,Not Classified,Notified C&L,74,Not classified:67;H302:7;H318:3
107471,"2-Naphthalenesulfonic acid, 6-amino-5-[2-[5-chloro-2-(2-chlorophenoxy)phenyl]diazenyl]-4-hydroxy-, sodium salt (1:1)",403-100-6,,Aquatic Chronic 2,Notified C&L,1,H411:1
107472,"4,4'-Dinonyl-2,2'-bipyridyl",604-301-3,142646-58-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
107474,"1,1,2,2,3,3-hexafluoro-1,3-bis[(trifluorovinyl)oxy]propane",237-579-6,13846-22-5,Flam. Liq. 2,Notified C&L,1,H225:1
107477,"4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholin-4-ium chloride",447-230-1,3945-69-5,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,Notified C&L,5,H318:3;H314:3;H302:5
107485,1-(4-methylphenyl)cyclopentane-1-carbonitrile,273-487-2,68983-70-0,Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H312:38;H332:38
107487,4-Amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]-2-morpholinyl]methyl]benzamide citrate,601-211-6,112885-42-4,Repr. 2,Notified C&L,1,H361:1
107488,"2,2-Bis(bromomethyl)propane-1,3-diol, oligomeric reaction products with 1-chloro-2,3-epoxypropane",500-073-3,31452-80-9,Skin Irrit. 2;Skin Sens. 1A;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,51,H319:42;H412:2;H315:41;H317:51;H335:40;H351:39
107490,(-)-B-Chlorodiisopinocampheylborane,617-675-8,85116-37-6,Skin Corr. 1B,Notified C&L,185,H314:185;H318:84;H400:92;H410:92;H336:9;H225:9;H304:9
107492,"5-((2,5-Bis(2-(acetyloxy)ethoxy)-4-aminophenyl)diazenyl)isophthalic acid",923-316-9,,Not Classified,Notified C&L,1,Not classified:1
107495,"1,2,4-triazolyl-3-alanine",233-301-2,10109-05-4,Acute Tox. 4,Notified C&L,38,H302:38
107496,"Phenol, dodecyl-, sulfurized, carbonates, calcium salts",272-233-8,68784-25-8,Eye Irrit. 2;Repr. 2,Notified C&L,278,H319:145;H361:250;H413:28;H360:8
107498,3-sec-butyl-2-methoxypyrazine,246-050-9,24168-70-5,Acute Tox. 4,Notified C&L,1524,H302:1513;Not classified:11;H315:2;H335:1;H319:2;H332:2;H312:2
107501,"Sodium 5-((1,8-dihydroxy-3,6-disulphonaphthalen-2-yl)azo)-4-hydroxy-3((8-hydroxy-3,6-disulphonaphthalen-1-yl)azo)naphthalene-2,7-disulphonate",223-283-4,3810-39-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
107502,"Threo-β,3-dihydroxy-DL-tyrosine",223-480-5,3916-18-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
107504,"Benzoyl chloride, 3-(acetyloxy)-2-methyl-",605-483-7,167678-46-8,,Notified C&L,4,H314:4;H317:4
107505,"2-methyl-2,3-epoxy-1,4-naphtalen-dione",433-300-9,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,REACH registration C&L,1,H315:1;H335:1;H319:1;H317:1;H334:1
107508,Naphthalene-1-thiol,208-462-7,529-36-2,Acute Tox. 4,Notified C&L,42,H302:42;H319:4;H315:4;H335:4
107510,"2-Propenoic acid, polymer with 2,2'-[1,4-butanediylbis(oxymethylene)]bis[oxirane]",614-108-6,67712-04-3,Not Classified,Notified C&L,7,Not classified:7
107512,Barium bis[2-[(2-hydroxynaphthyl)azo]naphthalenesulphonate],214-160-6,1103-38-4,Not Classified,REACH registration C&L,282,Not classified:281;H302:1
107514,Scarlet TG 0096 (notification presscake),472-090-3,,Aquatic Chronic 4,Notified C&L,37,H413:37
107517,"Barley, ext.",286-476-2,85251-64-5,Not Classified,Notified C&L,61,Not classified:60;H226:1
107520,2-(1-ethylpropyl)pyridine,230-998-5,7399-50-0,Not Classified,Notified C&L,126,Not classified:88;H301:38;H315:38;H319:38;H335:38
107521,"Aluminium, compound with nickel (1:1)",234-439-6,12003-78-0,Carc. 1A;Aquatic Chronic 3,REACH registration C&L,39,H350:2;H412:1;H351:37;H411:33;H334:5;H317:5;H261:1
107522,4-(3-phenylpropyl)piperidine,242-381-8,18495-82-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H315:39;H335:38;H312:1;H332:1;H302:1
107524,"Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, methyl ester, (αR,βS)-",608-809-6,32981-85-4,Not Classified,Notified C&L,1,Not classified:1
107526,"1,3,5-trifluorobenzene",206-751-2,372-38-3,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H225:46;H315:47;H319:47;H335:46;H224:1;H242:1
107528,(E)-p-fluorocinnamic acid,238-214-3,14290-86-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
107529,5-methyl-2-(isopropyl)cyclohexyl nicotinate,254-991-1,40594-65-8,Eye Irrit. 2,REACH registration C&L,2,H319:2
107532,"Linseed oil, polymerized",614-114-9,67746-08-1,Not Classified,REACH registration C&L,197,Not classified:197
107534,"N,N'-diphenylbenzidine",208-521-7,531-91-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H312:2;H332:2;H302:2;H351:1
107535,p-bromobenzenediazonium tetrafluoroborate,211-608-2,673-40-5,Skin Corr. 1B,Notified C&L,45,H314:45;H318:2;H302:2;H332:1;H312:1
107536,Phentolamine mesilate,200-604-6,65-28-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,41,H315:40;H302:41;H335:38;H319:40;H332:39;H312:39;H412:1
107538,Mestanolone,208-302-6,521-11-9,Carc. 2,Notified C&L,67,H351:66;H312:16;H360:26;H332:16;H362:10;Not classified:1
107543,Diutan,439-070-6,,Not Classified,REACH registration C&L,1,Not classified:1
107547,"3-Chloro-10,11-dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine sulfate",612-945-1,62128-51-2,Acute Tox. 4,REACH registration C&L,1,H302:1
107549,Calcium di-β-alaninate,252-973-8,36321-40-1,Eye Dam. 1,Notified C&L,83,H318:83
107550,ethyl 2-cyanoacrylate,230-391-5,7085-85-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0,H319:0;H315:0;H335:0
107553,Surfynol CT 131,605-473-2,167290-55-3,Not Classified,Notified C&L,31,Not classified:31
107560,"Fatty acids, C14-18 and C18-unsatd., branched and linear, 2-ethylhexyl esters",286-061-6,85186-76-1,Not Classified,REACH registration C&L,76,Not classified:74;H413:2
107564,Isopentyl benzoate,202-334-4,94-46-2,Not Classified,Notified C&L,97,Not classified:84;H411:11;H410:1;H226:1
107566,"Zinc bis(O,O-diisopropyl) bis(dithiophosphate)",220-897-4,2929-95-5,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,33,H319:33;H411:33
107567,butyl (dialkyloxy(dibutoxyphosphoryloxy))titanium (trialkyloxy)titanium phosphate,401-100-0,109037-78-7,Flam. Liq. 2;Eye Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H225:0;H411:0;H319:0
107568,Chlormethyl-propan-2-ylcarbonat,609-084-9,35180-01-9,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,37,H411:35;H315:36;H317:35;H319:1;H335:1;H318:1;H314:1;H226:1
107575,"Benzoic acid, 3-methyl-, calcium salt (2:1)",611-633-2,58213-95-9,Not Classified,Notified C&L,1,Not classified:1
107579,"Oils, babassu",293-376-2,91078-92-1,Not Classified,Notified C&L,1,Not classified:1
107581,"Gall (plant tumor), Turkish, ext.",296-279-3,92457-00-6,Not Classified,Notified C&L,1,Not classified:1
107583,(3-methoxy-2-methylpropyl)benzene,430-150-6,,Not Classified,REACH registration C&L,2,Not classified:2
107585,2-[2-hydroxy-5-(prop-2-en-1-yl)phenyl]-4-(prop-2-en-1-yl)phenol,610-903-7,528-43-8,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 2,Notified C&L,70,H411:44;H318:44;H315:70;H335:44;H319:26
107589,"4,6,8-trimethylazulene",213-383-6,941-81-1,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H400:38;H302:38;H410:38;H319:1;H315:1;H335:1
107591,"Fatty acids, C10-18 and C12-22-unsatd., C14-18 and C16-18-unsatd. alkyl esters",285-200-8,85049-31-6,Not Classified,REACH registration C&L,46,Not classified:46
107597,"2,5-Furandione, dihydro-3-(tetrapropenyl)-, reaction products with triethylenetetramine",271-522-6,68583-93-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,59,H319:59;H315:59
107598,"Benzenamine, 4-[(4-aminophenyl)(4-imino-2,5-cyclohexadien-1-ylidene)methyl]-2-methyl-, compd. with molybdenum tungsten hydroxide oxide phosphate",215-407-0,1325-80-0,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,24,H400:24;H410:24
107600,"Formaldehyde, reaction products with 2,2'-iminodiethanol and 4,4'-isopropylidenediphenol, propoxylated",500-408-3,158885-21-3,Acute Tox. 4;Eye Dam. 1,Notified C&L,83,H318:83;H302:83
107601,2-methylquinolinium chloride,263-722-7,62763-89-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,21,H312:21;H315:21;H319:21;H302:21
107602,"Dodecylbenzenesulphonic acid, compound with cyclohexylamine (1:1)",252-580-1,35465-67-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1;H302:1
107606,"Hydrocarbons, C12-C13, isoalkanes, cyclics, <2% aromatics",918-271-7,,Asp. Tox. 1;Aquatic Chronic 3,REACH registration C&L,1,H412:1;H304:1
107608,"11β-[p-(Dimethylamino)phenyl]-17β-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one",617-559-7,84371-65-3,Repr. 1B,Notified C&L,59,H360:58;H302:17;H362:16;H332:17;H312:17;H373:1
107610,1-amino-4-hydroxy-2-[(2-hydroxyethyl)thio]anthraquinone,267-764-7,67923-48-2,Not Classified,Notified C&L,31,Not classified:31
107615,"(±)-(R*,S*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran",419-630-6,793669-26-8,Aquatic Chronic 2,Harmonised C&L,0,H411:0
107619,"Fatty acids, C16-18, branched tridecyl esters",292-902-8,91002-25-4,Not Classified,Notified C&L,6,Not classified:6
107620,1-benzyl-4-(methylamino)piperidine-4-carboxamide,213-828-4,1024-11-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H302:38;H335:38
107622,3-p-tolylpropionaldehyde,226-460-4,5406-12-2,Skin Sens. 1,Notified C&L,258,H317:258
107623,"N,N-dibenzylhydroxylamine",210-667-1,621-07-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,86,H319:48;H315:48;H335:47;Not classified:38
107626,"1-Tetradecanol, phosphate",273-789-4,69029-24-9,,Notified C&L,2,Not classified:1;H319:1;H315:1
107627,"2,2'-isopropylidenebis(p-phenyleneoxy)diethanol",212-985-6,901-44-0,Aquatic Chronic 2,REACH registration C&L,72,H411:2;H315:61;H335:61;H319:61;H400:39;H410:39;H412:21;Not classified:9;H317:1
107633,2-methyltetrahydrofuran-2-carbonitrile,243-222-5,19679-75-5,Acute Tox. 4;Eye Dam. 1,Notified C&L,38,H318:38;H302:38
107634,"1-(2-hydroxy-4,6-dimethoxyphenyl)ethan-1-one",201-978-3,90-24-4,,Notified C&L,4,H319:4;H315:4;H335:4
107640,Didodecyl sulphide,219-587-1,2469-45-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
107642,"(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate",479-560-7,989-51-5,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,3,H319:2;H411:2;H302:2;H317:2;Not classified:1
107649,"1-[3-[4-((heptadecafluorononyl)oxy)-benzamido]propyl]-N,N,N-trimethylammonium iodide",407-400-8,59493-72-0,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H318:0;H400:0;H410:0
107651,METHACRYLOYL ISOCYANAT,610-211-5,4474-60-6,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 2;Carc. 2,Notified C&L,1,H318:1;H315:1;H302:1;H226:1;H330:1;H351:1;H312:1
107653,"2-Naphthalenepropanoic acid, α-amino-, (αS)-",611-652-6,58438-03-2,Not Classified,Notified C&L,1,Not classified:1
107656,Cyclohex-3-ene-1-carboxylic acid,225-314-7,4771-80-6,Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,47,H314:47;H302:2;H312:45;H318:1
107661,"Glycerides, tallow mono-, di- and tri-",294-535-9,91723-30-7,Not Classified,Notified C&L,1,Not classified:1
107662,Caryophyllene,201-746-1,87-44-5,Asp. Tox. 1;Skin Sens. 1B,REACH registration C&L,1986,H304:1976;H317:1523;H413:167;H319:8;H315:8;H335:8;Not classified:2
107664,"(E,E)-3,7,11-trimethyldodeca-1,4,6,10-tetraen-3-ol",423-240-1,125474-34-2,Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H318:0;H315:0;H400:0;H317:0;H410:0
107665,"1,3,3-trimethyl-2-[2-(1-methyl-2-phenyl-1H-indol-3-yl)vinyl]-3H-indolium acetate",281-585-1,83969-08-8,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,2,H411:2;H318:2;H302:2
107666,"2-chloro-1,5-dinitro-3-(trifluoromethyl)benzene",206-883-0,392-95-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:38;H315:39;H335:38;H312:4;H314:4;H332:5;H302:4;H318:1
107672,"1,1-diphenylmethanimine",600-205-0,1013-88-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H319:48;H315:51;H335:47;H411:3;H302:3
107674,"5-Propyl-2,4-imidazolidinedione",605-962-0,18227-41-3,Not Classified,REACH registration C&L,2,Not classified:2
107675,"Chromate(3-), bis[[]2-[[]2-[[]4,5-dihydro-3-methyl-5-(oxo-[?]O)-1-(4-sulfophenyl)-1H-pyrazol-4-yl]diazenyl-[?]N1]benzoato(3-)-[?]O]-, hydrogen, compd. with N-butyl-1-butanamine and N-cyclohexylcyclohexanamine (1:3:[?]:[?])",615-766-7,72479-91-5,Not Classified,Notified C&L,5,Not classified:5
107677,Tetrabutylphosphonium hydroxide,238-528-0,14518-69-5,Skin Corr. 1A;Eye Dam. 1;Aquatic Acute 1,REACH registration C&L,53,H318:1;H314:53;H400:2;H301:6;H411:6;H290:6
107679,"Phosphonic acid, P,P'-[[[2-(2-hydroxyethoxy)ethyl]imino]bis(methylene)]bis-",603-760-7,133669-95-1,Eye Irrit. 2,Notified C&L,20,H319:20
107684,Tetrabromophenol blue,204-086-2,115-39-9,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,Notified C&L,51,H312:32;H332:32;H319:32;Not classified:19
107685,"3,5-Dioxocyclohexane-1-carboxylic acid",610-069-4,42858-60-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,157,H319:157;H315:157;H335:157
107687,C.I. Solvent Blue 98,615-508-3,71819-49-3,Not Classified,Notified C&L,1,Not classified:1
107690,Chlordiazepoxide,200-371-0,58-25-3,Acute Tox. 4;STOT SE 3;Muta. 2;Repr. 2;Lact.,REACH registration C&L,43,H336:2;H302:43;H361:2;H362:2;H341:3
107692,"Barium bis(2,4,6-trinitroresorcinolate)",243-620-9,20236-55-9,Expl. 1.1;Acute Tox. 4;Acute Tox. 4;Acute Tox. 3,Notified C&L,1,H312:1;H331:1;H201:1;H302:1
107693,Dibutyl oxalate,218-092-8,2050-60-4,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H315:38;H317:38;H335:38
107697,"Phosphoric acid, 2-ethylhexyl ester, potassium salt",271-355-9,68550-93-6,Not Classified,Notified C&L,175,Not classified:83;H319:74;H315:76;H318:18;H290:15;H314:16
107698,m-ethoxybenzaldehyde,245-333-4,22924-15-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
107699,(4-Sulfamoylpheny)hydrazine monohydrochloride,479-480-2,17852-52-7,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,7,H302:6;H319:5;H400:6;H317:6;H410:6;H318:2;H315:1
107702,"1,2-dimethylhydrazine dihydrochloride",206-183-5,306-37-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Carc. 1B,Notified C&L,39,H301:39;H350:38;H331:38;H311:38;H351:1
107704,"1-chloro-2,3-epoxypropane;epichlorhydrin",203-439-8,106-89-8,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 3;Carc. 1B,Harmonised C&L,0,H226:0;H301:0;H314:0;H350:0;H331:0;H311:0;H317:0
107705,"Ocimum americanum, ext.",295-198-0,91845-26-0,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1286,H411:1286;H304:1286;H315:1286;H317:1286
107706,1-(4-(trans-4-ethylcyclohexyl)phenyl)ethanone,426-460-6,260415-81-4,Skin Sens. 1,Harmonised C&L,0,H317:0
107707,4-(ethylsulphonyl)-2-nitroaniline,245-568-2,23306-60-7,Acute Tox. 3;STOT RE 1,Notified C&L,83,H301:83;H372:83
107717,"(1R,2R)-1,3-Dihydroxy-1-(4-nitrophenyl)propyl-2-ammonium (1R, 5S)-5-(dimethylphenylsilyl)-2-(hydroxymethyl)cyclopent-2-ene-1-carboxylate",445-910-2,,Eye Irrit. 2A;STOT SE 3,REACH registration C&L,2,H319:2;H335:2
107718,"3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl acrylate",248-722-7,27905-45-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,59,H319:56;H315:56;H335:55;Not classified:3
107725,"Disodium 7-[(5-chloro-2,6-difluoropyrimidin-4-yl)amino]-4-hydroxy-3-[(4-methoxy-2-sulphonatophenyl)azo]naphthalene-2-sulphonate",273-401-3,68959-17-1,Skin Sens. 1;Resp. Sens. 1,Notified C&L,38,H334:33;H317:33;Not classified:5
107726,"Bis(ethylenediamine-N,N')palladium(2+) dichloride",240-538-5,16483-18-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H315:1;H302:1;H319:1;H332:1;H312:1
107730,C.I. Vat Blue 66,611-537-0,57456-24-3,Not Classified,Notified C&L,2,Not classified:2
107742,"Sulfonic acids, C13-17-sec-alkane, compds. with triethanolamine",288-492-5,85736-79-4,Eye Irrit. 2B,Notified C&L,1,H319:1;H320:1
107743,"2-butyl-5,6-dihydro-2,4-dimethyl-2H-pyran",263-394-5,62062-85-5,Not Classified,Notified C&L,112,Not classified:112
107744,"1,10-dibromodecane",223-871-0,4101-68-2,Not Classified,REACH registration C&L,8,Not classified:1;H319:6;H315:5;H335:5;H302:3;H332:1;H312:1
107746,Ceresin,232-290-1,8001-75-0,Not Classified,Notified C&L,120,Not classified:120
107747,2-methyl-3-(propyldithio)furan,262-650-3,61197-09-9,Acute Tox. 4,Notified C&L,235,H302:234;H301:1
107750,1-chloro-2-nitrobenzene,201-854-9,88-73-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Carc. 1B;STOT RE 1;Aquatic Acute 3;Aquatic Chronic 2,REACH registration C&L,182,H372:129;H301:140;H402:1;H350:85;H331:91;H311:140;H411:86;H302:39;H361:45;H351:45;H332:40;H317:48;H312:39;H412:15;H373:5;H330:4;H319:1;H371:1;H400:1;H410:1;H341:2;Not classified:1
107751,Methoxyphenamine,202-237-7,93-30-1,Not Classified,REACH registration C&L,2,Not classified:2
107753,Benzyldimethyl(octadecyl)ammonium chloride,204-527-9,122-19-0,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,628,H318:565;H400:107;H302:580;H410:86;H314:529;H315:77;H312:37;H319:15;H332:1
107754,"2-Oxa-7-thia-3,8-disiladecane, 3-methoxy-3,8,8,9,9-pentamethyl-",618-874-2,927395-20-8,Flam. Liq. 2;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H225:1;H412:1;H315:1;H317:1
107756,"Protein hydrolyzates, heart",293-482-9,91079-92-4,Not Classified,Notified C&L,1,Not classified:1
107759,"2,2'-[(2-nitro-1,4-phenylene)diimino]bisethanol",281-856-4,84041-77-0,Eye Irrit. 2,Notified C&L,36,H319:18;Not classified:15;H315:4;H335:4;H312:3;H332:3
107760,"Reaction mass of 1,3-diacetoxypropan-2-yl 12-acetoxyoctadecanoate and 2,3-diacetoxypropyl 12-acetoxyoctadecanoate",451-530-8,736150-63-3,Not Classified,Notified C&L,1,Not classified:1
107761,methane,200-812-7,74-82-8,Press. Gas;Flam. Gas 1,Harmonised C&L,0,H220:0;Not classified:0
107767,"1-chloro-3,3-dimethylbutane",220-665-2,2855-08-5,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H315:38;H302:38;H335:38;H225:42;H319:38
107768,"1,3,4,5-tetrahydroxycyclohexanecarboxylic acid",201-072-8,77-95-2,Eye Irrit. 2,REACH registration C&L,44,H319:5;Not classified:39;H315:4;H317:4;H335:4
107770,Barium m-toluate,268-460-7,68092-47-7,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,10,H319:8;H332:8;H302:8;Not classified:2
107771,Silidianin,249-848-5,29782-68-1,Acute Tox. 4,Notified C&L,39,H302:39
107778,Cycloheptanol,207-936-0,502-41-0,Flam. Liq. 3,Notified C&L,38,H226:38
107782,".alpha.-(hydroxymethyl)-benzeneacetic acid, (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester sulfate, hydrate (2:1:1)",611-792-8,5908-99-6,Acute Tox. 2;Acute Tox. 2,Notified C&L,111,H300:108;H330:111;H310:3;H317:4;H315:3;H302:3;H335:3;H319:3
107788,Disodium hexahydroxoplatinate,235-590-0,12325-31-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:43;H315:43;H317:38;H335:39;H290:1;H302:1
107789,Methazolamide,209-066-7,554-57-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,38,H312:38;H351:38;H332:38;H302:38
107790,"Propanoic acid, 2-fluoro-3-hydroxy-, methyl ester",614-020-8,671-30-7,,Notified C&L,33,Not classified:33
107791,Ammonium o-cresolate,266-891-5,67674-51-5,,Notified C&L,1,H319:1;H412:1;H315:1
107792,Potassium hydrogen DL-aspartate,213-088-2,923-09-1,Not Classified,Notified C&L,3,Not classified:3
107793,trilithium bis(4-((4-(diethylamino)-2-hydroxyphenyl)azo)-3-hydroxy-1-naphthalenesulfonato(3-))chromate(3-),414-290-5,149564-65-8,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0
107800,Vanadium nitride,246-382-4,24646-85-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,210,H312:209;H332:209;H302:209;Not classified:1
107802,"Fatty acids, C18-unsatd., C16 and C18-unsatd. alkyl esters",297-617-2,93685-70-2,Not Classified,Notified C&L,1,Not classified:1
107803,"1,3-dihydroxyacetone",202-494-5,96-26-4,Not Classified,REACH registration C&L,1449,Not classified:88;H319:1361;H315:1358;H335:1354
107809,"sodium 2-[[4-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]phenyl]sulfonyl]ethyl sulfate",430-890-1,81992-66-7,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H317:0;H410:0
107812,"1,1'-(2,2,4-trimethylhexane-1,6-diyl)bis-1H-pyrrole-2,5-dione",254-730-1,39979-46-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,15,H319:15;H315:14;H317:14;H330:1
107817,"5-(diisopropylamino)-2-[[4-(dimethylamino)phenyl]azo]-3-methyl-1,3,4-thiadiazolium trichlorozincate(1-)",298-265-2,93783-70-1,Acute Tox. 3;Skin Sens. 1B;Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,47,H373:16;H318:20;H301:20;H400:17;H317:16;H410:17;Not classified:26;H411:4
107819,"1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-5-[[3-[(phenylsulphonyl)oxy]phenyl]azo]nicotinonitrile",261-693-5,59312-61-7,Not Classified,REACH registration C&L,83,Not classified:51;H413:32
107821,1-(5-chloro-2-thienyl)ethan-1-one,228-630-3,6310-09-4,Acute Tox. 2;Eye Irrit. 2A,REACH registration C&L,8,H319:2;H300:2;H301:4;H312:6;H332:6;H302:2
107824,"Phenol, dodecyl-, sulfurized, carbonates, calcium salts, overbased",272-234-3,68784-26-9,Aquatic Chronic 3,Notified C&L,549,H412:446;H413:95;H360:40;H361:38;Not classified:6;H315:1
107828,8-Methyl-8-azabicyclo(3.2.1)oct-3-yl-(2-hydroxymethyl-2-phenyl)acetat Oxalat (2:1),611-791-2,5908-98-5,Acute Tox. 1;Acute Tox. 1,Notified C&L,1,H300:1;H330:1
107833,"1,10-decanediyl diacrylate",235-922-4,13048-34-5,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,9,H400:5;H317:5;H410:5;H319:4;H315:4;H411:1;H335:1
107836,L-2-amino-3-phenylpropan-1-ol,221-674-4,3182-95-4,Skin Corr. 1B,Notified C&L,46,H314:45;H319:1;H315:1;H302:1;H318:1
107837,4-ethyl-4-formylhexanenitrile,220-923-4,2938-69-4,,Notified C&L,4,H315:4;H302:4;H335:4;H319:4;H332:4;H312:4
107838,"Hexafluoroantimonate(1-), salt with N,N,N',N'-tetrakis[4-(dibutylamino)phenyl]benzene-1,4-diamine (1:1)",224-485-5,4379-85-5,,Notified C&L,1,H319:1;H315:1;H335:1
107840,Bis(4-chloro-3-nitrophenyl) disulphide,252-818-4,35964-48-8,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H319:38;H400:38;H410:38
107843,"5,6,7,8-tetrahydro-1-naphthol",208-461-1,529-35-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,133,H318:89;H315:133;H302:89;H319:44;H335:43
107848,"cis-cyclooctane-1,5-diol",245-649-2,23418-82-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
107850,"Amines, N-(3-aminopropyl)-N (or N')-coco alkyltrimethylenedi-",294-908-6,91771-18-5,Acute Tox. 3;Skin Corr. 1C;STOT RE 2;Aquatic Acute 1,Notified C&L,1,H301:1;H314:1;H400:1;H373:1
107853,"Hydrocarbon oils, process blends",268-609-6,68131-05-5,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,11,H319:11;H412:11
107857,"2,2'-(ethylenedioxy)diethyl diacrylate;triethylene glycol diacrylate",216-853-9,1680-21-3,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H319:0;H315:0;H317:0
107858,azoxystrobin (ISO);azoxystrobin (ISO); methyl (E)-2-{2-[6-(2-cyanophenoxy)pyrimi­din-4-yloxy]phenyl}-3-methoxyacrylate;methyl (E)-2-{}{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}}-3-methoxyacrylate,603-524-3,131860-33-8,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H331:0;H400:0;H410:0
107862,"1-(3,5-dimethylpyrazinyl)ethan-1-one",259-076-0,54300-08-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1417,H312:1288;H332:1287;H302:1288;Not classified:89;H319:41;H315:41;H335:41;H318:1
107866,"Soybean oil, deodorizer distillate, sapond., extn. residue",271-407-0,68554-74-5,Not Classified,Notified C&L,1,Not classified:1
107868,2-methoxy-4-prop-1-enylphenyl acetate,202-236-1,93-29-8,Not Classified,Notified C&L,1646,Not classified:1583;H319:39;H315:39;H335:39;H317:24
107870,"(±)-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)glutaric acid",218-952-2,2301-52-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H319:38;H315:38;H400:38;H335:38
107874,tau-fluvalinate (ISO);cyano-(3-phenoxyphenyl)methyl N-[2-chloro-4-(trifluoromethyl)phenyl]-D-valinate,600-363-0,102851-06-9,Acute Tox. 4;Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H315:0;H302:0;H410:0
107878,"Titanium IV, 2,2(bis-2-propenolatomethyl) butanolato,tris- (dioctyl) phosphato - O",600-964-8,110438-25-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,11,H319:11;H315:11;H335:2
107888,2-(1-methylethyl)-3-(methylthio)pyrazine,267-913-6,67952-59-4,Acute Tox. 4,Notified C&L,1374,H302:1374
107890,"Silicic acid, aluminum potassium salt",215-479-3,1327-44-2,Not Classified,Notified C&L,18,Not classified:18
107893,N-ethyl-m-toluidine,203-019-4,102-27-2,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,REACH registration C&L,81,H315:46;H335:45;H301:80;H319:46;H331:80;H311:80;H412:35;H302:1;H330:1;H310:1
107896,"Triisononyl benzene-1,2,4-tricarboxylate",258-847-9,53894-23-8,Not Classified,REACH registration C&L,14,Not classified:10;H413:4
107897,"1,4,7,10-tetraoxa-13-azacyclopentadecane",266-523-3,66943-05-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
107898,"2,2'-[azobis(1-methylethylidene)]bis[4,5-dihydro-1H-imidazole dihydrochloride",248-655-3,27776-21-2,Self-heat. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,164,H319:51;H252:2;H412:2;Not classified:109;H302:50;H301:47;H400:48;H410:48;H413:49;H315:3;H335:2;H332:1;H316:1;H320:1;H370:1;H317:1
107902,"2(3H)-Benzofuranone, 5-chloro-",608-160-9,28033-47-8,,Notified C&L,1,H319:1;H315:1;H335:1
107903,"Alkanes, C10-21, chloro",281-985-6,84082-38-2,,Notified C&L,33,Not classified:33
107904,1-amino-4-(methylamino)anthraquinone,214-944-8,1220-94-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,Notified C&L,11,H319:11;H412:11;H315:11;H335:11
107905,"Pyrazino[2,1-a]isochinolin-4-on, 4H-, 1,2,3,6,7,11b-hexahydr o-, Diphosphat",600-265-8,1020409-50-0,Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,2,H314:1;H302:1;H319:1;H315:1;H335:1
107907,"2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5'-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2'-[(2-ethylhexyl)thio]acetanilide",448-060-0,727678-39-9,Aquatic Chronic 4,Harmonised C&L,0,H413:0
107916,"3,3'-dimethylbiphenyl-4,4'-diyl diisocyanate",202-112-7,91-97-4,Skin Sens. 1A;Acute Tox. 4;Resp. Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,49,H400:46;H332:49;H317:47;H410:47;H334:48;H315:2;H302:2;H335:1;H319:2;H312:2;H341:1
107918,"Benzeneacetonitrile, 2-methyl-.alpha.-[2-[[(propylsulfonyl)oxy]imino]-3(2H)-thienylidene]-",457-540-9,852246-55-0,Skin Sens. 1,Notified C&L,83,H317:83
107919,"Tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione",227-285-6,5763-44-0,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,6,H318:4;H302:5;H312:1;H412:1;H317:1;H319:1;H315:1;H335:1
107920,Tributylphosphine,213-651-2,998-40-3,Pyr. Liq. 1;Acute Tox. 4;Skin Corr. 1A;Aquatic Chronic 2,REACH registration C&L,260,H250:260;H411:184;H314:260;H302:260;H318:119;H312:162;H226:43;H251:33;H252:5
107925,Triphenylarsine,210-032-9,603-32-7,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43,H301:43;H331:43;H400:39;H410:43;H373:4;H350:1
107928,N-2-bromoethylphthalimide,209-379-9,574-98-1,,Notified C&L,3,Not classified:2;H319:1;H315:1;H335:1
107929,Testosterone,200-370-5,58-22-0,Acute Tox. 4;Carc. 2;Repr. 1B;Aquatic Acute 1,REACH registration C&L,295,H351:218;H400:215;H360:251;H302:215;H362:64;H350:78;H361:44;H410:35;H372:35;H332:17;H312:17;H301:1
107934,"3,5-Dihydroxy-4-[3-(4-hydroxyphenyl)propanoyl]phenyl 2-O-(6-deoxy-α-D-mannopyranosyl)- β-D-gulopyranoside",700-320-7,18916-17-1,Not Classified,REACH registration C&L,110,Not classified:100;H319:10;H315:10;H335:10
107935,"p-dodecylbenzenesulphonic acid, compound with 2,2'-iminodiethanol (1:1)",267-204-1,67815-95-6,,Notified C&L,2,Not classified:2
107937,"4-bromo-2,6-dichlorophenol",221-740-2,3217-15-0,,Notified C&L,2,H319:2;H315:2;H335:2;H302:1
107939,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with 3-aminomethyl-3,5,5-trimethylcyclohexylamine and propoxylated propylenediamine",500-640-5,161308-01-6,,Notified C&L,2,H302:2;H412:2;H314:2;H317:2;H312:2
107943,Ammonium p-hydroxybenzenesulphonate,226-216-7,5328-97-2,,Notified C&L,2,H319:2;H315:2
107946,"1,3-Butadiene, 2-chloro-, homopolymer",618-463-8,9010-98-4,,Notified C&L,59,Not classified:59
107951,Dodec-2-enylsuccinic acid,237-640-7,13877-83-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38,H319:38;H315:38;H302:38
107960,2-Isocyanatoethyl acrylate,482-140-6,13641-96-8,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,3,H315:1;H335:1;H301:3;H319:1;H331:2;H318:1;H341:2;H314:2;H350:1;H317:2;H411:2;H334:2
107962,Ethyl 2-oxocyclohexanecarboxylate,216-731-5,1655-07-8,Not Classified,REACH registration C&L,7,Not classified:3;H319:4;H315:4;H335:4
107970,Tetratriacontane,238-013-0,14167-59-0,Not Classified,Notified C&L,6,Not classified:6
107972,Octan-4-ol,209-654-3,589-62-8,Eye Irrit. 2,Notified C&L,1,H319:1
107977,"Methyl (2α,5β,6α)-3,4-didehydroibogamine-18β-carboxylate",219-586-6,2468-21-5,Acute Tox. 4,Notified C&L,1,H302:1
107978,"Cobaltate(1-), bis[2-(3-chlorophenyl)-2,4-dihydro-4-[[2-hydroxy-5-(methylsulfonyl)phenyl]azo]-5-methyl-3H-pyrazol-3-onato(2-)]-, hydrogen, compd. with [1R-(1α,4aβ,10aα)]-1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-1-phenanthrenemethanamine (1:1)",243-855-7,20506-24-5,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,152,H400:84;H410:84;Not classified:68
107981,(2H8)naphthalene,214-552-7,1146-65-2,Flam. Sol. 2,Notified C&L,9,H228:6;H351:3;H400:3;H302:2;H410:3;Not classified:2
107983,"2-[N-(2-cyanoethyl)-4-[(2,6-dichloro-4-nitrophenyl)azo]anilino]ethyl acetate",226-070-4,5261-31-4,Aquatic Chronic 3,REACH registration C&L,96,H412:33;Not classified:55;H411:5;H317:3
107989,1-(2-deoxy-5-O-trityl-β-D-threopentofuranosyl)thymine,407-120-6,55612-11-8,Aquatic Chronic 4,Harmonised C&L,0,H413:0
107993,ATTAPULGITE,601-805-5,12174-11-7,Carc. 2,Notified C&L,784,H351:616;Not classified:168
107997,"2,3-dichloropyrazine",225-460-1,4858-85-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,48,H319:48;H315:48;H335:43;H341:1
107998,"2,2',6,6'-Tetrabromo-4,4'-isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane",500-107-7,40039-93-8,Not Classified,REACH registration C&L,319,Not classified:262;H319:45;H317:51;H315:4;H400:1;H410:1
107999,"Beech, Fagus sylvatica, ext.",286-477-8,85251-65-6,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,1,H319:1;H226:1
108002,Benzethonium chloride,204-479-9,121-54-0,Acute Tox. 3;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,279,H301:204;H314:260;H400:258;H410:216;H318:50;H302:69;Not classified:6;H315:11;H319:6;H411:5;H335:2;H332:1;H312:1
108010,"Rubber, natural",232-689-0,9006-04-6,Not Classified,Notified C&L,168,Not classified:80;H334:66;H317:87;H319:1;H315:1;H335:1
108013,4-Brom-2-Fluorphenol,606-697-3,2105-94-4,Not Classified,REACH registration C&L,49,Not classified:2;H319:46;H315:46;H335:45;H302:7;H301:1;H330:1;H311:1;H332:1;H312:1
108017,"(1R, 2R)-1,2-diphenylethane-1,2-diamine",609-071-8,35132-20-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H319:46;H315:46;H335:45;H314:4;H302:1
108019,Copper glycinate,251-238-9,32817-15-5,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H318:2;H302:2;H314:2;H400:2;H332:2;H410:2;H312:2
108021,edetic acid;(EDTA),200-449-4,60-00-4,Eye Irrit. 2,Harmonised C&L,0,H319:0
108023,Trihexylphosphine oxide,221-392-1,3084-48-8,Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,14,H314:14;H400:14;H410:14
108026,"Formaldehyde, oligomeric reaction products with 4-nonylphenol",500-074-9,31605-35-3,Aquatic Chronic 3,Notified C&L,1,H412:1
108029,ethyl methyl ether,611-089-6,540-67-0,Press. Gas;Flam. Gas 1,Harmonised C&L,0,H220:0;Not classified:0
